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ABSTRACT 
This thesis has assessed the outcomes of cataract surgery not only in terms of clinical 
measures of impairment and but also using patient perceived measures of disability and 
handicap. The inter-relationships between these measures and the additional 
contributions that patient perceived measures can make to the assessment of cataract 
outcomes have been identified. 
Two prospective cohort studies were conducted in which patients admitted for surgery 
for age related cataract were studied. The first of these described current surgical 
practice and clinical outcomes (visual acuity after surgery and complications) 
throughout the UK. Patients were followed up for three months and risk factors for 
poor clinical outcome were identified and quantified. Using Poisson logistic regression 
analysis, relative risks as measures of effect were calculated for this purpose. 
The second cohort study was concerned with patients' perceptions of their visual 
function (disability) and quality of life (handicap), before surgery and at 4 and 12 
months after. Visual function was assessed using the VF-14. The Sickness Impact 
Profile (SIP) was used to assess general quality of life, and its modification, the VR- 
SIP, was used as a vision-specific measure of quality of life. Measures of association 
(provided by multiple regression and analysis of covariance) were used to examine the 
relationships between the clinical measure of outcome (visual acuity) and the patient 
perceived measures. The influence of the sensory input from both eyes on these 
relationships was exarnined. Important confounders influencing the extent of change in 
patient perceived measures achieved after surgery were identified. 
The findings have implications for clinical practice as regards timing of surgery to 
maximise benefit, and the additional contribution of second eye surgery. These are 
discussed together with the role of clinical and patient perceived measures for the 
assessment of the outcome of cataract surgery. 
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Chapter 1 
BACKGROUND AND LITERATURE REVIEW 
1. INTRODUCTION 
A specific and systematic interest in the epidemiology of eye diseases - ophthalmic 
epidemiology - has probably only emerged in the last 15 years or so. In terms of 
research interest and methodology (in the widest sense of epidemiology and public 
health), it has received far less attention than cancer, heart disease, or communicable 
diseases. It has largely been concerned with aetiology - the study of the distributions 
and determinants of disease, particularly blinding eye disease. This initially started in 
the developing world and only more recently was extended to include the developed 
countries, notably the United States of America (USA) and the United Kingdom (UK). 
So far, these studies have used epidemiological methods to inform the planning and 
provision of eye health services by mapping the patterns of blinding disease and 
estimating the burden of these diseases in populations; and aetiological studies into risk 
factors for these diseases have aimed to inform their treatment, management and 
prevention. 
At the time that this work was started, there had been little work on health services 
research in ophthalmology making use of epidemiological methods. Little attention had 
been paid to the services provided, the effectiveness and outcomes of interventions - 
both the treatment (or management) of disease and preventive measures. By the 
application of epidemiological methods information can be obtained on the 
characteristics and distribution of health care and the determinants of the outcome of 
this care i. e. outcome indicators and risk factors for poor outcomes. This can 
contribute to planning and providing eye health services so as to maximise the public 
health impact of interventions. 
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The application of epidemiological methods to the study of health care requires a wider 
perspective than that adopted in aetiological epidemiology. The latter has, to date, 
centred on clinical assessment and definition of disease, and for eye conditions the 
impact of disease on vision has been assessed in terms of its effect on visual acuity in 
the affected eye(s). This has resulted in a range of standard measurement methods 
ranging from fairly simple field methods to more sophisticated photographic and 
imaging techniques such as lens grading systems. [1][2][3] Whilst these may also be 
applied to the clinical assessment of outcomes of treatment, they are limited both to the 
impact of treatment on the affected eye and to its physiological and optical functioning 
(impairment). The impact of interventions should however, also consider the impact 
of disease and its management on patients functioning (ability) and well being (quality 
of life or handicap). These are less well defined concepts and raise methodological 
issues regarding measurement, interpretation, and how they may relate to clinical 
factors. The principal aim of treatment is to restore or maintain vision (with vision 
being measured by visual acuity). This is based on the assumption that this will 
influence functioning and quality of life. Cataract provides a suitable model for 
assessing these relationships : 
0 Both the severity of a cataract and its effect on vision (visual acuity) may be 
defined in terms of the degree of lens opacity present and its location within the 
lens. On removal of the cataractous lens an immediate effect is usually 
observed. 
In conditions where other modalities of vision are involved, visual acuity is not 
necessarily the best indicator of the impact on vision or even severity of 
disease. For example, patients with advanced glaucoma may have good visual 
acuity (616) but have very constricted fields and diabetic patients may have 6/6 
vision but have severe sight threatening proliferative retinopathy. In such 
circumstances the relationships then become more complicated. 
Cataract is a common cause of treatable visual impairment and blindness. 
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Cataract extraction is a high volume procedure and little is known about its 
outcome not only in current surgical practice, but also in terms of functional 
ability and quality of life. 
This thesis is concerned with the application of epidemiological methods for the 
assessment and measurement of the outcomes of cataract surgery and in particular, the 
relationship between clinical outcome and patient perceived outcomes (visual 
functioning and health related quality of life) and their potential application in routine 
clinical practice. 
Whilst it may be important to identify the earliest changes that represent onset of 
disease in aetiological epidemiological studies for cataract, or to identify cataracts that 
are severe enough to interfere with vision in prevalence surveys designed to estimate 
the burden of cataract in a population, such studies may identify cases of cataract 
amongst persons that are asymptomatic or unaware of their impairment. (4][5][6]. In 
contrast, this thesis has used an operational definition of cataract based on a need for 
surgery as judged by the patient's surgeon, for the patient with functional disability 
from cataract that has presented to the health care system. 
28 
2. CATARACT SURGERY 
A cataract is an opacity of the otherwise transparent crystalline lens of the eye. The 
location and size of the opacity within the lens will determine the level of visual impairment. 
The term "cataract" in this thesis refers to a cataract that occurs in adults of 50 years of age 
or more, commonly known as age-related cataract. It does not include congenital and 
secondary cataracts which are specific entities with specific aetiologies and constitute a 
small proportion of all cataracts. Three main morphological types of cataract in adults are 
recognised : nuclear sclerosis, cortical and posterior subcapsular. No distinction between 
these types of cataract are made in this thesis. 
2.1 The Epidemiology of Cataract 
Cataract is widely distributed and is an important cause of visual impairment and blindness 
world-vAde. [7] Estimates of the prevalence of cataract from cross-sectional surveys 
indicate a strong relationship with increasing age. Although differences in the definition of 
cataract used in these studies have not always made them directly comparable, all 
definitions usually use a level of impairment of Snellen visual acuity that is attributed to lens 
opacity. The Snellen visual acuity chart bears letters of diminishing size, so that when 
viewed from a specified distance, the eye must have a limit of resolution of one minute 
of a degree. The largest letters have a viewing distance of 60 metres, with smaller 
letters for distances of 36,24,18,12,9,6 and 5 metres. The patient is usually 
positioned 6m from the chart. A visual acuity of 6/6 denotes optimal resolution of the 
eye, whilst an acuity less than that i. e. ranging from 6/9 to 6/60 and blindness, represent 
increasing levels of impairment. 
Data from the Melton Mowbray Study estimated that the prevalence of some degree of 
cataract reducing visual acuity to 6/9 or less is about 42% in people 76-84 years of age and 
65% in people 85 years and over. [8] The estimates for the 76-84 year age group are 
comparable to findings from the Framingham and Beaver Dam studies in North American 
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populations using the same definition for cataract. [9][ 10] The prevalence of lens opacities 
in younger age groups estimated from these American studies suggest that it is between 
4.5% to 7% amongst persons of 52-64 years of age, and 18% in persons of 65 to 74 years 
of age. [9] [10] 
Direct age-specific estimates of incidence of blinding cataract have been obtained for India 
where increasing incidence has been convincingly demonstrated with increasing age. The 
oldest age group in the cohort (65 years and over) had an incidence rate of blinding cataract 
of 0.0581 per person-year and the youngest age group (35-39 years) had an incidence rate 
of 0.0019 per person-year. [111 Currently these type of data are not available for an 
industrialised country for cataract that is not only blinding but one that is visually impairing, 
but are the subject of ongoing investigations. 
The cause of cataract is probably multifactorial. Apart from age, recent studies have 
identified a number of risk factors for cataract : 
* nutrition and socio-economic status [12] [13] [14] [15] [16] 
* dehydration/diarrhoeal crisis [17][18] 
* ultra-violet fight [19][20] 
* fife style - smoking, alcohol [21] [22][23][24][25] 
* diabetes mellitus [26] 
The relationship with age raises the question of whether cataract is a direct consequence of 
the ageing process or whether age is an indicator of the risk of being exposed to causes Of 
cataract. Although the scientific evidence is not complete yet, indications are that improved 
sanitation and nutrition would remove some of the global burden of cataract. 
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2.2 Management of Cataract 
Currently the only treatment to relieve visual impairment or blindness caused by age related 
cataract is surgical extraction of the lens. It is one of the oldest ophthalmic procedures - 
couching was first performed over 2000 years ago in India. [27] The objective of surgery is 
to restore or improve vision by removing the cataractous lens and providing some form of 
optical correction in replacement. For age-related cataract, in cases where both eyes are 
affected, the worst eye is usually offered surgery first. 
2.2.1 The Surgical Procedure 
Surgical techniques for cataract surgery have changed radically over the last twenty years 
or so as a result of the introduction of microsurgical techniques for extracapsular extraction 
and implantation of intraocular lenses. 
Prior to this development the surgical procedure of choice was an intracapsular cataract 
extraction which was performed in over 90% of cases in the 1970s. [28] The lens and its 
capsule in its entirety were removed. This not only left the eye anatomically and optically 
deficient, but also altered the stability and dynamics of the anterior and posterior segments 
of the eye. [291 
The resulting aphalda, (absence of the lens) required high powered (dioptric) convex lenses 
for optical correction, usually in the form of glasses, to focus light on the retina. Due to the 
physical properties of the lens, such high powered aphakic spectacle corrections are 
associated with optical aberrations. [30] In particular, these include image distortion and a 
ring scotoma which are most troublesome in the peripheral field viewed through the lens. 
This together with the magnification of the resulting image (33% relative spectacle 
magnification) seen through the corrective lens, compromises the quality of post-operative 
vision malcing these spectacles difficult for patients to tolerate. Contact lenses overcome 
some of these problems and were also used as an alternative to spectacles. [301 
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In contrast, extracapsular methods of cataract extraction express the nucleus of the lens and 
remove the cortical matter by aspiration and irrigation techniques. The posterior capsule is 
left intact to allow for positioning of a posterior chamber lens implant. [29] 
Intraocular lenses (anterior chamber) were first used in 1949 to correct the consequences of 
aphalda from cataract extraction [3 11, but their use was soon abandoned due to the nature 
of the complications that resulted. [32] Various types have been developed since then that 
fall into two main types : anterior chamber or posterior chamber lenses. The latter type is 
placed in the usual anatomical site of the natural lens and has subsequently become the 
prefeffed type of intraocular implant. By their location in the eye, intraocular lenses 
become an integral part of the optical system of the eye. Consequently they cause minimal 
magnification of the resulting image (0.1%), they are not associated with the problems of 
optical aberrations and are able to provide a superior optical quality of post-operative vision 
compared to aphaldc spectacles. [3 0] 
The combination of microsurgical extracapsular cataract extraction and intraocular lens 
implantation requires special instrumentation, materials and surgical training. By the mid 
1980s, extracapsular cataract extraction and intraocular lens implantation accounted for 
about 50% of procedures. [33][34] Surgical practice at this time was clearly changing with 
respect to technique, and was associated with various types of anterior and posterior 
chamber intraocular lens implant in varying stages of design and development. Other 
technologies continued to be developed to further refine the method of extracting the lens 
in extracapsular surgery (e. g. phako-emulsification, in which the nucleus of the lens is 
fragmented by ultrasound and aspirated). 
There has also been a gradual interest in the use of local anaesthesia for both types of 
procedure and more recently, the introduction of day-case surgery under local 
anaesthetic. [35][36] In other parts of the world this is almost routine[31] andithasbeen 
suggested that day case surgery will be a more cost-effective means of delivering a surgical 
service for such a high volume procedure. [3 8] 
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By the time that this thesis was started, it was possible that surgical practice and technical 
developments may have stabilised, but there was no evidence to support this assumption, 
and accurate and complete information on surgical practice was not available from routine 
sources. 
2.2.2 Indications for Surgery 
Cataract surgery is clinically indicated in the presence of a lens opacity when visual acuity 
has reached a stage where the patient is compromised in his or her daily activities. 
Requirements for good vision and the level of acuity at which it is compromised varies 
considerably between patients. The basic proviso has been that the benefits of surgery in 
restoring or improving vision should outweigh the risks associated with anaesthesia and the 
surgical procedure itself There is a clinical consensus on these principles[37][39] which 
have only been adjusted in response to developments and advances in surgical techniques 
that have altered the risk : benefit ratio toward greater benefit or less risk. 
However, for the vast majority of cataract patients in developing countries, surgery is often 
only available for blinding cataract. This is due to demand exceeding supply as result of a 
variety of factors which include amongst them an excess burden of cataract in some areas 
of the world, lack of resources, and poor access and availability of health services. In these 
situations those assessed as having greatest need are given priority, the blind getting priority 
over the visually impaired. [40] [11] 
Ideally, the threshold at which surgery is indicated would be given by the visual acuity at 
the time the decision for surgery is made. As this information is rarely if ever reported in 
the literature, visual acuity at the time of surgery, which is morewidely reported, has been 
used instead. As practice changed from intracapsular surgery with spectacle or contact 
lens correction of aphalcia in the 1970s to extracapsular cataract extraction with intraocular 
lens implantation in the mid 1980s with the potential of providing better optical correction 
and thus better quality of post-operative vision, the threshold of visual acuity at which 
surgery was performed fell from blindness or counting fingers to 6/60. [28][33[41](42] 
More recent thresholds have not been reported. 
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The optical aberrations associated with the aphakic correction after intracapsular surgery, 
made this type of surgery unsuitable for many patients. This included patients with 
monocular cataract with good vision in the fellow eye. The aniseikonia resulting from 
aphaldc spectacle correction would not only be intolerable, but also proclude binocular 
vision in these patients. [3 0] Patients with significant ocular comorbidity compromising the 
central field of vision which is essential for using an aphakic correction (e. g. ageing 
maculopathy), were also unsuitable for surgery. [43 ][44] Whilst contact lenses overcame 
these problems and were an alternative to spectacles[30], they were not suitable for all 
patients. [44] 
As intraocular lenses are not associated with these optical problems, their introduction 
made it possible to offer surgery to patients who would otherwise have been unsuitable for 
intracapsular surgery, and also to consider surgery at levels of vision other than bfindness or 
counting fingers. [28][33][41] [42] 
2.3 Demand for Cataract Surgery 
Cataract extraction for age related Cataract is one of the conunonest surgical procedures 
performed within the National Health Service (NHS) and consequently cataract poses a 
significant burden on ophthalmic surgical services. It accounts for a significant proportion 
of all new referrals to ophthahnic out-patient departments, and about a third of all 
ophthalmic procedures. [33][45] The number of operations performed has been steadily 
increasing. In England and Wales operations for cataract increased by almost two-thirds in 
the decade up to 1985. [461 A substantial proportion of patients (751/o) on ophthalmic 
waiting lists for surgery are those waiting for cataract surgery. [47] [481 
Improvements in surgical techniques and visual rehabilitation, notably extracapsular 
extraction with intraocular lenses, have resulted in falling thresholds[28][33][41][421 and 
changing indications of surgery[30][43](44] (including second eye surgery). This has 
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undoubtedly contributed to the increasing demand and, urith the prospect of an increasingly 
ageing population, it is likely to continue to do so. 
The demand as referred to above relates to a special group of patients who have recognised 
a visual problem themselves, presented to or been identified at the level of primary health 
care, and have had a diagnosis of cataract confirmed and treatment offered at secondary 
level care. 
3. ASSESSMENT OF OUTCOMES 
Measures of health have traditionally been based on the concept of the "disease model" 
(the presence or absence of disease), indicated by a set of signs and findings, providing 
an objective assessment of health outcomes in terms of mortality or morbidity. Whilst 
these may indicate ill-health, they fail to encompass other dimensions of health. A 
person's perceptions of change in usual functioning and well-being based on the 
concepts of "illness and ill-healtW', may also be important indicators of outcome. 
Although these are distinct concepts of health, they are not mutually exclusive. Those 
based on the former are referred to as clinical outcomes in this thesis and those based 
on the latter are referred to as patient perceived outcomes. 
Patient perceived outcomes require a subjective assessment of health in that it is based 
on individuals' own reports. Initially measures for this type of assessment were uni- 
dimensional, focusing on physical functioning or mental health. This was followed by 
the development of multidimensional measures that address a wide range of functions, 
and well-being (or quality of life). 
The theoretical model used in this thesis for the measurement of outcomes and 
assessment of the relationships between these different types of outcomes (clinical and 
patient-perceived), relates measures of outcome to impairment, disability and handicap 
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(Figure 1.1). [49] Impairment describes an anatomical or physiological defect. 
Disability describes the effect on an individual's physical or mental function, and 
handicap describes the extent to which the disability or impairment effects the 
individual's quality of life. 
Figure 1.1 Model for the Assessment of Cataract Surgery 
CLINICAL MEASURES PATIENT PERCEIVED MEASURES 
(Objective) (Subjective) 
Visual Acuity Visual functioning Modified generic measure 
DISEASE e-g. VF-14 e. g. Vision-Related SIP 
SPECIFIC Complications 
Symptom Severity Scores Symptom Bothersome Score 
Global measures of vision 
GENERIC 
IMPAIRMENT 
Functional component of a 
generic quality of life measure 
C. & SIP 
Global measures of health 
DISABILITY 
(Functlonal Status 
or Health Status) 
Measure of health related 
quality of life e. g. SIP 
IUNDICAP 
(Well Being or Health 
Related Quality of Life) 
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3.1 Clinical Measures 
Clinical measures provide an assessment of impairment and the impact of interventions 
on the disease state. As such, the outcomes of medical or surgical interventions have 
traditionally been considered in terms of mortality and morbidity. Mortality (or 
survival) is not relevant in ophthalmology as most conditions are not life threatening. 
Measures of morbidity include the results of a clinical evaluation, physiological or 
biological investigations, and the occurrence of complications. These are more 
relevant to the outcomes of ophthalmic interventions, including cataract surgery, than 
mortality. The main measures of morbidity are visual acuity and complications 
associated with the treatment. 
3.2 Patient Perceived Measures 
Patient perceived measures provide an assessment of the impact of the disease and the 
intervention(s) on daily life and functioning. 
3.2.1 Functional Status 
This is a component of health, measuring the effects of physical impairment on 
function. It can be used to assess outcome of care in a broader sense in terms of a 
person's ability to perform tasks of daily living. These may be more meaningful to 
people's lives than measures of impairment. 
Most measures of function (or disability) require the respondents to report limitations 
on their activities. There are many measures of functional status. These include broad 
measures of function like the Index of Activities of Daily Living (ADL), [501[51][52] 
and more disease specific measures like Symptom severity e. g. the Arthritis Impact 
Measurement Scale. [53] Symptom checklists are commonly used in studies of health 
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related quality of life. [54][55] Respondents are typically asked to indicate which, if 
any, they currently suffer from or are bothered by. 
The limitations of these methods are that the may include response errors and 
diagnostic errors - many people are not aware of the specific nature or cause of their 
afflictions. Reporting of morbidity may also depend on tolerance levels and pain 
thresholds. The decision to restrict activities may reflect an individual's attitude to 
illness and self-care, the expectations and demands of others (family, friends), 
knowledge and understanding of symptoms experienced and other social and cultural 
factors. [56] 
Most scales of this type have been developed on the basis of professional judgements 
about essential abilities for daily living. Lay judgements of essential functions were 
rarely included. [56] The areas most frequently addressed are self care, mobility and 
physical activity. 
3.2.2 Health Related Quality of Life 
This term is often (though incorrectly) used interchangeably with the term "health 
statue' or "functional statue'. Health status refers to a level of health in terms of 
physical functioning, social functioning and mental health. Health related quality of life 
refers to the impact of health states on an individual's quality of life or well being. 
Different patients react differently to apparently similar levels of functional status or 
disability depending on their expectations, previous experience, priorities, and social 
and physical envirorunent. [57] Indices of functional ability may distinguish between 
groups of people with different levels of ability, but do not take account of functioning 
in everyday social roles or the impact on emotional or social needs and well being of 
the patient i. e. are not concerned with quality of life. 
Whilst there is no consensus over the definition of "health related quality of life", [561 
it is accepted that physical, social and cognitive well being should all be included. The 
term is recognised as a concept representing individual responses to the physical, 
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mental and social effects of illness on daily living which influence the extent to which 
personal satisfaction with life circumstances can be achieved. [56][58][59] 
Health related quality of life represents a subjective assessment of health which 
assumes that individuals experience illness in ways that cannot be measured well, yet 
may influence outcomes. [60][6 1] Instruments for measuring health related quality of 
life which have been developed attempt to measure well being in the physical, 
psychological and social domains of health. These are seen as distinct areas that are 
influenced by a person's perceptions of health determined by their experiences, beliefs, 
and expectations of health. Many, however, have been derived from professionals' 
conceptions of well being. [56] The Sickness Impact Profile[62][63][64] and the 
Nottingham Health Profile[65] however, are two instruments that have been derived 
from interviews with lay people. 
Most instruments measure each domain separately by asking specific questions 
pertaining to its most important components. The responses are converted to 
numerical scores to provide a profile of scores for each domain. In some instruments 
component or category scores may be aggregated to yield overall index scores. - 
There is no "gold standard" for measuring health related quality of life, that may be 
used for the selection of an instrument, in assessing the performance of different 
instruments, or for assisting in the clinical interpretation of the scores or change in the 
scores produced by these instruments. [66] 
3.2.3 Generic v. Disease Specific Instruments 
Health related quality of life can be measured in two ways: by a generic measure or a 
disease-specific measure. Both generic and disease specific instruments have been 
developed with considerable attention to assessing their reliability, validity and more 
recently, their responsiveness to change. Both generic and disease specific instruments 
may be subject to ceiling and floor effects whereby patients who score at the extreme 
end of a questionnaire scale are unable to register any improvement (or deterioration) 
in later assessments. [67][68] 
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The generic instruments that have been developed have been designed to provide a 
general health profile and have been subjected to considerable psychometric testing for 
measurement properties (reliability, validity and responsiveness to 
change). [64][65][69][70][71][72] These have been designed to be used for assessing 
a wide range of domains applicable to a variety of health states, conditions and 
diseases. They permit comparisons of different populations and of the benefits of 
different health interventions. Generic measures used in condition or population 
specific situations may have low content validity because they contain items of little or 
no relevance to study participants, and may exclude certain particular concerns of 
study participants. This may also reduce their responsiveness to change. Also they 
may include items that assess areas that that are relatively static or not feasible targets 
of the intervention e. g. patterns of social relationships. [73] 
Disease specific instruments have been developed to focus on domains most relevant 
to the disease or condition under investigation and on the characteristics of patients in 
whom the condition is most prevalent. (73] [74] [75] These instruments are useful for 
identifying important concerns of patients with particular conditions and for measuring 
small, clinically important changes from specific treatments. Disease specific measures 
have items selected to assess particular concerns of study participants and have high 
content validity for clinical investigations of special populations. They may be 
particularly sensitive to within person changes and be more responsive than generic 
measures that contain items unrelated to change 
3.2.4 Global assessments of health 
These are single item measures that usually ask respondents to rate their health as 
"excellent", "good", "fair" or "poor", and sometimes in relation to their age or peers, 
providing a global health rating. Strong associations have been demonstrated with 
worsening global scores and worsening scores from more complex multidimensional 
profiles. [76] Ratings from such questions correlate well with subsequent mortality 
and admission to hospital. [77] They have also been used to assess the criterion validity 
of multidimensional scales. [78][79][80] 
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3.3 Clinical Measures of Cataract Surgery 
The outcome of cataract surgery has traditionally been considered in terms of the change in 
best corrected post-operative Snellen visual acuity in the eye that had surgery. 
Complications have also been considered, but usually in terms of the occurrence of an 
individual complication and its management. 
3.3.1 Visual Acuity 
ision is made up of both optical and neural components. All types of cataract 
interfere with vision through their basic effect on the optical system of the eye, by 
causing light scattering. 
Visual acuity is probably the single most significant measure of the functional integrity 
of the eye. It is routinely assessed in all patients with visual problems. Visual acuity 
refers to the limit of resolution or the resolving power of the eye i. e. the smallest angle 
of separation between two points which allows discernible images by an optical 
system. The normal limit of resolution (minimum angle of resolution) for the eye is 
one minute of a degree. Visual acuity provides a single measurement of visual 
performance at the limit of resolution for the combined effects of the ocular media and 
retina/brain at high contrast. 
Visual acuity in a clinical setting is routinely measured by the Snellen Test Type -a 
high contrast acuity chart. This Snellen chart bears letters of diminishing size, so that 
when viewed from a specified distance, the eye must have a limit of resolution of one 
minute of a degree. The largest letters have a viewing distance of 60 metres, with 
smaller letters for distances of 36,24,18,12,9,6 and 5 metres. The patient is usually 
positioned 6m from the chart. A normal eye reads the 6m. letters from a distance of 6m. 
and is said to have 6/6 vision. A weaker eye may only be able to resolve the larger 
letters e. g. the 36m size, and is said to have 6/36 vision. [30] Visual acuity is usually 
assessed unaided and best corrected (wearing glasses if wom, or with pin-hole or after 
refraction) for each eye, separately. 
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The design of the Snellen chart produces a variation in the ratio of letter size between 
successive lines; the separation of letters within and between lines; and the number of letters 
on each fine. The resultant variation in contour interaction consequently requires a different 
visual task for letters of different angular size at each level of the chart. The effects of 
contour interaction are responsible for the main limitations of the Snellen chart for 
measuring very good and very poor levels of visual acuity. [81][82][83] 
Other high contrast visual acuity charts have been developed to overcome these limitations 
of the Snellen chart e. g. Bailey-Lovie Letter Chart. [81] Such charts have an equal number 
of letters on each row, and the separation of letters within and between rows is uniform so 
that contour interaction is controlled. The visual task at each level of the chart is therefore 
the same irrespective of the acuity or test distance[81]. The chart employs a logarithmic 
progression of letter sizes and produces the logMAR visual acuity notation. The major 
advantage of the logMAR visual acuity notation and the use of this type of chart, especially 
for research purposes, is its ability to measure and score low visual acuities accurately, and 
consequently allows for them to be included and handled appropriately in statistical 
analyses. Whilst charts such as these have been used for research purposes in a variety of 
settings[84][85][86], they are not used in routine clinical settings. 
The test-retest reliability of uncorrected Snellen visual acuity measured at one moment in 
time, is reported to be comparable to uncorrected visual acuity measured by the Bailey- 
Lovie chart (r=0.94 and r=0.98, respectively). [87] These coefficients have been used to 
estimate the confidence limits of changes in uncorrected acuity measurements at a specified 
time i. e. if an observed change is real or within the bounds of chance variation. If it is 
accepted that a real change in uncorrected acuity would have to be two standard deviations 
outside the average variability, then for Snellen acuity this would constitute a doubling of 
the minimum visual angle. For example, an unaided visual of acuity of 616 would have to 
change to 6/12 before being accepted as a real change. For the Bailey-Lovie chart (or 
similar charts), a similar acuity of 6/6 would have to change to 6/9 before being considered 
as a real change. [871 
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3.3.2 Visual acuity and cataract surgery 
Irrespective of the type of procedure (intracapsular or extracapsular) or type of optical 
correction (spectacles, contact lenses, or intraocular lens implant), many studies have 
shown that cataract extraction will improve visual acuity after surgery. [88] [89] [90] [91] [92] 
The length of follow-up for the post-operative assessment varied in these studies as did the 
type of surgery performed, and all related to practice up to the mid 1980s. All reported 
that about 80% of patients achieved a best corrected visual acuity of 6/12 or better at the 
time of the post-operative assessment. If eyes with no other ocular comorbidity are 
considered, 90% of patients achieved such an outcome. [89] [90] [91] [93 ] 
3.3.2 Complications associated with cataract surgery 
The types of complications that occur as a result of surgery depend partly upon the type of 
procedure and type of intraocular lens implant used. [94][95] These are usually specific 
to cataract extraction and represent the risks associated with this intervention. 
Complications are clinically defined and classified in terms of severity according to the 
resultant effect on vision e. g. whether they are sight threatening or not, whether they 
are transient or not, or whether they have long term sequelae impairing visual acuity. 
The complications are usually clinically diagnosed and may or may not require specific 
diagnostic tests to confirm them. Those most commonly associated with cataract 
extraction are summarised in Table I. I. Most of these complications are amenable to 
treatment. Sight threatening complications, such as endophahnitis and retinal detachment, 
are infrequent events. 
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Table 1.1 Types of complications associated with cataract surgery. [951 
Complication Type of Cataract Extraction 
Capsule rupture Both 
Vitreous loss Both 
Expulsive hacmorrhage Both 
Hyphaema Both 
Wound leak Both 
Raised intraocular pressure Both 
Corneal oedema Both 
Uveitis Both 
Endophthalmitis Both 
Pupillary block ICCE > ECCE 
Vitreous touch ICCE > ECCE 
Vitreous wick syndrome ICCE > ECCE 
Cystoid macular ocdcma ICCE > ECCE 
Retinal Detachment ICCE > ECCE 
Residual lens matter ECCE 
Posterior capsule thickening ECCE 
IcCF, intracapsular cataract extraction 
ECCE extracapsular cataract extraction 
Improvements and developments in intraocular lens quality and design progressing from 
anterior chamber lenses and some form of iris fixated lenses to posterior chamber lenses, 
have reduced the occurrence of complications. [96] Compared to other types of intraocular 
lenses, posterior chamber lenses are associated with a lower occurrence of complications as 
seen in Table 1.2. [97] 
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Table 1.2. Complications associated with intraocular lens implants. 1971 
COMD]iCatiOlM 
Type of Intraocular I., ens Implant 
AC IF IC PC 
Cumulative (0 to 12 months): 
Munber of eyes 
macular oedema 
secondary glaucoma 
hyphaema 
lens dislocation 
pupillary block 
retinal detachment 
cndophthalmitis 
Persistent at one year: 
Number of eyes 
macular oedema 
secondary glaucoma 
hyphaema 
iritis 
corneal oedema, 
capsule thickening 
3587 539 1213 2703 
8 6.3 2.8 3.5 
5.5 4.3 0.7 1.6 
4.9 3.2 2.6 1 
0.2 5.6 1.1 0.4 
0.8 0.6 0.2 0.3 
0.9 0.4 0.2 0.5 
0.1 0.2 0 0 
4132 538 1213 2465 
2.2 2.4 0.3 0.8 
1.2 0.9 0.1 0.5 
0.1 9 0.1 0.3 
1.2 9.9 0.4 1 
1.2 1.5 0.6 0.6 
0.1 0.2 0 0 
AC anteirior chamber lens implant 
IF iris fixation lens implant 
ic irido-capsular lens implant 
PC posterior chamber lens implant 
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3.4 Patient Perceived Measures of Cataract Surgery 
3.4.1 Functional Status 
Ophthalmologists and other health care workers involved with patients with visual 
problems have always, albeit implicitly, considered functional status and quality of life 
(impact on social interactions), together with impairment (visual acuity), when 
assessing patients and their needs for eye health care. This is usually done in the 
context of a clinical assessment and may not be necessarily recorded in any formal or 
standardised manner as other clinical information might be. This emphasis on the 
assessment of function (however implicit or brief it may be) is demonstrated in the 
various definitions of blindness. [98] In the UK this definition includes the term "to be 
unable to perform any work for which eyesight is essentiaV'. [99][100] Thisisthe 
definition used when patients are placed on the blind register in this country. The 
purpose of the register is primarily for social purposes to meet the needs of blind or 
partially sighted persons, rather than for their medical needs. 
Whilst symptoms and global questions on vision are usually asked in the context of the 
clinical assessment of the patient, they are not usually recorded in any systematic or 
standardised fashion. Improvements in symptoms[92][88] and global measures of 
vision have been reported, [92[88][101][102] but again these were related to practice 
up to the mid 1980's. 
Consequently the measures of functional status that have been developed for use in 
ophthalmology have been based on clinical experience of the problems patients have 
reported as being due to their vision. The measures that have been developed relate 
predominantly to cataract and have been measures of visual function in varying forms 
of complexity. [ 101)[102][103][104]105][1061 The term visual function is used in this 
thesis to refer to functioning or performance in everyday activities that are dependent 
on vision. 
Only a few studies have explicitly considered the concept of assessing functioning in 
activities dependent on vision and other aspects of the patient's daily life after cataract 
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surgery. These studies were conducted on patients having surgery before the tnid 1980s, 
during periods where intracapsular extraction was the usual practice with glasses or contact 
lenses for aphakic correction, [88][92][107][108] or during periods of transition to 
extracapsular extraction and the introduction of intraocular lenses. [109[110][111][112] 
The findings reported were not necessarily related to the surgical practice i. e. type of 
procedure or optical correction used. 
Where intracapsular surgery had been performed and aphakic correction provided 
predominantly by high powered spectacles, a discrepancy between visual acuity and 
functional status post-operatively was observed. Whilst the majority of patients were able 
to demonstrate good visual acuity with their correction, about 39% were not able to utilise 
this acuity for reading or for performing other routine vision-dependent tasks. [107] Up to 
26% reported no change or dissatisfaction with their ability to perform routine tasks after 
surgery and two thirds of patients had problems in performing routine tasks with their 
aphakic correction. [88] This discrepancy between visual acuity achieved and ability to 
utilise it in routine activities was particularly evident in monophakic patients and those who 
had been moderately disabled pre-operatively. [108] These problems would not have been 
identified by conventional assessment of outcome by visual acuity alone. A subsequent 
study using similar methods for assessing post-operative function, demonstrated that the 
majority of patients having an iris-fixated intraocular lens were able to achieve a maximum 
functional status score post-operatively. [113] The discrepancy observed between post- 
operative visual acuity and post-operative visual functioning was attributed to the optical 
aberrations associated with aphakic correction, the patients' ability to adjust to them and 
possibly increasing age. [88](108] Optically, intraocular lenses were able to provide a better 
quality of post-operative visual acuity and were thus associated with better post-operative 
functioning. [ 113] 
Improvement in mental health status and physical function (e. g. timed manual performance 
tests) maintained up to a year after surgery, have also been demonstrated following cataract 
extraction. [1101 Pre-operative visual acuity and baseline functional status, including 
mental health state, are important factors determining long term functional benefit. [ I1 11 
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3.4.2 Health-Related Quality of Life 
There has been no assessment of the impact of cataract surgery on health related 
quality of life. 
SUMMARY 
Cataract is a common condition causing visual impaiment and blindness. In the UK it 
particularly affects the elderly population. 
There have been significant developments in the surgical technique for cataract extraction 
and in the technology for optical correction of aphakia, in the last 25 years. It is possible 
that these may have influenced the outcomes of cataract surgery. The current literature 
refers predominantly to surgical practices and clinical outcomes that are either outdated 
(intracapsular surgery) or were performed during periods of changing surgical techniques 
from intracapsular extraction to extracapsular extraction with varying types and design of 
intraocular lens. Whilst it was Rely that surgical practice had stabilised by the time this 
thesis had started, there was no evidence to support this assumption. Surgical practice for 
cataract extraction and its variations in this country were not known accurately at that time. 
Cataract extraction is a high volume surgical procedure within the National Health Service 
(NHS) which is associated Aith a significant improvement in post-operative visual acuity. 
Changes in surgical practice and optical correction have reduced the serious sight 
threatening complications of surgery and improved the optical quality of post-operative 
visual acuity. This may have reduced the thresholds at which surgery may be considered to 
be worthwhile and is indirectly observed by the falling levels of visual acuity on admission 
from blindness to 6160 between 1970 to the mid 1980s. In addition, technical advances 
have made surgery possible for patients who would previously not have been suitable, 
particularly those with ocular comorbidity. This, combined with changes in the age 
structure of the population, has probably contributed to the greater demand for surgery. 
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Although this is a trend which is likely to continue, the situation regarding current surgical 
practice and its outcomes in the United Kingdom remains unknown. 
The benefit of cataract surgery has so far, usually been measured exclusively by a single 
clinical indicator, improvement in visual acuity and, to a lesser extent surgical 
complications. Wlilst surgical practice has developed to improve the quality of the vision 
restored after surgery, little is known about its impact on patients' functioning in routine 
activities and on their quality of fife, particularly in the context of the process of care 
provided in established surgical practice for extracapsular cataract extraction and 
intraccular lens implantation. The influence of ocular and other comorbidity on the 
outcome of current surgical practice has not been established. This is probably because the 
methods required for such assessments have not been widely available nor applied to 
vision-related problems. 
® IBL 
rall"U'l 49 
5. AiMS AND OBJECTIVES 
The aim of this thesis was to compare methods for the assessment and measurement of 
clinical impairment (visual acuity), and patient perceived measures of disability (functional 
status) and handicap (quality of life) that may be used to evaluate the impact of cataract 
surgery. 
The aims of this thesis was to be achieved through the following objectives : 
1. To describe current surgical practice for age-related cataract in the UK 
2. To describe the clinical outcomes of cataract surgery 
3. To identify risk factors for a poor clinical outcome 
4. To describe the impact of cataract on visual acuity (impdment), visual function 
(disability), and health related quality of life (handicap) and determine their inter- 
relationsWps. 
S. To describe the short term (at three months), and medium term (at twelve months) 
outcomes of cataract surgery in terms of visual acuity, visual function and their 
inter-relationsHps. 
To achieve these objectives, two major studies were undertaken. First, a national 
prospective cohort study was conducted to consider surgical practice and clinical 
outcomes. This is presented in chapters 2 and 3. Second, a smaller, but more detailed 
prospective cohort study was undertaken in three hospitals to consider both clinical ( visual 
acuity), and patient perceived measures of outcome (visual nctio I ty lifi fu n and qua i of 0. 
This is presented in chapters 4 to 8. The findings relating to each of the objectives of 
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this thesis will be discussed in the relevant chapters. In chapter 9 the use of the methods 
for measuring and assessing impairment, disability and handicap in practice (patient-based) 
and for epidemiological health services research (population-based) and their specific 
contribution to the evaluation of the impact of cataract surgery are discussed. 
At the time this work was started, this area of research was just beginning to receive 
some interest and there was an opportunity to collaborate with colleagues on the 
Cataract Patient Outcomes Research Team (PORT), based at Johns Hopkins 
University, Baltimore, USA. To achieve this, standardised measures of functional 
status and health related quality of life were used. In doing so, this collaboration 
provided the opportunity to assemble comparable data for different populations in 
different health care settings. 
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Chapter 2. 
THE NATIONAL CATARACT SURGERY STUDY : METHODS 
INTRODUCTION 
This and the following chapter will be concerned with the clinical outcomes of cataract 
surgery. Since accurate and complete information on current surgical practice and its 
outcomes was not available either from routine sources or the literature, a national 
study was conducted - the National Cataract Surgery Study. It's objectives were : 
a. to describe the current surgical management of cataract in the NHS 
b. to describe the short term clinical outcomes of cataract surgery 
C. to identify risk factors for poor clinical outcome 
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2. STUDY DESIGN 
A prospective cohort design was chosen to describe current surgical practice and 
clinical outcomes within the NHS. When related to population denominators, this 
design would provide information on the frequency of the intervention (cataract 
surgery). In addition, information on the characteristics of current surgical practice 
could be obtained, and an opportunity to identify risk factors for poor clinical outcome 
was available. 
In order to ascertain the short term outcome, patients were followed up for three 
months after surgery. This period of follow-up was chosen as a clinical consensus 
suggested that by this time optical rehabilitation following surgery should have been 
established, and patients would have been discharged, or be ready for discharge, from 
care. 
A national approach was adopted with all ophthalmic departments in the United 
Kingdom invited to participate, so that an assessment of overall practice in the NHS 
could be made. Whilst this involved data collection on a wide scale, raising concerns 
regarding administration, monitoring, and follow-up, it allowed a large sample to be 
obtained rapidly. The survey period was one week: 26 to 30 November 1990. The 
study centre was the Royal College of Ophthalmologists, London. 
3. SAMPLE SELECTION 
The aim was to obtain a representative sample of patients undergoing cataract surgery 
within the NHS. It was assumed that, beyond administrative and managerial 
constraints, consultant ophthalmologists were responsible for the clinical management 
of patients. In order to describe clinical practice it was essential to obtain data on the 
actual management of patients and not the consultant's opinion of how his/her patients 
were managed. 
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The sampling frame consisted of all consultants who regularly performed surgery for 
age-related cataract. Consultants holding NHS appointments were identified from the 
Royal College of Ophthalmologists' database and were asked to confirm that they had 
patients under their care for cataract surgery, and that they performed at least one 
operating list per week for these patients. Only consultants fulfilling both criteria were 
regarded as eligible. Consultants were ineligible if they only performed specialist 
ophthalmic surgery (e. g. paediatric, vitreo-retinal), or if they were medical or academic 
ophthalmologists. 
All eligible consultants were invited to participate by providing clitfical data on all 
patients (fulfilling the inclusion criteria), admitted under their care for cataract surgery 
during the study week. All patients of 50 years of age and over, admitted for surgery 
for age-related cataract during the study week, were eligible for inclusion. Those 
patients undergoing combined procedures or surgery for other types of cataract (e. g. 
traumatic, congenital, iatrogenic), were excluded. 
SAMPLE SIZE 
It was estimated that there were about 500 consultants providing a cataract surgical 
service (as defined above), and that they each had about 5 admissions per week that 
could be eligible for inclusion in the study. Thus it was expected that about 2,500 
patients would be admitted for surgery. It was anticipated that 60% to 80% of 
consultants would participate, providing a cohort of between 1500 and 2000 patients. 
About 20% of patients have been reported to have a poor visual outcome following 
cataract surgery. Assuming that all estimates would be based on 95% confidence 
limits, a sample of 693 patients would give a precision of +/- 2.5% or better (e. g. 95% 
confidence limits of 17.5% to 22.5%) for a finding of 20% poor visual acuity outcome. 
[114] Similarly for cystoid macula oedema and sight threatening complications of 
surgery such as retinal detachment which are infrequent events that may occur in 
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about 1% of patients, it was estimated that a sample of 885 patients would give a 
precision of +/- 0.55% or better (e. g. 95% confidence limits 0.45% to 1.55%) to 
detect this level of complication occurring. [ 114] 
5. CONDUCT OF THE STUDY 
All eligible, consultant ophthalmologists were informed of the purpose and objectives 
of the study. They were told that their participation would require them to provide 
clinical data on patients admitted under their care for cataract surgery, and assurances 
were given regarding the maintenance of confidentiality of the data collected. They 
were also asked to indicate if they did not wish to participate, giving their reason(s) if 
possible. 
A prospective design was preferred to allow for collection of specific data for the 
study. In order that this design would not influence practice (a Hawthorne effect), or 
influence the selection of patients for inclusion in the study, each consultant was only 
informed of the study period on the last working day before or on the morning of the 
first day of the study week. Sufficient survey forms (Appendix Al) for data collection 
were supplied to each consultant at this time together with specimen forms and 
instructions for completion. Additional forms had to be obtained from the study 
centre. 
Consultants were reminded of the three month post-operative assessment shortly 
before it was due to take place. A general reminder in "College News", the Royal 
College of Ophthalmologists' quarterly newsletter, followed by an individual reminder 
were circulated after the three month follow-up period, to encourage return of any 
outstanding data that had not already been returned to the study centre. 
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All data were entered on a custornised computer database using Paradox 3.0 software, 
at the Royal College of Ophthalmologists, and held in accordance with the Data 
Protection Act 1984. 
Ethical pennission for the study was not sought as only data that would be collected in 
routine clinical practice was required for the Study, and no additional exatninations or 
procedures were being performed on patients. 
6. DATA COLLECTION ON PATIENTS 
individual patients were identified by a code ascribed by the study centre, to ensure 
confidentiality. Data collection on such a wide scale concentrated on those items that 
would reasonably be expected to be : part of the routine assessment for cataract 
patients at the pre-operative assessment; recorded in the operation notes; and recorded 
at follow-up in the out-patient clinic after surgery. Only clinically evident comorbid 
ophthalmic conditions and clinically evident complications related to the surgical 
procedure were sought. It is unlikely that this would have excluded more thanjust a 
few, subtle, minor conditions or events, that were not directly identifiable from routine 
clinical examination without further diagnostic investigations 
Before surgery, the following data obtained from the clinical history and ophthalmic 
examination, were collected on each patient : best corrected visual acuity in each eye at 
the time of listing for surgery and on admission; and clinically evident ocular 
comorbidity. 
Data on the surgical procedure included : the length of hospital stay ( in-patient or day 
case); the type of anaesthesia used (general or local); the type of procedure performed; 
the grade of surgeon performing the procedure; and the occurrence of intra-operative 
complications. 
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Three months after surgery information was obtained on whether the patient had been 
discharged from follow-up or not and whether visual rehabilitation by this time had 
been achieved ( i. e. had a final refraction been performed and glasses dispensed). The 
clinical outcomes of interest included the traditional indicators of change in best corrected 
Snellen visual acuity at three months post-operatively in the eye that had been operated on, 
and the occurrence of complications. 
Visual acuity is presented as best corrected Snellen acuity. A poor visual outcome was 
defined as visual acuity at three months after surgery of less than 6/12 (that is 6/18 to 
blind). Acuity of 6/12 is the minimum legal requirement for a driving licence in the 
UK[I 15] and was taken as an acceptable level of visual acuity. 
A complication was defined as an event that was a consequence of the surgical 
procedure, that would not have otherwise occurred. The occurrence of clinically 
evident complications during the surgical procedure, in the immediate post-operative period 
(within 24 hours of surgery), by the first post-operative out-patient assessment (within one 
month of surgery), and at three months after surgery, were recorded. 
(The data collection forms are provided in Appendix Al). 
7. DATA COLLECTION ON CONSULTANTS 
Information on consultants' clinical activity was also collected. This included the 
number of operating and out-patient sessions available per week for each consultant. These 
were examined for the study week, the weekly average for the period immediately prior to 
the study (January to September 1990), and the weekly average for the preceding year 
1989. This was ascertained by the consultants and their clerical staff from theatre diaries 
and out-patient clinic bookings for those periods. 
(The data coHection fonns are provided in Appendix Al) 
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8. STATISTICAL METHODS 
Snellen visual acuity, unless otherwise indicated, was treated as a categorical variable 
and grouped as follows [87] : 
good visual acuity 6/6 to 6/12 
moderate impairment - 6/18 to 6/24 
severe impairment - 6/36 to 6/60 
blind less than 6/60 
Age was considered as both a continuous variable and a categorical variable. In the 
latter case, age was grouped as follows : 
3 groups - 
50 to 64 years 
65 to 74 years 
75 years and over 
2 groups - 
less than 75 years 
75 years and over 
If more than one comorbid ocular condition was recorded, that which was considered to 
be the most severe by the attending ophthalmologist was taken for analysis. Similarly, if 
more than one type of complication occurred, that which was considered to be the most 
severe by the attending ophthalmologist was taken. 
The data were predominantly descriptive. Where appropriate, 95% confidence levels 
are provided for the estimates obtained. The 95% confidence intervals around 
proportions were calculated by the normal approximation to the binomial distribution for 
large proportions and by the exact method for smaller ones [116]. For continuous data 
(e. g. age), the unpaired t-test was used to test the significance of an observed difference 
between the mean values of sub-groups. The Chi-square test was used to determine 
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whether the observed differences in proportions between sub-groups (e. g. by age and sex) 
were statisticaffy significant. 
Cumulative incidence is used as a measure of frequency for complications occurring at the 
specified post-operative periods. It is given by the ratio of the number of patients who 
developed complications during a given period to the number of patients at the beginning of 
that period. It indicates the average risk a patient has of developing a complication in the 
specified period of time. 
Multivariate regression analysis methods were used to determine prognostic factors for 
poor clinical outcome using the EGRET (Epidemiological Graphics, Estimation and 
Tabulation) statistical programme [117]. The variables for poor clinical outcomes 
included: 
0 poor visual acuity at 3 months after surgery 
(defined as best corrected Snellen acuity in the surgery eye of less than 6/12) 
0 the existence of any complications at 3 months after surgery. 
These clinical outcomes were dichotomous variables i. e. poor clinical outcome did or did 
not occur. Risk factors for poor visual outcome and risk factors for complications were 
considered separately. 
Prior to multivariate regression modelling, bivariate cross-tabulations between the 
dependent (outcome) variables and the other independent variables of interest, were 
scrutinised to identify extreme correlations that might produce troublesome collinearities in 
the modelling. Also the associations between each independent variable and the dependent 
(outcome) variable were looked at when stratified by all the remaining variables, one at a 
time, in order to identify any obvious effect modification (interactions). 
A Poisson logistic regression model was fitted, first, with only the main variables of interest. 
This was then followed by fitting all the other variables of interest (including those 
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considered to be confounders) in a stepwise Poisson logistic regression model. The 
variables that demonstrated a significant effect on outcome, having adjusted for all the other 
variables in the stepwise model, were then fitted in a further regression model together with 
other possible confounding variables to evaluate their relative risks. (Details of the models 
used are provided in Appendix A2 and A3). 
Poisson regression was used because it provides an estimate of the relative risk for 
poor clinical outcome in a multivariate framework. The Poisson distribution provides a 
good approximation to the binomial distribution for rare events. It was assumed that 
as a patient could only experience a poor clinical outcome once (either visual acuity or 
a complication), depending on the model, the occurrence of these events could be 
treated as Poisson events. 
The relative risk is a measure of the strength of an association between a factor and the 
outcome of interest. In this case the relative risk was calculated as the ratio of the 
cumulative incidence of poor clinical outcome (visual acuity or a complication) among 
those patients with the variable of interest, such as ocular comorbidity, compared with 
those patients that do not have ocular comorbidity. It provides an estimate of the risk 
or probability of a poor clinical outcome associated with that factor. 
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SUMMARY OF METHODS 
The methods used to achieve the objectives of this study may be summarised as 
follows : 
0 The study method was that of a prospective cohort design. 
41 The measures of outcome were clinical. These were visual acuity in the eye 
that had surgery and complications. 
0 The main statistical methods provided measures of risk. Cumulative incidence 
provided and estimate of the average risk of an event of interest occurring. 
Poisson regression analysis provided estimates of relative risk as measures of 
effect between cataract extraction and poor clinical outcome. 
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Chapter 3. 
THE NATIONAL CATARACT SURGERY STUDY : RESULTS 
1. RESPONSE 
At the time of the study, there were 14 NHS regions in England, plus Wales, Northern 
Ireland, and for the purposes of the study, Scotland was divided into two regions. In 
addition, one special health authority provided a regular surgical service for age-related 
cataract. Although this special health authority provided a service predominantly for 
patients in its neighbourhood, it also treated patients from further afield. [118] For 
this reason and because of its size (number of consultant staff) it was considered 
independently of other areas. This made a total of 19 areas. 
There were 527 eligible consultant ophthalmologists in the UK who regularly 
performed surgery for age-related cataract based in 183 ophthalmic departments. 
157 (86%) of the departments participated, with every area in the UK represented. 
The participation rate of eligible consultants was 66.2% (n-- 349). 1498 patients were 
admitted for surgery, representing an estimated 86% of all possible admissions. 
(Figure 3.1) 
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Figure 3.1 
Estimates of completion of reporting of all possible eligible cases for inclusion in the study 
527 eligible consultants likely to contribute about 5 operations each per week 
4. 
Estimated number of admissions during study week in whole of the UK 
n= 2635 
Participating consultants 
n= 349 
1 
Estimated number of admissions by participating consultants during study week 
n= 1740 
Reported number of admissions during study week 
n= 1498 
Reported number of operations performed during study week 
n= 1445 
Follow-up data at 3 months 
n= 1153 
1 
complete data for visual acuity n= 959 
complete data for complications n= 998 
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As shown in Table 3.1, responders and non-responders were similar in respect of the 3 
main characteristics, and no significant differences were demonstrated. 
Table 3.1 Comparison of participating and non-participating consultants. 
Participants 
Characteristic N (%) 
Type of Hospital: 
Non-Participants 
N (/. ) 
Teaching 83 (23.8) 36 (20.2) 
District 212 (60.7) 112 (62.9) 
Eye 54 (15.5) 30 (16.9) 
Total: 349 (100) 178 (100) 
Chi square=0.89, df=2, p=0.64 
size of Unit. Number of Consultants : 
-c--2 Consultants 97 (24.9) 47 (26.4) 
3 Consultants 99 (28.4) 40 (22.5) 
4 Consultants 57 (16.3) 28 (15.7) 
>4 Consultants 106 (30.4) 63 (35.4) 
Total: 349 (100) 178 (100) 
Chi squarc=2.61, df=3, p=0.46 
Years since Appointment as Consultant: 
5 93 (23.3) 41 (26.3) 
10 73 (22.1) 36 (23.1) 
15 59 (17.8) 32 (20.5) 
20 56 (16.9) 28 (17.9) 
25 42 (12.7) 14 (8.97) 
30 8 (2.42) 5 (3.21) 
Total: 331 (100) 156 (100) 
Chi square=2.17 , df=5, p=0.82 
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2. SURVEY PERIOD 
Figures 3.2 and 3.3 present the distributions of the number of out-patient sessions and 
theatre sessions that were available for each consultant during the survey week, the 
period preceding it (January- September 1990), and the average number of these 
sessions available in the preceding year. When considered in these terms, the survey 
week was typical and did not exhibit any statistically significant differences with 
respect to activity in recent times: out-patient sessions Chi-square=5.35, df--14, p- 
value=O - 
98; theatre sessions Chi-square=9.3 5, df-- 10, p-value =0.49. 
Figure 3.2 Activity : Out-Patient Sessions 
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3. LOSSES To FOLLOW-UP AND D ATA COMPLETENESS 
1498 patients aged 50 years or more were reported by the participating consultants as 
having been admitted for cataract surgery during the study week. Of these, 1445 
patients had surgery performed during the study week. Of the 53 patients that did not 
have surgery, 20 patients had surgery cancelled for medical reasons, with no reason 
specified for the remaining 33 patients. 
Data on 1153 (80%) patients were available for post-operative follow-up at three 
months. No reason was ascertained for losses to follow-up despite reminders and 
requests. Of these 1153 patients, 959 had complete records for visual acuity (pre- 
operatively and at three months after surgery), and 998 patients had complete records 
for surgical complications. 
Patients lost to follow-up were slightly older than patients with follow-up data (Table 
3.2). Although fewer patients lost to follow-up had ocular comorbidity present in the 
surgery eye this difference was only of borderline significance. Otherwise no 
significant differences were identified between these patient groups. 
The proportion of records with missing data in the items listed ranged from zero for 
age to 17% for the visual acuity in the fellow eye at three months (Table 3.3). Most 
items had complete data for at least 90% of patients with the exception of: eye order 
(right or left eye); whether glasses had been dispensed by three months; and visual 
acuity in the fellow eye at three months. 
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Table 3.2 Characteristics of patients followed up after surgery and those lost to follow-up. 
Patients Followed Up Patients lost to Follow-Up 
n=1153 n=345 
n (*/. ) n (*/. ) 
Age on admission (yrs) 
50-64 157 (13.6) 36 (10) 
65-74 356 (31) 93 (27) 
>=75 640 (55.5) 217 (63) 
Chi-square=5.97, df=2, p=0.05 
Sex 
malcs 446 (38.7) 130 (38) 
fenialcs 706 (61.3) 214 (62) 
Chi-square=0.09, df=l, p=0.76 
Visual Acuity on admission 
in Surgery Eye 
6/6 to 6/12 80 (7) 22 (7) 
6/18 to /624 265 (24) 70 (21) 
6/36 to 6/60 246 (22) 86 (26) 
less than 6/60 528 (47) 154 (46) 
Chi-squarc=2.60, df=3, p=0.46 
Ocular Comorbidity on 
Admission In Surgery Eye 
present 460 (41) 116 (35) 
absent 656 (59) 213 (65) 
Chi-square=3.76, df=1, p=0.052 
Type of Admission 
In-patient 77 (7) 34 (10) 
Day-ease 1010 (93) 300 (90) 
Chi-square=3.4, df=l, p=0.065 
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Table 3.3 Data Quality - Completeness of Recording 
Field Total Number Number of Records % Records 
Records with Missing Data Missing Data 
On Admission 
(n=1498 patients admitted In survey period): 
Age 
Sex 
Ethnic group 
Eye order - first or second eye 
Visual Acuity - surgery eye 
Visual Acuity - fellow eye 
ocular Comorbidity (any eye) 
Patients that bad surgery performed ( n=1445) : 
1498 0 0.0 
1498 4 0.3 
1498 51 3.4 
1498 214 14.3 
1498 31 2.1 
1498 60 4.0 
1498 91 6.1 
Admission t)W - in-patient or day case 1445 75 5.2 
Anaesthctic used - local or general 1445 18 1.2 
Grade of surgeon 1445 11 0.8 
Intra-operativc complication 1445 21 1.5 
Immediate complication 1445 25 1.7 
Post-operative Follow-Up (n=1153 paired records): 
I month complication 1153 44 3.8 
Status at 3 months - discharge 1153 78 6.8 
Glasses dispensed by 3 months 1153 183 15.9 
3 month complication 1153 103 9.9 
Capsulotomy indicated at 3 months 1153 100 8.7 
Visual Acuity - surgery eye at 3 months 1153 61 5.3 
Visual Acuity - fellow eye at 3 months 1153 197 17.1 
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4. PATIENT CHARACTERISTICS 
4.1 Age and Sex 
There were 575 males and 919 females, a male: female ratio of I: 1.6. The age and 
sex distribution is presented in Figure 3.4. The mean age of patients on admission for 
cataract surgery was 75.9 years (95% C. I. 75.4 to 76.4). Females were slightly older 
than males, having a mean age of 76.8 years compared to a mean age of 74.4 years for 
males. The difference in mean age of 2.4 years between males and females was 
statistically significant (p-value <0.001, unpaired t-test). Overall 61% (n--853) of 
patients were 75 years of age and over. 563 (61%) of females were 75 years or over, 
compared with 290 (50%) of males. 
Figure 3.4. Age Distribution on Admission for 
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4.2 Ethnicity 
96% (n--1387) of patients were Caucasian, 2.8% (n=40) were Asian and 1.1% (n--16) 
were African-Caribbean. 
4.3 Ocular Comorbidity 
As seen in Table 3.4, over half of the patients had no other clinically evident ocular 
morbidity present (n--799) in either eye. Age related maculopathy was the commonest 
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comorbid condition identified. Most of these patients had moderate macular changes, 
with a few having severe changes. Only 4% (n--56) of patients had some form of 
diabetic eye disease. This was predominantly background retinopathy (n--30). Other 
less common conditions included corneal pathology (scarring secondary to 
infection/inflammation, and corneal dystrophies), retinal degenerations, vasculopathies 
and old retinal detachment and common lid disorders. 
Table 3.4 Comorbid Ocular Conditions Present on Admission for Surgery. 
EITHER EYE SURGERY EYE 
Type of Comorbidity N% 95% C. I. N% 95% C. 1 
None Present : 
Age Related Maculopathy: 
Drusen / RPE changes 
Disciform 
Diabetic Retinopathy 
Background 
Proliferative 
Maculopathy 
799 56.8 54.2 to 59.4 
173 12.3 
(153) (10.9) 
(20) (1.4) 
10.6 to 14.0 
56 4 
(30) (2.1) 
(8) (0.6) 
(18) (1.3) 
3.0 to 5.1 
887 65.5 62.9 to 68.0 
127 9.4 
(121) (8.9) 
(6) (0.5) 
7.9 to 11.1 
48 3.5 
(26) (1-9) 
(7) (0.5) 
(15) (1.1) 
2.6 to 4.7 
Glaucoma: 148 10.6 8.9 to 12.1 137 10.1 8.5to 11.7 
Amblyopla 34 2.4 1.7 to 3.4 14 1.0 0.6 to 1.7 
Other *: 197 14.1 142 10.5 
TOTAL : 1407* 100 13550 100 
-other* includes conditions such as conunon lid disorders, retinal degenerations, vasculoPathics, 
corneal scarringidystrophy, previous retinal detachment 
presence of ocular comorbidity was not known for 91 patients 
## presence of ocular comorbidity and Which was the surgery eyc (right or lcft) was not known for 143 
patients 
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468 patients (34.5%), had some clinically evident comorbid ocular conditions in the 
surgery eye on admission. As seen in Table 3.5, the proportion of patients with ocular 
comorbidity in the surgery eye rose with age. The differences observed between the 
sub-groups by age were significant (chi-square=5.1, df-ý-2, p-value=0.0005). No 
gender differences were observed for the presence or absence of ocular comorbidity. 
Table 3.5 Ocular Comorbidity on Admission in Surgery Eye by Age and Sex 
Ocular Comorbidity in Surgery Eye 
Age Group (years): 
50 to 64 134 (74.4) 46 (25.6) 
65 to 74 283 (69.4) 125 (30.6) 
>=75 470 (61.3) 297 (38.7) 
Absent 
n (rowO/o) 
Present 
n (row%) 
All 887 (65.5) 468 (34.5) 
Chi-squarc=15.1; df=2; p-valuc=0.0005 
Sex : 
males 
females 
356 (68.2) 
527 (63.6) 
166 (31.9) 
302 (34.6) 
All 883 (65.4) 468 (34.6) 
Chi-squarc--3.0; df=l-, p-value=0.08 
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4.4 Visual Acuity on Admission 
Table 3.6 presents the visual acuity in the surgery eye and in the better eye on 
admission. 47% (n--677) of patients were blind in the surgery eye on admission. 
About half of these patients (n=320) had no other ocular morbidity identified, and were 
adn-dtted for surgery to an eye blinded by cataract. The median acuity on admission for 
the surgery eye was 6/60. 
The median acuity on admission in the better eye was 6/18. Less than half (45%, 
n--647) of the patients had good visual acuity in the better eye. 
Table 3.6 Visual Acuity on Admission. 
Surgery Eye Better Eye 
Visual Acuity Group n%n% 
616 to 6/12 101 7.0 647 45.0 
6/18 to 6/24 333 23.1 373 25.9 
6/36 to 6/60 333 23.1 175 12.2 
less than 6/60 677 46.9 243 16.9 
All 1444* 100.0 1438* 100.0 
complete records for visual acuity in surgery eye 
complete records for visual acuity in better eye 
No significant age or gender differences were observed for visual acuity on admission 
in the surgery eye as seen below in Table 3.7. 
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Table 3.7 Visual Acuity on Admission in Surgery Eye by Age and Sex 
Visual Acuity in Surgery Eye 
616 to 6/12 6/18 to 6/24 6/36 to 6/60 less than 6/60 
n (rowl/6) n (row%) n (row%) n (row%) 
Age Group (years): 
50 to 64 17 (9.4) 44 (23.4) 37 (19.7) 90 (47.9) 
65 to 74 33 (7.7) 86 (20.0) 93 (21.6) 219 (50.8) 
>=75 51 (6.2) 203 (24.6) 203 (24.6) 368 (44.6) 
All 101 (7.0) 333 (23.1) 333 (23.1) 677 (46.9) 
Chi-square--9.4; df=6; p-value=0.15 
Sex: 
males 41 (7.4) 124 (22.5) 120 (21.7) 267 (48.4) 
females 60 (6.8) 207 (23.3) 212 (23.9) 409 (46.1) 
All 101 (7.0) 331 (23.1) 332 (23.1) 676 (46.9) 
Chi-square--l. 4; df=3; p-value=0.7 
5. SURGICAL PRACTICE 
5.1 First or second eye 
66% of admissions (n--87 1) were for surgery to the first eye and 3 4% (n=449) for 
surgery to the second eye 
5.2 Surgical threshold 
The distribution of visual acuity in the surgery eye at the time of listing for surgery is 
presented in Figure 3.5. It was not influenced by being a first or a second eye, with the 
median acuity being 6/36 in both groups. Although a small proportion of patients had 
good visual acuity (9.3%, n--811868 first eyes; 11.3%, w=48/410 second eyes), the 
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threshold at which most patients were listed for surgery was at 6/18 in both groups. 
The second peak seen at visual acuity less than 3/60 is the result of combining acuities 
not related to viewing objects of a specified size at a specified distance, and range from 
counting fingers to no perception of light. The proportion of patients that were blind 
(less than 6/60) on listing was 34% (n=434/1278). 
Figure 3.5 Visual Acuity in Surgery Eye : 
At Listing for First & Second Eye 
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5.3 Features of Practice 
These are summarised in Table 3.8. Most patients had surgery as an in-patient 
procedure (n-- 1265,92%). Local anaesthesia was used in about half of the patients 
(n--661,46%). The majority of patients (95%) having a day case procedure had 
surgery performed under a local anaesthetic block, whilst only 42% of patients having 
in-patient surgery had a local anaesthetic. 
92% (n--1316) of all procedures were standard extracapsular cataract extractions. A 
further 4% (n=56) of procedures were performed by phako-emulsification - another 
type of extracapsular procedure. 91% (n--1305) of all patients had an extracapsular 
procedure with a posterior chamber lens implant. An intracapsular extraction was 
performed in 4% (n--56) of patients. 
74 
VB" "ew "Or "081, 'ror2g, WWI "616(r 
Suellen Visual Acuity 
59% (n--847) of procedures were performed by surgeons of consultant grade, 35% 
(n--502) by resident staff (senior registrars 10%, registrars 16%, senior house officers 
9%), and associate specialists, clinical assistants or locurn staff collectively performed 
6% (n--85) of the procedures. 
Three months after surgery only one third of patients (n--357/1075) had been 
discharged. The remainder (n=718) were still being followed-up in the out-patient 
clinic. 182 patients had no identifiable reason for continued follow-up as they had no 
surgically related complication and had achieved a good visual outcome. 
Table 3.8 Surgical Practice. n= 1445. 
Number % 
Length of Stay: 
day-case 105 8 
in-patient 1265 92 
xnissing 75 
Type of Ansesthetic 
gcneral anacsthctic 766 54 
local anacsthetic 661 46 
nýssing 17 
Grade of Surgeon 
performing the procedure 
consultant 847 59 
senior registrar 146 10 
registrar 26 2 
senior house officer 130 9 
other 85 6 
missing II 
Type of Procedure : 
exft=psular extraction 1316 92 
phako-cmulsification 56 4 
intracapsular extraction 56 4 
missing 17 
Type of Intra-Ocular Lens Implant 
posterior chamber 1312 92 
anterior chamber 80 6 
none inserted 36 3 
missing 17 
Status at 3 months after surgery 
discharged from clinic 357 33 
follow-up in clinic 718 67 
missing 
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6. CLINICAL OUTCOMES 
6.1 Visual Acuity 
There were 959 records, %ith complete data. The distribution of visual acuity in the 
surgery eye before and after surgery, is shown in Table 3.9. Pre-operatively, a small 
proportion of patients (8%, n--80), had good visual acuity (6/6 to 6/12), 5 1% (n=489) 
were visually impaired with acuity of 6/18 to 6/60, and 41% (n--390) were blind (3/60 
to no perception of light - NPL). 
Three months after surgery, the distribution had signifcantly shifted such that about 
80% (n--764) of all patients achieving a good visual outcome of 6/12 or better (Chi- 
square= l026, df=3, p-value<0.00l). As shown in Table 3.8, post-operative visual 
acuity was unrelated to pre-operative visual acuity group. In other words, regardless 
of pre-operative visual acuity, patients ended up with a similar level of visual acuity 
after surgery. 
Table 3.9 Visual acuity in the surgery eye before and 3 months after surgery. 
Visual acuity 
on admission 
Number of 
patients % 
Visual Acuity at 3 months post-operatively 
6/6-6/12 6/18-6124 U36 - 6/60 less than 6160 
n (row %) n (row %) n (row %) n (row %) 
6/6-6/12 80 8.3% 68 (85%) 9 (11%) 3 (4%) 0 (0)0/. 
6/18-6/24 253 26.4% 220 (87%) 23 (9%) 7 (3%) 2 (1%) 
6136-6160 236 24.6% 189 (80%) 31 (13%) 12 (5%) 4 (2%) 
less than 6/60 390 40.7% 287 (74%) 46 (12%) 28 (7%) 30 (8%) 
All 959 100% 764 (79.7%) 109 (11.4%) 50 (5.2%) 36 (3.8%) 
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The visual acuity of 866 patients (90.3%) improved by three months after surgery in 
the sense that they gained at least one Snellen line of acuity after surgery. (Table 3.10) 
This did not however mean that achieved a "good" visual outcome in terms of their 
post-operative visual acuity as 20.4% still had a visual acuity of 6/18 or worse (Table 
3.9). 
Table 3.10 Gain in visual acuity at 3 months after surgery. n=959. 
Pre-operative 
Snellen Acuity 
(n) 616 6/9 
Post-Operative Snellen Visual Acuity (n) 
6/12 6/18 6/24 6/36 6/60 3/60 CF RM 
6/6 3 - - - - 
6/9 16 9 - 3 3 
6/12 16 16 9 2 1 2 
6/18 52 36 21 11 3 3 3 
6/24 42 50 19 7 3 1 - - 2 
6/36 38 45 23 13 4 4 2 - - 
6/60 32 32 19 10 4 1 5 1 3 
3160 8 9 8 2 1 - 5 1 2 
CF 56 63 37 20 8 3 7 2 11 2 
RM 33 52 21 10 4 6 7 2 64 
All 296 311 157 78 31 20 30 6 24 6 
CF - counting fingers 
lim - hand movements 
Sub-group descriptions of visual outcome 
Visual outcome differed significantly by age group. The proportion achieving a good 
visual acuity declined with age (Chi-square=24.4, df--6, P-value=0.0004). Outcome 
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was also significantly different between males and females, with fewer females 
achieving a good visual outcome (Chi-square=8.9, df--3, p-value=0.03). (Table 3.11) 
It was likely that the types of pre-operative ocular comorbidity present in these 
patients could influence visual acuity. As shown in Table 3.11, visual outcome was 
significantly different in patients with ocular comorbidity (Chi-square--94.4, df-ý-6, p- 
value<0.00001). 87% (569/651) of patients without ocular comorbidity achieved a 
good visual outcome, whilst this was the case for only 63.3% (195/308) of patients 
with ocular comorbidity. 93.3% (n--607/651) of patientswithout ocular comorbidity 
gained at least one Snellen line after surgery compared with 84% (n--259/308) of 
patients with ocular comorbidity. 
Table 3.11 Sub-group descriptions of visual outcome at 3 months after surgery. 
Visual Acuity Group - surgery eye at 3 months 
6/6 to 6/12 6/18 to /624 6/36 to 6/60 less than 6/60 
n (row%) n (row%) n (rowl/9) n (row%) 
Age Group (yrs): 
50 to 64 113 (85.6) 8 (6.1) 9 (6.8) 2 (1.5) 
65 to 74 426 (83) 52 (10.1) 21 (4.1) 14 (2.7) 
>--75 225 (71.7) 49 (15.6) 20 (6.4) 20 (6.4) 
All 764 109 50 36 
Chi-square--24.4; df=6; p-value=0.0004 
Sex: 
males 312 (84.1) 37 (10) 13 (3.5) 9 (2.4) 
females 450 (76.8) 72 (12.3) 37 (6.3) 27 (4.6) 
All 762 109 50 36 
Chi-squarc=8.9; df=3; p-valuc=0.03 
Ocular Comorbidity: 
none 569 (87.4) 53 
mild to moderate 129 (69) 29 
severe 66 (54-5) 27 
All 680 91 
Chi-sq, 
(8.1) 21 (3.2) 8 (1.2) 
(15.5) 13 (7) 16 (8.6) 
(22.4) 16 (13.2) 12 (9.9) 
41 33 
uarc=94.4; df=6; p-value<0.00001 
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6.2 Surgically Related Complications 
There were 998 records with complete data on surgically related complications at all 
the specified post-operative periods. 
Intra-operative complications 
Few patients (n--71,7%) had some complication during the surgical procedure. The 
single most frequent complication was rupture of the posterior capsule (n--50). This 
was not associated with vitreous loss in the majority of these patients (n--39). One 
patient had a retrobulbar haemorrhage following administration of a retrobulbar local 
anaesthetic block. 
Post-operative complications 
Within 24 hours of surgery, 224 (22%) patients experienced a complication, 176 
(18%) had a complication reported within one month of surgery (at the first follow-up 
assessment in the out-patient department); and three months after surgery, 200 (20%) 
of patients had a complication reported. I1 (1.1%) of all patients experienced some 
type of complication at all times from the intra-operative period to three months after 
surgery. The types of complications that occurred at each post-operative period are 
presented in Table 3.12. 
The complications seen in the immediate post-operative period consisted 
predominantly of corneal oedema and raised intra-ocular pressure, followed by wound 
leak, iris prolapse, uveitis and hyphaema. It is likely that these events were related to 
the handling of the eye during the surgical procedure. These gradually resolved, so 
that the pattern of complications at three months after surgery was quite different. The 
predominant complication at that time was posterior capsule opacification, followed by 
raised intra-ocular pressure, clinically detectable cystoid macular oedema and 
persistent uveitis. 
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Table 3.12. Post-operative complications of surgery. n= 998. 
Post-Operative Period 
Type of Complication Immediate 1st Out-patient At 3 Months 
(within 24 hours) (within I month) 
n % n % n % 
None 774 77.6 922 82.4 798 80 
Corneal ocdema 96 9.6 32 3.2 4 0.4 
Raised Intra-Ocular Pressure 53 5.3 33 3.3 23 2.3 
Wound leak 18 1.8 8 0.8 2 0.2 
Iris prolapse 3 0.3 2 0.2 2 0.2 
External infection 1 0.1 2 0.2 2 0.2 
Endophthahnitis 1 0.1 2 0.2 0 0 
Dislocated Intra-Ocular Lens 0 0 0 0 3 0.3 
Hyphaema 13 1.3 4 0.4 0 0 
Uveitis 14 1.4 21 2.1 11 1.1 
Retinal detachment 0 0 0 0 1 0.1 
Cystoid macular oedema 0 0 0 0 12 1.2 
Soft lens matter 0 0 0 0 3 0.3 
Posterior Capsule thickening 0 0 0 0 63 6.3 
Other 25 2.5 72 7.2 74 7.4 
All 998 100 998 100 998 100 
Complications are presented as those that occurred at the specified Post-operative period. 
Complications at three months are presented by age, sex and presence of pre-operative 
ocular comorbidity in Table 3.13. No significant differences were observed by age 
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and sex, but complications were significantly more frequent in the presence of pre- 
operative ocular comorbidity. 
Table 3.13 Sub-group descriptions of surgical complications at 3 months. 
Surgical Complications at 3 months 
Absent Present 
n (row*/*) n (row%) 
Age Group (yrs): 
50 to 64 102 (77.3) 30 (22.7) 
65 to 74 426 (83) 87 (17) 
>=75 248 (79) 66 (21) 
All 776 183 
Chi-squarc=3.4; df=2; p-valuc=O. 18 
Sex 
nudes 301 (81.1) 70 (18.9) 
females 473 (80.7) 113 (19.3) 
All 774 183 
Chi-squarc=0.02; df=l-, p-value=0.9 
Ocular Comorbidity: 
none 547 (84.0) 104 (16.0) 
mild to moderate 139 (73.8) 49 (26.2) 
severe 91 (75.2) 30 (24.8) 
All 776 183 
Chi-squarc=12.8; df=2; p-valuc=0.002 
The cumulative incidence of the major complications are presented in Table 3.14. The 
incidence of clinically detectable cystoid macular oedema at 3 months after surgery 
was 1.2% (n--12). This was associated with good visual acuity of 6/12 or better, in 
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eight of these patients. Three of these patients with good acuity had posterior capsule 
rupture during surgery, one of which was associated with vitreous loss. 
The incidence of endophthalmitis was 0.3%. All of these cases occurred within one 
month of surgery. (The definition of endophthalmitis did not distinguish between 
culture-proven and sterile endophthalmitis). The incidence of retinal detachment 
within three months of cataract surgery was 0.1% (n--I). This patient had had an 
extracapsular extraction with a posterior chamber intra-ocular lens implant. 
Table 3.14. Cumulative Incidence of the Major ComplicationL n=998. 
Type of Complication 
Intra-operative period : 
Number with Cumulative 95% C. I. 
Complication Incidence 
Capsule rupture 39 3.9% 2.79 to 5.30 
Capsule rupture and vitreous loss I11.1% 0.56 to 1.96 
Within one month : 
External infection 4 0.4% 0.1 to 1.2 
Endophthalmitis 3 0.3% 0.07 to 0.87 
At three months : 
Dislocated IOL 3 0.3% 0.07 to 0.87 
Retinal Detachment 1 0.1% 0.006 to 0.55 
Cystoid macular oedema 12 1.2% 0.63 to 2.09 
Posterior capsule opacification 63 6.3% 4.89 to 8.0 
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DETERMINANTS OF POOR CLINICAL OUTCOME 
Whilst the bivariate analyses provide some indication of the factors that appear to 
influence clinical outcome, the effect of confounding factors could not be assessed and 
no quantitative estimate of the adjusted risk of poor clinical outcome could be derived. 
The determinants of poor visual outcome and those for the occurrence of 
complications were considered separately using Poisson regression modelling 
procedures. Full details of these procedures are provided in Appendix A2 and A3. 
7.1 Risk Factors for Poor Visual Acuity Outcome 
The variables of interest used in the model are presented in Table 3.15. Due to the 
nature of the complications observed, those at three months after surgery were 
considered likely to influence visual acuity. Intra-operative complications were also 
considered as these may influence some of the complications seen at three months, 
particularly cystoid macular oedema and persistent uveitis. 
Univariate analysis had suggested that visual outcome was different amongst sub- 
groups of patients with and without ocular comorbidity. This was considered first in a 
Poisson regression model, unadjusted for the effects of any of the other variables. It 
was found to be a highly significant predictor variable, with increasing risk of poor 
visual outcome with increasing severity of comorbidity. This model was then extended 
to include those variables of interest that had complete records : age group, sex, visual 
acuity on admission in the surgery eye, geographic area, type of hospital, size of 
ophthalmic unit (given by number of consultants), occurrence of intra-operative 
complications, complications at three months, capsulotomy indicated, and whether 
glasses had been dispensed. A stepwise model fitted with these variables identified age 
of 75 years or over, female sex, the occurrence of complications at 3 months, if a 
capsulotomy had been indicated and if glasses had not been dispensed by three months 
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as additional predictors of poor visual outcome, having adjusted for the effects of all 
the other variables in the model. 
Interactions between age, sex, ocular comorbidity and the occurrence of surgically 
related complications were sought, but none were found to exert any statistically 
significant effect. 
The significant predictive factors identified were fitted on a restricted dataset which 
now included those with some missing values. Relative risks were obtained. The 
model was then extended to include the remaining variables of interest (length of stay, 
type of anaesthetic, grade of surgeon, and waiting time for admission) and a stepwise 
model performed. No additional significant predictive factors were identified. The 
estimates for relative risk for the significant predictive factors that had already been 
identified from the fuller dataset were only slightly affected with the exception of age. 
The confidence interval around the estimate for the relative risk for age from the 
restricted dataset included the null value and did not reach statistical significance. This 
was most likely the result of using a restricted dataset with fewer observations 
(Appendix A2). The findings of the model from the fuller dataset are reported and 
presented in Table 3.16. 
Increasing severity of ocular comorbidity was associated with increasing risk of poor 
visual outcome, having adjusted for all the other variables in the model. The presence 
of mild to moderate ocular comorbidity was associated with a relative risk of poor 
visual outcome of 1.9 (95% C. I. 1.4 to 2.8), with severe ocular comorbidity having a 
relative risk of 3,0 (95% C. I. 2.1 to 4.3). The occurrence of any complication 
(excluding posterior capsule thickening), at 3 months after surgery was associated with 
a relative risk for poor visual outcome of 2.0 (95% C. I. 1.5 to 2.8). Patients in whom 
a capsulotomy was indicated at 3 months after surgery also had a higher risk of poor 
visual outcome ( relative risk 1.7,95% C. I. 1.1 to 2.6). The older age group of 75 
years and over and female sex each had a relative risk for poor visual outcome of 1.4. 
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The following were not identified as risk factors for poor visual outcome : geographic 
area, type of hospital, size of ophthaln-dc department (given by number of consultants), 
length of stay, type of anaesthetic, grade of surgeon performing the procedure, and 
visual acuity on admission 
Table3.15 Variables used for Multivariate Analysis for Risk Factors for Poor Visual Outcome. 
Variable Description 
Dependent (Outcome) Variable: 
Visual Outcome 
Independent Variables: 
Patient characteristics - 
Agc (years) 
Sex 
Visual Acuity on admission - surgery eye 
Ocular Comorbidity on admission 
Structure - 
Area 
Type of hospital 
Number of consultants in ophthalmic department 
Surgical Process - 
Length of stay 
Type of anaesthetic 
Grade of surgeon performing procedure 
Waiting time for admission 
Interme&ate Outcomes - 
Complications at 3 months 
Capsulotomy indicated at 3 months 
Glasses dispensed by 3 months 
Good - visual acuity of 6/12 or better at 3 months 
Poor - visual acuity less than 6/12 at 3 months 
<75 years , >--75 years 
male or female 
6/6 to 6/12 
6/19 to 6/24 
6/36 to 6/60 
less than 6/60 
None 
Mild to moderate comorbidity: 
Drusen or RPE changes at the macula 
Background diabetic retinopathy 
Severe comorbidity : 
Disciform macular degeneration 
Diabetic maculopathy 
Proliferative diabetic retinopathy 
Glaucoma 
Amblyopia 
coded I to 19 
teaching, specialist eye, or district 
-c--2,3,4 or >4 
in-patient or day-case 
general or local 
Consultant, SR, Reg., SHO, Other 
<=6,7 to 12, >12 months 
present or absent 
yes or no 
yes or no 
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Table 3.16 Risk Factors for Poor Visual Acuity Outcome. 
Variable Relative Risk (RR) 95% CL p-value 
Age: >=75 years 1.4 1.1 to 1.9 0.017 
Sex : Female 1.4 1.05 to 1.9 0.025 
Ocular Comorbidity: 
Mild to Moderate 1.9 1.4 to 2.8 < 0.00 1 
Severe 3 2.1 to 4.3 < 0.001 
Other Outcomes : 
Complications at 3 months 2 1.5 to 2.8 < 0.001 
Capsulotomy indicated at 3 months 1.7 1.1 to 2.6 0.016 
Poisson regression model on 957 observations (having adjusted for the other variables in the model - Table 17). 
7.2 Risk Factors for Complications 
Only complications that were present at three months were considered as these 
appeared to be different to those occurring earlier in the post-operative period and 
were more likely to have long term sequelae, affecting visual acuity and requiring 
further care. The predictive variables of interest included in the model are shown in 
Table 3.17. 
Ocular comorbidity was considered first, unadjusted for the effects of the other 
variables of interest, and was found to be a significant predictive factor though its 
severity did not influence the estimate for the relative risk. The model was then 
extended to include the other variables of interest that had complete records, and a 
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stepwise model performed. No additional significant predictive factors were 
identified. Interactions between age, sex, ocular comorbidity and the occurrence of 
complications were sought, but none were found to exert any statistically significant 
effect (Appendix A3). 
Ocular comorbidity was then fitted on a restricted dataset which included those with 
some missing values, and the relative risks were obtained. The model was then 
extended to include the remaining variables of interest (length of stay, type of 
anaesthetic and grade of surgeon) and a stepwise model performed. No additional 
significant predictive factors were identified. A model was then fitted for ocular 
comorbidity on this restricted dataset, adjusting for the effect of age, sex, and grade of 
surgeon performing the operation. These other variables did not demonstrate any 
significant effect of their own, and the estimates for the relative risk for ocular 
comorbidity already identified from the fuller dataset were not seen to be affected 
(Appendix A3). The findings from the fuller dataset are reported and presented in 
Table 3.18. 
Neither the geographic area, the type of hospital , size of ophthalmic department 
(given by the number of consultants), length of stay, type of anaesthetic, nor the grade 
of surgeon performing the operation, was observed to influence the occurrence of 
complications at three months after surgery, in this sample of patients. 
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Table 3.17 Variables used for Multivariate Analysis for Risk Factors for Complications 
Variable Description 
Dependent (Outcome) Variable: 
Complications at 3 months 
Independent variables : 
Patient characteristics - 
Age (years) 
Sex 
Ocular Comorbidity on admission 
Strudure - 
Area 
Type of hospital 
Ntunber of consultants in ophthaln& department 
Surgical Process 
Length of stay 
Type of anaesthetic; 
Grade of surgeon perfonning procedure 
Prcscnt or Abscnt 
<75 years, >=75 years 
male or female 
None 
Mild to moderate 
Drusen. or RPE changes at the macula 
Background diabetic rctinopathy 
Severe : 
Disciform macular degeneration 
Diabetic maculopathy 
Proliferative diabetic rctinopathy 
Glaucoma 
Amblyopia 
coded I to 19 
teaching, specialist eye, or district 
<--2,3,4 or >4 
in-patient or day-case 
general or local 
Consultant, SR, Reg, SHO, Other 
Table 3.18 Risk Factors for Surgically Related Complications at 3 months 
Variable Relative Risk (RR) 95% CL P-value 
Ocular Comorbidity: 
Mid to Moderate 1.7 1.2 to 2.3 0.004 
Severe 1.6 1.04 to 2.3 0.03 
Poisson regression model on 957 observations (having adjusted for the Other variables in the model - Table 19. ) 
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8. DISCUSSION 
8.1 Study Method 
8.1.1 Possible Sources of Bias 
The biases of particular concern were selection bias and response bias that may have 
been operating during the identification of the sample of patients admitted for surgery. 
Either could influence the findings and compromise their generalisabilty. 
It was unlikely that any selection biases were operating through the selection of 
consultants (at the time of invitation to participate), as all eligible consultants were 
included in the sampling frame and were invited to participate, and there was no 
statistically significant difference between those that participated and those that did not 
(Table 3.1). As consultants were then required to identify and enter their patients into 
the study, it could have been possible to introduce a bias with respect topatient selection. 
Consultants were given very short notice of the study period and were only informed of 
the date of the study either on the last working day prior to, or the morning of the first day 
of, the survey week. This should not have provided sufficient time for consultants to 
change their admission plans. Although it seemed unlikely that admissions could not have 
been significantly altered, it was still possible for consultants to select only some (possibly 
the less complicated cases) of their eligible patients for inclusion in the study. It was not 
possible to validate the completeness of inclusion of all eligible admissions, and it had to be 
assumed that little or no selection bias was introduced at this stage. This assumption must 
be bourne in mind when considering the results. 
Another possible source of selection hias was the choice of the study week. It was 
possible that it may have been an atypical week for surgical activity though the findings 
indicate that this was not so in terms of the "activity" indicators defined for the study. 
The study week was found to be similar to levels of activity during the preceding 
months and the previous year. 
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Whilst it is not possible to exclude all possible sources of selection or response bias, it was 
considered that no important ones were operating during the study and that a representative 
sample of cataract patients was obtained from representative settings. 
8.1.2 Data Quality 
All data should have been collected at the time of admission, during the operation, and 
during post-operative follow-up. Whether this actually took place in all cases is not 
known. It was quite possible that some data were obtained retrospectively from the 
hospital clinical notes after the admission episode or the follow-up assessment, and that 
their quality or completeness could have introduced observation bias. 
Overafl, most data items were recorded for most patients, with most items being 
recorded in at least 90% of records. It is possible that where data were missing, the 
rest of the information on those patients may have been obtained retrospectively from 
the clinical notes, where some data may have been missing. Post-operative visual 
acuity in the fellow eye was the single most frequent item not recorded. As it is not 
the eye of primary interest, information on its acuity is less likely to be routinely 
recorded in the notes, unless there is a specific reason e. g. it may also need cataract 
surgery or management for some other condition. 
The accuracy (validity and reliabilty) of data recording was probably high as all forms 
were completed by ophthalmologists. As events of interest were confined to those that 
were clinically significant, this overcame any problems with interpretation of definitions 
and it was unlikely that important n-dsclassifications occurred. 
It was likely that the level of data completeness that was achieved from the large 
number of centres was because the data required were of the type that are used and 
recorded in everyday clinical practice. The findings demonstrate that it is possible for 
routine clinical data of this sort to be collected in a standardised manner, at a sufficient 
level of completeness, to provide useful information on surgical practice and clinical 
outcomes with sufficient detail to allow for case-mix adjustments to be made. 
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8.2 The Findings 
Micro-surgical practice is established with extracapsular cataract extraction and 
posterior chamber lens implantation being the procedure of choice. This is used 
routinely and widely offered to patients. A significant proportion of the surgical load 
(34%), is now devoted to surgery for second eyes. Although the median acuity at 
listing was 6/36, the implicit threshold at which surgery appeared to be clinically 
indicated was 6/18 for both first and second eyes. No age or gender differences in 
visual impairment were observed on admission for surgery. Whilst a small proportion 
of patients appeared to be admitted for surgery with good visual acuity, it is possible 
that surgery was indicated for the disability caused by cataract that may not be evident 
from Snellen acuity measurement alone. This study was not designed to consider these 
factors, but they are addressed more fully in the following chapters. 
The clinical outcomes of cataract surgery have been described. The findings indicate 
that cataract surgery is generally a clinically safe and effective intervention to improve 
visual acuity. Cataract surgery was found to be clinically safe in that sight threatening 
complications such as endoPhthalmitis and retinal detachment were infrequent events. 
The cumulative incidence reported for these events were consistent with comparable 
findings reported at similar post-operative periods. [97][119][120] [12 1] Thetypeof 
complications observed occurring during the intra-operative and immediate post- 
operative periods probably reflect handling and instrumentation of the eye during the 
surgical procedure. Whilst the complications in the immediate post-operative period 
are common, they are transient and resolve by three months and are not sight 
threatening. Cystoid macular oedema and persistent uveitis seen at three months are 
less frequent now compared to their occurrence using older surgical techniques. [97] 
The predominant complication three months after surgery was posterior capsule 
opacification. 6.3% of patients were affected, and in over half a further procedure 
(e. g. Yag laser capsulotomy) was indicated. Capsule opacification is now recognised 
as a common complication of modem cataract surgery. It has been estimated that at 
least 20% of patients are affected up to two years after cataract extraction. [ 122]. If 
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left unrecognised and untreated, it may progressively impair vision. Patients need to be 
informed about the possibility of this complication as many will have been discharged 
from care before they become symptomatic. 
Cataract surgery was found to be clinically effective in that 80% of all patients 
achieved a good visual outcome of an acuity of 6/12 or better, in the surgery eye, and 
that 90.3% of patients gained at least one Snellen line of acuity three months after 
surgery. It has been suggested that when change in visual acuity is considered over a 
relatively short period of time (7 weeks), then at least two lines of acuity, as measured 
by high contrast letter charts such as the Snellen chart, should be considered to 
constitute a statistically significant change in performance during routine follow-up of 
patients. [123] Using this criterion, 82% of patients gained at least two lines of 
Snellen acuity by three months after surgery. However, since the assessment of 
change in visual acuity in this study was made after a specific, and acute intervention, 
and that the time interval at which this was made was much longer (3 months), it was 
considered that a change in one line of Snellen acuity was likely to constitute a 
clinically important change when compared to the pre-operative acuity. Given the 
reliabilty of measuring uncorrected Snellen acuity at any one time, a real change in 
uncorrected acuity has been reported to constitute a doubling of the minimum visual 
angle. [87] In this study best corrected visual acuity was measured. Consequently it 
was possible that the reliability of measuring corrected Snellen visual acuity and that 
which constitutes a real change in acuity at separate occasions (before and three 
months after surgery), was at least the same as, or perhaps likely to better than that 
reported for measuring uncorrected Snellen acuity at any one time. Thus a change of 
one Snellen line of acuity three months after surgery as compared to pre-operative 
values, was considered likely to represent a clinically important change post- 
operatively. 
Outcome was not seen to be influenced by several measures of health care provision 
including grade of surgeon, type of hospital, size of unit, geographic area, length of 
stay or type of anaesthetic used. With a two-sided alpha error set at 0.05, the study 
had a power of 90% to detect a relative risk of 1.5 for poor outcome associated with 
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these factors. [124] Whilst it was possible that some smaller differences may have 
occurred and were not detected, it was unlikely that such small changes were of any 
practical significance. The predictive factors for poor clinical outcome that were 
identified, were not unexpected, except perhaps for age and sex which were identified 
as predictive factors for poor visual outcome. No adequate explanation was found for 
the observed risk of poor visual outcome associated with females and age 75 years and 
over, the estimates for their relative risks having been adjusted for the other variables 
in the model. Ocular comorbidity is an important predictive factor for both visual 
outcome and complications. As about a third of patients have some comorbid 
condition, quantification of the risk allows for patients to be better informed of the 
outcome of surgery they can expect, and for planning their post-operative 
management. 
Overall the findings provide previously unavailable information on the clinical 
outcomes associated with established riýiicro-surgical cataract extraction and posterior 
chamber intraocular lens implantation, that are achieved in routine clinical practice in 
the UK. 
Advances in surgical technique and intraocular lens technology have been aimed 
principally at providing better post-operative visual rehabilitation and quality of vision. 
Whilst the less frequent occurrence of complications is likely to be a direct 
consequence, of these developments, the impact of such changes on visual acuity is not 
as evident. The level of visual outcome currently achieved is about the same as that 
described over the last twenty years or so with less refined surgical techniques or 
during changing surgical practice, confirming that a cataract extraction (by any means) 
will improve visual acuity. This is not surprising for two main reasons. First, the 
burden of ocular comorbidity in cataract patients, which may influence visual outcome, 
is unlikely to have changed significantly over this time period. Second, visual outcome 
has only been assessed in terms of visual acuity (Snellen or its equivalent), measured in 
a clinical setting. Measurement of visual acuity by this means and in standard clinical 
settings does not reflect any improvement in the quality of the image or the quality of 
visual acuity and vision, that is provided by intraocular lenses (e. g. by the absence of 
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associated optical aberrations and negligible image magnification) and any influence 
that this improved quality of vision may have on visual functioning, and perhaps health 
related quality of life. This is considered in the following chapters. 
9. SUMMARY OF FINDINGS 
The main findings from this study may be surnmarised as follows: 
0A representative sample of patients having surgery for age related cataract was 
obtained from representative settings in the UK. 
Data collection was 90% complete 
Current clinical practice was described, confirming that microsurgical 
techniques for cataract extraction and posterior chamber intraocular lens 
implantation were procedures of choice and widely available. 
0 Second eye surgery constitutes a significant proportion of the cataract surgical 
workload. 
Cataract surgery was observed to be clinically effective in improving visual 
acuity in the eye that had surgery, with 80% of patients achieving a good visual 
acuity outcome. 
Cataract surgery was observed to be clinically safe in that most of the 
complications occurring after surgery were transient, resolving within 3 
months, and sight threatening complications were infrequent events. 
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0 Risk factors for poor clinical outcome were identified and quantified. These 
were patient-related factors, principally ocular comorbidity. 
0 Measures of health care provision were not found to be associated with poor 
clinical outcome. 
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Chapter 4 
THE CATARACT OUTCOME STUDY : METHODS 
1. INTRODUCTION 
The next five chapters (chapters 4 to 8) are concerned with patient perceived measures 
for the outcome of cataract surgery and their relationships with clinical measures, 
particularly visual acuity. A prospective cohort study of the impact of surgery on 
these measures in the context of the overall care provided was conducted - the 
Cataract Outcome Study. The main patient perceived measures used in this study 
were: 
i. visual function - this term refers to functioning in everyday activities that 
require vision 
I quality of life 
iii. vision-related quality of life 
The following approach was taken for their assessment and measurement : 
A disease specific measure of functional status (disability) was used. 
This was the VF-14, a functional index for vision related activities 
A generic measure was used for health-related quality of life (handicap) 
This was the Sickness Impact Profile (SIP). 
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A modified generic measure was used as a disease-specific measure for vision- 
related quality of life (handicap) - the Vision-Related -SIP. 
The objectives of the Cataract Outcome Study were : 
1. to describe and quantify the impact of cataract on visual acuity, visual 
function, and quality of life and their inter-relationships. 
to describe and quantify the short term (at 4 months) and medium term (at 12 
months) outcomes of cataract surgery in terms of visual function and quality of 
life and their inter-relationships. 
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2. STUDY DESIGN 
This was a prospective, observational cohort study of patients admitted for their first 
cataract extraction within the NFIS. It was conducted in three district general hospitals 
in two outer London districts in North Thames Region. All six consultants at the 
participating hospitals had agreed to take part in the study and to provide clinical data 
and access to their patients. The recruitment period for the study was from May 1994 
to August 1995. All patients were followed up for short term outcome at 4 months 
after surgery, and at 12 months after surgery for medium term outcomes. Some 
patients in the cohort were expected to have had surgery to the second eye during their 
12 month follow-up. 
Ethical approval from the appropriate district ethics committees was obtained. All 
patients received an explanation (verbal and written) about the objectives of the study 
and what would be required of them if they agreed to participate. Patients were 
required to provide written consent for their agreement to participate, prior to 
recruitment and entry into the study. 
The study centre was the Royal College of Ophthalmologists, London. 
3. SAMPLE SELEMON 
3.1 Centre Selection 
From the National Cataract Surgery Study, no significant associations were observed 
between clinical outcome and type of hospital, number of consultants in an eye unit, or 
by geographic area. Subsequently, the locations for the study were selected for the 
following reasons : 
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The hospitals selected provided a surgical service for cataract for an 
urban, suburban and rural populations 
The hospitals were typical in that they were district general hospitals 
The hospitals were of typical size in terms of the number of consultants in 
the department (n--3). 
North Thames Region was selected for the location of the study primarily for 
its proximity to the study centre thus facilitating administration of the study. 
3.2 Patient Selection 
All patients of 50 years of age and over that were to be admitted for surgery for age- 
related cataract to their first eye, during the recruitment period, were eligible for 
inclusion. Patients being admitted for second eye surgery and those patients having 
surgery for other types of cataract or combined procedures were not eligible for 
inclusion. 
All patients that had planned admissions for cataract surgery during the recruitment 
period were identified by the admissions departments of the participating hospitals. 
Those patients that were to be admitted for first eye surgery were sent a letter telling 
them about the study with an invitation to respond if they would be interested in taking 
part (provided in Appendix B 1). This was included with the routine admission 
correspondence which required a response regarding their availability for the proposed 
date of surgery. 
Patients who agreed to take part were then contacted by the study interviewer assigned 
to each district. At this time the interviewer was able to answer any queries that 
arose, and an appointment for the interviewer to visit the Patient at home (before their 
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pre-assessment and admission), was then arranged. At this first home visit the 
interviewer was required to obtain written consent from the patient before recruiting 
patients into the study and conducting the baseline pre-operative interview. 
The sample obtained was compared with a sample of at least equivalent size of the 
non-participating eligible patients, and the national sample from the National Cataract 
Surgery Study in terms of age and sex. 
SAMPLE SIZE 
The outcomes considered for sample size calculation were the patient perceived 
outcomes of visual function (VF-14) and quality of life (SIP and VR-SIP). Sample 
size was calculated to detect a specified level of difference 5T (effect size), in visual 
function and quality of life scores before and after surgery to the first eye, and between 
first and second eyes, , where 
8T ý Po - pi / cy. [125] (po is the mean score before 
surgery and pi is the mean score after surgery at the specified time, and a is the 
standard deviation of the scores before surgery. It has been suggested that 8T=0.2 
constitutes a small difference; BT ý-- 0.5 a moderate difference and 5T = 0.8 a large 
difference. [125] 
Sample size was calculated based on a paired t-test, using stringent criteria OT set at 
0.2) to detect a small difference in first eyes before and after surgery in patient 
perceived outcomes, with a two-sided alpha set at 0.05. A sample of 264 patients 
would have 90% power to meet these criteria, and a sample of 326 patients would 
have a power of 95%. 
For the outcome after second eye surgery, it was sufficient to detect a moderate 
difference in visual function and quality of life between surgery to the first, and 
subsequently the second eye, as it was possible that a small difference may not be 
distinguishable from the impact of surgery to the first eye. Sample size calculations 
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were based on an un-paired West, with5Tset at 0.5, a two-sided alpha set at 0.05. A 
sample of 85 patients in each group (first eye only and both eyes) would have 90% 
power to meet these criteria. 
5. CONDUCT OF THE STUDY 
Throughout the study, data collection was in two parts : clinical data and a patient 
interview. All clinical data were collected in a standardised manner on specific forms 
by ophthalmologists, and all interviews were conducted by trained interviewers. An 
interviewer-administered approach was chosen as, at least pre-operatively, patients 
were likely to be visually impaired, and this might have posed problems with self 
administration. In addition, the length of the interview might have caused difficulties 
for self-completion. 
All data were returned to the study centre and held on a custornised database using the 
Paradox 4.5 software, and all data were held in accordance with the Data Protection 
Act 1984. 
5.1 Clinical Data 
Before the study started, workshops were held at each hospital. All medical, nursing, 
clerical and administrative staff who were likely to be involved in the study were 
invited to attend. The objectives and the protocol for the study were presented and 
practical aspects of patient recruitment and follow-up that may be encountered during 
the conduct of the study were discussed. Contact personnel and phone numbers were 
also provided to ensure direct access and communication with study investigators. 
One consultant at each unit was identified as a local co-ordinator to take responsibility 
for the unit's overall participation and commitment, to supervise data collection and to 
facilitate communication between the unit and the investigators regarding progress of 
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the study and to facilitate the organisation of follow-up after surgery. The local co- 
ordinator was provided with feedback on a monthly basis on patient recruitment and 
data collection (e. g. completion, outstanding forms not returned to the study centre). 
In addition meetings were held with the principal investigator, every two months to 
discuss any issues arising . 
Clinical data based on the National Cataract Surgery Study were collected. The main 
items included : 
Pre-operatively - 
age 
sex 
best corrected visual acuity in each eye 
clinically evident ocular comorbidity 
history of medical comorbidity 
type of surgical procedure 
Peri-operatively andpost-operatively (within 48 hours) - 
the occurrence of complications : 
capsule rupture with and without vitreous loss 
endophthalnutis 
Post-operatively (at 4 and 12 months) - 
best corrected visual acuity in each eye 
the occurrence of complications: 
cystoid macular oedema 
posterior capsule opacification 
retinal detachment 
The full booklet of forms is provided in Appendix B2. Baseline pre-operative data 
were collected at the pre-assessment clinic, which was up to two weeks prior to 
surgery. The 4 month clinical follow-up was incorporated within the routine follow- 
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up arrangements for patients in the out-patient clinic. However, dedicated follow-up 
clinics were held for the 12 month clinical assessment, as this was not part of the 
routine post-operative management, unless specifically indicated. 
5.2 Patient Interview 
An interviewer was appointed for each district. This interviewer conducted all the 
interviews in his/her district. All the interviews (pre-operative, at 4 months and at 12 
months), were conducted at the patients' homes and were arranged by the interviewer. 
Training sessions were held for both interviewers together to standardise the 
administration of the interview. This also included instruction on dealing with 
additional explanations of questions that may be required before eliciting a response 
from the patient. Monthly meetings were held to review progress with recruitment and 
follow-up. The interviews contained several patient perceived measures and took 
about 45 minutes to administer. These measures included the following : 
a visual function index - the VF-14 
a generic quality of life instrument - The Sickness Impact Profile (SIP) 
a modified generic quality of life instrument - Vision-Related-SIP (VR-SIP) 
global measures of visual health 
global measures of health 
a cataract symptom scale 
a comorbidity "bothersome" scale 
The complete interview is provided in Appendix B3. The interview was administered 
in a standardised manner. It was appreciated that whilst the interview was 
comprehensive, this also meant that it was long. If, despite an explanation about their 
involvement in the study, patients felt that they could not or did not want to complete 
the entire interview, the interview was terminated at a standardised stage. This was 
half way through the interview and represented a natural break. The first half was 
related to vision and general health, and the second half was concerned with quality of 
fife (SIP and VR-SIP). 
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6. INSTRUMENTS FOR THE ASSESSMENT OF THE IMPACT OF 
CATARACT SURGERY 
6.1 Clinical Measure of Impairment : Visual Acuity 
As mentioned in Chapter 1, vision is made up of both optical and neural components. 
Visual acuity is probably the most significant measure of the functional integrity of the 
eye. All types of cataract, if sufficiently advanced, interfere with vision through their 
basic effect on the optical system of the eye, by causing light scattering. Although 
visual acuity receives the most attention in cataract, other aspects of the optical and 
neural functioning of the eye may also be affected and contribute to the overall effect 
on vision. These include contrast sensitivity, colour vision, visual field, binocularity 
and stereopsis. Although the symptoms of cataract quite often relate to these aspects 
of vision, unlike visual acuity, they are not routinely assessed in the management of 
patients with cataract. 
Visual acuity is regarded as an indicator of overall visual performance and as such, may 
be reasonably expected to be associated with "visual functioning" in the sense of the 
ability to perform vision-dependent tasks or activities. 
In this study, the purpose of measuring visual acuity was : 
0 to describe the overall visual outcome of cataract surgery i. e. the impact of 
surgery on the visual acuity of the affected eye. 
to describe and examine the relationship between visual acuity and the patient- 
perceived outcomes of visual function (VF-14) and quality of life (SIP and 
VR-SIP). 
to identify the appropriate measure of visual acuity that is associated with 
visual performance in everyday activities. 
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6.1.1. Measurement of Visual Acuity 
Visual acuity was measured by the Snellen Test Type. Whilst being aware of some of 
the limitations with this test type, [81][82][83] it was chosen because it is a universally 
recognised test of visual acuity, it enjoys legal status, and is the "standard" by which 
ophthalmologists judge and are judged. It is routinely used in clinical practice, it is 
widely available, and medical and nursing staff of ophthalmology departments are 
familiar with its use, recording and interpretation of the measurement. The standard 
back-illuminated Snellen optotype, conforming to British Standard 4274: 1968, [126] 
was used. 
Other types of high contrast acuity charts have been proposed as being more suitable 
for research purposes [84][85][86], but they are not routinely available in ophthalmic 
departments, and their use and the interpretation of the logMAR acuity provided is not 
as familiar to all staff involved in the care and assessment of routine cataract patients. 
6.1.2. Which Eye? 
Visual acuity is usually assessed unaided and best corrected (wearing glasses if worn, 
or with pin-hole or after refraction) for each eye, separately. Binocular visual acuity, 
assessed with both eyes simultaneously, taking account of the input from each eye, is 
not routinely assessed. When visual performance in both eyes are equal, binocular 
performance has been shown to be superior to that of the monocular -a phenomenon 
referred to as binocular summation [127. ] When the two eyes are not equal, binocular 
performance is lower than that for the better eye -a phenomenon referred to as 
binocular inhibition. [128-135] 
Whilst this may not affect the clinical outcome of cataract surgery assessed by the 
change in post-operative visual acuity in the surgery eye, it may be more important 
when considering the relationship between visual acuity and visual functioning (ability 
to perform vision-dependent activities) and quality of life. The best acuity in the better 
eye has been conventionally regarded as indicating the visual acuity that influences the 
individual's functioning in everyday activities. However this does not take account of 
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the individual contribution from each eye and the influence that this has on binocular 
vision. 
In the study, visual acuity was recorded for each eye (the surgery eye and the fellow 
eye), both unaided and best corrected. It was measured pre-operatively, and at 4 
months and 12 months after surgery. As the visual acuity in the fellow eye is not 
routinely measured and recorded in practice (especially after surgery), the need to do 
so was highlighted in the training workshops with clinical staff. The possibility of 
recording binocular visual acuity was also raised with the clinicians, but was 
abandoned because it was felt to be too far removed from routine practice and would 
therefore suffer from poor compliance and compromise data quality. 
6.2 The VF-14 - An Index of Visual Functioning 
A Disease-Specific Patient Perceived Measure of Disability 
The VF-14 is a new instrument designed to provide a specific measure of functioning 
(visual functioning) in cataract patients. [ 136] It contains 14 items which include a 
broad spectrum of vision-dependent activities performed in everyday life that may be 
affected by cataract. It has been used for the first time in the UK in this study. 
6.2.1. Development of the VF-14 
The instrument was developed by the Cataract-PORT Team based at Johns Hopkins 
University. Although it was designed to provide a patient-ofiented assessment of the 
impact of cataract and cataract surgery on visual functioning, its origins were based in 
clinical practice and clinical experience. 
Initially, relevant items (based on clinical observations in practice) were identified by 
the ophthalmologists on the team. These were based on the functional symptoms they 
commonly ascertained from patients in routine practice when assessing a patient for 
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cataract surgery. In addition the team reviewed vision-dependent tasks in other 
instruments assessing functional status and vision-research 
questionnaires[ 103][137][13 8], to identify any functional activities that might be 
affected by cataract, for inclusion in the initial list. This list was then reviewed by an 
expert national advisory panel (Cataract-PORT Study), which was composed of 
ophthalmologists and optometrists. The panel were asked to ensure that : the list 
contained the full spectrum of functional limitations experienced by cataract patients; 
to exclude or combine any items that may constitute functionally equivalent tasks with 
respect to vision; and to specify relevant functional activities that had not yet been 
identified. [ 13 6]. Following this process, the final instrument contained 14 items. 
6.2.2. Content and Administration of the VF-14 
The full instrument is presented in Appendix B3. The range of activities encompass 
all Possible aspects of vision: 
e near vision e. g. reading small print (labels etc. ), reading a book or 
newspaper, sewing, carpentry, writing letters/ filling out forms 
intermediate e. g. watching TV, seeing steps/kerbs, cooking 
e distance vision : e. g. reading street / shop / traffic signs, recognising people 
close by, sports, driving 
The 14 items addressed by the index were assessed by 18 questions. For each of the 
12 items not related directly to driving, patients were asked whether, even with their 
most recent glasses, they had any difficulty in doing the activity. The responses 
allowed were "yes", "no", or "do not do that activity for reasons unrelated to visiorf. 
For each activity for which patients responded to as "yes", they were asked how much 
difficulty they currently had with that activity - "a little', "moderate amount", "great 
deal" or "unable to do", because of their vision. The last two items in the index were 
concerned with difficulties with day-time and night-time driving and were asked in a 
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slightly different fashion to take account of current drivers and those patients who 
either did not currently drive or had never driven. 
The VF-14 was contained in the patient interview and was administered by trained 
interviewers pre-operatively and at 4 and 12 months after surgery. 
6.2.3 Scoring of the W-14 
For each of the items addressed in this index, a score of 4 was assigned when patients 
reported "no difficulty" with the activity; a score of 3,2 or 1, when patients reported 
"a little", "a moderate amount", or "a great deal" of difficulty, respectively, with the 
activity, and a score of 0 when patients were "unable to do" that activity because of 
their vision. The score is based on applicable items and the amount of reported 
difficulty experienced in performing those activities. An item was not included in the 
scoring if patients did not do that activity for a reason other than their vision e. g. if 
patients had never taken part in sports or if they never cooked for themselves . No 
minimum number of applicable items was required. 
Scores on all activities that the patients performed or did not perform because of their 
vision were then averaged, producing an average score between 0 and 4. This average 
score was multiplied by 25 to provide a possible final score ranging from 0( unable to 
do all applicable activities because of vision) and a maximum of 100 (able to do all 
applicable items without difficulty). 
The purpose of measuring visual function using the VF-14 was to : 
0 describe and quantify the impact of cataract and surgery on visual function 
41 to describe and examine the relationship between visual function and visual 
acuity and quality of life. 
to assess its contribution to measuring the outcome of cataract surgery 
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6.3 Global measures of vision: 
Disease-Specific Patient Perceived Measure of Disability 
Patients were asked two general questions regarding their vision. The first related to 
the overall amount of trouble they were having with their vision. The response options 
were "none', "a little', "a moderate amount ", or "a great deal". The second question 
related to the overall satisfaction of the patients with their vision. The response 
options were "very dissatisfied", "moderately dissatisfied", "moderately satisfied", or 
"very satisfied". (Appendix B3) 
6.4 Global measures of health: 
Generic Patient Perceived Measure of Disability 
Patients were asked two questions regarding their general health. The first related to 
their rating of their general health. The response options were : "excellent", "very 
good", "good", "fav, or "poor". The second question related to their assessment of 
their general health compared to other people their own age. The response options 
were: "much better, "somewhat better", "about the same', "somewhat worse", or 
"much worse'. (Appendix B3) 
6.5 The Sickness Impact Profile: 
A Generic Measure of Health-Related Quality of Life - Handicap 
The Sickness Impact Profile (SIP) was used to assess the quality of life of patients 
having cataract surgery. it has not been used before on cataract patients in the UK. It 
was selected for this study in preference to the UK version of the SIP (the FLP), [149] 
to allow for consistency with a similar study carried out in the USA. The SIP is also a 
well established generic measure of health status and quality Of life, which has been 
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extensively evaluated, validated and widely used. [63][136][139 - 148]. Acopyis 
provided in the Appendix B3. 
6.5.1. Background and Development of the SIP 
The SIP was developed as a measure of patient perceived health-related quality of life, 
for use as an outcome measure for health care evaluation across a wide range of health 
problems and diseases, across socio-demographic and cultural sub-groups. It was 
designed to be sensitive to change or differences in health-related quality of life that 
occur over time or between groups and was intended for use in measuring outcomes of 
health care. [63 [64] 
Sickness is measured in relation to its impact on behaviour. The profile emphasises 
sickness-related dysfunction (impact of sickness on daily activities and behaviour ) as 
such reports can be verified by observation and can be obtained whether or not a 
patient is receiving care. The items included in the SIP focus upon changes in 
performance rather than capacity i. e. they are concerned with what a person does or 
does not do, rather thanwith what they can or cannot do. 
The instrument was developed on the basis of a literature review, statements collected 
from health professionals, and interviews with healthy and ill people which described 
"sickness related dysfunction! '. Following a succession of field trials the final version 
contained 136 items referring to illness-related dysfunction in 12 categories : work, 
recreation and pastimes, emotional behaviour, alertness behaviour, home management, 
sleep and rest, eating, body care and management, ambulation, mobility, 
communication and social interaction. [64] Only those statements which apply to 
respondents on the day of completion and are related to their health are endorsed. 
6.5.2 Reliability and Validity of the SIP 
The reliability and validity of the SIP have been evaluated and described in detail [64] 
and are summarised here. 
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Regarding reliability, the SIP has high internal consistency (r--0.94) and high test-retest 
reliability (r--0.92). Reliability in these terms was also high when considered by mode 
of administration of the SIP : test-retest reliability r--0.97 for interviewer administered, 
r--0.87 for self-administration; and internal consistency was similar for both modes of 
administration (r--0.94). Criterion validity and convergent and discriminant validity of 
the SIP were moderate to high and in the direction hypothesised. [64] Thesewereall 
tested in the USA. It had to be assumed that the validity and reliability in the UK 
would also be satisfactory, as no testing as has been reported. 
6.5.3. Scoring of the SIP 
The responses can be summarised by an overall score, by physical and psychosocial 
dimension scores or by category scores. All scores range from 0 to 100. The lower 
the score the better the respondents' health status. A score of 0 indicates no reported 
dysfunction and as score of 100 severe dysfunction. 
The score for the SIP may be calculated using item weights that indicate the relative 
severity of limitation implied by each statement. [64][139] The overall score is 
calculated by adding the scale values for each item checked across all categories and 
dividing by the maximum possible dysfunction score for the SIP. This figure is then 
multiplied by 100 to obtain the overall SIP score. The two dimension scores are 
calculated using a similar formula but limiting the calculations to the relevant items 
ambulation, body care and management, and mobility for the physical dimension score; 
and social interaction, alertness behaviour, emotional behaviour and communication for 
the psychosocial dimension score. The remaining categories - sleep and rest, eating, 
work home management and recreation and pastimes - are each calculated separately 
as independent category scores. 
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6.6 Vision-Related Sickness Impact Profile (VR-SIP) : 
A Disease Specific (Modified Generic) Measure of Vision-Related Quality 
of Life - Handicap 
The Vision-Related SIP (VR-SIP) represents a modification of the generic SIP (see 
Appendix 133). It was developed by the Cataract PORT team at Johns Hopkins 
University. Its purposes were to quantify how much of their general dysfunction and 
quality of life patients attributed to their vision i. e. provide a measure of vision-related 
quality of life, and to improve the sensitivity of the SIP. Each time patients responded 
positively to an item contained in the SIP, they were asked whether they thought the 
statement applied because of their vision. Responses to the latter questions were used 
to calculate a Vision-Related SIP score in the same manner as for SIP, providing an 
overall score, two dimension scores and category scores. This modification has 
previously only been used on a sample of cataract patients in the U. S. This is its first 
use in the UK. 
The purpose of using the SIP and VR-SIP was: 
9 to describe the impact of cataract and surgery on health and vision-related quality 
of life. 
to describe and examine the relationship between health and vision-related quality 
of life and visual acuity and visual function. 
to assess their contribution to measuring the outcome of cataract surgery 
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6.7 Cataract symptom "bother" score: 
A Disease Specific Measure - Handicap 
Patients were asked about whether they were bothered by any of five symptoms that 
are commonly reported by patients with cataract. These included : double or distorted 
vision; seeing glare, halo or rings around light; blurry vision; colours looking different 
than they used to in a way that is disturbing ; and worsening of vision within the past 
month. If the patient was bothered by a symptom, a score of I was assigned to it, 
and a score zero if the patient was not bothered by that symptom. The sum of the 
scores for all five symptoms was then multiplied by 20 to provide a cataract symptom 
score ranging from 0 (not bothered by any of the symptoms), to 100 (bothered by all 
five of the symptoms). 
The full symptom scale is provided in Appendix B3. 
6.8. Comorbidity "bothersome" score: A Generic Measure- Handicap 
Patients were also asked whether they had any of 29 medical symptoms or conditions 
derived in part from the list of illnesses in the Functional Assessment Inventory [ 1501 
and, if they did, how much each interfered with their activities C'not at all", "a little', 
or sca great deal"). For each symptom or condition, a score of 0 was assigned if the 
patient did not have the symptom or condition. A score of 1,2, or 3, was assigned if 
the patient had the symptom or condition and was either "not bothered by it", was 
bothered "a little' by it, or was bothered "a great deal" by it, respectively. Scoreson 
the 29 items were summed yielding possible medical comorbidity bothersome scores 
ranging from 0 to 87. 
The complete scale is provided in Appendix B3. 
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STATISTICAL METHODS 
7.1 Introductory Notes 
The descriptive findings regarding the characteristics of the study sample and the 
clinical outcomes are reported first. Where appropriate, the 95% confidence intervals 
are provided for the estimates obtained. For proportions, these were calculated by the 
normal approximation to the binomial distribution for large proportions and by the 
exact method for smaller ones. [116] For continuous variables the un-paired Mest was 
used to test the significance of an observed difference between the mean values of 
different groups or sub-groups. For comparing patients before and after surgery the 
paired Mest was used. For categorical variables the Chi-square test was used to 
detern-dne whether the observed differences in proportions between sub-groups was 
statistically different. 
The methods of analysis for the main outcome measures of interest (visual acuity, 
visual function, health- and vision-related quality of life) and their relationships are 
described in the following sections. All analyses were performed using SPSS 6.1 for 
Windows [151 - 153]. 
7.2 Clinical Measure: Visual Acuity 
Snellen visual acuity was treated both as a continuous variable and as a categorical 
variable when grouped according to level of acuity. The visual acuity groups were 
defined as : 
6/6 to 6/12 good visual acuity 
6/18 to 6/24 moderate visual impairment 
6/36 to 6160 severe visual impairment 
less than 6/60 blind. 
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A Snellen acuity of 6/12 is the minimum legal requirement for a driving licence in the 
UK. Acuity of 616 to 6/12 is thus regarded as "good" visual acuity. The visual acuity 
groups took into consideration the reliability of measuring acuity, at any one time, 
using the Snellen (or equivalent high contrast) test types, [87] and the limitations of this 
chart for measuring very good or very poor levels of visual acuity [81] [82] [83]. 
Visual acuity was considered in terms of the : 
a. Surgery eye visual acuity - the best corrected visual acuity in the eye that had 
surgery before and after surgery 
b. Better eye visual acuity - the best corrected visual acuity in the patient's better 
eye . Pre-operatively this was most 
likely to be the fellow eye, but could possibly be 
the surgery eye in some cases. Post-oPeratively this was most likely to be the surgery 
eye. 
c. Person Visual Acuity (VP) Score - this represents an attempt to take account of 
the visual acuity input from both eyes and is described below. 
7.2.1 Calculation of the VP Score and VP% 
To calculate the VP score, the monocular visual acuity from each eye was first 
grouped as follows: 
616 to 6/9 1 
6/12 to 6/18 2 
6/24 to 6/36 3 
6/60 4 
6/60 5 
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The groups in this case were distinguished by two Snellen lines of acuity up to 6/36 
and then acuities of 6160 and less than 6160 constituted separate 
groups[81][82][83][87]. A score matrix was then produced as shown in Table 4.1. 
for all fifteen possible, distinct combinations of visual acuities ranging from 0 to 14, 
based on this grouping. 
Table 4.1 Matrix of Possible Combinations of Grouped Visual Acuities from Both Eyes 
VPSCORES 
Right Eye Visual Acuity 
6/6 to 6/9 6/12 to 6/18 6/24 to 6/60 6/60 less than 6160 
Left Eye Visual Acuity 1 23 4 5 
616 to 6/9 1 14 13 12 11 10 
6/12 to 6118 2 13 98 7 6 
G24 to 656 3 12 85 4 3 
6160 4 11 74 2 1 
less than 6160 5 10 65 1 0 
Ughlighted cells (14.9.5,2,0) wiffiin the table represent equal visual acuities in each eye 
Each combination (VP score) was then scaled to a maximum score of 100, calculated 
as follows: 
Vp %= (VP/14)] x 100 
A maximum score of 100 represented equal vision of 6/6 in both eyes and a minimum 
score of 0 represented bilateral blindness. This score reflected not only the visual 
acuity in each eye but also the disparity between the two eyes. It corresponded to a 
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weighting of about 75% to the eye with better acuity. For example, taking extreme 
visual acuities of 6/6 in one eye and blind in the fellow eye, corresponds to a combined 
VPscoreofIO(Table4.1), andaVP%of72. This approach was consistent with 
' 
other reported methods for combining the visual acuities of both eyes to arrive at a 
visual acuity score for the person. [154][155][156] 
7.2.2 Associations between measures of visual acuity 
In order to identify which measure of visual acuity (surgery eye, better eye, VP score) 
would be the most appropriate indicator of visual performance influencing visual 
function (ability to perform vision-dependent activities and tasks) and quality of life, 
bivariate correlations (Pearson and Spearman) were first made between surgery eye 
acuity, better eye acuity and VP score, both before and after surgery. Next, 
associations between measures of visual acuity and measures of Visual function and 
health- and vision-related quality of life were investigated by means of bivariate 
correlations. 
7.3 Patient Perceived Measures : VF-14, SIP9 VR-SIP 
The VF-14 provided a score of visual functioning ranging from 0 (greatest 
dysfunction) to 100 (no reported dysfunction). Both the actual score (either pre- or 
post-operatively) and the change in score post-operatively, were continuous variables 
and were treated as such in all analyses. 
The SIP and VR-SIP each provided an overall score, dimension scores and twelve 
category scores ranging from 0 to 100. These scores were continuous variables and 
were treated as such in all analyses. 
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The relationships between visual acuity, visual function and health and vision-related 
quality of life were examined pre-operatively using the actual visual acuity and actual 
scores for visual function and quality of life; and post-operatively with the change in 
visual acuity and change in score. 
The change in score, rather than the absolute score achieved after surgery, was 
preferred for analysis of post-operative data as it represents the impact of cataract 
surgery on visual acuity, visual function, health and vision-related quality of life. The 
VF-14, SIP and VR-SIP each provide a finite, maximum achievable score of 100, and 
the maximum achievable Snellen visual acuity was 6/6. The actual score or visual 
acuity achieved after surgery represents the level of performance at that time, and does 
not provide any indication of the gain (or loss) achieved from pre-operative levels. As 
it is highly unlikely that all patients would have the same, or similar levels, of visual 
acuity, visual functioning or quality of life pre-operatively, they would therefore have 
different capacities for gain or loss as a result of surgery. The actual post-operative 
score or acuity does not take this into account, nor does the change in score or change 
in acuity per se. Therefore the change in score or acuity was adjusted for by the pre- 
operative values, thereby providing a better indication of the effect of cataract surgery 
on acuity, visual function or quality of life. (This is discussed in detail later in 7.3.7). 
7.3.1 Reliability and Validity of the VF-14 
The VF-14 is a new instrument. Aspects of the reliability and validity of the VF-14 
have been reported for a sample of cataract patients in the U. S. [136] Wehaveused 
the VF-14 for the first time on cataract patients in the UK and performed an 
independent assessment of these characteristics for this instrument. Reliability and 
validity was assessed using the pre-operative VF-14 score. 
The reliability of the VF-14 was only assessed in terms of its internal consistency. 
It was expected that the items should be modestly correlated with one another and that 
each item should correlate with the total score. This was done by computing 
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Cronbach's alpha. Cronbach's alpha is a reliability coefficient based on the internal 
consistency of a test. It is an inter-item correlation statistic and is based on the average 
correlation of itemswithin the test. It can be interpreted as correlation coefficient with 
a value ranging from 0 to 1. [153] 
The validity of the VF-14 was considered in terms of content validity and criterion 
validity. 
Content Validity - The final instrument containing 14 items was produced following 
a review by an expert national advisory panel composed of ophthalmologists and 
optometrists to ensure that : the list contained the full spectrum of functional 
limitations experienced by cataract patients; to exclude or combine any items that may 
constitute functionally equivalent task with respect to vision; and to specify relevant 
functional activities that had not yet been identified. [ 136] In doing so, this exclusively 
professional and clinical expert panel assessed the content validity of the instrument. 
Criterion Validity - Since the VF-14 is an index of visual functioning, the basic a 
priori assumption was that it should have some, though not necessarily a close 
relationship with visual acuity. Criterion validity was assessed by examining the 
correlation between the pre-operative VF-14 scores and several other measures of 
vision. These included visual acuity on admission and global self rating of function for 
the overall amount of difficulty and satisfaction patients had with their vision. 
Correlation with quality of life was also examined. 
7.3.2. Reliability and Validity of the SIP and VR-SIP: 
Whilst it was assumed that the reported validity and reliability of the SIP would also 
apply to UK patients, neither the SIP nor the VR-SIP have been used in the UK for 
cataract patients. 
Their criterion validity was assessed by using their pre-operative scores. In the case of 
SIP, the assumption was that it should have some relationship with measures of health. 
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This involved an examination of the correlation between the pre-operative scores and 
other measures of health: global self rating of health and the comorbidity 
"bothersome' score. In the case of VR-SIP, the assumption was that it should have 
some relationship with visual health. This involved an examination of the correlation 
between the pre-operative scores and other measures of visual health : visual acuity, 
VF-14 scores, and global self rating of vision. 
7.3.3 Description of Scores : 
Pre-operatively and at 4 and 12 months after surgery 
Descriptive summaries of all scores (pre-operative and post-operative scores, and 
change in scores post-operatively) are presented first for each time period. These are 
described in terms of their means Arith standard deviation and 95% confidence 
intervals; the median and inter-quartile range; and the minimum and maximum values. 
Crude (unadjusted) relationships between pre-operative score, or change in score, and 
continuous variables of interest (pre-operatively and post-operatively) were then 
examined. First, scatterplots and Pearson and Spearman (non-parametric) correlation 
coefficients indicate whether an association exists or not for criterion validity. Simple 
linear regression with pre-operative score or change in score, as the dependent variable 
and any one of the other variables of interest, in turn, provide regression coefficients to 
describe the strength of this association. Diagnostic plots for the validity of these 
regressions were also examined. 
Absolute scores and change in scores, within sub-groups of categorical variables were 
then considered. The mean scores (s. d. and 95% confidence intervals) and median 
score (with inter-quartile range) within each sub-group are presented. The means 
were compared either by a t-test for comparison of two groups; or by a one-way 
analysis of variance using the Bonferroni test of significance for multiple comparisons, 
with the level of si0ficance set at 0.05. [151] Where the Levene test for homogeneity 
indicated that the assumption of equal variances was not held for a one-way analysis of 
120 
variance, the non-parametric Kruskal-Wallis test was used. This is a non-parametric 
alternative to a one-way analysis of variance. 
7.3.4 Determinants of Pre-operative Scores : VF-14, SIP and VR-SIP 
Independent factors that may influence pre-operative score (VF-14, SEP and VR-SIP) 
were considered in separate multiple regression models. The models provided 
regression coefficients (partial regression coefficients in the case of pre-operative VF- 
14 scores), which indicate how much the value of the dependent variable changes when 
the value of the independent variable increases by one unit, when the effect of the other 
independent variables are removed (i. e. adjusting / controlling for the other variables 
in the model). It indicates the nature of the relationship between the dependent 
variable (e. g. pre-operative VF-14 score) and the independent variable under 
consideration. The t-statistic and its observed significance level is used to test the null 
hypothesis that the population partial regression coefficient observed for a variable is 
zero. It indicates whether a significant relationship exists or not. 
The accompanying analysis of variance tests several equivalent hypotheses : 
0 there is no linear relationship in the population between the dependent variable 
and the independent variables 
0 that all the population regression coefficients are zero 
that the population value for multiple R=0. 
This is the correlation coefficient between the observed value of the dependent 
variable and the predicted value based on the regression model. 
The validity of the regression models was tested through: 
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a. plotting a histogram of the standardised residuals. These should be normally 
distributed. 
b. normal P-P plot of residuals of SIP and VR-SIP scores - this is a plot of the 
distribution of observed standardised residuals against a standard normal 
distribution. The observed residuals should lie close to the expected normal 
line. 
Complete details of all models and accompanying diagnostic plots are presented in the 
Appendix C (C2, C3 and C4). 
The presence of any important interactions in the model were examined using a 
multifactor general ANOVA. 
7.3.5. Change in Score Post-Operatively 
Paired Wests and equivalent non-parametric tests (Wilcoxon Matched-Pair Signed 
Ranks Test and the Sign Test) were performed to assess the magnitude and statistical 
significance of the change in VF-14 scores, SIP and VR-SIP scores post-operatively, 
(at 4 and 12 months). 
7.3.6 Responsiveness to Change 
The minimum amount of change in VF-14 score, SIP score or VR-SIP score, that may 
be considered clinically significant in cataract patients is not known. Responsiveness 
to change, is the ability of an instrument to detect small but important change after 
surgery. [ 157][158] In addition to validity and reliability, responsiveness to change is 
recognised as an important characteristic of patient perceived measures which indicates 
the suitability of an instrument for measuring change. [ 15 8] [15 9] [160] 
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Responsiveness to change was considered in terms of effect size. Effect size has been 
suggested as a measure to assess responsiveness to change that provides a standard 
unit of measurement for comparison purposes. [ 160] Effect size is given by the ratio 
of the mean change in scores post-operatively and the standard deviation of the pre- 
operative scores. Its computation takes into account the variability in baseline scores 
as well as the change in scores after an intervention (pre- and post-operative in this 
case). [160] To allow for the presence of highly skewed score distributions, effect 
size was also computed and is presented as the ratio of the median change in score 
post-operatively and the inter-quartile range of pre-operative scores. [ 160]. Effect 
sizes for SIP and VR-SIP were computed for overall scores, dimension and category 
scores. 
An effect size of 1.0 is equivalent to a change of one standard deviation in the sample. 
As a benchmark for assessing the relative magnitude of a change, it has been suggested 
that an effect size of 0.2 is a small, 0.5 is a moderate and 0.8 is a large effect size. [125] 
7.3.7 Determinants of Change in Score Post-Operatively 
The multifactor general ANOVA model was used to identify some of the determinants 
of change in scores. This method allowed for analysis of paired data (change in visual 
function score) and factored variables (e. g. presence of ocular comorbidity), whilst 
examining covariates that may be "determinants" of change in visual fiinction post- 
operatively. It also provides information regarding the contribution made by 
covariates and factors to the model and their relationships with each other. The 
validity of the ANOVA analysis models were tested through : 
a. tests for homogeneity of variance (Cochran's and Bartlett-Box tests) - these 
should give p-values well in excess of 0.05. 
b. plotting the standardised residuals by cases - there should be no obvious 
pattern in the scatterplot. 
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C. Normal Q-Q plot of residuals of change in VF-14 score at 4 months or 12 
months - this is a plot of observed residuals by residuals that would be 
expected if they had a normal distribution. The observed residuals should lie 
close to the expected normal line. 
Details of all the models are provided in the Appendix D. 
Models were first fitted to establish the relationship between change in visual function 
post-operatively and visual acuity i. e. pre-operative visual acuity in the better eye, and 
the change in better eye visual acuity post-operatively. 
As patients had different levels of visual function or quality of life pre-operatively, their 
capacity for change after surgery was taken into account when identifying determinants 
of change after surgery. This required inclusion of the pre-operative score in the 
models. Although the pre-operative score is correlated with, and involved in the 
calculation of, the change in score post-operatively, its inclusion in the ANOVA 
models as a covariate was to control for its potential confounding effect on the 
relationship between change in score and visual acuity. Similarly when examining the 
relationship between change in score and change in better eye visual acuity post- 
operatively, the pre-operative better eye acuity was also included as a covariate to 
adjust for the capacity for change in visual acuity that was possible after surgery. 
The presence of confounding was assessed by comparing the unadjusted and adjusted 
estimates for the regression coefficients for pre-operative better eye visual acuity and 
change in better eye visual acuity. Confounding was considered to be present if the 
estimate for the regression coefficients meaningfully changed when the variables for 
capacity for change were included in the model. The interpretation of a "meaningful" 
change was based on [ 16 11: 
9 the comparison of the size of the estimates numerically 
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the examination of the effect on the confidence intervals of the adjusted and 
unadjusted regression coefficients - whether adjusting for the confounding 
variable had any effect on the precision of the estimate for the regression 
coefficient - i. e. were the confidence intervals for the adjusted regression 
coefficients narrower than those for the unadjusted estimates. 
8. SUMMARY OF METHODS 
The methods used to achieve the objectives of this study may be summarised as 
follows : 
The study method was that of a prospective study design of patients admitted 
for surgery for age related cataract in their first eye, some of whom went on to 
have surgery to their second eye during the study period. Patients were 
followed up at 4 months and 12 months after surgery. 
The main measures of outcome were both clinical (visual acuity) and patient 
perceived (visual functioning and quality of life) 
The instruments used for these main outcome measures were - 
Snellen visual acuity - the surgery eye, the better eye, and v-person 
acuity 
Visual functioning - the VF- I 
Quality of life - the Sickness Impact Profile (SIP) 
Quality of life affected by vision - the VR-SIp (modified SIP) 
The main statistical methods using multiple regression and analysis of 
covariance methods, provided measures of association describing and 
examining the relationships between visual acuity, visual function and quality of 
life. 
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Chapter 5. 
THE CATARACT OUTCOME STUDY : RESULTS 
SAMPLE CHARACTERISTICS, DATA COMPLETENESS, 
CLINICAL OUTCOMES AND MEASURES OF VISUAL ACUITY 
1. RECRUITMENT 
There were 2409 patients that were admitted for cataract surgery in the participating 
hospitals, during the recruitment period (May 1993 to August 1994). Of these, 840 
(34.5%) patients were being admitted for second eye surgery and 91 (3.8%) patients 
were adn-dtted for combined procedures or for surgery for other types of cataract, and 
were not eligible for inclusion. There were thus 1478 eligible patients that were invited 
to participate in the study of whom 337 (22.8%) consented and were recruited to the 
study. (Figure 5.1) 
A random sample of 376 patients who were eligible for inclusion but that did not take 
part in the study was obtained. This represented a third (33%, n=376/1141) of all non- 
participants. Participants were compared with the non-participants and with the 
patients included in the National Cataract Surgery Study. As presented in Table 5.1, 
they were found to be similar and no significant differences were observed in terms of 
age and sex. 
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Figure 5.1 Recruitment of patients to the study, and follow-up. 
2409 
patients admitted for surgery in participating hospitals 
during recruitment period 
Eligible patients 
invited to participate 
1478 
22.8% 
Not Eligible = 931 
840 (34.5 %) admitted for second eye surgery. 
91 (3.8 %) admited for combined procedures or for 
other types of cataract. 
Lost to follow-up 
21 
316 
Lost to follow-up 
38 
12 Months follow-up 
278 
Total lost to follow-up = 59/337 = 17.5 
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14 Months follow-up I 
Table 5.1 Comparison of the Study Sample with Non-Participating Patients and a National 
Sample of Cataract Patients 
Participants Non-Participants National Sample # 
n--337 n=376 n=1495 
n (11/0) n (l/e) n (OM 
Age (yrs) 
50-64 35 (11.3) 36 (9.6) 199 (13.3) 
65-74 99 (29.4) 108 (28.7) 449 (30) 
>-75 200 (59.3) 232 (61.7) 850 (56.7) 
Chi-square--0.69 99 Chi-square=1.22 
df=2; p=0.71 
. 
df=2; p=0.54 
Sex 
males 131 (38.9) 121 (32.1) 576 (38.5) 
females 206 (61.1) 253 (67.9) 919 (61.5) 
Chi-square=3.29 ## Chi-square=0.014 
df=l; p=0.07 df=l, p=0.91 
Eligible patients that did not participate in this study 
Comparison between participants (study sample) and non-participants 
# Sample from the National Cataract Surgery Survey 
## Comparison between participants (study sample) and the national sample of patients 
1.1 SIP Responders and Non-Responders 
Of the 337 participants, 273 (8 1 %) patients had complete interviews , providing 
responses to the SIP and VR-SIP before surgery. These patients were compared with 
those that did not complete the interview. No significant d ff i erences were 
demonstrated between the groups in terms of marital status, living alone or not, and 
pre-operative visual acuity in the surgery eye. This was also true for length of stay. 
(Table 5.2) 
128 
Table 5.2 SlIP and VR-SIP : Responders and Non-Responders before surgery. 
SIP Respondents SIP Non-Respondents 
n=273 n=64 
n (0/6) n (%) 
Marital Status 
married 137 (50.2) 35 (54) 
not married 136 (49.8) 29 (46) 
Chi-squarc--0.42; df=l, p=0.52 
Uving alone 115 (42.2) 29 (44.1) 
Not living alone 158 (57.8) 36 (55.9) 
Chi-square=0.06-, df=l; p=0.81 
Visual Acuity In 
Surgery Eye (n=250) 
616 to 6/12 59 (23.6) 10 (18.8) 
6/18 to /624 112 (44.8) 27 (51) 
6136 to 6160 42 (16.8) 10 (18.8) 
less than 6/60 37 (14.8) 6 (11.4) 
Chi-square=1.27; df=3; p=0.74 
lAngth of Stay (n--254) 
In-patient 135 (53.1) 36 (65, S) 
Day-case 119 (46.9) 19 (34.5) 
Chi-square=2.77; df=l; p=0.09 
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2. LOSSES To FOLLOW-UP 
At 4 months after surgery 21 patients were lost to follow-up. At 12 months after 
surgery there were an additional 38 patients lost to follow-up, making a total of 59 
patients by that time, (17.5% of the recruited sample). (Figure5.1) 
Reasons for losses to follow-up were identified for 24 patients, and these were: 
Deceased 
111-health 
Moved away 
Uncooperative patient 
Dissatisfied with surgery 
Did not want to continue 
5 patients (range 64 to 92 yrs, mean 79.6 yrs) 
5 patients 
5 patients 
2 patients 
I patient 
6 patients 
No reason was ascertained for the remaining 35 patients lost to follow-up during the 
study. This was after at least two attempts by the interviewers (letter and phone-calls), 
and two attempts from the hospital (letter and phone call). 
When the patients lost to follow-up during the study were compared with those with 
continued follow-up, no major differences were apparent in terms of age, sex and 
ocular comorbidity in the surgery eye. Patients lost to follow-up appeared to have 
poorer better eye visual acuity on admission, but these differences were not found to 
be statistically significant. (Table 5.3) 
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Table 5.3 Characteristics of patients followed up after surgery and those lost to follow-up. 
Patients Followed Patients lost to Follow-Up 
to 12 months by 12 months 
n=278 n=59 
n (%) n (%) 
Age on admission (yrs) 
50-64 28 (10) 10 (17) 
65-74 86 (31) 13 (22) 
>=75 164 (59) 36 (61) 
Chi-square=3.39, df=2, p=0.18 
Sex 
males 112 (40) 19 (32) 
females 166 (60) 40 (68) 
Chi-squarc=1.34, df=l, p=0.25 
Visual Acuity on admission 
In Better Eye 
6/6 to 6/12 161 (61.7) 21 (48.8) 
6/18 to /624 78 (29.9) 16 (37.2) 
636 to 6/60 16 (6.1) 5 (11.6) 
less ffian 6160 6 (2.3) 1 (2.3) 
total 261 43 
Chi-square=3.27, df=3, p=0.35 
Ocular Comorbidity on 
Admission In Surgery Eye 
present 184 (69) 27 (61) 
absent 81 (31) 17 (39) 
total 265 44 
Chi-square-- 1.13, df=l, p=0.29 
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2.1 Losses to Follow-Up - SIP Responders 
60 of the 273 patients who had completed SIP and VR-SIP before surgery, failed to do 
so 4 and 12 months after surgery. However, no significant differences were 
demonstrated between patients followed -up and those lost to follow-up in terms of 
pre-operative characteristics, as presented in Table 5.4. 
Table 5.4 Characteristics of patients with complete SIP and VR-SIP, followed up after 
surgery and those lost to follow-up 
Patients Followed Up 
to 12 months 
n=213 
n (%) 
Patients lost to Follow-Up 
by 12 months 
n--60 
n (%) 
Age on admission (yrs) 
50-64 30 (9) 10 (17) 
65-74 63 (30) 20 (33) 
>=75 130 (61) 30 (50) 
Chi-square=3.45, df=2, p=0.18 
Sex 
males 83 (39) 26 (43) 
females 130 (61) 34 (57) 
Chi-squarc=0.37, df=l, p=0.54 
Marital Status 
married 101 (47.4) 36 (60) 
not married 112 (52.6) 24 (40) 
Chi-square=2.95, df=l, p=0.09 
Living alone 123 (58) 42 (70) 
Not Ming alone 90 (42) 18 (30) 
Chi-square--2.93, df=l, p=0.09 
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DATA QUALITY 
3.1 Patient Interview 
Data collection from the patient interview was complete for all the main measures of 
interest. 
Table 5.5 Data Quality - Completeness of Recording: Patient Interview 
Field Total Number 
of Records 
Number of Records 
with Missing Data 
% records with 
Missing Data 
On Admission (n=337): 
Age 337 0 0.0 
Sex 337 0 0.0 
Global assessment of vision (Al) 337 0 0.0 
Global assessment of vision (A2) 337 0 0.0 
Cataract Symptom Score 337 0 0.0 
VF-14 337 0 0.0 
Comorbidity "bothersome" score 337 0 0.0 
SIP * 273 0 0.0 
VR-SIP 273 0 0.0 
At 4 Months After Surgery (n=316): 
VF-14 316 0 0.0 
SIP * 213 0 0.0 
VR-SIP 213 0 0.0 
At 12 Months After Surgery (n=278): 
VF-14 278 0 0.0 
SE? * 217 0 0.0 
VR-SIP 217 0nn 
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3.2 Clinical Data 
Before surgery, clinical data were available for 316 (94%, n=316/337) recruited 
patients. At 4 months after surgery, clinical data were available for 279 (82.8%, 
n--279/337) patients with interview data. At 12 months 243 (72.1%, n--243/337) 
patients had clinical data to accompany interview data. 
The proportion of clinical data forms with missing data ranged from 0.8% to 9.7% by 
item. Most items had complete data for over 95% of patients with the exception being 
complications within 48 hours of surgery. 
Table 5.6 Data Quality - Completeness of Recording: Clinical Data 
Field Total Number Number of Records % records with 
of Records with Missing Data Missing Data 
On Admission (n--316): 
Visual Acuity - Surgery Eye 316 6 1.9 
Visual Acuity - Fellow Eye 316 9 2.9 
Ocular Comorbidity 316 0 0.0 
Medical Comorbidity 316 0 0.0 
Comorbidity "bothersome" score 316 0 0.0 
Perl-Operatively (n=309): 
Intra-opcrative complications 309 
Complications within 48 hours 309 
0 0.0 
30 9.7 
At 4 Months After Surgery (n=279) : 
Visual Acuity - Surgery Eye 279 9 3.2 
Visual Acuity - Fellow Eye 279 12 4.3 
Complications 279 0 0.0 
At 12 Months After Surgery (n--243): 
Visual Acuity - Surgery Eye 243 2 0.8 
Visual Acuity - Fellow Eye 243 6 2.5 
Complications 243 2 0.8 
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4. CLINICAL OUTCOMES 
Clinical outcomes are presented in terms of visual acuity in the surgery eye at 4 months 
after surgery, and the occurrence of complications. 
4.1 Visual Acuity 
265 patients had complete data on visual acuity in the surgery eye both before and 4 
months after surgery. Following surgery, visual acuity in the surgery eye underwent a 
significant shift. 84.5% (224/265) of patients achieved a good visual acuity of 6/12 
or better in the surgery eye by 4 months. (Chi-square = 198.9, df = 3, p-value, <0.001). 
Table 5.7 Visual acuity in surgery eye on admission and 4 months after surgery 
Visual Acuity at 4 months after surgery 
Visual Acuity 
on Admission 
Number of 
Patients (%) 
6/6 to 6/12 
n (row%) 
6/18 to 6/24 
n (row%) 
6/60 to 6/36 
n (row 0/6) 
less than 6160 
n (row%) 
6/6 to 6/12 63 (23.8) 59 (93.7) 3 (4.8) 0 (0) 1 (1.6) 
6/18 to 6/24 122 (46) 104 (85.2) 17 (13.9) 1 (0.8) 0 (0) 
6136 to 6160 46 (17.4) 38 (82.6) 6 (13) 2 (4.3) 0 (0) 
less than 6/60 34 (12.8) 23 (67.6) 5 (14.7) 3 (8.8) 3 (8.8) 
All 265 (100) 224 (94.5) 31(11.7) 6 (2.3) 4 (1.5) 
This was comparable to the findings in the National Cataract Surgery Study, in which 
80% of patients achieved a good visual acuity after surgery. The observed difference 
between these two samples in the proportion of patients achieving good visual acuity 
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was 4.5%, (S. E. of difference = 2.57; 95% C. I. for this difference was -2.8 to 9.8) and 
was not statistically significant. 
4.2 Complications of Surgery 
The frequency of major complications during each post-operative period was similar 
to the sample in the National Cataract Surgery Study. With the exception of capsule 
rupture without vitreous loss which occurred less frequently in this sample, no 
significant differences were observed between the samples for the other major 
complications. 
Table 5.8 Occurrence of major complications 
STUDY SAWLE NATIONAL SAMPLE 
n=241 n--998 
Observed S. E. 95% C. 1 
Difference of the for the 
Type of Number with Number with between Observed Observed 
Complication Complication (%) Complication (%) Proportions Difference Difference 
Per! -operative period 
Capsule rupture 
without vitreous loss 2 (0.8) 39 (3.9) -3.1 0.8 - 4.7 to -1.4 
with vitreous loss 4 (1.6) 11 (1.1) 0.6 0.9 - 1.2 to 2.4 
Within 1 month: 
Endophthalmitis 2 (0-9) 3 (0.3) 0.5 0.7 - 0.7 to 1.8 
At 4 months: 
Retinal detachment 0 (0) 1 (0.1) -0.1 0.1 -0.3 toO. 1 Cystoid macular oedetna 2 (0.8) 12 (1.2) -0.4 0.7 - 1.7 to 1.0 Post. capsule opacification 13 (5-5) 63 (6.3) -0.8 1.7 - 4.1 to 2.4 
*- Sample from the National Cataract SurgerY StudY 
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5. MEASURES OF VISUAL ACUITY 
There were 312 patients with visual acuity data in both eyes on admission. 267 (86%) 
patients had complete visual acuity data in both eyes at 4 months and 239 (77%) 
patients at 12 months. Visual acuity was considered in terms of the best corrected 
Snellen visual acuity for the surgery eye, and the better eye, and also in terms of the 
VP% score (person visual acuity score). The distributions of surgery eye visual 
acuity, better eye visual acuity and VP% score, pre-operatively and post-operatively, 
were all skewed. 
On admission, 22.5% of patients had a visual acuity between 6/6 and 6/12 in the 
surgery eye; with 60% of patients having this level of acuity in the better eye at that 
time. After surgery, 85% of patients had achieved a good visual acuity outcome of 
6/6 to 6/12 at 4 months in the surgery eye, with 90% of patients having this level of 
visual acuity in the better eye. Pre-operatively, 38% (117/312) of surgery eyes were 
the better eye. Post-operatively, 85% (226/267) of surgery eyes were the better eye at 
4 months; and 82% (195/239) of surgery eyes were the better eye at 12 months. 
5.1 Correlations between measures of visual acuity 
As the distributions of all measures of visual acuity were skewed, the Spearman 
correlation coefficients are presented in Table 5.9. (Pearson correlation coefficients 
were also computed and these were of a similar order of magnitude). 
Before surgery, better eye acuity and VP% score were highly correlated ( 0.91) and 
the surgery eye correlated better with VP% score (0.58) than with better eye visual 
acuity (0.39). After surgery, as the surgery eye became the better eye in most cases, 
the surgery eye acuity and better eye acuity were highly correlated (0-89 at 4 months 
and 0.82 at 12 months). VP% score correlated highly with both, but slightly better 
with better eye visual acuity, at both 4 and 12 months. 
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6. DISCUSSION 
6.1 Study Method 
6.1.1 Possible sources of bias 
The biases of particular concern in this study were selection bias and those that may 
have been introduced from losses tofollow-up. 
The sample of patients recruited into the study represented about a quarter of all 
patients eligible for inclusion. Since all the eligible patients were identified and invited 
to participate, it was unlikely that a selection bias would have been introduced at that 
stage of the study. However, the subsequent selection factors that may have been 
operating would have been characterised by a possible "volunteer" effect. There was 
no evidence for this, at least in terms of age and sex on admission for surgery, as the 
sample obtained was comparable to a random sample of those non-participating 
patients that were having surgery in the hospitals during the same time period; and 
was also comparable to a larger sample of patients from the National Cataract Surgery 
Study in this respect. It was possible however, that the study participants may have 
differed from non-participants in other, unrecorded respects. 
64 (19%) patients did not complete the interview, and so no information on health or 
vision-related quality of life was obtained from them. No significant selection factors 
in terms of age, sex, marital status, living alone or not, and visual acuity on admission 
were observed when this group was compared to the patients that had completed the 
interview. 
59 (17.5%) of patients were lost to follow-up. Despite having locally based 
interviewers who established good contacts with the Patients, a reason for loss to 
follow-up was still not ascertained for half of these Patients. However, no significant 
differences were observed between the patients lost to fOllow-up and the patients that 
were followed-up throughout the course of the study, in terms of pre-operative 
characteristics. Similarly, no significant differences were observed amongst the 
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patients with complete interview (SIP and VR-SIP) and those amongst them that were 
lost to follow-up. 
In summary, it was considered that a representative sample of cataract patients was 
obtained and losses to follow-up were unlikely to have introduced any major biases 
into the post-operative findings. 
6.1.2 Data Quality 
Considerable effort had been made to standardise methods and to ensure prospective 
data collection, without interfering with routine clinical practice. It was still possible 
that some data were obtained retrospectively from the hospital clinical notes after the 
admission episode or the follow-up assessment at 4 months, and that their quality or 
completeness could have introduced an observation bias. However, as the 12 month 
clinical assessment was made in a dedicated specially arranged clinic. it is unlikely that 
this occurred at that time. 
overall, clinical data were complete for over 95% of cases for most items, including 
visual acuity recording in the fellow eye. The validity and reliability of clinical data 
collection was probably high as the forms were completed by ophthalmologists. As 
the events of interest were confined to those that were clinically significant, this 
overcame problems with interpretations of definitions and it was unlikely that 
important misclassifications occurred. 
The patient interview was standardised and contained specific, closed questions, and 
the interviewers were trained to standardise its administration. One interviewer 
conducted all the interviews in his/her area, and consequently each patient had 
interviews conducted by the same interviewer. Although this removed any inter- 
interviewer variability in eliciting responses from the patients, it was still possible for a 
systematic bias to be operating for the individual interviewer during interview 
conduction. However, as the interview did not require open responses, and it 
contained instructions for administration within the construct of the major questions, it 
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was unlikely that any significant errors of this type were introduced from the patient 
interview 
6.2. Clinical Outcomes 
The clinical outcomes were found to be typical for visual acuity after surgery and for 
the occurrence of complications, when compared to the national sample from the 
National Cataract Surgery. On this basis, subsequent analysis of patient perceived 
measures and their relationships with visual acuity was then conducted. 
6.3 Measures of Visual Acuity 
The surgery eye visual acuity provided a direct assessment of cataract and cataract 
surgery, on the resultant visual impairment (before and after surgery) in the affected 
eye. Although the surgery eye visual acuity was highly correlated with better eye 
visual acuity after surgery, it did not represent all the better eyes. At least 15% of 
surgery eyes were not the better eyes four months after surgery and 18% of surgery 
eyes at one year were not the better eyes. The VP% score and better eye acuity were 
highly correlated before and after surgery. As the calculation of the VP% score was 
weighted in favour of the better eye acuity this was not surprising. 
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7. SUMMARY OF FINDINGS 
The main findings reported in this chapter may be summarised as follows : 
0a representative sample of cataract patients was obtained 
0 losses to follow-up were unlikely to have introduced bias into the post- 
operative findings 
0 interview data were complete for all items 
0 clinical data were complete for 95% of the main items 
0 the clinical outcomes were typical 
0 the surgery eye provided a direct assessment of cataract and surgery on the 
resultant visual impairment in the affected eye 
0 VP% score and better eye visual acuity were highly correlated before and 
after surgery 
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Chapter 6. 
THE CATARACT OUTCOME STUDY : RESULTS 
VISUAL FUNCTIONING - THE VF-14 
1. INTRODUCTION 
This chapter will present the findings related to visual functioning (functioning in 
vision-dependent activities performed in everyday life) associated with cataract and the 
imPact surgery may have on it. 
The reliability and validity of the VF-14, the index of visual functioning used in this 
study, are considered first. Pre-operative and post-operative findings are then 
presented in separate sections, but follow the same format : 
0a description of visual functioning at that time (before surgery or 4 and 
12 months after surgery) 
aa descriPtion of the change in visual function afler surgery 
the responsiveness of the VF-14 to'change after surgery 
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2. RELIABILITY AND VALIDITY OF THE VF-14 
2.1 Reliability of the VF-14 
The reliability of the VF-14 as assessed in terms of its internal consistency was given 
by Cronbach's alpha. The findings are presented in Table 6.1. 
The overall Cronbach's alpha was 0.74 indicating that the index is reliable. The 
standardised item alpha was 0.75, which is the value if all of the items were 
standardised to have a variance of 1. Since the items on the VF-14 had fairly 
comparable variances, little difference between these two alphas was observed. If the 
question "Drivers I" (difficulty driving during the day) was omitted, then an alpha of 
0.7646 was achieved.. As this was a modest change in the overall alpha it was felt that 
deletion of this item from the index was unlikely to have any significant effect on 
improving the homogeneity of the index. Elimination of the remaining items had little 
change on alpha (Table 6.1). 
The item-total correlation is also presented in Table 6.1. It is the correlation of each 
individual item with the overall scale score omitting that item. The item-total 
correlations range from 0.06 to 0.67. It has been suggested that items should correlate 
with the total score above 0.20, and items with lower scores should be discarded 
[165][166]. The item with the lowest item-total correlation related to difficulty 
driving during the day. This item was not discarded on the basis that any effect that 
this may have had on internal consistency would have been modest. More importantly 
the instrument was designed to cover a spectrum of vision-dependent activities 
performed in everyday life that may be affected by cataract, and by omitting this item, 
content validity may have been compromised. The aim of this instrument is to draw 
valid inferences on visual functioning amongst cataract patients, and in this context it 
will depend more on content validity than internal consistency, as it is concerned with 
vision dependent activities that are quite heterogeneous (near, intermediate and 
distance vision). 
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Table 6.1 Reliability of the W-14 Index : Internal Consistency. Item-Total StatiStiCL 
N of cases - 337. N of items = 14. 
Item 
Scale Mean 
If Item 
Deleted 
Scale Variance 
If Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Squared 
Multiple 
Correlation 
Alpha 
If Item 
Deleted 
A40 64.92 418.62 0.62 0.59 0.70 
A41 62.87 405.03 0.67 0.65 0.69 
A42 59.99 435.58 0.49 0.39 0.71 
A43 60.40 445.67 0.41 0.31 0.72 
A44 61.27 449.94 0.38 0.27 0.72 
A45 61.73 429.88 0.49 0.32 0.71 
A46 64.84 445.15 0.34 0.20 0.73 
A47 61.49 415.59 0.55 0.38 0.70 
A48 65.31 474.56 0.12 0.05 0.75 
A49 67.41 495.17 0.11 0.09 0.74 
A50 61.03 472.71 0.14 0.19 0.75 
A51 61.35 438.01 0.49 0.32 0.71 
Drivers 1 65.93 479.93 0.06 0.35 0.76 
Drivers 2 67.16 482.94 0.22 0.34 0.74 
Scale Statistics : Reliability Coefficients on 14 Items 
Scale Mean = 68.13 Cronbach's Alpha = 0.74 
S. D. = 22.6 Standardised Itcm Alpha =0.75 
Variance = 510.69 
A40 to ASI -items relating to vision-dcpendcnt activities in VF-14 (Appendix 133). 
Drivers I and Drivers 2- items in VF-14 relating to current drivers and difficulty driving (Appendix 133). 
2.2 Validity of the VF-14 
2.2.1 Content Validity 
As indicated above, the final instrument containing 14 items was produced following a 
review by an expert national advisory panel composed of ophthalmologists and 
optometrists to ensure that : the list contained the full spectrum of functional 
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limitations experienced by cataract patients; to exclude or combine any items that may 
constitute functionally equivalent task with respect to vision; and to specify relevant 
functional activities that had not yet been identified. [ 136] In doing so, this exclusively 
professional and clinical expert panel, assessed the content validity of the instrument, 
and found this to be satisfactory. 
2.2.2 Criterion Validity 
The correlations between pre-operative VF-14 scores and pre-operative visual acuity, 
global self rating of function for the overall amount of trouble or satisfaction patients 
had with their vision are presented in Table 6.2. 
Both Pearson and Spearman correlation coefficients were computed (Appendix D 1). 
Since the pre-operative VF-14 score was not normally distributed, the Spearman 
correlation coefficients were used to examine these associations. 
The VF-14 scores correlated moderately with the global assessments of vision for 
"trouble' and "dissatisfaction7' with vision (-0.5553 and -0.4880 respectively) and were 
better than the correlations with better eye visual acuity (-0.4763) and VP% score 
(0.4537). The correlation between VF-14 score and visual acuity in the better eye and 
VP% score were higher than for the visual acuity in the surgery eye (0.2065). It would 
seem that visual function in terms of ability to perform vision-dependent activities, is 
determined more by the visual acuity in the better eye than the surgery eye (the 
affected eye and which is most likely to be the worst eye in the majority of cases). 
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3. PRE-OPERATIVE VISUAL FUNCTIONING 
The mean VF-14 score on admission for cataract surgery was 68.1 (s. d. 22.6), the 
median was 72.2, with the scores ranging from 0 to 100. The distribution of scores 
was skewed towards the higher scores (less disability) - Figure 6.1 and Table 6.3. 
Twelve patients (3.6% ) had a maximum score of 100, pre-operatively. Whilst it 
would not be possible for these patients to show any gain in visual function after 
surgery, they could show loss. 35.6% of all patients had a score of 80 or more before 
surgery. 18.4% patients had a score of less than 50. 
Table 6.3 Distribution of Pre-operative VF-14 Scores 
(on Admission for Cataract Surgery). 
VF-14 Score n % 
0- 4 1.2 
10- 9 2.7 
20- 12 3.6 
30- 16 4.7 
40- 21 6.2 
50- 41 12.2 
60- 54 16.0 
70- 60 17.8 
80- 59 17.5 
90- 49 14.5 
100 12 3.6 
ALL 337 100.0 
Mean score = 68.13 
S. D. = 22.59 
S. E. = 1.23 
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Figure6.1 Distribution of Pre-operativeVF-14 Scores. n= 337 
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No statistical transformation was effective in normalising the distribution of pre- 
operative VF- 14 scores, so the untransformed VF- 14 score was used in all further 
analysis. 
The mean number of items that contributed to the score was 10.5 (s. d. 1.5). 80% of 
patients had 10 or more items contributing to the score . 
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3.1 Characteristics of Response to VF-14 Items 
The responses to the individual items is presented in Table 6.4. At least half of all 
patients reported "a great deal of difficulty" or inability to do an activity involving 
near vision. For activities that involved intermediate or distance vision, at least a third 
of patients reported "a great deal of difficulty" or inability. 
on admission only 28% (94/337) of patients reported they were current drivers. Of 
these, a third reported difficulty driving during the day-time and 82.3% reported 
difficulty driving at night. 
Table 6.4 Visual Function (VF-14) : Item Responses Before Surgery. N=337 
VF-14 Item 
Number (%) 
Patients Reporting 
Difficulty with Item 
Number (0/9) 
Patients Reporting 
lea great deal difficulty 
"or unable to do" Item 
Near ruion: 
Reading small print 290 (86.1) 227 (67.4) 
Reading book / newspaper 233 (69.1) 142 (42.1) 
Fine handwork: sewing / carpentry 177 (52.5) 122 (36.2) 
Writing letters / cheques / filling forms 132 (39.2) 71 (21.1) 
Interme&ate rision: 
Watching TV 184 (54.6) 47 (14.0) 
Seeing steps / kcrbs 164 (48.7) 53 (15.8) 
Recognising people close by 100 (29.7) 49 (14.5) 
Reading large print 71 (21.1) 31 (9.2) 
Playing games: bingo / card ctc. 62 (18.4) 30 (8.9) 
Cooking 61 (18.1) 18 (5.4) 
Distance rision: 
Reading signs : street / shop / traffic 163 (48.4) 66 (19.6) 
Sports: bowling / golf / tennis 30 ( 8.9) 19 (5.3) 
Current Drivers (n=94) 
Difficulty driving during day-time 31 (33.0) 
Difficulty driving at night 79 (82.3) 
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4. POST-OPERATIVE VISUAL FUNCTIONING AFTER SURGERY 
There were 316 (93.8%) patients with complete data 4 months after surgery. Their 
mean VF-14 score was 88.5 (s. d. =17.16; 95% C. I. 86.6 to 90.4); the median was 
95.4 (inter-quartile range = 16.5), with the scores ranging from 7.5 to 100. This 
distribution was highly skewed towards the higher scores (less disability) and could not 
be effectively normalised by statistical transformation. (Table 6.5 and Figure 6.2). 
81% of all patients achieved a score of 80 or more at this time, with 35% of all patients 
having a maximum score of 100. 
At 12 months after surgery there were 278 (82.5%) patients with complete data. Their 
mean score was 91.2 (s. d. =14.4,95% C. I. 89.4 to 92.9); median was 97.6 (inter- 
quartile range = 11.5), with scores ranging from 2.5 to 100.85.7% of all patients had 
achieved a score of 80 or more at this time. 34% of all patients had a maximum score 
of 100. The distribution was highly skewed towards the higher scores. (Table 6.5 and 
Figure 6.3). 
Table 6.5 Frequency Distribution of VF-14 Scores After Surgery. 
AT 4 MONTHS AT 12 MONTHS 
N= 316 N= 278 
VF-14SCORE 
0- 1 0.3 1 0.4 
10- 1 0.3 1 0.4 
20- 6 1.9 0 0.0 
30- 3 0.9 2 0.7 
40- 5 1.6 2 0.7 
50- 6 1.9 6 2.2 
60- 9 2.8 9 3.2 
70- 29 9.2 19 6.8 
so- 49 15.5 33 11.9 
90- 97 30.7 90 32.4 
100- 110 34.8 115 41.4 
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Figure6.2 Distribution of VF-14 Scores at 4 Months after Surgery. 
n= 316 
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Figure 6.3. Distribution of VF-14 Scores 12 Months after Surgery. 
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5. CHANGE IN VISUAL FUNCTIONING AFTER SURGERY 
A significant improvement in visual function was observed at both 4 months and 12 
months after surgery, compared to functioning before surgery. Paired Mest and non- 
parametric tests gave 2-tailed p-values of <0.0001. The mean change in visual 
function score at 4 months was 19.8 (s. d. = 20.9 ; 95% C. I. 17.53 to 22.16), with the 
median being = 15.9 (inter-quartile range = 26.2). The change in scores ranged from - 
37.5 to 87.5. The mean change in visual function score at 12 months was 22.69 (s. d. 
= 20.8; 95% C. I. 20.24 to 25.15), with the median change in score being 20.1 (inter- 
quartile range = 27.9). The change in scores ranged from -50 to 86.36. The 
distributions for change in VF-14 scores after surgery approximated better to a normal 
distribution (Table 6.6, Figure 6.4 and Fig 6.5) 
Table 6.6 Frequency Distribution : CHANGE in W-14 Score After Surgery 
(compared to pre-operative scores) 
AT 4 MONTHS AT 12 MONTHS 
N=316 N=278 
CHANGEin n%% 
VF-14 Score 
45- 2 0.6 1 0.4 
-36 - 1 0.3 1 0.4 
-27 - 2 0.6 2 0.7 
-18 - 7 2.2 3 1.0 
-9 - 21 6.6 10 3.6 
0- 73 23.1 62 22.3 
9- 63 19.9 54 19.4 
18 - 46 14.6 39 14.0 
27 - 41 13.0 39 14.0 
36 - 21 6.6 27 9.7 
45 - 16 5.1 17 6.1 
54 - 11 3.5 13 4.7 
63 - 5 1.6 3 1.0 
72 - 5 1.6 4 1.4 
81 - 2 0.6 3 0.4 
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Figure6.4. Distribution of CHANGE in VF-14 Score at 4 Months 
AfterSurgery. n=316 
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Of the 316 patients, 267 (84.6%) had improved VF-14 scores, there was no change in 
16 (5%) patients, and 33( 10.4% ) scored less after surgery. There was not much 
capacity for change (in the direction of gain) in the sixteen patients who did not change 
their VF- 14 score post-operatively, Eleven of these patients had a maximum score of 
100 pre-operatively, and the remaining 5 patients had scores ranging from 75 to 97.7. 
Ten patients had good visual acuity of 6/6 to 6/12 in the better eye before surgery and 
all of them had good post-operative acuity in the better eye. Of the thirty-three 
patients who lost visual function after surgery, 18 had pre-operative VF-14 scores of 
80 or more and 23 patients had good visual acuity in the better eye both pre- 
operatively and after surgery. There were no differences in age, sex or the presence of 
ocular comorbidity amongst patients who either gained VF post-operatively, lost VF 
or did not change. 
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Figure 6.5. Distribution of CHANGE in VF-14 Scores 12 Months 
afterSurgery. n=278 
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Of the 278 patients, 248 (89.2%) had improved VF- 14 scores, there was no change in 
VF- 14 score in 13 (4.7% ), and 17 patients (6.1 %) had lost visual function after 
surgery. There was not much capacity for change in the thirteen patients who did not 
have any change in visual function at this time. Ten of these patients had pre-operative 
scores of 100 and the remaining three patients had scores ranging from 50 to 87.5. 
Nine patients had good pre-operative visual acuity in the better eye with all but one 
patient achieving good post-operative acuity in the better eye. Of the seventeen 
patients who lost visual function, twelve patients had pre-operative VF- 14 scores of 80 
or more and 86% achieved good post-operative visual acuity in the better eye. There 
were no differences in age, sex or the presence of ocular comorbidity amongst those 
patients who gained, lost, or did not change visual function at 12 months after surgery. 
5.1 Gains in Visual Function at 4 months 
The improvement in visual function by 4 months after surgery was also demonstrated 
in the group of patients that did not achieve a good visual acuity outcome (n=40). The 
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mean change in visual function in this group was 16.1 (s. d. 20.2; 95% C. I. 9.7 to 22.6) 
and compared to their pre-operative values, this was a significant gain (paired t-test 
and non-parametric tests gave 2-tailed p-values < 0.001). No significant differences in 
the mean gain in visual function was seen between the sub-groups of patients that had 
a good visual acuity outcome and those that had a poor outcome. 
Table 6.7. Change in Visual Function by Visual Acuity Outcome 4 months after surgery 
Visual Acuity Outcome 
Good Outcome (6/6 to 6/12) 
Poor Outcome Oess than 6/12) 
All N 
Mean Change In Visual Function (s. d. ) 
n4 Months after Surgery 
228 20.6 (21.1) 
40 16.1 (20.2) 
268 19.9 (20.9) 
* All were significant changes (gains) compared to mean pre-operative visual fimction: paired West 
p-values <. 001 
No significant differences in mean change were demonstrated between visual acuity outcome groups :p >0.05 
# Complete data for visual acuity in surgery eye and visual function both before and 4 months after surgery. 
5.2 Change in Visual Function between 4 and 12 months 
86 patients had second eye surgery performed between 4 and 12 months. As shown in 
Table 6.8, no significant mean change in visual function was observed between 4 and 
12 months in those patients that had surgery to their first eye only. Significant mean 
change in visual function was observed between 4 and 12 months in those patients that 
had had surgery to the second eye during this interval. 
156 
Table 6.8 Change in Visual Function between 4 and 12 months after surgery 
DRST EYES only by BOTH EYEs by 
12 months 12 months 
n= 192 n=86 
Mean Visual Function Score (s. (L) 
At 4 months : 89.3 (17.0) 88.3 (16.0) 
At 12 months : 90.1 (15.9) 
no significant change between 4 and 12 months, paired Mcst p-value = 0.35 
significant change between 4 and 12 months, paired West p-value < 0.001 
6. RESPONSIVENESS TO CHANGE 
93.4 (10.2) 
The effect size for the VF-14 after cataract surgery were generally higher when 
computed using the mean scores than with median scores. At 4 months effect size was 
0.89 when computed using the mean score. This represents a high responsiveness to 
change in the assessment of visual function after surgery. When the median change in 
score was used, the effect size was moderate at 0.50. 
The VF-14 was highly responsive to change 12 months after cataract surgery having an 
effect size of 1.02 (with mean change in score). When the median change in score was 
used effect size was moderate (0.65). Effect sizes were higher when second eye 
surgery had been performed - 1.5 for surgery to both eyes compared to 0.85 for 
surgery to one eye only (1.02 v 0.5 respectively, if median change was used). 
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7. DISCUSSION OF FINDINGS 
The VF-14 was found to be a valid (criterion validity) and reliable (internal 
consistency) instrument to assess visual function in everyday activities that were 
dependent on vision, amongst cataract patients. 
The pre-operative VF-14 scores in this sample of cataract patients ranged from the 
minimum to the maximum possible score, with a wide variation in the mean VF-14 
score for any given sub-group considered. There are no available data for VF-14 
scores amongst the population of this age group (50 years and over) for comparison 
and assessment of the level of reduced function experienced by cataract patients above 
that experienced by persons of a sinfilar age group who do not have cataract. The 
wide spread of scores suggested that a variety of factors may be influencing the 
reported visual functioning. 
Cataract extraction improved visual function (as measured by the NT-14). A mean 
gain in VF-14 scores was demonstrated both in the short term (4 months after surgery) 
and long term (at 12 months after surgery), compared to pre-operative values. Post- 
operatively, at least 80% of patients achieved VF-14 scores of 80 or more, with at 
least a third of all patients achieving the maximum score of 100. Since data on visual 
function in a population of 50 years and over is not yet available, it is not possible to 
conclude that this level of achievement (scores of 80 or more), after surgery is within 
the range of visual function expected amongst this age group. 
The mean gains in visual function observed at 4 months were maintained at one year in 
those patients that had surgery to one eye only. Those patients that proceeded to have 
second eye surgery between 4 and 12 months of surgery to the first eye, demonstrated 
additional mean gain in visual function by 12 months. Significant mean gain in visual 
function were also observed in the sub-group of patients that did not achieve good 
visual acuity outcome. 
158 
Large effect sizes were observed [125], indicating that the VF-14 as an index of visual 
functioning was responsive to change and that the observed change was likely to be 
clinically important also. [157][158][159][160] 
It was unlikely that the observed changes in visual function score were due to a 
placebo effect because of the magnitude of the observed changes and the effect sizes, 
As the patient interview was conducted at sufficiently long intervals of 4 and 8 months 
of one another, it was also unlikely for the magnitude of the observed change to have 
been due to a learning effect as a consequence. However as there was no control 
group of cataract patients that did not go on to have surgery for comparison, some 
influence from these effects cannot be completely overlooked. 
S. SUMMARY OF FINDINGS 
The key findings relating to visual function in cataract patients are : 
0 The VF-14 as an index of visual functioning in cataract patients is valid, reliable 
and responsive to change. 
0 Visual functioning in everyday activities is affected by cataract in the majority 
of patients 
9 Cataract surgery improves visual function 
0 The mean gains in visual function after surgery to the first eye are maintained at 
one year 
0 Additional mean gain in visual function were achieved by second eye surgery 
0 Mean gains in visual function were also achieved in patients with a poor visual 
acuity outcome 
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Chapter 7. 
THE CATARACT OUTCOME STUDY : RESULTS 
QUALITY OF LIFE 
1. INTRODUCTION 
This chapter will present the findings related to the quality of life associated with 
cataract and the impact surgery may have on this. 
The measures of quality of life used in this study were the Sickness Impact Profile 
(SIP) and the Vision-Related Sickness Impact Profile (VR-SIP). Whilst it was 
assumed that the reported validity and reliability of the SIP would also apply to UK 
patients, neither the SIP nor the VR-SIP have been used before in the UK for cataract 
patients. The criterion validity of the SIP and VR-SIP are presented first. Pre- 
operative and post-operative findings are then presented as follows : 
a description of quality of life before surgery and 4 and 12 months after 
surgery 
a description of the change in quality of life after surgery 
the responsiveness of the SIP and VR-SIP to change after surgery 
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2. CRITERION VALIDITY OF THE SIP AND VR-SIP 
Table 7.1 presents the correlation matrix of pre-operative SIP and VR-SIP scores with 
other pre-operative variables. Spearman coefficients are presented, but Pearson 
correlation coefficients provided similar findings. 
SIP scores correlated better with age and with other measures of health such as the 
comorbidity "bothersome" score and comparative assessments of health, and visual 
functioning, and correlated poorly with global assessments of vision. 
VR-SIP scores were correlated highly with visual functioning. VR-SIP scores 
correlated better with other vision related variables such as global assessments of 
vision, better eye visual acuity; and poorly with other measures of health. No 
significant correlation with age was observed. f 
Both SIP and VR-SIP had correlations of a similar order with better eye visual acuity, 
and both correlated poorly vAth visual acuity in the surgery eye. 
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3. PRE-OPERATIVE QUALITV OF LIFE 
The distribution of pre-operative scores for both SIP and VR-SIP were highly skewed 
towards the lower scores (less reported handicap), and are presented below in Figures 
8.1 and 8.2 respectively. No statistical transformation was effective in normalising 
either of these distributions, so the untransformed pre-operative SIP and VR-SIP 
scores were used in all further analysis. The category scores were also highly skewed 
distributions towards the lower scores (less reported handicap). Given this, means 
(and standard deviations) are reported to be consistent and comparable with published 
literature, but medians (with inter-quartile range) are also provided as these provide a 
further, and perhaps more appropriate description of the distributions. 
Figure 7.1 Distribution of Pre-operative SIP Score. n= 273 
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The mean SIP score on admission was 11.9 (s. d. 9.7), and the median was 9.5 (inter- 
quartile range 10.2), with scores ranging from 0 to 47.8 patients (2.9%) had scores 
of zero pre-operatively, indicating no health related handicap, and so these patients 
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could not demonstrate any gain (benefit) after cataract surgery. As seen in Table 7.2, 
the categories with the highest scores were recreation and pastimes, work, and home 
management. 
Table 7.2. Pre-Operative Sickness Impact Profile (SIP) Score. N=273 
Scores Mean 95% Cl. Median Inter-Quartile 
Score s. d. for Mean Score Range 
Total Score 11-88 9.66 10.72 to 13.03 9.46 10.25 
Dimension Scores 
Physical 9.96 11.54 8.58 to 11.33 5.75 12.40 
Psychosocial. 9.30 10.07 9.09 to 10.49 6.33 11.74 
CategoryScore: 
Ambulation 15.78 16.40 9.86 24.47 
Alertness Behaviour 13.06 18.70 9.41 19.20 
Body Care & Management 6.59 11.06 3.20 8.49 
Communication 6.21 9.32 0.00 9.63 
Eating 3.35 5.27 0.00 5.25 
Emotional Behaviour 8.29 14.05 0.00 11.06 
Home Management 17.94 22.51 10.33 26.20 
Mobility 12.52 15.13 7.79 19.19 
Recreation & Pastimes 26.44 21.88 24.17 32.70 
Social Interaction 9.27 10.89 5.93 12.76 
Sleep & Rest 13.62 18.96 9.82 21.84 
Work 26.24 22.53 46.10 46.10 
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The mean VR-SIP score on admission was 1.9 (s. d. 3.3), and the median was 0.6 
(inter-quartile range 2.1), with scores ranging from 0 to 21.9.41%(n=112/273), of 
patients had a score of 0. These patients did not attribute any aspect of their quality of 
life to their vision and could not therefore, demonstrate any gain (benefit) after cataract 
surgery. 
Figure7.2 Distribution of Pre-operativeVR-SIP Score. n=273 
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As seen in Table 7.3, recreation and pastimes was the category that had the highest 
mean score (10.6), indicating greatest handicap attributed to vision, in this area. 
However as indicated by the mean and inter-quartile range, this category was affected 
in about 25% of patients (in the highest quartile). 
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Table 7.3. Pre-Operative Vision-Related Sickness Impact Profile (VR-SIP) Score. n =273. 
Scores Mean . 95% CL Median Inter-Quartile 
Score s. d. for Mean Score Range 
Total VR-SlIP Score: 1.85 3.32 1.46 to 2.25 0.57 2.10 
Dimension Scores: 
Physical 0.86 2.22 0.59 to 1.12 0.00 0.00 
Psychosocial 1.99 3.96 1.52 to 2.46 0.00 2.28 
Category Score: 
Ardbulation 
Alertness Behaviour 
Body Care & Management 
Communication 
Eating 
Emotional Behaviour 
Home Management 
Mobility 
Recreation & Pastimes 
Social Interaction 
Sleep & Rest 
work 
1.14 4.38 0.00 0.00 
2.69 7.06 0.00 0.00 
0.27 1.16 0.00 0.00 
3.22 6.69 0.00 0.00 
0.00 0.00 0.00 0.00 
1.63 5.70 0.00 0.00 
3.49 11.96 0.00 0.00 
2.16 6.53 0.00 0.00 
10.61 15.34 0.00 19.43 
1.17 3.40 0.00 0.00 
2.64 9.57 0.00 0.00 
0.82 5.71 0.00 0.00 
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4. POST-OPERATIVE QUALITY OF LIFE 
There were 213 patients with complete data that were available for analysis at 4 
months and 217 patients at 12 months after surgery. 
4.1 Post-operative SIP Scores 
The distributions of post-operative scores for SIP at 4 and 12 months after surgery 
(Figures 7.3 and 7.4 respectively), were both highly skewed towards the lower scores, 
and no statistical transformation was effective in normalising these distributions. 
Figure7.3 Distribution of SIP Scores 4 Months after Surgery. 
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The mean SIP score at 4 months was 9.0 (s. d. 8.7), the median was 5.9 (inter-quartile 
range 9.9), with scores ranging from 0.4 to 45.8. The mean SIP score at 12 months 
was 8.1 (s. d. 7.7), the median was 5.3 (inter-quartile range 9.0) and scores ranged 
from 0.4 to 44.7. 
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Figure 7.4 Distribution of SIP Scores 12 Months After Surgery 
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4.2 Change in SIP Score (compared to pre-operative scores) 
The distributions of change in SIP scores at 4 months and 12 months approximated to 
a normal distribution and these are shown in Figures 7.5 and 7.6 respectively. The 
changes in post-operative scores at both 4 and 12 months were statistically 
significantly different from the pre-operative score (paired t-test, p-value <0.0001). 
Non-parametric tests also gave 2-tailed p-values <0.000 1. 
The mean change in SIP score at 4 months was 3.1 (s. d. 5.3; 95% C. I. 2.3 to 3.8), the 
median change was 3.1 (inter-quartile range 5.24), with change in scores ranging from 
19.9 to 19.8. The mean change in SIP score at 12 months after surgery was 2.5 (s. d. 
4.9; 95% C. I. 1.9 to 3.2). The median change was 2.7 (inter-quartile range = 4.9), 
with change in score ranging from -20.2 to 19.0. 
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Figure 7.5 Distribution of CHANGE in SIP Scores 
4 Months after surgery. n=213 
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Figure 7.6 Distribution of CHANGE in SIP Scores 
12 Months after surgery. n=217 
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4.3 Post-Operative VR-SIP Scores 
The mean VR-SIP score at 4 months was 0.3 (s. d. 0.7), the median was 0 (inter- 
quartile range 0.4), and scores ranged from 0 to 4.2.156 (73%) patients had a score 
of zero - quality of life was not affected due to vision at this time. The mean VR-SIP 
score at 12 months was 0.19 (s. d. 0.5), median 0 (inter-quartile range = 0) with scores 
ranging from 0 to 3.3.178 (82%) patients scored 0 at twelve months. Both these 
distributions were highly skewed towards the lower scores of little affect on quality of 
life and are shown in Figures 7.7 and 7.8. Statistical transformations were not 
effective in normalising these distributions. 
Figure7.7 Distribution of VR-SIP Scores 4 Months after Surgery. 
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Figure7.8 Distribution of VR-SIP Scores 12 Months after Surgery. 
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4.4 Change in VR-SIP Score (compared to pre-operative scores) 
The mean change in VR-SIP scores at 4 months was 1.3 (s. d. 2.6), the median change 
was 0.4 (inter-quartile range 1.5), with change in scores ranging from -3.3 to 13.6. 
35% (n = 74/213) of patients did not demonstrate any change (gain or loss) in VR-SIP 
score compared to pre-operative scores. The mean change in VR-SIP score at 12 
months was 1.5 (s. d. 2.9), median 0.52 (inter-quartile range = 1.6), with change in 
scores ranging from -3 to 21.9. At this time, 38% (n = 82/217) of patients did not 
have any change (gain or loss) in score from pre-operative values. The change in 
VR. -SIP score at both 4 and 12 months after surgery was statistically significant 
from 
pre-operative values (paired t-test, p-value <0.001). Non-parametric tests also gave 2- 
tailed p-values <0.00 1. 
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The distributions of change in VR-SIP scores at these times were both skewed towards 
the lower scores and are shown in Figures 7.9 and 7.10, and statistical transformations 
were not effective in normallsing them. 
Figure7.9 Distribution of CHANGE in VR-SIP Scores 
4 Months after Surgery. n= 213 
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Figure7.10 Distribution of CHANGE in VR-SIP Scores 
12 Months after Surgery. n=217 
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4.5 Change in Quality of Life at 4 Months and 
Visual Acuity Outcome 
The changes in quality of life by 4 months after surgery were also demonstrated in the 
group of patients that did not achieve a good visual acuity outcome (n--27 with 
complete SIP and VR-SIP at 4 months). As seen in Table 7.4, the mean change in 
SIP scores in this group was 5.8 (s. d. 5.8; 95% C. I. 3.6 to 8.1), and the mean change 
in VR-SIP scores was 2.9 (s. d. 3.8; 95% C. I. 1.3 to 4.4). Compared to their pre- 
operative values, these represented significant gains (paired Mest and non-parametric 
tests gave 2-tailed p-values < 0.001). However, the mean change in these scores 
between the sub-groups of patients by visual acuity outcome were not statistically 
significant. 
Table 7.4. Change in Quality of Life by Visual Acuity Outcome -4 months after surgery 
ft Mean Change by 4 months after surgery (s. d. ) 
Visual Acuity Outcome n SIP VR-SEP 
Good Outcome (616 to 6/12) 151 2.8 (5.1) 1.2 (2.4) 
Poor Outcome (less than 6/12) 27 5.8 (5.8) 2.9 (3.8) 
All N 178 3.2 (5-2) 1.4 (2.7) 
* All were significant gains compared to pre-operative values: paired West p-values <-- 0.001 
No significant differences in mean change were demonstrated between visual outcome groups: un-paired West 
P>0.05 
# Complete data for visual acuity in the surgery eye, SIP, and VR-SIP, both before surgery and at 4 months 
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4.6 Change in Quality of Life Between 4 and 12 Months after 
Surgery 
Of the 86 patients that had cataract surgery to their second eye between 4 and 12 
months, 72 patients had complete SIP and VR-SEP at both 4 and 12 months. 
As shown in Table 7.5, no significant mean changes in quality of life scores (SIP and 
VR-SIP) were observed between 4 and 12 months after surgery in those patients that 
had surgery to their first eye only. Those patients that had surgery to the second eye 
(between 4 and 12 months of surgery to the first eye), had significant mean changes in 
both SIP and VR-SIP scores at one year. 
Table 7.5. Change in Quality of Life between 4 and 12 months after surgery 
FIRST EYES only by 12 Months 
4 Month Score 12 Month Score 
mean (s. d. ) mean (s. d. ) 
Quality 0eN: 
BOTH EYES by 12 Months 
4 Month Score 12 Month Score 
mean (s. d. ) mean (s. d) 
Sickness Impact Profile (SEP) 8.00 (7.9) 8.50 (8.2) 9.10 (8.3) 7.30 (6.8) 
Vision-Related SIP 0.33 (0.8) 0.22 (0.6) 0.26 (0.6) 0.13 (0.3) 
significant gain between 4 and 12 months for first eye surgery only, paired West p-value = 0.02 
significant gain between 4 and 12 months - when second eye surgery performed during this interval, 
paired West p-value <0.05 
# SIP and VR-SIP: first eyes n--145 ; second eyes n--72 
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5. Responsiveness to Change 
This is presented in terms of effect sizes for overall, dimensions and categories of SIP 
and VR-SIP in terms of both the mean change and median change in score at 4 and 12 
months. 
The overall effect size for SIP at 4 months after cataract surgery was 0.33 and at 12 
months the effect size was 0.31 and were of a similar order when computed using the 
mean scores (Tables 7.6 and 7.7). Effect sizes were higher for the psychosocial 
dimension than for the physical dimension. 
The overall effect sizes for VR-SIP were lower than for SIP. At 4 months after 
surgery effect size for VR-SIP was 0.21 and at 12 months effect size was 0.28 and 
were generally lower than those computed by the mean scores. However as the VR- 
SIP scores were highly skewed, effect size is likely to better described using the 
median scores. Effect sizes for the physical and psychosocial dimensions were 0. 
(Tables 7.8 and 7.9. ) 
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Since effect sizes post-operatively were small and of a similar order at both 4 and 12 
months for both instruments, further examination of effect size by categories was 
performed for 4 month scores only. As both the pre-operative, and the change in 
category scores were highly skewed, effect size by categories are probably better 
described by those computed with median scores and inter-quartile range. 
The SIP categories with the highest effect sizes (for gain), were work, and recreation 
and pastimes. The eating category demonstrated a loss in function after surgery 
(indicated by the negative sign). (Table 7.10. ) 
Individual category scores for VR-SIP were not responsive to change after cataract 
surgery, having effect sizes of zero (Table 7.11). Patients that had a pre-operative VR- 
SIP score of zero (who could not demonstrate any gain), were then excluded and the 
findings are presented in Table 7.12. The only category that demonstrated an effect 
size was that for recreation and pastimes (0.5). All the remaining categories had effect 
sizes of zero. The overall effect size for gain although slightly higher, was still poor at 
0.4, effect size for the physical dimension was 0, and that for the psychosocial score 
was 0.3. 
178 
0 
I- 
5 
9 q qq LQ q qq LQ C! q cq c! q -: 0 0 009 0 0 0 0 0 0 0 0 0 0 
w w LL N 
U. 
ui Z; 
q cl c! P": cl 0ý C4 c! r*: ci ": Ci 
9 0 0 0 0 0 UJ N LL 
U. 
Ci cq q ui C4 CR Ci Ci q q q (R qT Ci OR 
c CO M C. ) IM CD CO (D CO " LO N 0 W) IV LO co IT 
0 0 0a t- 0 0 0 co a 0 0 0 N Go 
o 6 C4 6 6 6 6 6 6 6 6 6 
.2 Cl) 
uj 
cc q q OR qN cq cl CR q "t Ci C4 Cl 0 0) LO LO CO Ln 0 LO ;: 0) C) r- Lo U) LO fý- C-4 
z 
ui 
a 
z c (D 0 r- (0 r- 0) co v IT v 0) (D cl fe 4 6 C4 6 vi ad C4 wi L6 ci c; C') 
C4 Cq ul CR cl r cq C4 q (Q q q LQ q c qw M CO 0) In (D (D C14 C'i C4 (D 0 04 C4 cq co N w - 
w 0 
cc tr a 
0 
U c a r- cli 00 0 N in C4 a Go ý co 0) C%j > d as vi c; d c; C6 ad Vi Lfi Ci cd ci ui (d 
LU 0 N IT 2 > 4) 
cc w -d Liz r Ci LQ Ui Ci aq 11% R lo: N Iýt LQ Cý Ci 0 0 
CL 
4 IL 
a; 
U) a 0 0) U) V 0 IV - ý 0) - (7) 0 0 ca 6 
CY CY 0) 0 > W 0 C 
CL CD 
W! 
9 = 
cd 10 
0 Lf) Vi (D L(i Vi cd co cy to 0) m m N (D (7) 3 
2 N C-4 Z 7 0 
CD 0) 
C 
r- to 
E 
(D (D 
0 3 0 ý 
E E 
(D 
E 
cc c ý' 40 E to C 0 0 z 
0 CD C. 6 
0) 
in 
tm C3 a 
CC 
Im 0 - - In o 0 45 to kv 3 c m = E r- -r (a N N to 
0 75 0) E 
0 
:; -- 0 (d CL 
u 
0 
, 
0 
= - M t: -0 c E ;p 0 E :a 
15 -a zi > ,ý 0 E 0 - 0 M E O 0 0 0 2 0 - 1 = > 0 a < ; ( ca 8w w = 2 Ir ca V) ý: 12 a. co 0. w w 
179 
0 
0 00 00 0 0 00 0 0 0 Ci 0 0 
ci ci ö ci ci ö ci c: i ö ci cs ö ci ci 6 o 
N 
W 
N ci 7 ci 9 ci ci ci ue ci c4 N q Ci ný 
15-- 0 00 00 0 0 0 0 0 0 0 00 0 
0 
N 
ci ö ci ci d ci ci ci ci ci ö ö 4ö ö 
Co 
E 
Cý cý cý cý cý 1q: cý 
0 E 0 0 
KL CY CO 't -0 0 U') cl 0 Co e Co (0 Co -e 
cý (6 4 Lii 4 (6 tz ui li cý (IS (6 cý cý 
> 
r- 
CO 0- 0 le Ln LO LD N CD (0 CI) Lf) Lo 
Co 
w 
ä 
cý ö oj cý 4 cý -: rz Z o E 
0 0 00 00 0 0 0 0 0 0 0 (0 0 0 cn r_ ä ci ci ö ci ci cs ä ci ci ö ö 6 cq 
5 
0 
cý 
0 0 E 
> n cq c4 -7 0 0 Ln tn Ln CD 't OD r- (X) LO (D Ci Lii rz ui .i cý cd cci w 1: cli 
0) ei 
a 
0 
a) 
(3) e CY Co 0 N Lo Co - (D - - (0 r_ OD CL ci cý c: i cq d 4 cý -: ö 4 ci 
E 
c 4) E 
Z 0 r- E k% 0c >0 
. - > cu E 
*.. = c 
E c 0 0 Z (D CL 0 cm 
0 0 0) 2 la 
r_ 
cö r: 0) a) 0 ýg 08 (1) 
r 
:3 r_ 0 E e 
0 
:2 0 E z» r_ lp 0 0 C L 
Z 0 > E * E 0 0 O i§M ý U) E . To o 
iU E o E 2! 0 - 2 a 0. tu Co 0 0 (1) 0 m u ) U ) A 49 it 19 
180 
9 Ck 9 9 c:! cý Ln cý c:! c:! Ict 9 Ci 
00 0 0 0 0 0 
ä ll ci e7 ul 9 'le qt 'le 
Ce LQ ti c4 rlý Illý (Q 
0 0000 0 0 000 0 0 0 0 0 LU 0 
,0 
im 
0 
0 00 (0 0 0 0 0 c4 0 0 0 0 0 C) A c; ö c: i 0; ci cs 6 ö CM) ci cs cs cý 6 cý 
0 t 0 
g, 
- E 
Co fe - 0 0000 0 0 0 1: 0 0 0 cy 0 cl ci cs ö cs c: i c; 6 ö CY (S c; cs 4 ci 
0 E 
0 u m 0 Co CL 
Co 0 0 d -: 9 P, % vý e 0 e 0 
41 in 
LO 
": Co 0 CY 0 
cr 
> 
r_ 
Co 
c cm 
0 r_ 
Ln 0 cy 0 0 C» 0 'E» 'ý5 c5 cý i ci cý cs ei 
CP E 
m 0 0000 0 0 0 
C4 
Ln 0 0 0 CY Co "- ci ci cs c: i ci 6 ci ö r) cý r4 cs ci ei ö lý > 
0 
,» - 0 u c 
m 0 
.2 0 0000 0 0 0Ick0 0 0 r) o c» 
c; ci ci cs cs cs 6 ci le ci cs cs 4 c; Z 0 Q 0 & E 
,e 
u 0 
>. 9 0 cg 
e 
q: Ln t cý -t 0 0 
Co ,N0 N 0 0 ei od ri cý 1q: 
> 0 
C 0. 0. 
0. 0. l g LQ -: "0: bý 1: ý e -: 0 1: Co r to cy) Co CY 0 o E 0 le 0 c4 le , - 4m c4 4 cý 
cz 3: 
% 
E ui 
2 ý t9 Z 
Z - 
C E 
> x .2 cu 
o - > CD E -5 c > c E0 to M Co to 0 CL CY 
CO tu 0 0 0 r 
0 0 
E .2E Cd 0 m m c >, Er E :., 0 
0 E 
= to 
-0 .! 
2 12- 
0) 
0 
cc E 20 Vg E 0 u 00 E A 0 M CL 0 0. 1- to Co 000 CP Z w iß * 2 > > i. : 
181 
6. DISCUSSION OF FINDINGS 
The SIP scores provided a measure of the quality of life of pre-operative cataract 
patients. The VR-SIP scores provided a disease-specific measure of quality of life i. e. 
a measure of the quality of life affected by vision (vision-related quality of life). 
The criterion validity of the instruments were acceptable. The findings indicated that in 
this sample of cataract patients, both the generic instrument (SIP), and its modification 
(VR-SIP), function as expected, as presented by their relationships with the other pre- 
operative variables considered. The SIP correlated best with measures of health and 
better with visual function than with other measures of visual acuity and visual health. 
VR-SIP scores correlated best with visual function and measure of visual acuity than 
with measures of general health. 
These instruments provided scores with distributions that were highly skewed towards 
the lower scores of less reported dysfunction and handicap, particularly in the case of 
VR-SIP. In this situation, the mean as measure of central tendency and its standard 
deviation as a measure of the spread of observations about the mean may be 
misleading. The median (and inter-quartile range) may be more stable in these 
circumstances as it is less likely to influenced by extreme values. Both were presented 
but greater emphasis was laid on the median scores. 
An overall mean SIP score of 11.9 (s. d. 9.7; 95% C. I. 10.72 to 13.03), and median 
9.5 has been obtained for pre-operative cataract patients, and the distribution had a 
wide spread of pre-operative scores about the mean (or median). This score 
represents a measure of the quality of life amongst these patients. Direct comparisons 
with other patient groups is difficult in that insufficient data are provided in published 
reports to make standardised comparisons (at least by age and sex). However taken 
at face value, this score for cataract patients is higher than that described for otherwise 
healthy adults [ 140], and for patients with angina and myocardial infarction [ 14 1 ], but 
lower than that describing patients with chronic conditions such as low back pain 
[142][143]; rheumatoid arthritis [144]; cancer [145] end-stage renal disease [146]; 
and chronic obstructive airways disease [147] [148]. 
182 
The mean VR-SIP score was 1.8 (s. d. 2.7; 95% C. I. 1.5 to 2.2), and median 0.57, 
indicating little overall reported impact on patients' quality of life due to their vision. 
A floor effect was observed with a considerable proportion of patients (41% ) not 
attributing any of their handicap to vision and thereby not being able to demonstrate 
any benefit from cataract surgery in this regard. 
Examination of the category scores identified the category recreation and pastimes as 
having the highest scores in both SIP and VR-SIP, (in fact it was the only category 
that had a median above zero in VR-SIP). Work and home management were other 
high scoring categories in SIP. These, or similar categories (assessed by other 
instruments), have also been reported for patients with visual impairment in the 
community. [167] The other VR-SIP categories had very low median dysfunction 
scores suggesting that the presence of a cataract did not have a great impact on these 
categories of quality of life. 
A significant change in the quality of life scores (in the direction of mean gain) was 
demonstrated after cataract surgery. These suggested an improvement in the overall 
quality of life and vision related quality of life after cataract surgery. The mean gains 
achieved at 4 months were maintained at one year after surgery in the group of patients 
that had surgery to their first eye only. The group of patients that had surgery to the 
second eye between 4 and 12 months of surgery to the first eye, demonstrated 
additional mean gains in quality of life at one year. Mean gains were also 
demonstrated in patients that did not achieve a good visual acuity outcome. 
As already discussed in the previous chapter, although change in both the absolute SIP 
and VR-SIP scores was small, it was unlikely that the observed changes in quality of 
life scores were due to a placebo effect or due to a learning effect because the patient 
interview was conducted at sufficiently long intervals of 4 and 8 months of one 
another. However, as there was no control group of cataract patients that did not go 
on to have surgery for comparison, some influence from these effects cannot be 
completely overlooked. 
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Overall effect sizes were poor indicating that both SIP and VR-SIP had limited 
responsiveness to change, and that clinically important changes were likely to be small. 
Although change scores for SIP were better approximated to a normal distribution, the 
VR-SIP change scores remained highly skewed. Effect sizes were computed using the 
mean change in score post-operatively and the pre-operative standard deviation, as 
well as using the median change post-operatively and the pre-operative inter-quartile 
range. Effect sizes were consistently higher when computed from mean changes and 
pre-operative standard deviation and it is possible that in this situation, effect sizes 
computed in this manner are likely to provide overestimates. Consequently, further 
interpretation and discussion of effect size will be based on the computation of effect 
size from median change and pre-operative inter-quartile range as these provide a 
better estimate of effect size in this situation. Both computations were presented to 
illustrate this point and to provide consistency with methods employed in published 
literature. 
It had been anticipated that the VR-SIP would more responsiveness to change than the 
SIP, but this was not observed. There are several possible explanations for the small 
effect sizes observed. A floor effect was present with the VR-SIP with 41% of 
patients having scores of zero before surgery i. e. reported that their quality of life was 
not affected by their vision. These patients could not demonstrate any gain after 
cataract surgery. This limited the responsiveness of the VR-SIP to change and also 
limited any improvement on the SIP in this regard, that it may have potentially been 
expected to provide. 
In addition, examination of category scores suggested that many of the categories of 
quality of life measured were not affected in these cataract patients. Recreation and 
pastimes was identified as the category most affected before and after surgery. It was 
also the category where the both SIP and VR-SIP displayed greatest responsiveness 
to change, with moderate effect sizes for gain after surgery. Other categories of 
quality of life that were affected before surgery included work and home management 
(SIP). These were not identified as affecting quality of life affected by vision (VR- 
SIP). SIP demonstrated a large effect size after surgery for work, but not for home 
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management. A curious finding was greater dysfunction and handicap in the eating 
category post-operatively. This was only observed with SIP and no adequate 
explanation for this was found. 
SUMMARY OF FINDINGS 
The key findings relating to quality of life in cataract patients are : 
0 The SIP and VR-SrP displayed criterion validity for cataract patients and had 
limited responsiveness to change. 
Quality of life for cataract patients was not greatly affected by their vision 
Cataract had a greater effect on visual impairment (visual acuity in the surgery 
eye) and disability (visual functioning), than on handicap (quality of life). 
0 Cataract surgery improved quality of life 
0 Mean gains in quality of life after surgery to the first eye were maintained at 
one year 
0 Additional mean gains in quality of life were achieved after second eye surgery 
Mean gain in quality of life was achieved in patients with poor visual acuity 
outcome 
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Chapter 8. 
THE CATARACT OUTCOME STUDY : RESULTS 
RELATIONSHIPS BETWEEN 
VISUAL ACUITY, VISUAL FUNCTION AND QUALITY OF LIFE 
1. INTRODUCTION 
This chapter will present the findings relating to the relationships between the clinical 
and patient perceived measures of outcome examined in this thesis: visual acuity, 
visual function and quality of life. It was assumed that the sensory input from both 
eyes would influence visual function and quality of life. To allow for this, visual acuity 
was assessed in terms of the best corrected Snellen acuity in the surgery eye, the better 
eye and by VP% score (person visual acuity). Before relationships between the 
measures was could be examined, the visual acuity that was the most appropriate for 
this purpose had to be established. Although visual function and quality of life were 
significantly different after surgery, the change that was achieved (compared to pre- 
operative values) was of interest in assessing the inter-relationships between the clinical 
and patient perceived measures after surgery. Pre-operative findings are presented 
first, followed by the post-operative findings as follows : 
a description of the relationship between visual acuity and visual function and 
quality of life hefore surgery 
0 the delenninants of visual function and quality of life before surgery 
0a description of the relationship between change in visual function and visual 
acuity after surgery 
0 the detenninams of change in visual function after surgery 
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2. CORRELATION OF VISUAL ACUITY WITH VISUAL FUNCTION AND 
QUALITY OF LIFE 
As shown in Table 8.1, before surgery, the surgery eye visual acuity correlated poorly 
with the pre-operative visual function given by the VF-14 score, and the health-related 
a nd vision-related quality of life scores given by the SIP and VR-SIP scores, 
respectively. Correlations with better eye visual acuity and VP% scores were better 
and of a sin-dlar order. 
Table 8.1. Correlation matrix : pre-operative measures of visual acuity with 
pre-operative visual function (VF-14) and quality of life (SIP and VR-SIEP) 
VSEYADM VBEYADM VPADM 
Surgery Eye Visual Acuity Pre-Op : VSEYADM 
Better Eye Visual Acuity Pre-Op : VBEYADM 0.39 
VP% Score Pre-Op : VPADM -0.58 -0.91 
Pre-op Visual Function (VF-14) Score : VFADM -0.21 -0.48 0.45 
Pre-op Sickness Impact Profile (SIP) score : SIPADM 0.19 0.34 "' -0.33 
Pre-op Vision-Related VR-SIP score VR-S11PADM 0.17 0.34 
_-0.34 
All are Speannan Correlation Coefficients, p-value <0.01 
Four months after surgery, all the measures of visual acuity had similar correlation 
coefficients with the visual function(VF-14) and health (SIP) and vision-related (VR- 
SIP) quality of life scores. Table 8.2 
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Table 8.2 Correlation matrix : measures of visual acuity with visual function (VF-14) and 
quality of life (SIP and VR-SIP) at 4 MONTHS after surgery 
VSEY4M VBEY4M VP4M 
Surgery Eye Visual Acuity 4 Months VSEY4M 
Better Eye Visual Acuity 4 Months VBEY4M 0.89 
VP% Score 4 Months VP4M -0.67 -0.73 
Visual Function (VF-14) score 4 months ; W144M -0.31 -0.34 0.33 
Sickness Impact Profile (SEP) score 4 months : S]P4M 0.25 0.25 -0.24 
Vision-Related VR-SIP score 4 months : VR-Sl1P4M 0.23 0.23 -0.23 
All arc Spearman Correlation Cocfficients, p-valuc <0.01 
At twelve months after surgery, although correlations with the measures of visual 
acuity were similar for visual function (VF-14), and vision-related quality of life (VR- 
SIP), they were higher for better eye visual acuity and VP% score. Correlations with 
health-related quality of life were better with surgery eye acuity and better eye acuity 
than with VP% score. Table 8.3. 
Table 8.3 Correlation matrix : measures of visual acuity with visual function (VF-14) and 
quality of life (SIP and VR-SEP) at 12 MONTHS after surgery 
VSEY12M VBEY12M VP12M 
Surgery Eye Visual Acuity 12 Months : VSEY12M 
Better Eye Visual Acuity 12 Months : VBEY12M 0.82 
VP% Score 12 Months : VP12M -0.63 -0.66 
Visual Function (VF-14) score 12 months : W14-12M -0.31 -0.38 0.39 
Sickness Impact Profile (SIP) score 12 month : SIP12M 0.27 0.24 -0.15 
Vision-Related VR-SIP score 12 months : VR-SIP12M 0.29 0.34 -0.33 
All are Speaffnan CorTelation Coefficients, p-value <. O I 
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3. PRE-OPERATIVE RELATIONSHIPS 
In addition to the correlations with visual acuity presented above, as seen in Table 8.4, 
VF-14 scores before surgery correlated strongly with VR-SIP scores measuring quality 
of life affected by vision (correlation coefficient = -0.71). Both VF-14 and VR-SIP 
correlated moderately well with global measures of vision. SIP scores measuring 
overall quality of life correlated less well with visual function (correlation coefficient 
-0.37), and poorly with global measures of vision. 
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3.1 Visual Function Before Surgery 
3.1.1 Relationship (unadjusted) between Pre-operative VF-14 Score and 
Continuous Pre-operative Variables 
These are surnmarised in Table 8.5. 
Table 8.5. Relationship (unadjusted) between : Pre-Operative VF-14 Score and 
Continuous Pre-Operative Variables. N= 337 cases 
TYPE OF COEFFICIENT 
Variable Correlation Coefricient Regression Coefficient 
(Spearman's) p-value Coefficient beta p-value R-square 
Pre-Operative 
Better Eye Visual Acuity 0.4763 <0.0001 7.57 0.55 <0.0001 0.3 
Age (on admission) -0.0109 0.842 0.002 0.0007 0.99 <0.001 
Scatterplots were plotted and the diagnostics for the regression coefficients were satisfactory. 
The Spearman correlation coefficient was 0.48. The regression coefficient was 7.6 (p- 
value <0.0001), suggesting that the VF-14 score improves as visual acuity in the better 
eye improves. For every one unit change in better eye vision (approximates to one line 
of Snellen acuity), then on average there will be a change of 7.6 units in the VF-14 
score. 30% of the variability in VF-14 scores was explained by visual acuity in the 
better eye (R-squared = 0.3). The diagnostics for the validity of the regression model 
were satisfactory and confirmed a significant linear relationship between the visual 
function and visual acuity in the better eye. 
No significant relationship was observed between age and pre-operative VF-14 score. 
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3.1.2 Relationship (unadjusted) between Pre-operative VF-14 Score and 
Categorical Pre-operative Variables 
The mean VF-14 scores were examined by : visual acuity group for better eye on 
admission, global self assessments of vision, age group, sex and presence of ocular 
comorbidity (Table 8.6). Overall there was a wide variation in scores about the mean 
score for all the sub-groups of the variables considered, as seen by the standard 
deviations of the mean scores. 
As visual acuity decreased from good acuity to blindness, then mean VF-14 score fell 
also. The mean scores for severe visual impairment and blindness are not significantly 
different from each other. There are smaller numbers of patients in these two groups 
and the confidence intervals for these means are wide. However, as seen for any level 
of visual acuity, there is a wide spread of scores about the mean score. 
The global assessments of vision showed a similar pattern - as the amount of "trouble 
with vision" reported increased, or the amount of "dissatisfaction with vision" 
increased, the group mean VF-14 scores fell. 
No significant differences were observed in the mean VF-14 scores by age group, sex 
or the presence or absence of ocular comorbidity. 
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Table 8.6 Relationship (unadjusted) of Pre-Operative VF-14 Score 
and Pre-Operative Categorical Variables 
n Mean VF-14 score (s. d. ) 95% CL for Mean 
Better Eye 
Visual Acuity 
6/6 to 6/12 181 76.2 (16.6) 73.8 to 78.6 
6/18 to U24 92 62.2 (23.4) 57.4 to 67.1 
6136 to 6/60 20 42.9 (24.0) 31.7 to 54.1 
blind 7 28.9 (20.3) 10.1 to 47.7 
Reported "Trouble" 
with Vision 
none 8 85.8 (15.6) 72.8 to 98.9 
little 46 86.3 (13.9) 82.2 to 90.5 
moderate 142 73.6 (16.9) 70.7 to 76.4 
great deal 104 52.6 (22.8) 48.2 to 57.1 
Reported "Satisfaction" 
with Vision * 
satisfied 26 89.7 (11.7) 84.8 to 94.5 
dissatisfied 193 71.9 (20.2) 68.9 to 74.7 
very dissatisfied 81 54.0 (22.0) 49.2 to 58.9 
Ocular Comorbidity # 
absent 204 70.2 (21.7) 67.2 to 73.2 
present 96 65.1 (65.1) 60.3 to 69.9 
Age (years) # 
50 to 64 33 65.6 (22.6) 57.6 to 73.6 
65 to 74 97 68.4 (22.3) 63.9 to 72.9 
75 and over 170 69.3 (22.6) 65.9 to 72.2 
Sex N 
males 113 71.8 (23.7) 67.6 to 76.2 
females 187 66.7 (21.6) 63.6 to 69.8 
Kruskal-Wallis p-value<0.0001 
# one-way anova p-value > 0.05 
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3.1.3 The Determinants of Pre-operative VF-14 Score 
Since the crude analysis suggested that visual acuity could "explain" only 30% of the 
variability in the VF-14 scores observed, other factors were most likely to be 
contributing to the VF-14 score itself, and to the variation in scores for any particular 
sub-group. The influence of other independent factors on VF-14 score was 
considered in a multiple regression model. The variables in the model were : 
Dependent variable pre-operative VF- 14 score (VFSD) 
Independent variables 
Age 50-64 years (referent group) 
65-74 years 
75 years and over 
Better eye 6/6 to 6/12 - good 
visual acuity 6/18 to 6/24 - moderate impairment 
6/36orworse- severe impairment (referentgroup) 
Sex male =0 (referent group) 
female =I 
Ocular comorbidity absent= 0 (referent group) 
present =I 
Comorbidity "botherso=-ness" score (continuous variable) 
Cataract Symptom score (continuous variable) 
The diagnostics for the validity of this model were satisfactory [Appendix C2] and the 
findings are summarised in Table 8.7. 
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Table 8.7 Determinants of Pre-Operative Visual Function (Pre-Operative W-14 Score) 
Multiple Regression Model 
Dependent Variable: Pre-Operative VF-14 Score (VFSD) 
Model Characteristic3 
Multiple R=0.61 
R-square= 0.38 F= 22.1 
Adjusted R-square = 0.36 Significance of F <. 0001 
Standard Error = 17.99 
Variables In Model Coefficient [95% C. L] beta p-value 
Visual Acuity In 
Better Eye on admission: 
Scvcrc Impairment: <--6/36 refcrcnt 
Visual Impairment: 6/19 to 6/24 22.13 [14.3 to 29.9] 0.75 <0.0001 
Good visual acuity- 6/6 to 6/12 34.55 [27.0 to 42.1] 0.45 < 0.0001 
Ocular Comorbidity 
present . 1.061 [-5.5 to 3.4] -0.02 0.6 
Cataract Symptom Score -0.25 [-0.3 to -0.21 -0.3 < 0.0001 
Comorbidity "bothersome" score -0.53 [-0.8 to -0.21 -0.2 < 0.001 
Age: 
50 to 64 years referent 
65 to 74 years 4.16 [-3.1 to 11.4] 0.1 0.26 
75 years and over 7.70 [0.7 to 14.7] 0.2 0.03 
Sex 
female -2.34 [-6.7 to 2.0] -0.05 0.29 
This model explained 38% of the variability of the VF scores (R-square = 0.38), having 
adjusted for all the other variables in the model. It demonstrates the presence of a 
linear relationship between VF-14 score and the other independent variables (F=22.1, 
significance of F <0.00005). 
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The variables with significant partial regression coefficients identified by this model 
are better eye visual acuity, comorbidity "bothersome" score, cataract symptom score 
and age. The coefficient for better eye visual acuity was positive, indicating that, 
having adjusted for the other variables in the model, as visual acuity improves the VF- 
14 score rises, with a greater average change of visual function score for unit of visual 
acuity change in the group with good pre-operative better eye visual acuity. 
Comorbidity and cataract symptoms have negative coefficients indicating that as these 
scores rise (worsening of comorbidity or cataract symptoms) visual function 
deteriorates. 
The positive regression coefficients for age suggest that visual function score rises on 
average with age, having adjusted for all the other variables in the model. As seen 
above, the crude relationship between VF-14 scores and age did not indicate this. In 
case the effect seen in the model was due to the fact that there were small numbers of 
people in the referent group (youngest age group, n--33), the model was then fitted, 
first with age considered in just two groups of under 75 years and 75 years or over, 
and then it was next fitted with age as a continuous variable. Neither of these changed 
the relationship between age and VF-14 score having adjusted for all the other 
variables in the model. 
Although ocular comorbidity and sex did not demonstrate any significant relationships 
with baseline VF-14 score in the regression model, they are both significantly 
correlated with better eye visual acuity (Spearman correlation coefficients -0.143 3, p- 
value= 0.012 and -0.1921, p-value=0.001, respectively). It is possible that they may 
be operating through their relationship with visual acuity and do not have any unique 
contribution to make to the model. 
An analysis of variance with better eye visual acuity as the covariate, VF-14 score as 
dependent variable, and age group, sex and ocular comorbiditY as factors, did not 
demonstrate any significant effects either as main effects or as interactions between the 
factors. The relationship between better eye visual acuity and W-14 score was 
similar when controlling for age, sex and ocular comorbidity. 
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The regression model was then fitted with age as the dependent variable and all the 
others as independent variables, to explore the factors associated with age, particularly 
acuity which may be influencing the effect observed on VF-14 scores. The findings are 
summarised in Table 7.8 (details are provided in Appendix C2). As the partial 
regression coefficients indicate, after adjustment for the other variables in the model, 
visual acuity falls with increasing age and visual function improves with increasing age. 
Cataract symptom score falls with rising age, whilst general comorbidity "bothersome" 
score rises on average with age. 
The model was then fitted excluding cataract symptom score, in case the effect of age 
on visual function was working through this, but the age and visual function 
relationship persisted. Only the full model is presented in Table 8.8 . 
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Table 8.8 Pre-Operative Factors Associated with AGE on admission for cataract surgery. 
Multiple Regression Model 
Dependent Variable: AGE (continuous) 
Model Characteristics: 
Multiple R=0.41 
R-square = 0.16 
Adjusted R-square = 0.14 
Standard Error = 7.64 
F=8.24 
Significance of F <0.0001 
Variables In Model Coefflclent [95% C. L] beta P-value 
Visual Acuity In 
Better Eye on admission: 
Severe Impairment: -C-6/36 referent 
Visual Impairment: 6/18 to-6/24 -3.55 [-7.0 to -0.071 -0.2 0.04 
Good visual acuity- 6/6 to 6/12 -7.60 [4 1.2 to -4.0] -0.45 < 0.0001 
Ocular Comorbidity: 
present 1.81 [-0.1 to 3.7] 0.1 0.06 
Cataract Symptom Score -0.05 [-0.1 to -0.011 -0.15 0.007 
Comorbidity "bothersome" score: 0.14 [0.01 to 0.3] 0.12 0.03 
Pre-Operative VF-14 score (VFSD) 0.05 [0.01 to 0.21 0.15 0.02 
Sex : 
female 2.4 [0.6 to 4.2] 0.14 0.01 
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3.2 Quality of Life Before Surgery 
3.2.1 Relationship (unadjusted) Between Health-Related Quality of Life (SIP) 
and other Pre-operative Continuous Variables 
These are summarised in Table 8.9. 
Table 8.9. Relationship (unadjusted) between: Pre-Operative SIP Score (SIP) and other 
Pre-operative Continuous Variables. N= 273 cases 
Regression 
Variable Coefficient [95% C. 1] beta p-value R-square 
Age (on admission) 0.31 [0.18 to 0.45] 0.27 < 0.0001 0.07 
Comorbidity "Bothersome" Score 0.82 [ 0.68 to 0.961 0.60 < 0.0001 0.36 
Pre-Operative Better Eye Visual Acuity -1.65 [-2.33 to -0.981 . 0.29 < 0.0001 0.09 
Pre-Operative Visual Function Score -0.17 [-0.22 to -0.121 -0.39 < 0.0001 0.15 
Scatterplots, correlation coefficients, and diagnostics for regression coefficients were performed and were 
satisfactory. 
As the regression coefficient (0.3 1) indicates, SIP scores rise with increasing age. 
Although a significant linear relationship was demonstrated, the impact of age on 
overall SIP score is small as it only explains 7% of the variability of the pre-operative 
scores (R-square = 0.07). 
The coefficients indicate that SIP scores rise with increasing "bothersome-ness" from 
other comorbidities (regression coefficient 0.82). A significant linear relationship was 
demonstrated, with 36% of the variability of the pre-operative SIP score (R-square 
0.36) being explained by the comorbidity "bothersome' score. 
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The negative regression coefficient (-1.65) indicates that SIP scores rise with 
decreasing visual acuity in the better eye. However better eye visual acuity could 
only explain 9% of the variability of the SIP score (R-square =0.09). 
The negative coefficients (correlation -0.37 and regression -0.17), indicate that SIP 
scores rise as visual functioning decreases. About 15% of the variability of the pre- 
operative SIP scores could be explained by the visual function score (R-square = 0.15). 
3.2.2 Relationship (unadjusted) Between Vision-Related Quality of Life 
(VR-SIP) and other Pre-operative Continuous Variables 
These are surnmarised in Table 8.10. There was a strong correlation with VR-SIP 
(Spearman correlation coefficient -0.71). Although a linear relationship was 
demonstrated, with 41% of the variability in pre-operative VR-SIP scores being 
explained by the visual function score (R-square = 0.41), the unadjusted regression 
coefficient was -0.095 suggesting very little change in average VR-SIP score with unit 
increase in visual function score. 
Similarly, for VR-SEP scores, as indicated by the negative regression coefficient 
(-0.78), VR-SIP scores rosewrith poorer visual acuity in the better eye. 14% of the 
variability of the pre-operative VR-SIP scores being explained by better eye visual 
acuity. 
For comorbidity and age regression coefficients were not valid as the diagnostics for 
the model were highly unsatisfactory and a linear relationship could not be 
demonstrated. 
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Table 8.10. Relationship (unadjusted) between : Pre-Operative VR-SIP Score (VR-SIEP) and 
other Pre-operative Continuous VariableL N= 273 cases 
Regression I 
Variable coefficient 195% C. 11 beta p-value, R-square 
Pre-Operative Visual Function Score -0.095 [-0.11 to -0.08] -0.64 < 0.0001 0.41 
Pre-Operative Better Eye Visual Acuity -0.78 [-1.02 to -0.54] -0.38 < 0.0001 0.14 
Comorbidity "Bothersome" Score 0.05 [-0.01 to 0.11] 0.09 0.12 0.01 
Scatterplots, correlation coefficients and diagnostics for regression coefficients were performed and were 
satisfactory. 
3.2.3 Relationship (unadjusted) of Pre-operative SIP Score and 
Categorical Pre-operative Variables 
The mean SIP scores were then examined by : age group, sex, comparative 
assessments of health, visual acuity group for better eye on admission, global self 
assessments of vision, and presence of ocular comorbidity, and are shown in Table 
8.11. Overall there was a wide variation in scores about the mean score for any of the 
sub-groups of the variables considered, as seen by the standard deviations of the mean 
scores. 
Both the mean and median SIP scores were higher with increasing age. The oldest age 
group 75 years and over had significantly higher scores than the 65 to 74 year age 
group. Although no significant difference was observed between the 50 to 64 year age 
group and the other age groups, this group had fewer numbers and wider confidence 
intervals, which must be considered in its interpretation. Pre-operative SIP scores 
were higher amongst females, as comparative assessments of health were towards 
poorer health, with poorer visual acuity in the better eye, and with greater reporting of 
trouble with vision and dissatisfaction with vision. 
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Table 8.11. 
Relationship (unadjusted) between Pro-operative SIP and Pre-operative Categorical Variables 
n Mean SIP Sears sd. 95% C. I. Median Inter-quartile 
for Mean Score Range 
Age (years) 
50 to 64 30 9.3 iOA 5.5 to 13.1 8.2 29.7 
65 to 74 83 10A 8.8 8.2 to 12.0 7.5 23.3 
75 and over 160 13.3* 9.8 11.8 to 14.8 11.0 28.1 
Sax ## 
majes 109 10.0 9.0 8.3 to 11.7 8.1 23.8 
females 184 13.1 9.9 11.6 to 14.7 10.7 27.3 
Comparative Assessment 
of Health : 
C1. "is your health 
Excellent 30 7.0 6.8 4. a to 9.5 5.4 21.1 
Very good 87 8.0 8.4 6.7 to 9.4 6.7 13.3 
Good 78 11.3 7.8 9.5 to 13.0 8.9 20.0 
Fair 53 15.8 10.2 12.9 to I8. a 12.8 25.6 
Poor 24 24.3 12.0 25.0 27.1 
C2. *Compar*d to others r# 
Much better 74 8.1 6.9 6.8 to 10.0 7.1 20.1 
Better 108 10.4 8.7 8.8 to 12.0 8.6 20.5 
About the same 87 15.0 10.4 12.4 to 17.6 11.2 27.0 
Worse 19 20.2 10.8 15.11 to 2S. 3 21.8 31.4 
Much worse 2 33.8 0.5 - 33.8 0.7 
Bout Eye Vision 
8/6 to 6/12 153 9.7 8.3 8.4 to 11.0 7.5 22.0 
8/18 to 8124 72 13.2 9.4 11 .0 to 15.5 11.1 28.7 
6/38 to 6160 19 19.7 12.8 13.5 to 25.8 17.2 37.7 
blind 6 15.5 4.5 10.8 to 20.2 15.0 10.4 
Reported "Trouble" 
with Vision 
none 9 11.8 9.8 4.2 to 19.3 5.5 20.8 
tilde 42 9.9 8.6 7.2 to 12.6 a. 2 22.3 
moderate 131 10.4 9.2 8.8 to 12.0 a. 4 28.4 
great deal 91 14.9 10.2 12.8 to 17.0 11.3 26.6 
Reported "Satisfaction' 
with Vision 
satisfied 27 10.3 11.2 5.9 to 14.8 5.5 27.2 
dissatisfied 175 10.7 8.7 9.4 to 11.9 8.9 28.6 
very dissatisfied 69 15.4 10.5 12.8 to 17.9 12.5 27.1 
Ocular Comorbidity ## 
absent 173 10.8 SA 9.5 to 12.0 8.9 21. S 
present 111 13.8 10.7 11.4 to 16.2 11.0 28.7 
# Kruskal-Wallis Test p -cO. 0005 
## Kruskal-Wallis Test p -C 0.05 
Unless Indicated otherwise, all other group comparisons were made by a one-way analysis of variance with adjustment for 
multiple comparisons being made by the Bonferror'O test. p<0.05 
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3.2.4 Relationship (unadjusted) of Pre-operative VR-SIP Score and 
Categorical Pre-operative Variables 
The mean VR-SIP scores were then examined as above with similar sub-groups of pre- 
operative variables and are presented in Table 8.12. Overall there was a wide variation 
in scores about the mean score for any of the sub-groups of the variables considered, 
as seen by the standard deviations of the mean scores. 
No significant differences were observed in the mean or median VR-SIP scores by age 
group, or by the presence or absence of ocular comorbidity. Both the mean and 
median VR-SIP scores rose with poorer visual acuity in the better eye and with greater 
trouble and dissatisfaction with vision. 
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Table 8.12. 
Relationship (unadjusted) : Pro-Operative VR-SIP Scores and Pre-operative Categorical Variables 
n MeanVR-SIPScor s. d. 95% C. I. Median Inter-quartile 
for Mean Score Range 
Age (years) 
50 to 64 30 3.0 4.7 1.3 to 4.8 0.2 5.1 
65 to 74 83 2.1 3.6 1.3 to 2.9 0.9 2.6 
75 and over 160 1.5 2.8 1.1 to 1.9 0.5 1.6 
Sex ## 
males 109 1.9 4.0 0.0 1.7 
females 164 1.9 2.8 0.8 2.6 
Best Eye Vision # 
6/6 to 6/12 153 1.1 2.0 0.8 to 1.5 0.4 1.3 
6/18 to 6/24 72 2.4 4.3 1.4 to 3.4 0.7 2.7 
6/36 to 6/60 19 4.8 5.5 2.2 to 7.5 3.3 6.1 
blind 6 6.9 2.5 4.3 to 9.6 7.5 4.5 
Reported wTroublea 
with Vision - Al # 
none 9 1.5 2.3 -0.3 to 3.2 0.0 2.8 
little 42 0.3 0.5 0.1 to 0.4 0.0 0.4 
moderate 131 1.1 2.4 0.7 to 1.5 0.4 1.3 
great deal 91 3.7 4.4 2.8 to 4.6 2.4 4.3 
Reported 'Satisfaction' 
with Vision - A2 # 
satisfied 27 0.3 0.9 -0.1 to 0.7 0.0 0.0 
dissatisfied 175 1.4 2.6 1.0 to 1.8 0.5 1.6 
very dissatisfied 69 3.6 4.7 2.5 to 4.7 2.0 3.4 
Ocular Comorbldity 
absent 173 1.7 3.3 1.2 to 2.2 0.6 1.9 
present 81 2.3 3.6 1.5 to 3.0 0.8 2.9 
#- Kruskal-Wallis Test p <0.0005 
## - Krus kal-Wallis Test p<0.05 
*- No significnat differences between groups demonstrated by both parametric and non-parametric tests 
Unless indicated otherwise, all other group comparisons were made by a one-way analysis of variance with adjustment f 
multiple comparisons being made by the Bonferroni test p<0.05 
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3.2.5 The Determinants of Pre-operative Quality of Life 
Given the crude relationships described above, multiple regression models were used 
to identify the independent factors that were the detern-dnants of pre-operative Sip 
and VR-SIP scores, having adjusted for the effect of other important variables. 
a. Determinants of Pre-Operative SIP Score 
Sex, ocular comorbidity and better eye visual acuity were included in the initial model 
building process, but were found to be non-significant factors not contributing to the 
model. In the interest of simplicity, these variables were excluded from the final 
model, so that the latter may be optimally efficient. The final model included age, 
comorbidity "bothersome" score and pre-operative visual function score. The 
diagnostics for the validity of the final model were satisfactory [Appendix C3] and the 
findings are summarised in Table 8.13. 
Table 8.13 Detenninants of Pre-Operative SIP Score. 
Multiple Regression Model 
N=249 
Dependent Variable: Pre-operative SIP Score (TOTAL) 
Model Characteristics: 
Multiple R=0.69 
R-square = 0.49 
Adjusted R-square = 0.47 
Standard Error = 6.79 
Variables In Model Coefficient 
Comorbidity "bothersome-ness" 0.69 
Pre-Operative Visual Function Score -0.12 
Age 0.24 
[95% CLI beta p-value 
[0.56 to 0.821 0.51 < 0.0001 
[-0.16 to -0.081 -0.29 < 0.0001 
[0.13 to 0.34] 0.21 < 0.0001 
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This model explained 48% of the variability of the pre-operative SIP scores. Having 
adjusted for the effects of the other variables in the model, comorbidity "bothersome" 
score was the single most important determinant of pre-operative SIP score in this 
model (having the highest standardised beta 0.5 1). The effects of the other variables 
on the standardised beta for comorbidity "bothersome"' score was minimal, the 
unadjusted standardised beta being 0.6 (as seen in Table 8.9). 
Age and pre-operative visual function score were significant independent determinants 
of pre-operative SIP score. 
b. Determinants of Pre-Operative VR-SIP Score 
Sex and ocular comorbidity were not included in the final model because they did not 
contribute significantly in the initial models. The final model included visual function 
score, better eye visual acuity, and age on admission. The diagnostics for the final 
model were satisfactory and are provided in Appendix C4. The findings are 
summarised in Table 8.14. 
This model explained 41% of the variability of pre-op VR-SIP scores. Pre-operative 
visual function (VF-14 score) was the most important determinant of VR-SIP score, 
(standardised beta -0.59), having adjusted for the other variables in the model. 
Adjustment for the effects of the other variables in the model had little impact on the 
estimates of the unadjusted regression coefficient and standardised beta for visual 
function score (as seen in Table 8.10). 
Age and better eye visual acuity on admission were not significant, once the effect of 
visual function score had been controlled for. Age was included in this model to adjust 
for its effect on better eye acuity and visual function score. Better eye acuity is 
significantly correlated with visual function score (correlation coefficient 0.4763) and 
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presumably does not have any significant unique contribution to make to the model 
above that operating through visual function score. 
Table 8.14. Determinants of Pre-Operative VR-SIEP Score. 
Multiple Regression Model 
N=250 
Dependent Variable: Pre-Operative VR-SIP Score (VrOTAL) 
Model Characteristics: 
Multiple R=0.66 
R-square = 0.44 
Adjusted R-square = 0.43 
Standard Error = 2.58 
Variables In Model 
Pre-Operative Visual Function Score 
Pre-Operative Better Eye Visual Acuity 
Age (on admission) 
Coefficient [95% C11 bets p-value 
0.09 [-0.11 to -0.07] -0.59 < 0.0001 
-0.16 [-0.41 to 0.091 -0.08 0.22 
-0.04 [-0.09 to 0.001] -0.10 0.06 
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4. POST-OPERATIVE RELATIONSHIPS 
Since change in measures of quality of life were small, that a significant proportion of 
patients reported that their quality of life was not affected by their vision (4 1 %), and 
the effect sizes for SIP and VR-SIP were poor, further analysis of the relationships 
between visual acuity and the change in quality of life, and the determinants of change 
in quality of life were not pursued. 
Post-operative relationships between visual acuity and visual function at 4 and 12 
months after surgery were examined and are now presented. 
4.1 Relationship (unadjusted) Of CHANGE in VF-14 Score After 
Surgery and Continuous Variables 
These are summarised in Table 8.15 and Table 8.16 for change at 4 and 12 months 
respectively. 
Pre-Operative VF-14 Score 
Significant linear relationships was demonstrated between pre-operative visual 
functioning and the change achieved after surgery. The negative regression 
coefficients after surgery suggest that on average poorer pre-operative NT-14 score 
had more change in visual function at 4 and 12 months after surgery. 47% of the 
variability in change in visual function scores at 4 months was being explained by the 
pre-operative visual function scores (R-squared = 0.47), with 60% of the variability of 
change in VF-14 scores at 12 months after surgery being explained by the pre- 
operative scores ( R-squared = 0.6). 
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Pre-Operative Visual Acuity in Better Eye 
The negative regression coefficients suggest that patients with poorer pre-operative 
visual acuity in the better eye on average, achieved more change (gain) in visual 
function than patients with better pre-operative acuity in the better eye. Although 
significant linear relationships were demonstrated, pre-operative better eye visual 
acuity could only explain about 8% of the variability of the change in VF-14 scores at 
4 months and 9% at 12 months after surgery. (Table 8.15 and 8.16) 
Change in Visual Acuity in Better Eye at 4 Months after Surgery 
The positive regression coefficients indicate that as more change in better eye visual 
acuity was achieved post-operatively, then more change (gain) in visual function was 
achieved. Linear relationships were demonstrated. The change in better eye acuity 
explained 11% of the variability of the change in VF-14 scores at 4 months (R-square 
= 0.11), and 24% of the variability at 12 months (R-square = 0.24). 
Table 8.15 Relationship (unadjusted) between : Change in VF-14 Score 4 MONTHS After 
Surgery and Continuous Variables. n- 316 cases 
Variable Regression Coefficient beta p-value R-square 
[95% C11 
Pre-Operative VF-14 Score (VFSD) 
Pre-Operative Better Eye 
Visual Acuity (BVHI) 
Change in Better Eye Visual Acuity 
4 Months after surgery (BVCH4M) 
-0.64 [-0.72 to -0.57] -0.69 < 0.0001 0.47 
-3.6 [-5.01 to -2.19] -0.29 <0.0001 0.08 
4.86 [3.20 to 6.53] 0.34 <0.0001 0.11 
Scaftcrplots, correlation coefficients (Pearson and Spearman) and diagnostics for regression c0cfficients were 
performed and were satisfactory. 
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Table 8.16 Relationshil) (unadjusted) between Change in VF-14 Score 12 MONTHS After 
Surgery and Continuous VariableL n= 278 cases 
Variable Regression CoeMcient beta p-value R-square 
[95% C. L] 
Pre-Operative VF-14 Score: -0.73 [-0.79 to -0.66] 
(VFSD) 
Pre-Operative Better Eye 
Visual Acuity (BVHI) -3.93 [-5.44 to -2.421 
-0.78 < 0.000 0.60 
-0.3 < 0.000 0.09 
Change In Better Eye 
Visual Acuity 12 months 7.09 [5.38 to 8.80] 0.49 < 0.000 0.24 
after surgery(BVCH12M) 
Scaftcrplots, correlation cocfficicnts (Pearson and Spearman) and diagnostics for regression coefficients were 
performed and were satisfactory. 
4.2 Relationship (unadjusted) between CHANGE in VF-14 Score 
After Surgery and Categorical Variables 
These are summarised in Table 8.17 and 8.18 for change at 4 and 12 months 
respectively. 
There was a wide spread of scores about the mean change for all sub-groups 
considered, as indicated by the standard deviations of the sub-group means. The mean 
change in visual function after surgery at both 4 and 12 months was higher amongst 
patients with poorer pre-operative visual acuity in the better eye. No significant 
differences were observed by age group, sex, the presence or absence of ocular 
comorbidity, and at 4 months, by visual acuity outcome. Second eye surgery was 
associated with a greater mean change in visual function at 12 months. 
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Table 8.17 Change in VF-14 Score at 4 Months Post-Operatively by Sub-Group of 
Categorical Variables 
n Mean Change 95% C. L Median Inter-quartile 
VF-14 score (s. d. ) for Mean range 
Better Eye 
Visual Acuity 
on Admission # 
616 to 6/12 178 15.37 (15.93) 13.02 to 17.7 12.50 22.76 
6/19 to 6/24 89 26.10 (23.61) 21.13 to 31.1 24.32 34.46 
6/36 to 6160 21 32.40 (29.14) 19.14 to 45.7 23.86 41.82 
blind 7 27.95 (36.31) -5.64 to 61.5 20.45 59.44 
Ocular Comorbidity 
'absent 207 19.85 (20.17) 17.01 to 22.7 15.91 25.41 
present 93 21.43 (21.41) 16.03 to 24.8 15.91 30.00 
Age (yrs) 
50 to 64 34 25.42 (19.34) 18.67 to 32.2 22.82 30.44 
65 to 74 98 21.23 (18.63) 17.49 to 24.9 17.84 25.00 
75 and over 184 18.08 (22.18) 14.85 to 21.3 13.55 26.42 
Sex * 
males 122 17.23 (19.02) 13.82 to 20.6 12.50 17.50 
females 194 21.49 (21.91) 18.39 to 24.5 20.29 30.45 
Visual Acuity Outcome 
good (6/12 or better) 228 20.6 (21.1) 17.9 to 23.4 
poor (less than 6/12) 40 16.1 (20.2) 9.7 to 22.6 
# Kruskal-Wallis p-value = 0.0009 
No significant differences demonstrated p-value >0.05 
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Table 8.18 Relationship (unadjusted) between Change in VF-14 Score at 12 Months after 
surgery and other Categorical Variables 
Variable n Mean Change 
in VF-14 
Score (s. d. ) 
95% C. 1 
for 
Mean Change 
Median 
Changeln 
VF-14 Score 
Inter-quartile 
Range 
Better Eye 
Visual Acuity 
on Admission # 
6/6 to 6/12 161 17.9 (16.7) [15.4 to 20.61 15.7 23.7 
6/18 to 6/24 78 29.4 (23.9) [23.9 to 34.81 26.8 32.9 
6/36 to 6/60 16 37.2 (26.3) [23.2 to 51.21 30.9 37.1 
blind 6 32.9 (29.9) [ 1.6 to 64.3] 29.1 28.9 
Ocular 
Comorbidity 
absent 
present 
194 24.0 (20.6) 
81 20.1 (21.7) 
[2 1.0 to 27.0] 20.8 28.3 
[15.3 to 24.91 16.7 23.1 
Second Eye 
Surgery ## 
no 192 18.9 (19.6) [16.2 to 21.8] 15.9 25.5 
yes 86 30.9 (20.9) [26.5 to 35.5] 28.0 29.6 
Age (yrs) * 
50 to 64 28 29.1 (18.6) [21.9 to 36.4] 26.9 24.9 
65 to 74 86 24.3 (20.9) [19.8 to 28.7] 21.8 25.9 
75 and over 164 20.8 (20.9) [17.5 to 23.9] 16.1 29.4 
Sex * 
males 112 20.7 (19.1) [17.01 to 24.11 14.6 20.8 
females 166 24.1 (21.8) 120.78 to 27.5] 24.0 30.2 
# Kruskal-Wallis p-value - 0.0003 
## One way analysis of variance p-value < 0.05 
No significant differences demonstrated p-value > 0.05 
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4.3 The Determinants of CHANGE in VF-14 Score After Surgery 
For all the models described in this section, the tests for homogeneity of variance 
(Cochran's test and Bartlett-Box test), and the analysis of residuals suggested that no 
serious violations occurred and that the ANOVA analysis was valid for all the models 
described. These details are presented in full in Appendix D (D I, D2, D3 and D4). 
Sex was included in the initial model building process, but was found to be a non- 
significant factor that did not contribute to the models. In the interest of simplicity, the 
SEX variable was excluded from the final ANOVA models, so that the latter may be 
optimally parsimonious. 
4.3.1 Relationship between Change in Visual Function Score and Visual Acuity 
The models below describe the pragmatic linear relationship between change in visual 
function after cataract surgery and visual acuity, first using pre-operative better eye 
visual acuity and second, the change in better eye visual acuity post-operatively. 
The relationships at 4 months and 12 months were considered in separate models 
a. Using pre-operative better eye visual acuity 
The models were fitted with change in visual function (at 4 months and 12 months) as 
the dependent variable, with pre-operative better eye visual acuity and age as 
covariates. Ocular comorbidity was a factor in both the 4 and 12 month models, with 
second eye surgery as an additional factor in the 12 month model. The findings at 4 
months are summarised in Table 7.19 and in Table 7.20 for those at 12 months. 
At 4 months the overall model explained 10.3% of the variability of the change in 
visual function (R-square = 0.103; model adjusted R-square = 0.093). At 12 months 
after surgery the overall model explained 19.7% of the variability of the change in 
visual function (R-square = 0.197; model adjusted R-square= 0.18 1). 
213 
The findings suggested that after adjustment for the other variables in the model, 
ocular comorbidity was not a significant factor influencing change in visual function 
after surgery. At 12 months however, second eye surgery performed by 12 months of 
the first cataract extraction was a significant factor after adjustment for the effects of 
the other variables in the model. The combined adjusted mean change in visual 
function score at 12 months was significantly and substantially higher in patients who 
had second eye surgery compared to those who had not (29.28 v. 19.88). There was 
no significant interaction at 12 months whereby the association of second eye surgery 
with change in visual function score might depend upon whether or not ocular 
comorbidity was present ( the interaction p-value was 0.56) 
Pre-operative better eye visual acuity was a significant covariate associated with 
change in visual function after surgery. The data suggested that, after controlling for 
age, patients vAth poorer pre-operative better eye visual acuity tend on average to gain 
more visual function after surgery (regression coefficient = -4.25 at 4 months and -4.61 
at 12 months). 
Age was also a significant covariate associated with change in visual function after 
surgery. The findings suggested that after controlling for the other variables in the 
model, change in visual function decreased with increasing age (regression coefficient 
-0.44 at 4 months and -0.5 1 at 12 months). 
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Table 8.19 Change in Visual Function 4 MONTHS after surgery and Pre-operative Better 
Eye Visual Acuity 
ANOVA: 272 case3 with complete data 
Adjusted 
Variables In Model Coefricient [95% C. L] beta P-value Mean VFCH12M 
FACTORS 
Ocular comorbidity (OM: 0.36 [-2.31 to 3.021 0.792 OH absent 20.38 
present 19.67 
COVARIATES Average R-squared 
Pre-Operative 
Better Eye Visual Acuity : 4.25 [-5.81 to -2.691 -0.33 <0.001 0.74 
Age on Admission : -0.44 [-0.74 to -0.131 -0.17 0.006 0.05 
s Squared correlation between covariates and predicted WCH4M 
R-Square = 0.103 
Model Adjusted R-squared = 0.093 
The tests for homogeneity of variance gave p-valucs of 0.763 and 0.779. Tlese. together with the analysis of 
residuals suggest that no serious violations occurred and that the ANOVA analysis was valid (Appendix D3 
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Table 8.20 Change in Visual Function 12 MONTHS after surgery and Pre-operative Better 
Eye Visual Acuity 
ANOVA : 261 cases with complete data 
Adjusted 
Variables In Model Coefficient [95%C. L] bets p-value Mean VFCH12M 
FACTORS 
Ocular Comorbidity 2.47 [-0.54 to 5.47] 0.11 OH absent 27.05 
(010 present 22.11 
Second Eye Surgery 
(E212ND 
4.70 [-7.66 to -1.74] 0.002 E212M no 19.88 
ycs 29.28 
OH by E212M 
COVARUTES 
-0.86 [-3.81 to 2.091 0.56 OH=O, E212M=O 21.48 
OH=O, E212M=l 32.61 
OH=I, E212M=O 18.27 
OH=I, E212M=l 25.95 
Average 
R-squared 
Pre-Operative Better Eye 
Visual Acuity (BVRI) 4.61 [-6.11 to -3.11 -0.35 <0.001 0.47 
Age on Admission -0.51 f-0.81 to 0.21] -0.19 0.001 0.07 
* Squared correlation between covariates and predicted VFCH12M 
R-Square = 0.197 
Model AdjustcdR-squared = 0.181 
The tests for homogeneity of variance gave p-valucs of 0.296 and 0.170. These together with the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid (Appendix D4). 
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b. Using change in better eye visual acuity after surgery 
This model was fitted as before but used change in better eye visual acuity as a 
covariate instead of pre-operative better eye visual acuity. The findings at 4 months 
are presented in Table 8.21 and in Table 8.22 for those at 12 months. 
These models explained more of the variability of change in visual function after 
surgery. At 4 months after surgery 13.8% of this variabilty was explained (R-square 
0.13 8; model adjusted R-square = 0.127), and at 12 months 3 0.8% was explained (FL- 
square = 0.308; model adjusted R-square = 0.291). 
Ocular comorbidity was not a significant factor influencing the relationship between 
change in visual function and change in better eye visual acuity after surgery. However 
at 12 months second eye surgery was a significant factor after adjusting for the other 
variables. The combined adjusted mean change for visual function was significantly 
higher when second eye surgery was performed (27.77 v 19.98). There was no 
significant interaction term whereby the association between second eye surgery and 
change in visual function might depend on levels of ocular comorbidity (the interaction 
p-value =0.882). 
Having controlled for the effects of the other variables in the model, change in better 
eye visual acuity was a significant covariate associated with change in visual function 
after surgery. As more change in better eye visual acuity was achieved, then on 
average, more change in visual function was gained (regression coefficient = 5.18 at 4 
months, and 6.82 at 12 months). Age remained a significant covariate, indicating that, 
having controlled for the other variables, as age increased, then on average less change 
in visual function was achieved post-operatively (regression coefficient = -0.40 at 4 
months, and -0.43 at 12 months). 
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Table 8.21 Change in Visual Function 4 MONTHS after surgery and Change in Better Eye 
Visual Acuity at 4 Months 
ANOVA: 241 cases with complete data 
Adjusted 
Variables in Model Coefflcient [95% C. 1L] beta p-value Mean VFCH12M 
FACTORS 
Ocular Comorbidity (OH) -1.12 [-3.93 to 1.70] 0.44 OH absent 19.25 
present 21.49 
COVARIATES Average R-squared 
Change in Better Eye 
Visual Acuity 5.18 [3.44 to 6.91] 0.36 < 0.001 0.84 
Age on Admission -0.40 [-0.72 to -0.081 -0.15 0.014 0.07 
* Squared correlation between covariates and predicted VFCH4M 
R-Square = 0.138 
Model Adjusted R-squared = 0.127 
The tests for homogeneity of variance gave p-values of 0.727 and 0.751. These, together with analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid (Appendix D3). 
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Table 8.22 Change in Visual Function 12 MONTHS after surgery (VFCH12M) and 
Change in Better Eye Visual Acuity 
ANOVA: 210 cases with complete data 
Variables In Model Coefficient [95% C. L] beta p-value 
Adjusted 
Mean VFCH12M 
FACTORS 
Ocular Comorbidity 1.85 [-1.29 to 4.991 0.246 OH absent 25.72 
(011) present 22.02 
Second Eye Surgery -3.89 f-7.04 to -0.75] 0.015 E212M no 19.98 
(E212r*f) yes 27.77 
OH by E212M -0.23 [-3.34 to 2.88] 0.882 OH=O, E212M=O 21.59 
011=0, E212M--l 29.85 
OH=I, E212M=O 18.36 
OH=l, E212M=l 25.68 
COVARIATES 
Change In Better Eye 
Visual Acuity at 6.82 [5.14 to 8.491 
12 months (BVCH12M 
0.47 <. 001 
Average R-squared a 
0.791 
Age on Admission -0.43 [-0.74 to -0.121 -0.16 0.007 0.058 
* Squared correlation between covariates and predicted VFCH12M 
R-Square = 0.308 
Model Adjusted R-squared = 0.291 
Ile tests for homogeneity of variance gave p-values of 0.242 and 0.091. ncsc to9cthcr%vith the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid. (Appendix D4). 
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Clearly there are other factors influencing or determining the change in visual function 
achieved post-operatively as pre-operative better eye acuity and change in better eye 
acuity post-operatively can only explain a small proportion of the variability in change 
in visual function achieved after surgery. It must also be noted that from the analysis 
of pre-operative visual function scores, poorer pre-operative better eye visual acuity 
was associated with lower pre-operative visual function scores and thereby having 
more capacity for change (particularly in the direction of gain), post-operatively. 
Similarly, pre-operative visual function scores were higher (less reported dysfunction) 
with increasing age, thereby reducing the capacity for change (particularly for gain), 
with age. Both pre-operative better eye visual acuity and age are determinants of pre- 
operative visual function score. Consequently, pre-operative visual function not only 
influences the capacity for change possible after surgery, but it may also possibly 
confound the relationships observed between change in visual function and visual 
acuity (both pre-operative better eye acuity and change in better eye acuity post- 
operatively). Whilst this may not be of primary concern when considering the validity 
of the findings regarding the overall relationship between change in visual function 
after cataract surgery and visual acuity, it is important in the interpretation of the 
findings for the determinants of change in visual function after surgery. 
4.3.2 Determinants of change in visual function after surgery adjusting for the 
capacity for change 
The following models were then constructed to identify the determinants of change in 
visual function after cataract surgery, taking account of the capacity for change 
possible after surgery and possible confounding factors. As before, the relationships at 
4 months and 12 months were considered in separate models and full details provided 
in Appendices D3 and D4. 
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a. Model I: Determinants of change in visual function operating through 
visual acuity 
Assessing the influence of (or association of) factors and covariates on change 
in VF-14 scores after surgery (4 months and 12 months), including the 
component of the influence (association or correlation), if any, that might 
operate through "causing" loss or gain in visual acuity. 
This ANOVA model included pre-operative visual function score (VFSD), pre- 
operative better eye visual acuity (BVIE) and age as covariates, with ocular 
comorbidity as a factor. The term for change in better eye visual acuity (BVCH4M at 
4 months and BVCH12M at 12 months), was omitted from this model, so that any 
estimates of factor effects would include the effect on visual acuity change (if any) 
which in turn affected change in the VF- 14 score. 
The findings at 4 months are summarised in Table 8.23 and in Table 8.24 for those at 
12 months. 
The findings show that after adjustment of the other variables in the model, ocular 
comorbidity was not a significant factor determining change in visual function score at 
4 months after surgery. However at 12 months, ocular comorbidity (OH) and second 
eye surgery by 12 months after first extraction, were significant factors, suggesting that 
these might be determinants of change in visual function, after adjustment for effects of 
the other variables in the model. The combined adjusted mean change in visual 
function at 12 months for patients with no ocular comorbidity was substantially (and 
significantly) higher than that in patients with comorbidity (27.45 v. 21.70). 
Similarly, the mean gain in visual function was greater in patients who had second eye 
surgery compared to those who had not (26.89 v. 22.27). Further breakdown of the 
adjusted mean change in visual function scores at 12 months showed that the greatest 
gain in visual function (30.24) occurred in the sub-group who had no ocular 
comorbidity but had second eye surgery, and the least gain in visual function (19.87) 
occurred in those who did have ocular comorbidity but did not have second eye 
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surgery. There was no significant interaction whereby the association of ocular 
comorbidity with change in VF-14 score at 12 months, might depend upon levels of 
whether second eye surgery was performed or not, or whereby the second eye surgery 
and change in VF-14 score at 12 months association might depend upon whether or 
not comorbidity was present (the interaction p-value was 0.629). 
The pre-operative visual function score was found to be a significant and powerful 
covariate influencing change in visual fiinction after surgery. The findings show that at 
4 months 96% of the variation in the change in visual function scores (as predicted by 
the model) was "explained" by the variation in pre-operative visual function score, and 
at 12 months this was 92%. The negative regression coefficients (-0.75 at 4 months 
and -0.79 at 12 months), indicated that patients with higher initial pre-operative visual 
function scores on average gained less visual function. The correlation was 
characterised by a reduction in change in visual function of 0.75 units or 0.79 units (at 
4 and 12 months respectively) for each unit increase in pre-operative visual function 
score. The standardised coefficient, beta, was by far the greatest compared to that of 
the other two covariate variables in the models. The data suggest that pre-operative 
visual function score may be an important "determinant" of the amount of gain or loss 
in visual function after surgery. 
The pre-operative visual acuity in the better eye before surgery was also found to be a 
significant variable that influences the change in visual function gain after surgery. 
The data suggested that patients with better initial visual acuity tend on average to gain 
more visual function after surgery. The correlation was highly significant but not 
impressive since only a small fraction (14%) of the variation in change in visual 
function at both 4 and 12 months was "explained" by the variation in pre-operative 
better eye visual acuity. 
Age was not a significant covariate. The findings suggested that when the effects of 
the other variables in the models were taken into account and adjusted for, the amount 
of gain or loss in visual function after surgery was not dependent upon age at surgery, 
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Table 8.23 Change in Visual Function 4 MONTHS after surgery (VFCH4M) and 
Pre-operative Better Eye Visual Acuity - Adjusting for Pre-operative Factors 
ANOVA: 272 cases with complete data 
Adjusted 
Variables In Model Coefficient 195% C. 1] beta li-value Mean VFCH4M 
FACTORS 
Ocular Comorbidity (OM 0.61 [-1.30 to 2.521 0.533 OH absent 20.63 
present 19.42 
COVARIATES Average R-square 
Pre-Operative VF-14 Score: -0.75 f-0.84 to -0.66] -0.81 <0.001 0.96 
(VFSD) 
Pre-Operative Better Eye 
Visual Acuity 2.02 [0.66 to 3.39] 0.16 0.004 0.14 
Age on Admission -0.09 [-0.31 to 0.141 0.11 0.44 0.01 
* Squared correlation between covariates and predicted WCH4M 
R-Square = 0.539 
Model Adjusted R-squared = 0.532 
Ihe tests for homogeneity of variance gave p-values of 0.763 and 0.779. Ilese, together with the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid (Appendix D3). 
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Table 8.24 Change in Visual Function 12 MONTHS after surgery and Pre-operative ]Better 
Eye Visual Acuity, Adjusting for Pre-operative Factors. 
ANOVA: 261 cases with complete data 
Adjusted 
Variables in Model CoeMcient 195% C. L] beta p-value Mean VFCH12M 
FACTORS 
Ocular Comorbidity 2.88 [0.90 to 4.851 0.004 OH absent 27.45 
(Om present 21.70 
Second Eye Surgery -2.31 [4.26 to - 0.35] 0.021 E212M no 22.27 
(E212M) yes 26.89 
OH by E212M -0.47 [-2.4 to 1.461 0.629 OH=O, E212M=O 24.67 
OH=O, E212M=l 30.24 
OH=I, E212M=O 19.87 
OH=I, E212M=l 23.53 
COVARUTES 
Pre-Operative -0.79 [-0.87 to -0.70] 
W-14 Score(VFSD) 
-0.84 <0.001 
Average R-squared 
0.92 
PmOperative 
Better Eye Visual 
Acuity (BV) 
Age on Admission 
1.74 [0.55 to 2.94] 0.13 0.004 
-0.1 f-0.30 to 0.10] -0.04 0.327 
* Squared correlation between covariates and predicted WCH12M 
0.14 
0.02 
R-Square = 0.656 
Model Adjusted R-squared = 0.648 
T"he tests for homogeneity of variance gave p-valucs: of 0.296 and 0.170- These together with the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid. (Appendix 134) 
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It is important to note here that assuming a causal relationship, the significant influence 
of ocular comorbidity and second eye surgery within 12 months upon change in visual 
function may be partly (or even entirely) mediated through gain or loss in visual acuity. 
For example, does second eye surgery result in higher gain in visual function because it 
causes further improvement in best visual acuity? Or, does it result in higher gain in 
visual function because of improvement in some other aspect of visual function over 
and above that of visual acuity? Or both?. Similar questions may be asked in respect 
of all the other significant variables reported above. The next section of the analysis 
addresses these questions. 
b. Model 2: Determinants of change in visual function excluding the 
influence operating through visual acuity 
Assessing the influence of (or association of) factors and covariates on change 
in visual function after surgery, excluding the component of the influence 
(association or correlation), if any, that might operate through "causing" loss or 
gain in visual acuity. 
To achieve this, the tenn for change in better eye visual acuity after surgery 
(BVCH4M at 4 months and BVCH12M at 12 months), were now included in the 
ANOVA model, so that any estimates of factor effects would exclude the effect on 
visual change (if any) which in turn affected change in visual function score. 
The findings at 4 months are summarised in Table 8.25 and in Table 8.26 for those at 
12 months. 
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Table 8.25 Change in Visual Function 4 MONTHS (VFCH4M) after surgery and Change 
in Better Eye Visual Acuity - Adjusting for Pre-operative Factors 
ANOVA: 241 cases with complete data 
Adjusted 
Variables In Model Coefflcient [95% C. L] beta p-value Mean VFCH4M 
FACTORS 
Ocular Comorbidity (011): -0.40 [-2.28 to 1.47] 0.67 OH absent 19.96 
present 20.77 
COVARIATES Average R-square 
Pre-Operative VF-14 Score -0.81 [-0.90 to -0.721 -0.87 < 0.001 0.815 
(VFSD) 
Pre-Operative Better Eye 
Visual Acuity (BVHI) 7.19 [5.38 to 9.011 0.55 < 0.001 0.105 
Change In Better Eye 
Visual Acuity at 6.48 [4.79 to 8.17] 0.45 < 0.00 1 0.18 
4 Months (BVCH4A1) 
Age on Admission -0.03 [-0.24 to 0.191 -0.01 0.803 0.016 
* Squared correlation between covariatcs and predicted VFCH4M 
R-Square = 0.64 
Model Adjusted R-squared ý-- 0.634 
The tests for homogeneity of variance gave p-values of 0.727 and 0.751. Ibese, together with the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid (Appendix D3). 
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Table 8.26 Change in Visual Function 12 MONTHS after surgery and Change in Better 
Eye Visual Acuity, Adjusting for Pre-operative Factors 
ANOVA: 210 cases with complete data 
Adjusted 
Variables in Model Coefficient [95%C. 1] beta p-value Mean VFCH12M 
FACTORS 
Ocular Comorbidity 0.96 [-0.74 to 2.67] 0.267 011 abscnt 24.84 
(OID present 22.91 
Second Eye Surgery -1.92 [-3.59 to -2.4] 0.025 E212M no 21.95 
(E212NO yes 25.79 
OH by E212M 0.53 [-1.13 to 2.191 0.529 OH=O, E212M=O 23.45 
011=0, E212M=l 26.23 
011=1, E212M=O 20.45 
OH=I, E212M=l 25.36 
COVARIATES Average R-squared 
Pre-Operative -0.85 [-0.92 to -0.771 -0.88 < 0.00 1 0.79 
VF-14 Score (VFSD) 
Pre-Operative 7.37 [5.92 to 8.821 0.54 < 0.001 0.13 
Better Eye Visual 
Acuity (BVHI) 
Change In Better 
Visual Acuity 7.53 [6.22 to 8.831 0.52 < 0.00 1 0.301 
at 12 months 
(BVCH12AD 
Age on Admission : 0.08 f-0.09 to 0.26] 0.03 0.358 0.022 
* Squared correlation between covariates and predicted VFCH12M 
R-Square = 0.808 
Model Adjusted R-squared = 0.802 
The tests for homogeneity of variance gave p-values of 0.242 and 0.08 1. Ibcse together with the analysis of 
residuals suggested that no serious violations occurred and that the ANOVA analysis was valid (Appendix D4). 
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The findings show that after adjustment for effects of other variables in the model, 
ocular comorbidity was not a significant factor. Second eye surgery was however a 
significant factor, suggesting that it might be a determinant of change in VF-14 score, 
after adjustment for the effects of the other variables in the model. The combined 
adjusted mean change in visual function for patients that had second eye surgery was 
significantly higher than those who did not have second eye surgery (25.8 v. 21.9). 
The combined adjusted mean change in visual function score was higher (but not 
significantly) for patients without ocular comorbidity than for those with comorbidity 
(24.8 v. 22.9). There was no significant interaction term whereby the association of 
second eye surgery with change in visual function score at 12 months might depend on 
levels of ocular comorbidity, or whereby the association of ocular comorbidity with 
change in visual function score at 12 months might depend upon whether second eye 
surgery had been performed or not (the interaction term p-value = 0.529). 
Age was not a significant covariate for change in visual function after surgery. The Q, 
nature of the relationship between change in visual function score after surgery and 
change in better eye visual acuity after surgery and pre-operative visual function score, 
was examined for any departures form linearity, and interactions with ocular 
comorbidity and sex were sought. In the case of the model for the relationships at 12 
months, whether second eye surgery had been performed or not by this time was also 
included. No significant interactions were demonstrated to suggest violations from 
linearity in the important relationships demonstrated. 
The pre-operative visual function score was found to be a significant and powerful 
covariate. 82% of the variation in the change in visual function scores at 4 months (as 
predicted by the model), and 79% of the variation observed at 12 months was 
"explained" by the variation in the pre-operative visual function scores. The negative 
regression coefficients (-0.81 at 4 months and -0.85 at 12 months) indicate that 
patients with a higher initial visual function score before surgery gained less visual 
function on average, after surgery. 
228 
Visual acuity in the better eye before surgery was also a significant variable that may 
affect the gain in visual function after surgery. It explained about 10% of the variation 
in change in visual function scores at 4 months and 14% at 12 months. The positive 
regression coefficients at both 4 and 12 months indicate that patients with better initial 
visual acuity in the better eye before surgery tend on average to gain more visual 
function after surgery. The correlation was characterised by a gain in visual function 
of 7.2 units at 4 months and 7.53 units at 12 months, for each unit increase in pre- 
operative better eye visual acuity. 
The amount of change in visual acuity in the better eye after surgery was also found to 
be a significant covariate. 18% of the variation in the change in visual function score 
at 4 months and 30% of the variation at 12 months was "explained" by the change in 
better eye visual acuity after surgery. The positive regression coefficient indicates that 
for every unit increase in change in visual acuity in the better eye after surgery at 4 
months, a change 6.5 units in visual function score on average could be predicted from 
the model. Similarly for a change in unit increase in visual acuity at 12 months, a 
change of 7.5 units on average could be predicted from the model. 
The estimates from the full model may be used to predict change in visual function at 
12 months from pre-operative visual function and the change in better eye visual acuity 
at 12 months. 
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5. DISCUSSION OF FINDINGS 
The relationships between clinical and patient perceived measures i. e. visual acuity, 
visual function and quality of life, have been presented. 
5.1 Visual Acuity 
As measures of visual acuity, the VP% score and better eye acuity were highly 
correlated before and after surgery. As the calculation of the VP% score is weighted 
in favour of the better eye acuity this is not surprising. Both VP% score and better eye 
acuity consistently had higher correlations (both before and after surgery) with visual 
function (VF-14) and measures of quality of life (SIP and VR-SIP), compared to the 
surgery eye acuity. The VP% score did not improve on better eye acuity in its 
correlations with visual function score (VF-14), and measures of quality of life (SIP 
and VR-SIEP), either before or after surgery, and the better eye visual acuity was 
consistently slightly better. These findings suggest that better eye acuity and VP% 
score (visual acuity of the person), better represent the visual acuity that is used in 
everyday life, both before and after surgery. As shown earlier, whilst surgery eyes are 
often the better eyes after cataract extraction, they do not represent all the better eyes 
after surgery. 
The association with visual acuity and other measures of outcome has not been 
considered in this way previously. Whilst it may have been recognised that the visual 
input from both eyes should be considered when assessing the disability from cataract, 
and that the better eye visual acuity should also be consideredj 103] this concept has 
rarely been used to relate visual acuity with function or quality of life, beyond an 
assessment of the criterion validity of these latter measures. [103][136] Moreoftenin 
such assessments, it has been the visual acuity in the surgery eye (both before and 
after surgery) that has been used i. e. the clinical indicator of outcome and its 
associations if any, with visual ffinction and quality of life before surgery. 
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[88][104][107][162] After surgery, any association with function and quality of life 
has so far been considered in terms of the visual acuity in either the surgery eye or the 
better eye before surgery [163], and more recently, 'Writh a weighted visual acuity 
(derived from the visual acuity from each eye separately) to take account of both eyes 
[156][164]. The role of the better eye acuity on everyday life has not been previously 
appreciated. 
Best corrected better eye visual acuity is a readily available measure of visual acuity 
and does not require additional computations or interpretations of the measurement. It 
was thus used in all further analysis for examining the relationships between visual 
acuity and visual functioning in vision-dependent activities and health and vision- 
related quality of life, before and after surgery. 
5.2 Visual Function 
5.2.1 Relationships Before Surgery 
There was a wide variation about the mean VF-14 scores for any given sub-group of 
visual acuity considered, suggesting that multifactorial influences may have been 
operating on the reported level of visual functioning ascertained before surgery. 
A linear relationship with visual acuity in the better eye before surgery was described 
that explained about 30% of the variability in the pre-operative visual function scores 
observed. Clearly other factors were also influencing pre-operative functioning. Such 
a relationship had been alluded to previously but it had not been quantified [103]. 
Whilst a relationship with visual acuity had been anticipated at the start of this study, a 
perfect relationship had not been expected. This is because the VF-14 index is a 
measure of functioning in everyday tasks dependent on vision, and visual acuity is only 
one component of vision. 
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A multiple regression model including other factors that may have been influencing 
visual functioning was able to make only a slight improvement in explaining the 
variability of pre-operative VF-14 scores - 38%. Clearly the VF-14 score was 
influenced by other factors not examined in this study. The independent determinants 
of pre-operative visual function that were identified from these data, were - 
Visual acuity in the better eye before surgery 
Cataract symptoms 
Comorbidity "bothersome-nese' 
Age 
Adjusted estimates, controlling for the effects of the other variables in the model, 
suggested an inverse relationship between cataract symptoms and how bothered 
patients were by their other comorbidities. The more that patients were bothered by 
their cataract symptoms or their other comorbidities, the worse was their reported 
visual function. 
Visual function scores rose with increasing age. The relationship with age could not 
be directly explained. Since the VF-14 score is composed of the reported difficulty in 
performing a vision-dependent activity and also the amount of difficulty experienced in 
performing it, it would seem that with increasing age there is less reporting of the 
difficulty experienced with performing the activities in question. It is possible that this 
may reflect a period of adaptation and disengagement in the older age group - they 
may be still doing an activity e. g. reading, but not as much as before, because of their 
vision, and thus can still function in that respect (albeit with a limited capacity), to their 
satisfaction. Younger patients may not have adapted their activities to this extent and 
are more aware of the limitations imposed on them in this respect by their vision. 
Similarly, it is possible that these influences are operating in the finding that younger 
patients have higher cataract symptom complaints than the older patients. It is 
possible that older patients may have the same symptoms but that they are not as 
aware of the consequences of these symptoms because they have had the for longer 
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and adapted their lifestyle accordingly. This study design and its findings can only 
speculate or generate hypotheses regarding these issues. Further exploration and 
exarnination of these issues, and possibly other related factors influencing initial VF-14 
score are beyond the scope of this study design and data set and require specific 
investigation. 
5.2.2 Relationships After Surgery 
The variation in VF-14 scores across sub-groups of visual acuity in the better eye 
persisted post-operatively as seen by the spread of scores about the mean VF-14 score 
for any visual acuity group. The crude relationships between change in VF-14 scores 
and pre-operative VF-14 score, pre-operative better eye visual acuity and change in 
better eye visual acuity after surgery, demonstrated the presence of linear associations 
between them. 
Multiple regression models adjusting for the effects of indicators as determinants of 
change in visual function after surgery, identified pre-operative visual function score 
as a major determinant of change in visual function, with pre-operative better eye 
visual acuity and change in better eye acuity after surgery also being important 
determinants of change in visual function. The regression models adjusted for the 
effects of all the other variables in the model (i. e. adjusting for confounding), thus 
allowing for the effect of each of the indicators as determinants of change in VF-14 
score, in their own right, to be assessed. 
The most striking observation was the identification of confounding by pre-operative 
visual function which was seen in the reversal in the regression coefficients for pre- 
operative better eye visual acuity and change in visual function after surgery. Crude 
analysis had suggested that patients with poorer pre-operative better eye acuity tended 
on average to gain more visual function after surgery. However when the effects of 
other variables and the capacity for change (pre-operative Visual function score) were 
adjusted for in the regression model, then patients with better visual acuity in the better 
eye before surgery tended on average to gain more visual function after surgery. 
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Similarly pre-operative visual function confounded the relationship between age and 
change in visual function after surgery. Crude analysis had suggested that with 
increasing age, then on average there was less change in visual function after surgery. 
When the capacity for change that was possible was adjusted for, together with other 
confounding variables, then age was not seen to be a significant determinant of change 
in visual function after surgery. 
The crude relationship observed between pre-operative better eye acuity and change in 
visual function post-operatively, and that between age and change in visual function 
was spurious. As shown earlier, patients with poorer pre-operative visual acuity have 
poorer initial visual function before surgery, and older patients tended to have better 
reported visual function. Also, pre-operative visual acuity and age were determinants 
of visual function before surgery. The crude relationship (unadjusted for capacity for 
change) observed between change in visual function and pre-operative visual acuity in 
the better eye on the one hand, and age on the other hand, was thus being confounded 
by pre-operative visual functioning. 
Model I provided indicators for change in visual function after surgery when the 
effects working through vision were included. Model 2 provided indicators for 
change in visual function after surgery when the effects on vision working through gain 
or loss in visual acuity were excluded. Overall when components operating through 
visual acuity were removed , the regression coefficients were larger. The variables for 
change in better eye visual acuity at 4 or 12 months (BVCH4M and BVCH12m), 
took account of the fact that everyone did not start at the same level of visual acuity. 
(Proportional changes in visual acuity were considered but as they were highly 
correlated with change in better eye acuity variables (BVCH4M and BVCH12M), only 
the latter were used in all further analysis). By adjusting for the effects of 
confounding between pre-operative visual function and pre-operative better eye visual 
acuity, the models could predict the mean change in visual function that may be 
expected for a unit change in better eye visual acuity after surgery, and the mean 
change in visual function that may be expected for unit change in pre-operative visual 
function. 
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At both 4 and 12 months, pre-operative visual function was a major determinant of 
change in visual function after surgery (operating both through any effects on vision 
working through visual acuity and independent of visual acuity). Patients with better 
(less dysfunction) pre-operative visual function on average gained less visual function 
after surgery. For any given level of visual functioning pre-operatively, the multiple 
regression models suggest that those patients with better pre-operative visual acuity in 
the better eye, gain on average, more visual function after surgery. This would suggest 
that more gain, in terms of visual functioning, is achieved if, for a given level of 
reported functioning, intervention takes place before visual acuity in the better eye 
becomes significantly compromised. Thus if surgery was performed on a patient with 
both eyes that were visually impaired, then despite achieving a good visual acuity 
outcome in the surgery eye, the gain in visual function that could be achieved would 
not be as great as that in a patient that had surgery performed on a visually impaired 
eye with a fellow (better) eye that was not impaired, had both patients had an 
equivalent level of reported visual functioning to begin with. 
Ocular comorbidity was a significant factor influencing the association between 
covariates and change in visual function exerted its effect primarily through its effect 
on visual acuity and this was seen only at 12 months after surgery. Second eye 
surgery by 12 months after surgery was also a significant factors influencing the 
association between covariates and change in visual function at 12 months, operating 
through both its effect on vision through visual acuity and independently of visual 
acuity. In the latter case, second eye surgery presumably influenced gain in visual 
function (change in VF-14 score) through some other aspect not mediated solely by 
Snellen visual acuity e. g. better field, binocularity, or stereopsis that may have been 
achieved by second eye surgery. For a given covariate, the mean change in visual 
function will depend on the level of the factor - i. e. for a given covariate, the mean 
change in visual function will be greater if there is no ocular comorbidity present and if 
second eye surgery has been performed. 
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The assessment of visual function is subjective. It will depend not only objective 
measures such as visual acuity, but also many other complex influences e. g. social, 
cultural, expectations of function and adaptation of lifestyle with age. These are 
presumably also operating here as seen pre-operatively, older patients tend to have 
higher visual function scores, lower cataract symptom scores and comorbidity 
"bothersome" scores. The findings from this study can only speculate that this 
observation may be a result of these other factors. Only a specifically designed study 
examining these factors could reasonably expect to ascertain a more conclusive 
explanation of these observations and their influence on function. 
Over 80% of all patients achieve a good post-operative visual acuity of 6/6 to 6/12, at 
4 and 12 months. Similarly, over 80% of patients achieve a post-operative visual 
function scores of 80 or more with a third achieving a maximum score of 100. Overall, 
the gains in the routine clinical indicator (Snellen visual acuity) reflect the gains 
achieved in visual function. The discrepancy first described by Bernth-Petersen for 
intracapsular cataract extraction 25 years ago, is now not as evident. 
[82][104][107][162] This is not surprising as most of the earlier differences between 
visual acuity and visual function were caused by the limitations of the optical 
correction of aphakia and their incumbent optical aberrations, that were available at 
that time. Current surgical practice and optical rehabilitation with intra-ocular lenses 
have overcome these difficulties so any effect on visual functioning that is operating 
through visual acuity is now not seen. 
Assessment of visual function also provided insight into the benefits from cataract 
surgery that were not apparent by assessment of visual acuity alone. Patients with 
poor visual acuity outcome were observed to achieve significant mean gains in VF-14 
score. It is likely that these patients may have achieved some improvement in acuity 
after surgery but they did not achieve an acuity of 6/12 or better. They may have 
gained improvement in visual function though some other component of vision e. g. 
through gain in visual field, binocularity or stereopsis. Assessment of outcome by the 
conventional clinical indicator of visual acuity would not have identified the benefits of 
cataract surgery for these patients. Although there are objective clinical measures and 
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tests for the assessment of visual field, binocularity or stereopsis, that are available in 
any ophthalmic department, these are not routinely assessed before or after cataract 
surgery. 
5.3 Quality of Life 
The major determinant of the overall SIP score was the comorbidity "bothersome" 
score indicating that quality of life was influenced principally by other health factors. 
Visual function score was the major determinant of the quality of life affected by vision 
(VR-SIP score) indicating that in this case the level of reported disability was 
associated with the handicap experienced. 
6. SUMMARY OF FINDINGS 
The key findings relating to the relationships between visual acuity, visual function and 
quality of life are : 
The appropriate measure of visual acuity should be selected for examining 
relationships between measures of outcome (clinical and patient perceived) 
The best corrected surgery eye visual acuity reflects the visual impairment 
caused by cataract and the direct effect of surgery on this 
0 The best corrected better eye visual acuity is the visual acuity which is 
operating in everyday life for vision-dependent activities and quality of life. 
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Visual acuity in the better eye is linearly related to visual function and is an 
important determinant of pre-operative visual function and change in visual 
function after surgery 
Visual function assessment before surgery may be underestimated in older 
patients 
0 Quality of life in cataract patients was not greatly affected by their vision 
0 Quality of life amongst cataract patients was determined by their medical 
comorbidity 
Change (gain) in better eye visual acuity was associated with change (in 
direction of gain) in visual function 
0 Adjustment for the capacity for change in both visual function and visual acuity 
identified important effects from confounding by pre-operative visual 
functioning : 
For a given level of visual functioning, better visual acuity in the better 
eye before surgery was associated with more gain in visual function 
may be achieved 
Change in visual function after surgery was not age-related. 
Ocular comorbidity was not a significant factor influencing the relationship 
between visual acuity and visual function except at one year after surgery 
Second eye surgery was an important factor influencing the relationship 
between visual acuity and change in visual function after surgery 
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0 The impact of cataract surgery on change in visual function was achieved both 
through effects on vision mediated by visual acuity, and through effect on 
vision not mediated by visual acuity. 
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Chapter 9. 
CONCLUSIONS 
The outcomes of cataract surgery have been assessed in terms of clinical measures of 
impairment (visual acuity), and patient perceived measures of disability (visual 
function) and handicap (quality of life). This thesis suggests that whilst age related 
cataract is associated with impairment and disability, the strength of the relationship 
with handicap is weaker. Surgery has been seen to improve visual acuity, visual 
function and quality of life. The findings have contributed to understanding the effect 
of cataract on visual impairment, disability and handicap, and the impact of surgery on 
these. 
Understanding the inter-relationships between visual acuity, visual function and visual 
handicap can inform the interpretation of the impact of the gains observed following 
surgery. In this chapter, the use of the methods employed in this thesis both for clinical 
practice (patient-based) and for epidemiological purposes (population-based) for the 
evaluation of the impact of cataract surgery are discussed. 
1. METHODS FOR THE ASSESSMENT AND MEASUREMENT OF 
IMPAIRMENT9 DISABILITY AND HANDICAP 
The definition of cataract used in this thesis was an operational one, based on a need 
for surgery that was recognised by both the patient and his or her ophthalrnic surgeon. 
This inevitably resulted in patients with a wide range of severity of visual impairment, 
even including some with only minimum loss of acuity. This is in contrast to that used 
in many aetiological studies where the earliest onset of cataract (which may not 
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necessarily be associated with impairment or disability), is often of interest. Also, from 
the start it was recognised that both eyes contribute to the biological functioning of the 
eyes and social functioning in everyday life and that this would need to be considered 
when assessing the impact both of cataract and of surgery on one eye. 
Clinical impairment was measured by visual acuity using the Snellen optotype. Patient 
perceived methods were used to measure disability (visual function) and handicap 
(quality of life). The VF-14 was used for visual function and SIP and VR-SIP were 
used for quality of life. 
1.1 Visual Acuity 
Visual acuity is a recognised indicator of vision. Snellen visual acuity is well- 
established and is routinely employed in clinical practice as part of the basic clinical 
examination of any eye disorder. Its limitations and interpretation of change in visual 
acuity over time or following treatment are recognised. The findings of this thesis 
indicated that the visual acuity from each eye provided quite different information. 
The visual acuity in the affected eye indicated the impairment caused by cataract and 
subsequently the direct impact of surgery on this. The relationships between visual 
acuity, visual function and quality of life, suggested that the visual acuity of the better 
eye provided a better indication of the vision that was used in everyday life (disability), 
and to a much lesser extent the handicap experienced by the patient. Visual acuity in 
the better eye was observed to be a major determinant of visual function before 
surgery. The strength of this relationship reflected the fact that visual acuity is only 
one component of overall vision that is required in everyday life. The quality of life of 
cataract patients was affected more by how bothered they were by their comorbid 
conditions rather than by their vision. After surgery, change in better eye visual 
aciiity was associated with change in visual function and was a significant determinant 
of change in visual function. 
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These findings suggest that visual acuity, as a measure of impairment was an indicator 
of disability, and to a lesser extent handicap. The surgery eye visual acuity indicated 
the impairment caused by cataract while the better eye visual acuity served as a proxy 
indicator of the disability and/or handicap caused by cataract. This suggests the need 
for a significant shift from the traditional clinical approach which has been based on the 
impact of cataract and surgery on the visual acuity in the affected eye. Previously, only 
the visual acuity in the affected (surgery) eye had been considered and had been found 
to be poorly related to disability and handicap, especially after surgery. The role of the 
better eye acuity in everyday life, particularly after surgery, had not previously been 
examined or recognised. 
1.2 Visual Function 
The VF-14 was found to be a valid (face and criterion validity) and reliable (internal 
consistency) index of visual functioning in cataract patients. The variability in the VF- 
14 scores observed before surgery suggested that there were multifactorial influences 
determining the reports of visual function. The VF-14 represents the patients' 
perception of their visual functioning, and not necessarily their actual functioning. 
Whilst some of the possible factors determining reported visual function were 
considered in this thesis, there were others (e. g. duration of symptoms, adaptation), 
that may have had important contributions to reported functioning, that were not. Until 
the influence of these other factors are understood, the implications of visual function 
scores for clinical practice are limited. 
Whilst some form of assessment of disability (visual function) is usually made in 
routine clinical practice it is not usually undertaken in a standard and validated form 
that may be used to compare patients or to assess the impact of surgery on an 
individual. The VF-14 represents just such a method for standardising this assessment 
in clinical practice. Although self-completion of the VF-14 by patients was not tested 
this may be feasible. It is possible however that, at least before surgery self- 
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completion would pose problems for those patients who are severely visually impaired. 
In such circumstances, the quality of proxy information for the VF-14 in terms of 
completeness and accuracy, has still to be established. The findings suggest that the 
VF-14 may be a useful tool for assessing disability in cataract patients both in routine 
clinical practice and in health services research. 
1.3 Quality of Life 
Both the SIP and VR-SIP demonstrated criterion validity for measuring quality of life 
of cataract patients. Quality of life of cataract patients was seen to be affected more by 
their comorbid conditions than by their vision. Only a limited range of categories of 
quality of life were affected, principally "recreation and pastimes". The items covered 
in this category provided the quality of life component to complement the functional 
index, the VF-14. Given that vision was not a major factor affecting quality of life, it 
was not surprising that the modified generic measure, the VR-SIP, did not show any 
improvement over the generic measure (SIP). 
This thesis identified the limited impact of elective cataract surgery on patients' overall 
quality of life, and the extent of change which may realistically be expected. If a more 
precise assessment of the quality of life of cataract patients is required, it may be more 
appropriate to develop a cataract-specific quality of life measure tapping into the most 
relevant categories (e. g. recreation and pastimes, and perhaps work and home 
management). This would, however, require further research, development and 
evaluation before being available for use either for routine practice or for research. 
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1.4 Interpretation of the Gains in Visual Function and 
Quality of Life 
Overall, significant mean gains in the patient perceived measures of visual function and 
quality of life were demonstrated after surgery compared to pre-operative values. 
Whilst the value of patient perceived measures in providing insight into the impact of 
disease on a patient's daily life has received attention, the clinical significance of the 
impact of an intervention as assessed by these measures has received considerably less 
attention. A universal definition of the amount of change in say, quality of life 
measured by the SIP, that constitutes a clinically important change, is unlikely. For 
cataract patients no data are available on what constitutes clinically or socially 
significant changes in visual function and quality of life, using either the instruments 
employed in this study, or for other similar patient perceived measures. 
Effect size was used to assess responsiveness to change and also the amount of change 
that may be clinically and socially important. Based on the magnitude of change and 
the effect sizes observed, the likely level of change in quality of life and visual function 
that may be socially significant was shown to be a change of 3 units in the SIP score, 
1.3 units in the VR-SIP score, and less than or equal to 20 units in the VF-14 score. 
These need to be confirmed in other samples of cataract patients. 
2. IMPLICATIONS FOR CLINICAL PRACTICE 
The patient perceived measures of visual functioning and quality of life have provided 
insight and complementary information to visual acuity for the assessment of the 
outcomes of cataract surgery. This has several implications for clinical practice. 
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2.1 Influence of advances in optical correction of aphakia on the 
outcome of surgery 
Despite advances in both surgical technique and in the optical correction of aphakia 
provided by intraocular lenses, there has not been any significant improvement in 
clinical outcome (as measured by visual acuity), in the surgery eye over the last two 
decades. About 80% of patients achieve a good visual acuity irrespective of type of 
procedure or type of optical correction. [81][82][83][84][85] The findings from this 
thesis indicate that the discrepancy between post-operative visual acuity in the surgery 
eye and visual function that was first described at least 15 years ago, [81] has now been 
considerably narrowed. Although the measure of visual function used at that time 
may not be directly comparable with the VF-14, both indices have a similar content. 
About 80% of patients now achieve good visual acuity and 80% now also achieve 
good visual function. This is probably a result of posterior chamber intraocular lenses 
for optical correction after cataract extraction. They are able to provide a better 
quality of vision as they are not burdened by the problematic optical aberrations 
associated with the optical correction available before the introduction of microsurgical 
techniques and intraocular lens implantation. 
Visual acuity assessment alone was not able to detect the impact of better quality of 
vision that may be obtained from intraocular lens implants on patients' functioning. 
Anecdotally, this may have been acknowledged clinically, but had not been explicitly 
expressed before in these terms. 
2.2 Improved identirication of the benerits of cataract surgery 
Significant gains in visual function and quality of life were observed in the group of 
patients who did not achieve good visual acuity (6/12 or better). A third of the 
patients having cataract surgery had ocular comorbidity in the surgery eye, and were 
found to be at greater risk of having a poor visual acuity outcome than patients 
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without ocular comorbidity. The traditional clinical indicator of visual acuity alone 
would have underestimated the benefit of surgery to a significant proportion of 
patients. 
2.3 Gains in visual function from effects on vision not operating 
through, nor measured by visual acuity. 
Analysis of the determinants of change in visual function clearly demonstrated that 
gains were achieved not only through effects on vision operating through visual acuity 
but also through other effects on vision. This reflected the fact that visual acuity is 
only one component of vision influencing function. Other components of vision that 
may influence visual function that are not directly measured by visual acuity include 
binocularity, stereopsis, and visual field. There are objective clinical tests available to 
measure these but they are not routinely used in the assessment of cataract patients 
either before or after surgery. The relationships between visual function and quality of 
life and these other components of vision need to be investigated further. 
2.4 The Contribution of Second Eye Surgery to Outcome 
A third of the cataract surgical workload is taken up by second eye surgery. The thesis 
has demonstrated the additional contribution of second eye surgery to outcome. 
Significant gains in visual function and quality of life beyond those gained after first 
eye surgery were demonstrated. The gains in visual function were achieved through 
effects on both visual acuity, and other components of vision. These findings support 
the value of second eye surgery which other studies have reported. [168][169] 
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2.5 Timing of intervention for maximising benefit 
The concept of the potential "capacity for change" as a result of surgery takes 
account of the fact that not all patients have the same level of acuity or functioning 
before surgery. Investigation of this provided further information for the interpretation 
of the overall impact of surgery on visual function, allowing inferences for routine 
clinical practice to be drawn.. This concept has not been used before to examine the 
impact of cataract surgery on visual function. Pre-operative visual function was 
identified as an important confounder for the extent of change after surgery. The 
findings suggested that for a given level of pre-operative visual function, the better the 
pre-operative visual acuity in the better eye, then on average the greater the gain in 
visual function after surgery. The relationship with change (gain) in better eye visual 
acuity remained unchanged. 
Given the wide variability in visual function scores before surgery for any level of 
visual acuity, and the important effect of age on pre-operative visual acuity and 
function, the findings suggested that for a given level of function before surgery, more 
benefit (in terms of visual function) was gained post-operatively if cataract extraction 
was performed on the affected eye before visual acuity in the better eye was 
compromised. By identifying the importance of pre-operative helter eye acuity and 
visual function on outcome, insight and information was provided regarding the timing 
of surgery to achieve most benefit in terms of visual function. This would not have 
been evident from clinical assessment of outcome by surgery eye visual acuity alone. 
3. FUTURE HEALTH SERVICES RESEARCH 
Finally, by identifying the current uses, limitations and contributions of the methods 
used to measure impairment (visual acuity), disability (visual function) and handicap 
(quality of life) for the assessment of the outcome of cataract surgery, the findings 
have informed their use in health services research : 
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i. For international comparisons of impairment, disability and handicap 
experienced by different populations of cataract patients and the outcomes of surgery 
in different health care settings. The patient perceived measures for disability and 
handicap used in this thesis were comparable to a similar study conducted in the United 
States, with the intention that comparative analyses will be undertaken now that both 
studies have been completed. The findings have provided information on their use and 
interpretation in the proposed comparative analyses. 
ii. To evaluate the impact of change in routine surgical practice. 
For the assessment of alternative methods of delivering a service, such as 
in-patient versus day care 
For the assessment of new technologies and developments in intraocular lens 
design such as foldable lenses facilitating small incision surgery, and bifocal 
lenses 
0 For the assessment of alternative surgical techniques for cataract extraction. 
Visual function (VF-14) is already being used as an outcome measure in a 
randomised controlled trial of alternative surgical techniques for cataract 
extraction as a result of the work carried out in this thesis. 
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COLLEGE OF OPHTHALMOLOGISTS 
BRAIMBER COURT, 2 BRAMBER ROAD. LONDON W149PQ 
TELEPHONE: 071-395 6281 FACSIMILE: 071-381 1799 
November 1990 
THE NATIONAL CATARACT SURGERY SURVEY 
I am pleased to be able to inform you that the survey week is: 
WEEK 48 : MONDAY 26 - FRIDAY 30 NOVEMBER 1990. 
Please find enclosed - 
10 sets of patient survey forms 
Each set consists of Part 1 and Part 2 per patient, (Forms 
COAU/001 and COAU/002 respectively. 
These are specifically for adult patients admitted -'under your care for surgery for age related cataract, during 
the survey week. 
Each set of forms is specially coded for patients of 
each participating Consultant. If we have not sent you 
sufficient, please contact - 
Miss N. Mahmood 
Audit Secretary 
College of Ophthalmologists 
Bramber Court, 2 Bramber Rd, 
London W14 9PQ 
Tel: 071 - 385 - 6281 
Part 3- Routine Hospital Data per Consultant. 
(Form COAU/003] 
This information relates to each Consultant and may be 
obtained from your Hospital Management Information 
Department. 
* Specimen survey form with a guide to form completion. 
PTO 
Once completed Part 1 and Part 3 should be returned to the 
College at your earliest convenience, but preferably by 
Monday 10 December 1990. 
Part 2 should he returned to the College when completed at 
months post-operatively. 
Thank you for your cooperation and participation in the 
survey. 
Yours sincerely, 
e, *176D"49 
Ms P Courtney MSc FRCS FCOphth 
Audit Fellow 
COLLEGE OF OPHTHALMOLOGISTS 
NATIONAL CATARACT SURGERY SURVEY 
NOTES ON SURVEY FOPJkf COMPLETION 
PART 1: Pre- and Peri-Operative Data 
This data should be obtained for all adult patients admitted f or 
surgery for age related cataract during the survey week: 
Monday 26 - Friday 30 November 19go. 
It includes pre-operative and peri-operative data on each patient 
in the survey. This data should be collected during the 
admission episode for surgery and should be returned as soon as 
it is completed to the College of Ophthalmologists by 
Monday 10 December 1990. 
PERSONAL DATA. 
Etbnic Group - classify as apparent to the Ophthalmologist: 
Caucasian European origin 
Asian Indian sub-continent origin 
Afro-Caribbean African or Caribbean origin 
oriental Far Eastern, Chinese, Japanese origin 
other mixed origin or not include in above. 
ocqu ation ip - 
Employed - if still in active employment (full or part-time) 
Unemployed - if not in employment at time of admission but 
has previous history of employment 
Retired - retired from full-time or part-time work 
Housewife 
1 
PRE-OPERATIVE. 
Referral source - 
GP General Practitioner 
oMP / optician - referral directly to hospital 
other - another department in'the hospital 
e. g. Geriatric or Diabetic clinic. 
Date of referral letter - 
This should refer to the date at which an Ophthalmic consult was 
requested for the patient (including referrals from , other" 
sources. 
Date of first OPD appt. - 
Date at which patient was first seen in the Ophthalmic out- 
Patient Clinic from any referral source. 
PERI-OPERATIVE. 
Surgery Performed - 
No, medical reason - unfit for surgery 
No, other reason - theatre closure, staff shortage, 
operating list overbooked. 
IMMEDIATE POST-OP. 
This section relates to the first POst-operative examination for 
both in-patients and day-cases. 
For day-cases this would be the morning af ter surgery when these 
patients are requested to attend for their "first day" post- 
operative examination. 
2 
AT DISCHARGE. 
For In-Patients - this section refers to the date that the 
patient is discharged from hospital after 
surgery. 
For Day-Cases - this section refers to the day after surgery 
when these patients are requested to attend f or 
their "first day" post-operative examination. 
PART 2: Post-Operative Data 
This post-operative data should be obtained prosp-ctively for all 
patients who have been included in the survey and have had Part 
1 completed. 
1ST POST-OP OPD VISIT. 
This relates to data at the first Post-operative visit in the 
Out-Patient Clinic. 
3 MONTH POST-OP OPD VISIT. 
This refers to post-operative data on patients 3 months after 
their operation. It relates to data available on the patient at 
that time. 
Once completed the survey f orms should be returned to the College 
of ophthalmologists at your earliest convenience. 
PART 3: Routine Hospital Data per Consultant 
This information may be obtained from the Hospital Management 
Information Department. 
(If this is not possible it may be obtained from Theatre 
Registers and the out-Patient Appointments Diary). 
If possible it should be completed and returned to the College 
with PART 1 by Monday 10 December 199o. 
3 
L'()Ak', b01 
COLLEGE OF OPHTHALMOLOGISTS 
National Cataract Surgery Survey 
Pre and Peri-Operative Data for 
Cataract Operations in Adults 
PERSONAL DATA (Please circle) 
Ethnic Group: 
Sex: M ". i -ý 
i 
[Date 
of Birth: 7- /2 /19Z 
2= Asian 
3= Afro-Caribbean 
4= Oriental 
5= Other 
6= Not recorded 
PART 1: 
CENTRE ID: [0 10 I'f I q7id 
CONSULT ID: K(I Iq I 
PATIENT Ib: ' 10 10 1CI (-T R6 
HOSPITAL NUMBER: 
p jj3 Iq 16 1! 5 1,1 -:, -1 q 
Occupation: I= Employed 
2= Unemployed 
3= Retired 
5= Not known 
PRE-OPERATIVE (Please circle) 
Referral source: <EýE> 
2= OMP/Optician 
3= Other 
4= Not known 
Type of admission: 
EYE: Right 
VISUAL ACUrrY 
At Ist OPD appointment: 
With coffection: 
Best correcte4/Pin-hole: 
Day case 
2ND 
D referral letter: 
Date fit D appt: 
. ted for surgery: 
Otte admission for surgery: 
(Please insert c 
IU T yFr 
F*-I 
Date listed for surgery: 
With correction: 
Best correctvMn-hole: 
FG-1 cloj 
3 
Date admission for surgery: 
With correction: fjýl F8-1 
Best corromd/Pin-hole: 1-3fl FU 
OCULAR PATHOLOGY ON ADMISSION 
RIGHT LEFT 
In order of severity: P-1 
El 
m 
1-1 
El F-1 
If OTHER, please specifY: 
No 
CODE: 
0= Not recorded 
1 =6/6 
2= 6/9 
3= 6112 
4= 6/18 
5= 6/24 
6= 6/36 
7= 6/60 
8= 3/60 
9= CF 
10=HM 
11 = NPL 
CODE: 
0= None 
Age related maculopathy 
I= RPE changes/Drusen 
2= Disciform 
Diabetic Retinopathy 
3= Background 
4= Prolifer-afive 
5= Maculopathy 
6= Glaucoma 
7= Amblyopia 
8= Other 
9= Not known 
Day Month Year 
/19 V'R 
/19 eq 
10 /4 /Igqo 
26 / It /19 qO 
(D Couege of Ophthalmologists, Br2mber 
Couri, 2 Bramber Road, London, W14 9PQ PAGEIOF4 PTO 
PERT-OPERATIVE (Please circle) 
Pre-op topical antibiotic: Anaesthetic: Local 
I Yes 
Surgery (iý3D Type o(extractioniCl - Extzw. Msýý IOL: I- PosL 
performed: 2= No, medkal rewons 2= Inaw-apstilAr 2 =-Ant. Cfiýber 
3= No, other rcason 3= Other 3= None 
Peri-op compfications: 
I= Upule rupture 
2= Vitrem k)ss 
3= Choroidal haemrrhage 
4= Retro-bulbar haemorrhage 
5= Other 
If OTHER, pkm specify- 
IMMEDIATE POST-OP (Please insm code) 
; gý 
Immediate post-op complicaWns 
In order of severity: 
91 
F11 
r-I 
If OTHER, please specify: 
Additional ocular pathology detected 
after surgery in operated eye 
In order of severity: 
F] 
If OTHER, please specify: 
I 
Return to theatre for compikatkms: Yes 
8 
AT DISCHARGE (Please insert code) 
Date discharged after surgery: 30 1 11 /19qo 
visual acuity: RIGHT LEFT 
With Conwtion: Fo-I 
Beg coffecwd/Pin-hole: F671 
Intra-op antibiotk: 
0- None 
I- Topical 
2= Topical + steroid 
3= Subcomunctival 
e4-I-=-§-ubc; o-n'7 -+sýtými 
5- Othcr 
6- Not recorded 
Grade of Surgeon-. 
I= Consultant 
4= btlU 
5= Offier 
If OTHER, specify 
CODE. 
0- None 
I= Corneal oedema 
2= Raised IOP 
3- Wound leak 
4- Iris probq)se 
5= External infection 
6- Endophthalmitis 
7- Dislocated IOL 
8- Hyphaema 
9- Fibrinous uveitis 
10 - Retinal detachment 
II= Other 
CODF- 
0- None 
Age related maculopathy 
I- RPE changes/Drusen 
2= Disciform 
Diabetic Retinopathy 
3- Backgmund 
4- Proliferative 
5= Maculopathy 
6- Glaucoma 
7- Amblyopia 
8- Other 
9= Not known 
CODE: 
0- Not recorded 6= 6/36 
1-6/6 7= 6/60 
2-6/9 8= 3/60 
3= 6/12 9= CF 
4= 6/19 10 = HM 
5= 6/24 
I 
NPL 
__j 
IC College of Ophthalmologists, Bramber Court, 2 Bramber Road, London, 
W 14 9PQ PAGE 2 OF 4 
COA U/002 
COLLEGE OF OPHTHALMOLOGISTS PART 2: 
National Cataract Surgery Survey CENTREID: 1()IC)I-;, l 
CONSULT ID: 10 10 1q 
Post-Operative Data for PATIENT ID: 01C ZT(c], Cataract Operations in Adults 
PERSONAL DATA (Please circle) HOSPITAL NUMBER: 
Sex: M ýE51 
I 
Date of Birth: 2- /19 2ý0] 10 131 q 161: 511 1y no 
IST POST-OP OPD VISIT (Please insert code) 
[Date Ist post-op OPD visit: 12 12 /1990 
1 
CODE: 
VISUAL ACUITY AT IST POST-OP OPD VISIT: 0= Not recorded 6= 6/36 
1= 6/6 7= 6/60 
RIGHT LEFF 2= 6/9 8= 3/60 
i Wi 
3= 6/12 9= CF 
4= 6/18 10=HM th Correct on: 
Rest corrected/Pin-hole: 
5= 6/24 11 = NPL 
CODE: 
0= None 
<Z> I= Corneal oederna 
Complications at Ist post-op OPD 0 2= Raised IOP 
in operated eye 3= Wound leak 
In order of severity: 4= Iris prolapse 
5= External infection 
6= Endophthalmitis 
If OTHER, please specify: 
7= Dislocated IOL 
8= Hyphaema 
9= Fibrinous uveitis 
10 = Retinal detachment 
II= Other 
(Please circle or insert code) 3 MONTHS POST-OP It 
L! Wtus. 4ýLischar ed 40follow-up 
Number of post-op visits at 3 months: 
Date post-op medications discontinued: 6 /ig 91 
VISUAL ACUITY AT 3 MONTHS: CODE: 
0= Not recorded 6= 6/36 
RIGHT LEFT I= 6/6 7= 6/60 
571 571 
2= 6/9 8= 3/60 
3= 6/12 9= CF With Correction: 
Best correc ted/Pi n -hole: Fo I F61 4= 6/18 10=HM 5= 6/24 11 = NPL 
(D College of Ophthalmologist,,, Bramber 
Court, 2 Bramber Road, London, W14 9PQ PAGE30F4 PTO 
3 MONTHS POST-OP OPD VISIT (Please circle or insert code) 
W 
Complications at 3 months in operated eye 
In order of severity: 
K 
F-1 
F] 
If OTHER, please specify: 
I Suture removal: (2D Indication for suture removal: 
Cl =-Astigmn-Z"mý) 
2= Loose suture 
3= Routine 
4= Other 
If OTHER, specify 
CODE: 
0= None 
I= Corneal oedema 
2= Raised IOP 
3= Wound leak 
4= Iris prolapse 
5= External infection 
6= Endophthalmitis 
7= Dislocated IOL 
8= Hyphaema 
9= Persistent uveitis 
10 = Retinal detachment 
II= Cystoid macula oedema 
12 = Soft Lens Matter 
13 = Capsule Thickening 
14 = Other 
Capsulotomy indicated: Yes 4S I 
Final refraction: (Zb_ 1 refraction performed at: Lo'cal Optician 
Glasses dispensed: Glasses dispensed at: Hospital Local Optician 
Contact lAns dispensed: Yes No [-jo-ntact Lens dispensed at: Hospital Local Optician 
ADDITIONAL NOTES (if indicated) 
Please return Part I when completed and thereafter Part 2 to: - 
Ms P Courtney FCOphth 
Audit Unit 
College of Ophthalmologists 
Bramber Court 
2 Bramber Road 
London 
W14 9PQ 
THANK YOU FOR PARTICIPATING IN THIS SURVEY 
0 College or Ophthalmologists, Bramber Court, 2 Bramber Road, London, W14 9PQ 
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COLLEGE OF OPHTHALMOLOGISTS PART 3: 
National Cataract Surgery Survey CENTREID: 10101-Tjq_T_4ý 
Routine Hospital Data 
CONSULT ID: I C1 01q jVFj 
Per Consultant 
Study Week Weekly average Weekly average 
Week 48 (1990) Jul/Aug/Sep 1990 Jan-Dec 1989 
Number of Theatre sessions per week: 
Number of OPD sessions per week: 
SURGICAL WAITING LIST FOR CATARACT 
Total number of patients on waiting list: 
Number awaiting admission 6 months or I 
Number awaiting admission more than 6 
FIRST OUTPATIENT APPOINTME? 
Total number of patients on waiting list 
Average waiting Lime for routine appointi 
I 
Average waiting time for urgent appoir*q 
Number of cataract 
in 3rd quarter 1990: 
Total number of cataract 
Total number of 
Source of 
= HospiLal 2= Other 
I isio [61 
1 1210101 
-1 II I-n lo lo 
II Illowl 
Aug 1990 Sep 1990 
1 12-1: 1] 111 -12 10 
If other, please specify: 
Please return Part 3 when completed to:. 
Ms P Courtney FCOphth 
Audit Unit 
College of Ophthalmologists 
Bramber Court 
2 Bramber Road 
London 
W14 9PQ 
LI I I' I 
JzJ IZI 
End of third quarter End of fourth quarter 
30 Sep 1990 31 Dec 1989 
14- Is k> 
lzýo Fol 
[5 Is fol 
Jul 1990 
L11 12-1 
1990: 11 16111 
1989: 
THANK YOU FOR YOUR CO-OPERATION IN PROVIDING THIS INFORMATION 
or Ophthalmologists, Bramber 
Court, 2 Bramber Road, London, W14 9PQ PAGE I OF I 
COAU/001 
COLLEGE OF OPHTHALMOLOGISTS PART 1: 
National Cataract Surgery Survey CENTRE ID: 
CONSULT ID: 
Pre and Peri-Operative Data for PATIENT ID: 
Cataract Operations in Adults 
PERSONAL DATA (Please circle) HOSPITALNUMBER: 
Ethnic Group: 1= Caucasian 
IIIIII11: 1 
Sex: MF2= Asian Occupation: I= Employed 
3= Afio-Caribbean 2= Unemployed 4= Oriental 
[Date 
or Birth: 15= Other 
3= Retired 
4= Housewife 6= Not recorded 5= Not known 
PRE-OPERATIVE (Please circle) Day Month Year 
Referral source: I=GP Date referral letter: /19 
2= OW/Optician Date first OPD appt: /19 3= Other 
4= Not known Date listed for surgery: /19 
Date admission for surgery: /19 Type of admission: In-patient 
5a-y case 
EYE: Right Left I ST - ii; D Biometry: Yes No 
VISUAL ACUITY (Please insert code) CODE* 
RIGHT LEFr 0= Not recorded 
At Ist OPD appointment: 
i 
I= 6/6 
2=09 
With correct on: 
EJ El 
3= 6/12 
Best correcte4lPin-hole: 4= 6/18 
5= 6/24 
Date listed for surgery: 
El EJ 
6= 6/36 
7= 6/60 
rection: With con 
EJ 
8= 3/60 
Best coffecte4Mn-hole: 9=CF 
10 - HM 
Date admission for surgery: ll=NTL 
With correction: El 
-hole: Best coffecte4fPin El CODE., 
0= None 
OCULAR PATHOLOGY ON ADMISSION Age related maculopathy 
I= RPE changcs/Drusen 
RIGHT LEFr 2= Disciform 
in order of severity: EJ El 
Diabetic Retinopathy 
3- Background 
EJ F 4- Proliferative 5= Maculopathy 
EJ El 6= Glaucoma 
7= Amblyopia 
If OTHER, please specify: 8= Other 
9= Not known 
College of Ophthalmologists, Bramber Court, 2 Bramber Road, London, W14 9PQ PAGE10F4 PTO 
PERI-OPERATIVE (Please circle) 
Pre-op topical antibiotic: Yes No Anaesthetic: Local General 
I 
Surgery I= Yes Type of extraction: I= Extrw. Vsular IOL: I= Post. Chambcr 
performed: 2= No. medical reasons 2= Intracapsular 2= Ant. Chamber 
3= No. other reason 3= Other 3= None 
Peri-op complications: 
If OTBER, please specify: 
0= None 
I= Capsule rupture 
2= Viurous loss 
3= Choroidal haemorrhage 
4= Retm-bulbar haemonbage 
5= Other 
IMMEDIATE POST-OP 
Immediate post-op complications 
In order of severity: 
It OTIER, please specify: 
(Please insert code) 
Fl 
Fl 
F1 
Additional ocular pathology detected 
after surgery in operated eye 
In order of severity. 
F-1 
E-1 
If OTHER, please specify: 
I Return to theatre for compikations: I es No 
I 
AT DISCHARGE (Please insert code) 
Date discharged arter surgery: /19 
Visual acuity: RIGHT LEFr 
With Con=tion: Fl F-1 
Bcst cormwdRin-hole: m El 
0- None 
I= Comeal oadema 
2= Raised IOP 
3= Wound IcA 
4= Iris prolapse 
5= External infection 
6= Endophthalmitis 
7= Dislocated IOL 
8= Hyphaema 
9= Fibrinous uveitis 
10 = Retinal detachment 
II= other 
CODE: 
0a None 
Age related maculopathy 
I= RPE change&Mmsen 
2c Disciform 
Diabetic Retinopathy 
3w Background 
4a Proliferative 
5= Maculopathy 
6= Glaucoma 
7= Amblyopia 
8= Other 
9= Not known 
CODE: 
0= Not recorded 6= 6/36 
1= 616 7= 6160 
2= 6/9 8= 3/60 
3= 6/12 9= CF 
4-6/18 10 = IHM 
5= 6/24 11 = NPL 
Intrs-op antibiotk: 
0= None 
I- Topical 
2w Topical + steroid 
3- Subconjunctival 
4= Subconj + steroid 
5= Other 
6= Not recorded 
Grade of Surgeon: 
I 
I= Consultant 
2=SR 
3= Registw 
4= SHO 
5= Other 
If OTHER, specify 
CODE: 
x 
a college or Ophthalmologists, Bramber Court, 2 Bramber Road, London, W14 9PQ PAGE20F4 
COA U/002 
COLLEGE OF OPHTHALMOLOGISTS PART 2: 
National Cataract Surgery Survey CENTREID: F] 
CONSULT ID. 
-11 Post-Operative Data for PATEENT ID: I I_71 
Cataract Operations in Adults 
PERSONAL DATA 
S 7-ý ex: M 
(Please circle) 
- rDate -of 
Birth: /19 
HOSPITAL NUMBER: 
- 
IST POST-OP OPD VISIT (Please insert code) 
p- Date 1st pod-op OPD visit: /19 
CODE: 
VISUAL ACUITY AT IST POST-OP OPD, VISIT: 0- Not recocftd 6' 6136 
1= 6/6 7: 6160 
RIGHT LEFr 2=Q9 8-3)60 
With Coffection: El F-1 
3= 6/12 
4w 6118 
9-CF 
10=11w 
Bcst conectedRin-hole: Fý F-1 L 5-6/24 11-NPL 
Complicatioims at Ist post-op OPD F-1 in operated eye 
In order of severity. 
If OTFIER, plum specify: 
CODE. - 
0= None 
I- Corneal oedesna 
'2 - Raised IOP 
3- Wound iesk 
4m Ids pol*w 
5- Exlemal infection - 
6= Endoplulmilinitis 
7- Diskx*W IOL 
8= Hyphaema 
9- Fitwinous uveitis 
10 - Retinal detachment 
II- Otter 
3 MONTHS. POST-OP OPD VISIT (Please circle or insert code) 
Status: Discharged FD11ow-up 
Number of post-op visits at 3 months:, 
Da-te post-op medications discontinued: /19 
VISUAL ACUITY AT 3 MONTHS: 
RIGHT 
with Correction: EJ 
Best corrocte4, Pin-hole- 
LEFr 
F-I 
CODE 
0= Not recordad 6= 6/36 
1= 6/6 7= 6/60 
2= 619 8= 3160 
3= 6/12 9= CF 
4= 6/18 10= HM 
5= 6/24 
ýl 
I= NPL 
Cdlege c)f OphthalmologMs., Bramber Court, z vramucr 
I%UMU, &APIRMIR, TV 1-0 711%4 rAk, Li Ur 4 
3 MONTHS POST-OP OPD VISIT 
CODE: 
ComPliKations at 3 awnths In operated eye 
In order of severity: 
It MHER, p1me specifr. 
I Suture removah Yes No 
(Please circle or insert code) 
011% dD 
F-I 
El 
El 
ludicaflm for sutare remowg: 
I- Astigmatism 
2- Lmw suture 
3- Routine 
4n Other 
If OTHER. sl=ify 
0= None 
I= Corneal oedenia 
2- RaLsed JOP 
3- Wound leak 
4a Iris prolqpse 
5= External infeWon 
6- Endophdudmitis 
7m Dislocated IOL 
9- Hyphý 
9- PCrdStCrA UvCitiS 
10 w Retinal deUchummt 
IIm Cysioid macula oedems 
12 w Soft Lou Nis= 
13 - CVwAc Thidmaing 
14 n Other 
Capsalotomy bmikste& Yes M 
Fhudrefrwdm. Yes M1 
r1lWnbecdomperfon"ft 
110*ul L": d OpWan 
Ghumn dispensed: Glasm dh4wmed at: Hospiw LAml 
Contad Leas dbpenW: Yes No as digpc=W at: HCOW Local Opdcian 
ADDMONAL NOTES (If indkstcd) 
Please retorn Part I wbeu completed und Ibemifter Part 2 to: - 
Ms P Coustmey FCOphth 
Audit Unit 
College o( Ophthalmologists 
Bramber Court 
2 Bramber Road 
Landon 
W14 9PQ 
THANK YOU FOR PARTICIPATING IN THIS SURVEY 
Q College of Ophthahnolog6ts, Bramber Court, 2 Bramber Road, London, W14 9PQ PAGE 4 OF 4 
COA LV003 
COLLEGE OF OPHTHALMOLOGISTS PART 3: 
National Cataract Surgery Survey CENTRE ID: I F-1 
Routine Hospital Data 
CONSULTID: 
Per Consultant 
Study Week Weekly average Weekly average 
Week 48 (1990) Jul/Aug/Sep 1990 Jan-Dec 1989 
Number of Theatre sessions per week: 
Number of OPD sessions per week: 
End of third quarter End of fourth quarter 
30 Sep 1990 31 Dec 1989 SURGICAL WAITING LIST FOR CATARACT 
Total number of patients on waiting list: _7 T-1 
Number awaiting admission 6 months or less: 17F] r] 
Number awaiting admission more than 6 months: 
FIRST OUTPATIENT APPOINTMENT WAITING LIST 
Total number of patients on waiting list: I _T1 
Average waiting time for routine appointment (in weeks): 
Average waiting time for urgent appointment (in weeks): 
Jul 1990 Aug 1990 Sep 1990 
Number of cataract operations per month [111 R 
in 3rd quarter 1990: 
Total number or cataract operations JUL-SEP 1990: [_ IIIR 
Total number of cataract operations JAN-DEC1989: 
Source or In formation: (Please Circle) 
I= Hospital Management Information 2= Other 
if other, please specify: 
Please return Part 3 when completed to:. 
Nls P Courtney FCOphth 
Audit Unit 
College or Ophthalmologists 
Bramber Court 
2 Bramber Road 
London 
W14 9PQ 
THANK YOU FOR YOUR CO-OPERATION IN PROVIDING THIS INFORMATION 
t College of Ophthalmologl0s, llr; jml)cr Court, 
2 Bramber Road, London, W14 911Q PAGIE I OF I 
Appendix A2 
Poisson Logistic Regression Model : 
Risk Factors for Poor Clinical Outcome - Visual Acuity 
270 
-R 
T) 
Epidemiological GRaphics, Estimation, and Testing package 
ANALYSIS MODULE (PECAN), version 0.26.6 ; EPIXACT (R), version 0.03 
(c) Copyright 1985 - 1991, SERC and CYTEL 
THIS COPY LICENSED TO: 
Dr. D. C. Minassian 
Preventive Ophthalmology, Institute of Ophthalmology 
Bath Street, London ECIV 9EL, United Kingdom 
Today's date: 3/18/96 at 11: 51 
Data file name: vaegl 
23 variables and 959 observations 
-VARIABLES 
1. CARD 2. REGION 3. TYPE 4. SIZE S. SEXY 
6. AGE2G 7. AGE3G 8. ADMTYPE 9. EYEorder 10. VAAD4G 
11. OCPATHG 12. AN01 13. PERIG 14. Surgeon 15. VA3MG 
16. C3mOl 17. CAPSULOTOM 18. REF 19. GLASS 20. POOR1 
21. DENOM 22. LWAIT 23. AWAIT 
VARIABLE MISSING VALUE CODE(S) 
SEXY 99.00000 
ADMTYPE 99.00000 
EYEorder 99.00000 
AN01 99.00000 
Surgeon 99.00000 
REF 99.00000 
LWAIT 99.00000 
AWAIT 99.00000 
ANALYSIS MODEL: Poisson regression 
RISK TYPE: Relative risk (multiplicative) 
RATE MULTIPLIER: -none- 
OUTCOME SPECIFICATION: Outcome Variable Name: POOR1 
(X) 
(F) 
VARIABLE #LEVELS BASE 
kXwTUKLU 
VARIABLE 
VAKlRk5lZb 
#LEVELS BASE VARIABLE #LEVELS BASE 
REGION 19 1 TYPE 3 1 SIZE 4 1 
SEXY 2 1 AGE2G 2 1 AGE3G 3 1 
ADMTYPE 2 1 EYEorder 2 1 VAAD4G 4 1 
OCPATHG 3 0 AN01 2 0 PERIG 4 0 
Surgeon 5 1 VA3MG 4 1 C3MO1 2 0 
CAPSULOTOM 2 0 GLASS 2 0 AWAIT 3 1 
IX) 
(C) 
Configuration 
DATAFILE ...... vaegl 
ANALYSIS .... PR 
VARIABLES ..... 23 
RATE MULT ... -none- 
OBSERVATIONS.. 959 OUTCOME..... pOOR1 
-RESULTS -IPRI- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -2.084 (. 111) <. 001 . 1244 
OCPATHG-'l' . 9134 (. 
172) <. 001 2.493 
OCPATHG='2' 1.296 (. 175) <. 001 3.653 
DEVIANCE ON 956 DF - 560.145 
OUTCOME- POOR1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 1244 . 1001 . 1547 
OCPATHG-'l' 2.493 1.779 3.492 
OCPATHG-*2* 3.653 2.594 5.145 
Excluding unknown SEX 
-RESULTS -[PRI- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -2.081 (. 111) <. 001 . 1248 
OCPATHG-*l' . 9103 (. 172) <. 001 2.485 
OCPATHG='2' 1.293 (. 175) <. 001 3.642 
DEVIANCE ON 954 DF - 559.647 
OUTCOME- POOR1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 1248 . 1004 . 1552 
OCPATHG-'l' 2.485 1.774 3.481 
OCPATHG-'2* 3.642 2.586 5.129 
Extend to include all others (excluding variables 
with missing values) 
RESULTS [PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
REGION-'2' . 3712 1.439 1 . 230 
REGION-'3' . 5864 4.338 1 . 037 
REGION-'4' -. 1285 . 1582 1 . 691 
REGION-'5' . 3587E-01 . 6053E-02 1 . 938 
REGION-'6' . 5004E-01 . 1610E-01 1 . 899 
REGION-'7' . 3823 1.422 1 . 233 
REGION-'8' -. 6421 3.965 1 . 046 
REGION-'9' -. 7943E-01 . 8210E-01 1 . 774 
REGION-'10' -. 2565 . 5012 1 . 479 
REGION-'Il' -. 2997 . 8337 1 . 361 
REGION-'12' . 2044 . 5823 1 . 445 
REGION-'13' . 1709 . 2397 1 . 624 
REGION-'14' -. 1270 . 1396 1 . 709 
REGION-'15' . 1939 . 4163 1 . 519 
REGION='16' -. 4486 . 7031 1 . 402 
REGION-'17' -. 3271 1.420 1 . 233 
REGION-'18' -. 1358 . 2173 1 . 641 
REGION-'19' . 1185 . 1085 1 . 742 
REGION 15.68 18 . 615 
TYPE-'2' . 7564E-01 . 1528 1 . 696 
TYPE='3' -. 5306E-02 . 1248E-02 1 . 972 
TYPE . 2128 2 . 899 
SIZE-'2' . 1647 . 9504 
1 
. 356 
SIZE-'3' -. 1335 . 6862 1 . 407 
SIZE-'4' -. 9114E-01 . 2901 1 . 590 
SIZE 1.589 3 . 662 
SEXY-*2' . 3138 4.466 
1 
. 035 
AGE2G-'2* . 4302 
8.681 1 
. 003 
VAAD4G-'I': -. 4442 
7.087 1 
. 008 
VAAD4G-'3 -. 9368E-01 . 
3249 1 
. 569 
VAAD4G-'4* . 4644 
10.12 1 
. 001 
-RESULTS 
OUTCOME- POOR1 
TERM COEFFICIENT 
%GM -2.625 
OCPATHG='l' . 7128 
OCPATHG-12' 1.155 
C3MOl-'l* . 8515 
GLASS-*l' . 6708 
DEVIANCE ON 952 DF - 
LIKELIHOOD RATIO STATISTIC ON I DF - 
STD ERROR 
(. 149) 
(. 174) 
(. 176) 
(. 149) 
(. 154) 
502.591 
20.093, p 
P-VALUE 
<. 001 
<. 001 
<. 001 
<. 001 
<. 001 
< . 001 
JPRJ- 
RATE RATIO 
. 7241E-01 
2.040 
3.176 
2.343 
1.956 
RESULTS [PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
SIZE-'2' . 1157 . 4294 1 . 512 
SIZE-'3' -. 1375 . 7257 1 . 394 
SIZE='4' -. 5621E-01 . 1077 1 . 743 
SIZE 1.184 3 . 757 
SEXY-'2' . 3844 6.763 1 . 009 
AGE2G-'2' . 3886 7.011 1 . 008 
VAAD4G-'2' -. 3339 3.660 1 . 056 
VAAD4G='3' -. 8418E-01 . 2626 1 . 608 
VAAD4G='4' . 3275 5.054 1 . 025 
VAAD4G 6.004 3 . 111 
PERIG='l' -. 8139E-01 . 2783E-01 1 . 868 
PERIG-'2' . 4736 1.895 1 . 169 
PERIG-'3' -. 1489 . 7463E-01 1 . 785 
PERIG 1.957 3 . 581 
REGION=12' . 3792 1.484 1 . 223 
REGION='3' . 6373 4.957 1 . 026 
REGION-'4' -. 2467 . 6443 1 . 422 
REGION='5' . 9532E-02 . 4355E-03 1 . 983 
REGION-'6' . 1534E-01 . 1564E-02 1 . 968 
REGION='7* . 6132E-03 . 4757E-05 1 . 998 
REGION-t8' -. 6062 3.222 1 . 073 
REGION-'9' . 8600E-02 . 8877E-03 1 . 976 
REGION-'10' -. 1492 . 1498 1 . 699 
REGION-'11' -. 2143 . 3840 1 . 535 
REGION-'12' . 2010 . 5641 1 . 453 
REGION-'13' -. 4087E-01 . 1605E-01 1 . 899 
REGION-'14' . 5097E-01 . 1888E-01 1 . 891 
REGION-'15' . 1509 . 2592 1 . 611 
REGION-'16' -. 3518 . 3697 1 . 543 
REGION-'171 -. 3445 1.601 1 . 206 
REGION='18' -. 2982E-01 . 9432E-02 1 . 923 
REGION='19' . 1423E-01 . 17OOE-02 1 . 967 
REGION 12.82 18 . 802 
CAPSULOTOM-'I' . 
5615 5.214 1 
. 022 
TYPE-121 -. 1859E-01 . 9757E-02 1 . 921 
TYPE=*3' . 5731E-01 . 1465 1 . 702 
TYPE . 1738 2 . 917 
OVERALL SCORETEST ON 32 DF 44.438, p- . 071 
-RESULTS (PRI 
OUTCOME= POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -2.849 (. 176) <. 001 . 5789E-01 
OCPATHG-'l' . 6841 (. 
174) <. 001 1.982 
OCPATHG-121 1.113 (. 176) <. 001 3.044 
C3MOl-'l' . 8468 (. 
148) <. 001 2.332 
GLASS-'l' . 6525 (. 154) <. 001 1.920 
AGE2G-'2' . 4072 (. 155) . 009 1.503 
DEVIANCE ON 951 DF - 495.375 
LIKELIHOOD RATIO STATISTIC ON 1 DF - 7.216, p= . 007 
RESULTS (PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
SEXY-121 
. 3379 5.066 1 . 024 SIZE-'2' 
. 7600E-01 . 1876 1 . 665 SIZE-131 -. 1341 . 6878 1 . 407 SIZE-'4' -. 5042E-01 . 8624E-01 1 . 769 SIZE 1.085 3 
. 781 VAAD4G-'2' -. 3726 4.630 1 . 031 VAAD4G-'3' -. 1078 . 4335 1 . 510 VAAD4G-141 . 3695 6.350 1 . 012 VAAD4G 
. 
7.545 3 
. 056 PERIG-111 -. 9650E-01 . 3963E-01 1 . 842 PERIG-'2' . 4205 1.542 1 . 214 PERIG-'3' -. 1327 . 580BE-01 1 . 810 PERIG 1.602 3 
. 659 REGION='2' . 4225 1.791 1 . 181 REGION-'3' . 7284 6.147 1 . 013 REGION='4' -. 2266 . 5329 1 . 465 REGION-'5' . 3465E-01 . 5617E-02 1 . 940 REGION-'6' -. 3139E-01 . 6814E-02 1 . 934 REGION='7' -. 5735E-02 . 4192E-03 1 . 984 REGION='8' -. 6007 3.120 1 . 077 
REGION-'9' -. 3414E-01 . 1449E-01 1 . 904 REGION-'10' -. 1392 . 1291 1 . 719 REGION='11' -. 2640 . 6145 1 . 433 REGION='12' . 2736 . 9885 1 . 320 REGION='131 -. 6371E-01 . 3970E-01 1 . 842 REGION='14' . 2124E-01 . 3362E-02 1 . 954 REGION='15' . 1192 . 1658 1 . 684 REGION-1161 -. 2618 . 1792 1 . 672 REGION-'17' -. 3617 1.801 1 . 180 REGION-'18' -. 4596E-01 . 2271E-01 1 . 880 REGION='19' . 1320E-01 . 1462E-02 1 . 970 REGION 14.63 18 
. 687 CAPSULOTOM-'l' . 6061 5.936 1 . 015 TYPE='2' -. 2292E-01 . 1486E-01 1 . 903 TYPE-'3' . 5386E-01 . 1294 1 . 719 TYPE . 1436 2 . 931 
OVERALL SCORETEST ON 31 DF 37.533, p- . 195 
RESULTS JPRI- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -2.881 (. 177) <. 001 . 5609E-01 OCPATHG-'l' . 7176 (. 175) <. 001 2.049 
OCPATHG-12' 1.106 (. 176) <. 001 3.021 
C3MOl-'l* . 6937 (. 166) <. 001 2.001 
GLASS-'l' . 6570 (. 154) <. 001 1.929 
AGE2G-'2' . 4247 (. 15s) . 006 1.529 
CAPSULOTOM-'l' . 5324 (. 221) . 016 1.703 
DEVIANCE ON 950 DF - 489.954 
LIKELIHOOD RATIO STATISTIC ON 1 DF - 5.421, p- . 020 
RESULTS [PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST OF P-VALUE 
SIZE='2' . 9131E-01 . 2690 1 . 604 
SIZE-'3' -. 1088 . 4457 1 . 504 
SIZE-'4' -t-. 9031E-01 . 2802 1 . 597 
SIZE 1.096 3 . 778 
VAAD4G-'2' -. 3771 4.753 1 . 029 
VAAD4G-'3' -. 9670E-01 . 3468 1 . 556 
VAAD4G-'4' . 3610 6.045 1 . 014 
VAAD4G 7.371 3 . 061 
PERIG-'l' -. 9821E-01 . 4099E-01 1 . 840 
PERIG-'2' . 3503 1.112 1 . 292 
PERIG='3' -. 2550 . 2402 1 . 624 
PERIG 1.325 3 . 723 REGION-121 . 4729 2.168 1 . 141 REGION-'3' . 7651 6.650 1 . 010 REGION-141 -. 2917 . 9183 1 . 338 REGION-151 . 5502E-01 . 139GE-01 1 . 906 REGION-'61 -. 4033E-01 . 1138E-01 1 . 915 REGION-'71 -. 4745E-01 . 2949E-01 1 . 864 REGION-*8' -. 6091 3.258 1 . 071 REGION-'9' -. 5986E-02 . 4330E-03 1 . 983 
REGION-'10' -. 1604 . 1755 1 . 675 REGION-'111 -. 2594 . 5890 1 . 443 REGION-'12' . 2577 . 8863 1 . 346 REGION-'131 -. 9923E-01 . 995SE-01 1 . 752 REGION-'141 . 5435E-01 . 2132E-01 1 . 884 REGION-'15' . 1179 . 1621 1 . 687 REGION-'16' -. 2362 . 1412 1 . 707 REGION-'17' -. 3582 1.754 1 . 185 REGION-'181 -. 1743E-01 . 3174E-02 1 . 955 REGION-'191 . 6027E-01 . 2919E-01 1 . 864 REGION 16.06 18 . 589 SEXY-*2' . 3384 5.073 1 . 024 TYPE-'2' -. 5846E-02 . 9560E-03 1 . 975 TYPE-'3' . 6011E-01 . 1616 1 . 688 TYPE . 2297 2 . 891 
OVERALL SCORETEST ON 30 DF 31.946, p- . 370 
-RESULTS ý[PRJ- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -3.097 (. 205) <. 001 . 4517E-01 OCPATHG='l' . 6929 (. 175) <. 001 1.999 
OCPATHG-'2' 1.106 (. 176) <. 001 3.021 
CM01-111 . 7046 (. 166) <. 001 2.023 
GLASS-'l' . 6880 (. 154) <. 001 1.990 
AGE2G-'2' . 3738 (. 156) . 017 1.453 
CAPSULOTOM-'l' . 5325 (. 221) . 016 1.703 
SEXY-'2' . 3551 (. 158) . 025 1.426 
DEVIANCE ON 949 DF - 484.724 
LIKELIHOOD RATIO STATISTIC ON 1 DF - 5.230, p- . 022 
RESULTS JPRJ- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
VAAD4G-'2' -. 3810 4.869 1 . 027 
VAAD4G-*3' -. 9954E-01 . 3669 1 . 545 
VAAD4G-'4' . 3729 6.434 1 . 011 
VAAD4G 7.728 3 . 052 
PERIG-'l' -. 1561E-01 . 9475E-03 1 . 975 
PERIG-'2' . 2560 . 6270 1 . 428 
PERIG-13' -. 2937 . 3317 1 . 565 
PERIG . 9022 3 . 825 
REGION-121 . 4521 2.008 1 . 156 
REGION-13' . 7645 6.651 1 . 010 
REGION-'4' -. 3638 1.498 1 . 221 
REGION-'5' . 4217E-01 . 8255E-02 1 . 928 
REGION-'6' -. 8577E-01 . 5359E-01 1 . 817 
REGION-'7' -. 2482E-01 . 7929E-02 1 . 929 
REGION-'8' -. 6320 3.645 1 . 056 
REGION-'9' -. 8995E-02 . 9813E-03 1 . 975 
REGION-'10' -. 1630 . 1816 1 . 670 
REGION-'11' -. 2946 . 7868 1 . 375 
REGION-'12' . 3103 1.234 1 . 267 
REGION-'13' -. 5798E-01 . 3268E-01 1 . 857 
REGION-'14' . 9252E-01 . 5973E-01 1 . 807 
REGION-'15' . 9711E-01 . 1117 1 . 738 
REGION='16' -. 2482 . 1581 1 . 691 
REGION-'17' -. 3288 1.4120 1 . 233 
REGION-'18' -. 4479E-01 . 2147E-01 1 . 884 REGION-'19' . 1239 . 1165 1 . 733 REGION 17.17 18 . 511 SIZE-'2' . 7255E-01 . 1716 1 . 679 SIZE-13' -. 1078 . 4368 1 . 509 SIZE='4' -. 1229 . 5246 1 . 469 SIZE 1.557 3 . 669 TYPE-'2' . 1264E-01 . 4413E-02 1 . 947 TYPE-'3' . 36OOE-01 . 5740E-01 1 . 811 TYPE . 1260 2 . 939 
OVERALL SCORETEST ON 29 DF 26.704, p- . 588 
End stepwise 
Final Model -1 
RESULTS (PRI- 
OUTCOME- POOhl 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -3.097 (. 205) <. 001 . 4517E-01 OCPATHG-'l' . 6929 (. 175) <. 001 1.999 
OCPATHG='2' 1.106 (. 176) <. 001 3.021 
C3MOl-'l* . 7046 (. 166) <. 001 2.023 
GLASS-'I' . 6880 (. 154) <. 001 1.990 
AGE2G-12' . 3738 (. 156) . 017 1.453 
CAPSULOTOM-11' . 5325 (. 221) . 016 1.703 
SEXY-12' . 3551 (. 158) . 025 1.426 
DEVIANCE ON 949 DF - 484.724 
LIKELIHOOD RATIO STATISTIC ON 1 DF - 5.230, p . 022 
-RESULTS (PRI- 
OUTCOME- POOR1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 4517E-01 . 3022E-01 . 6753E-01 OCPATHG-'l' 1.999 1.420 2.816 
OCPATHG-'21 3.021 2.139 4.267 
C3MO1-*l' 2.023 1.461 2.801 
GLASS-'l' 1.990 1.471 2.691 
AGE2G-'2' 1.453 1.070 1.975 
CAPSULOTOM-'l* 1.703 1.105 2.625 
SEXY-'2' 1.426 1.046 1.946 
testing for int eractions with o cpath 
RESULTS JPRJ- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
OCPATHG-'l'. C3mOl-'lo -. 4642E-01 . 2107E-01 1 . 885 OCPATHG-'2'. C3MOl-'l* -. 4309 1.777 1 . 182 OCPATHG. C3MOl 2.421 2 . 298 OCPATHG-'l'. GLASS-'l' -. 3781 1.204 1 . 273 OCPATHG-'2'. GLASS-*I' -. 2774E-01 . 6682E-02 1 . 935 OCPATHG. GLASS 1.506 2 
. 471 
OCPATHG-'l'. CAPSULOTOM-'l' -. 2519 . 3011 1 . 583 
OCPATHG-'2'. CAPSULOTOM-'l' -. 7447 3.213 1 . 073 OCPATHG. CAPSULOTOM 5.277 2 . 071 
OCPATHG-'I'. SEXY-*2' -. 9072E-01 . 6661E-01 1 . 796 
OCPATRG-*2'. SEXY-*2' -. 1744 . 2562 1 . 613 
OCPATHG. SEXY . 5027 2 . 778 
OCPATHG-'l'. AGE2G-'2' . 3813E-01 . 1248E-01 1 . 911 
OCPATHG-'2'. AGE2G-121 -. 2086 . 3512 1 . 553 
OCPATHG. AGE2G . 3670 2 . 832 
OVERALL SCORETEST ON 10 DF - 7.690, p- . 659 
End stepwise - no significant interactions 
Final Model -I- 
-RESULTS 11PRI- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -3.097 (. 205) <. 001 . 4517E-01 
OCPATHG-'l' . 6929 (. 175) <. 001 1.999 
OCPATHG-*21 1.106 (. 176) <. 001 3.021 
C3MOl-'l' . 7046 (. 166) <. 001 2.023 
GLASS-'1' . 6880 (. 154) <. 001 1.990 
AGE2G-'2' . 3738 (. 156) . 017 1.453 
CAPSULOTOM-'1' . 5325 (. 221) . 016 1.703 
SEXY-'2' . 3551 (. 158) . 0415 1.426 
DEVIANCE ON 949 DF - 484.724 
LIKELIHOOD RATIO STATISTIC ON I DF - 5.230, p- . 022 
Restricted Model - using only all known values: 
[Using 856 observations; 103 have missing values] 
-RESULTS CPR]- 
OUTCOME- POOR1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -3.112 (. 218) <. 001 . 4450E-01 
OCPATHG-'l' . 7125 (. 188) <. 001 2.039 
OCPATHG-'2' 1.119 (. 193) <. 001 3.062 
C3MOl-'l' . 7170 (. 182) <. 001 2.048 
GLASS='l' . 6960 (. 165) <. 001 2.006 
AGE2G='2' . 2518 (. 167) . 132 1.286 
CAPSULOTOM='l' . 5711 (. 237) . 016 1.770 
SEXY='2' . 4144 (. 174) . 017 1.514 
DEVIANCE ON 848 DF - 425.923 
-RESULTS ý[PRI- 
OUTCOMEý POOR1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 4450E-01 . 2901E-01 . 6826E-01 
OCPATHG='l' 2.039 1.412 2.945 
OCPATHG-'2' 3.062 2.099 4.468 
C3MOl-'I' 2.048 1.435 2.923 
GLASS-'I' 2.006 1.451 2.772 
AGE2G-'2' 1.286 . 9273 1.784 
CAPSULOTOM-'l* 1.770 1.113 2.815 
SEXY-'2' 1.514 1.076 2.128 
-RESULTS JPRJ- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
ADMTYPE-'2* -. 1516 . 2436 1 . 
622 
AN01-'l' -. 298SE-02 . 3527E-03 1 . 985 
Surgeon-'2' . 1732 . 3722 1 . 542 
Surgeon-'3' -. 1716 . 7021 1 . 402 
Surgeon-'4' -. 1499 . 2573 1 . 612 
Surgeon-'5' . 7531E-02 . 613SE-03 1 . 980 
Surgeon 1.279 4 . 865 
AWAIT-121 -. 4679E-01 . 6372E-01 1 . 801 
AWAIT-'3' -. 2625 1.734 1 . 188 
AWAIT 2.120 2 . 347 
OVERALL SCORETEST ON 8 DF - 3.585, p- . 893 
End stepwise 
-RESULTS ý(PRI- 
OUTCOME- POOR1 ; 
TERM COEFFICIENT STD RROR ý-VALUE RATE RATIO 
%GM -3.112 (. 218) <. 001 . 4450E-01 
OCPATHG-'l' . 
7125 (. 188) <. 001 2.039 
OCPATHG-'2' 1.119 (. 193) <. 001 3.062 
C3MO1='l' . 7170 (. 182) <. 001 2.048 
GLASS-'l' . 6960 (. 
165) <. 001 2.006 
AGE2G-'2* . 2518 (. 167) . 132 1.286 
CAPSULOTOM-'l' . 
5711 (. 237) . 016 1.770 
SEXY='2' . 4144 (. 
174) 
. 017 1.514 
DEVIANCE ON 848 DF - 425.923 
Maximum number of reals used in dynamic memory: 
27314 out of 40000 
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L--i _L. 16- L---ä -1- 
Epidemiological GRaphics, Estimation, and Testing package 
ANALYSIS MODULE (PECAN), version 0.26.6 ; EPIXACT (R), version 0.03 
(c) Copyright 1985 - 1991, SERC and CYTEL 
THIS COPY LICENSED TO: 
Dr. Parul Courtney 
Audit Unit, College of Ophthalmologists 
Bramber Court, 2 Bramber Road, London W14 9PQ, United Kingdom 
Today's date: 3/24/96 at 20: 52 
Data file name: c: \concas\vaeg2 
23 variables and 959 
-VARIABLES 
observations 
1. CARD 2. REGION 3. TYPE 4. SIZE 5. SEXY 
6. AGE2G 7. AGE3G 8. ADMTYPE 9. EYEorder 10. VAAD4G 
11. OCPATHG 12. AN01 13. PERIG 14. Surgeon 15. VA3MG 
16. C3MO1 17. CAPSULOTOM 18. REF 19. GLASS 20. POORI 
21. DENOM 22. LWAIT 23. AWAIT 
ANALYSIS MODEL: Poisson regression 
RISK TYPE: Relative risk (multiplicative) 
RATE MULTIPLIER: -none- 
OUTCOME SPECIFICATION: Outcome Variable Name: C3MOl 
VARIABLE MISSING VALUE CODE(S) 
SEXY 99.00000 
ADMTYPE 99.00000 
EYEorder 99.00000 
AN01 99.00000 
Surgeon 99.00000 
REF 99.00000 
LWAIT 99.00000 
AWAIT 99.00000 
I FACTORED 
VARIABLES I 
VARIABLE #LEVELS BASE VARIABLE #LEVELS BASE VARIABLE #LEVELS BASE 
REGION 19 1 ITYPE 3 1 ISIZE 4 1 
SEXY 2 1 JAGE2G 2 1 JAGE3G 3 1 
ADMTYPE 2 1 JEYEorder 2 1 IVAAD4G 4 1 
OCPATHG 3 0 JAN01 2 0 IPERIG 4 0 
Surgeon 5 1 jVA3MG 4 1 ICAPSULOTOM 2 0 
REF 0 IGLASS 2 0 LWAIT 3 1 
AWAIT 3 1 
REGRESSION TERMS [PRI- 
IGM b. OCPATHG 
-RESULTS (PRI 
OUTCOME- C3MO1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -1.844 (. 985E-01) <. 001 . 1582 
OCPATHG=11' . 5045 (. 174) . 004 1.656 
OCPATHG-12' . 4492 (. 207) . 030 1.567 
DEVIANCE ON 956 DF - 594.745 
-RESULTS [PRI 
OUTCOME- C3MO1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
SGM . 1582 . 1304 . 1919 
OCPATHG-'I' 1.656 1.179 2.327 
OCPATHG-12' 1.567 1.043 2.353 
Excluding all records with missing values for SEX : 
NO OBSERVATIONS WITH MISSING VALUES IN 
ANY OF THE FOLLOWING VARIABLES WILL BE USED 
A. SEXY 
(Using 957 obs; 2 have missing values in key or use variables) 
-REGRESSION TERMS (PRI- 
%GM b. OCPATHG 
[Using 957 observations; 2 have missing values] 
-RESULTS [PRI- 
OUTCOME- C3MO1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -1.841 (. 98SE-01) <. 001 . 1587 
OCPATHG-11' . 5014 f. 1741 . 004 1.651 
OCPATHG-12' . 4461 (. 207) . 032 1.562 
DEVIANCE ON 954 DF - 594.111 
-RESULTS i E'Rj- 
OUTC(*4E- C3MOl 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 158'7 . 1308 . 1925 
OCPATHG-'l' 1.651 1.175 2.320 
OCPATHG-'2' 1.562 1.040 2.346 
Extend model to include all other variables (excluding those 
with missing values) : 
REGRESSION TERMS (PRI- 
a. %GM b. OCPATHG c. REGION 
d. TYPE e. SIZE SEXY 
g. AGE2G 
RESULTS - (PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE: 
REGION-121 -. 4367 1.825 1 . 177 REGION=13' . 2976 1.092 1 . 296 REGION-141 . 5446 2.405 1 . 121 REGION-151 . 4645 1.012 1 . 314 REGION-'6' -. 2574 . 4227 1 . 516 REGION-171 1.013 9.415 1 . 002 REGION-181 -. 3801 1.282 1 . 258 REGION-191 -. 3877E-01 . 1876E-01 1 . 891 REGION-110' -. 1583 . 1702 1 . 680 REGION-111' -. 1241 . 1327 1 . 716 REGION-'12' -. 9041E-01 . 1067 1 . 744 REGION-1131 . 4128E-01 . 1254E-01 1 . 911 REGION-1141 -. 4540 1.722 1 . 189 REGION=115' . 6588E-01 . 4584E-01 1 . 830 REGION-116' -. 4661 . 7815 1 . 377 REGION-'171 . 2024 . 5107 1 . 475 REGION-1181 -. 4346 2.083 1 . 149 REGION-119' . 3990 1.210 1 . 271 REGION 23.74 18 . 164 TYPE='2' . 3053 2.354 1 . 125 
TYPE-'3' -. 3146 4.162 1 . 041 TYPE 4.333 2 . 115 SIZE-12' . 2618E-01 . 1969E-01 1 . 888 SIZE-13' -. 5343E-01 . 1033 1 . 748 SIZE-'4' -. 1415 . 6600 1 . 417 SIZE 1.253 3 . 740 SEXY-12* -. 1087E-01 . 5054E-02 1 . 943 AGE2G-'2' . 1304 . 7547 1 . 385 
OVERALL SCORETEST ON 25 DF - 27.305, p- . 341 
End stepwise 
Final Model -1- : 
-RESULTS i[PRI- 
OUTCOME- C3MO1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -1.841* (. 985E-01) <. 001 . 1587 OCPATHG-11' . 5014 (. 174) . 004, 1.651 
OCPATHG-12' . 4461 (. 207) . 032 1.562 
DEVIANCE ON 954 DF - 594.111 
-RESULTS (PRI- 
OUTCOME- C3MOl 
TERM RATE PATIO 95% CONFIDENCE BOUNDS 
%GM . 1587 . 1308 . 1925 
OCPATHG-111 1.651 1.1*75 2.320 
OCPATHG-12' 1.562 1.040 2.346 
testing for interactions between ocular pathology, age and sex 
REGRESSION TERMS (PRI - 
a. %GM b. OCPATHG C. OCPATHG. SEXY 
d. OCPATHG. AGE. ZG 
RESULTS [FRI 
OUTCOME- C 3MOl 
TERM COEFFICIENT STD ERROR P-VALUIE RATE RATIO 
SGM -1.841 (. 985E-01) <. 001 . 1587 
OCPATHG-111 . 7397 (. 2841 . 009 2.095 
OCPATHG-121 . 3558 (. 392) . 364 1.427 
OCPATHG-III . SEXY=12' -. 
2432 (. 298) . 415 . 7841 
OCPATHG=12' . SEXY=12' . 
9051E-01 (. 379) . 811 1.095 
OCPATHG-Ill . AGE2G-'21 -. 1379 (. 294) . 639 . 8712 
OCPATHG=12' . AGE2G-121 . 
5414E-01 (. 379) . 886 1.056 
DEVIANCE ON 950 DF - 592.990 
LIKELIHOO D RATIO STATISTIC ON 4 DF - 1.120, p- . 891 
ýRESULTS 
OUTCOME- C 3M0l 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
IGM . 1587 . 1308 . 1925 
OCPATHG='l' 2.095 1.202 3.653 
OCPATHG-121 1.427 . 6616 3.079 
OCPATHG-III . SEXY-121 . 
7841 . 4370 1.407 
OCPATHG-'21 . SEXY-121 
1.095 . 5207 2.302 
OCPATHG-Ill . AGE2G-'2' . 
8712 . 4899 1.549 
OCPATHG-12* . AGE2G-121 
1.056 . 5021 2.220 
Restricted Model - to include all variables of interest, but 
using only all known values : 
NO OBSERVATIONS WITH MISSING VALUES IN 
ANY OF THE FOLLOWING VARIABLES WILL BE USED 
A. SEXY B. ADMTYPE C. AN01 D. Surgeon 
(Using 669 obs; 90 have missing values in key or use variables) 
REGRESSION TERMS [PRI- 
SGM b. OCPATHG 
[Using 869 observations; 90 have missing values) 
-RESULT -(PRj- 
OUTCOME- C3MO1 
TERM COEFFICIENT STD ERR OR P-VALUE RATE RATIO 
IGM -1.875 (. 105) <. 001 . 1533 
OCPATHG-'l' . 5448 (. 181) . 003 1.724 
OCPATHG='2' . 5253 (. 216) . 015 1.691 
DEVIANCE ON 866 DF - 535.533 
-RESULTS 
OUTCOME- C3MOl 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 1533 . 1247 . 1885 
OCPATHG-11' 1 . 72 4 1.209 2.460 
OCPATHG-12' 1.691 1.106 2.584 
Extending the model to include the other variables of interest : 
a. %GM 
d. TYPE 
g. AGE2G 
Surgeon 
REGRESSION TERMS 
b. OCPATHG c. REGION 
e. SIZE f. SEXY 
h. ADMTYPE i. AN01 
(PRI- 
RESULTS -[PRI- 
EXTENSION PARAMETER/TERM BETA STEP SCORETEST DF P-VALUE 
REGION-'2' -. 3277 . 8774 1 . 349 
REGION-'3' . 7204E-01 . 5425E-01 1 . 816 
REGION-'4' . 5016 1.926 1 . 165 
REGION-'S' . 3592 . 5579 1 . 455 
REGION-'6' -. 1467 . 1206 1 . "7 28 
REGION=171 1.028 8.612 1 . 003' 
REGION-'8' -. 5705 2.669 1 . 102 
REGION=*9' -. 9327E-01 . 9700E-01 1 . 755 
REGION-'10' -. 5341E-01 . 1732E-01 1 . 895 
REGION=111' -. 1733 . 2384 1 . 625 
REGION-1121 -. 9651E-01 . 1126 1 . 737 
REGION=113' . 2178 . 3004 1 . 584 
REGION-'14' -. 4266 1.447 1 . 229 
REGION='15' . 5925E-02 . 3565E-03 1 . 985 
REGION='16' -. 4578 . 7401 1 . 390 
REGION=1171 . 2123 . 4891 1 . 484 
REGION-'18' -. 3441 1.145 1 . 285 
REGION-119' . 4190 1.313 1 . 252 
REGION 19.74 18 . 348 
TYPE=12' . 3891 3.513 1 . 061 
TYPE-'3' -. 3345 4.271 1 . 039 
TYPE 4.932 2 . 085 
SIZE-'2' . 574SE-02 . 8387E-03 1 . 977 
SIZE-'3' -. 8929E-01 . 2597 1 . 610 
SIZE=14' -. 1170 . 4071 1 . 523 
SIZE 1.319 3 . 725 
SEXY-12' . 1732E-02 . 1158E-03 1 . 991 
AGE2G-12' . 1988 1.577 1 . 209 
ADMTYPE-'2' . 3047 . 8159 1 . 366 
AN01-'l' -. 1824E-01 . 1329E-01 1 . 908 
Surgeon-121 . 1094 . 1755 1 . 675 
Surgeon-'3' -. 9556E-01 . 2193 1 . 640 
Surgeon-141 -. 2303 . 6158 1 . 433 
Surgeon-'5' -. 3040E-01 . 9613E-02 1 . 922 
Surgeon 1.054 4 . 902 
OVERALL SCORETEST ON 31 DF 28.303, p- . 605 
End stepwise 
Final Restricted Model 2- : 
-RESULTS -[PRI- 
OUTCOME= C3MOl 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -1.875 (. 105) <. 001 . 1533 
OCPATHG='l' . 5448 (. 181) . 003 1.124 
OCPATHG-'2' . 5253 (. 216) . 015 1.691 
DEVIANCE ON 866 DF 535.533 
RESULTS -[PRI- 
OUTCOME= C3MO1 
TERM RATE RATIO 95% CONFIDENCE BOUNDS 
IGM . 1533 . 1247 . 1885 
OCPATHG-'I* 1.724 1.209 2.460 
OCPATIIG-'2' 1.691 1.106 2.584 
Adding age, sex, and surgeon to final restricted model -2- : 
a. %GM 
d. AGE2G 
REGRESSION 
b. OCPATHG 
e. Surgeon 
TERMS 
c. SEXY 
(PRI- 
-RESULTS (PRI- 
OUTCOME- C3MO1 
TERM COEFFICIENT STD ERROR P-VALUE RATE RATIO 
%GM -1.934 (. 174) <. 001 . 1446 
OCPATHG-*l' . 5244 (. 183) . 004 1.689 
OCPATHG-12' . 4956 (. 219) . 023 1.641 
SEXY-121 -. 22BOE-01 (. 163) . 889 . 9775 
AGE2G-12' . 2100 (. 163) . 197 1.234 
Surgeon=121 . 5593E-01 (. 257) . 828 1.058 
Surgeon='3' -. 1206 (. 217) . 579 . 8864 
Surgeon-'4' -. 2848 (. 333) . 393 . 7522 
Surgeon='5' -. 7714E-01 J. 320) . 810 . 9258 
DEVIANCE ON 660 DF - 532.750 
LIKELIHOOD RATIO STATISTIC ON 6 DF - 2.783, p . 836 
-RESULTS [PRI- 
OUTCOME- C3M01 
TERM PLATE RATIO 95% CONFIDENCE BOUNDS 
%GM . 1446 . 1028 . 2034 
OCPATHG='l' 1.689 1.179 2.420 
OCPATHG=*2' 1.641 1.070 2.519 
SEXY-'2' . 9715 . 7100 1.346 
AGE2G='2' 1.234 . 6965 1.698 
Surgeon-121 1.058 . 6387 1.751 
Surgeon=131 . 8864 . 5788 1.357 
Surgeon-141 . 7522 . 3914 1.446 
Surgeon='5' . 9258 . 4941 1.735 
Maximum number of reals used in dynamic memory: 26881 out of 40000 
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THE COLLEGE OF OPHTHALMOLOGISTS 
and 
THE WELLHOUSE TRUST 
THE CATARACT OUTCOME STUDY 
This study is being conducted in the hospital that you are having your cataract 
operation. It is being conducted with the College of Ophthalmologists and has 
the support of the Department of Health and your Eye Consultant. 
The study is trying to reach a better understanding of the problems people with 
cataracts experience in carrying out their daily activities and how the operation 
changes this. We already have a lot of information on how surgery effects the 
eye, but there is a great need to advance our knowledge of the patient's 
experience of the process. 
Participation is totally voluntary. It will involve 3 interviews of about 45-60 
minutes each. The first will be conducted before your operation, the second at 
four months afterwards and the third interview will be conducted one year after 
the operation. If you have an operation on the second eye you may be asked 
to continue your participation in the study and have two further interviews. 
These interviews will take place in the hospital and will be conducted by a 
trained interviewer who is a part of the investigating team. 
In the interview we will ask you questions about your vision, your general 
health, your everyday activities and how they are affected by your cataract, as 
well as the care you are receiving for your cataract. You may of course leave 
out an answer to any of the questions or even leave the study itself and it will 
not affect the timing of your operation or the post-operative follow-up in any 
way at all. 
P. T. O. 
Your answers will be confidential and will not be seen by your doctor or 
anyone else involved in your medical care. The information collected will go 
to the College of Ophthalmologists where only the study investigators will have 
access to it. At the end of the study, your name will be removed from all the 
interviews. 
We hope that this study will give us a better understanding of how we are 
caring for our cataract patients and how we can improve on it. 
If you would like to take part in the study, we would hope to interview you 
when you come in to the hospital for your pre-operative assessment. However 
if you particularly want to be interviewed at your home then we would do our 
best to arrange this for you. 
A member of the Cataract Outcome Study Team will contact you by telephone 
within 2 days of the time we would have expected you to have received this 
letter to ask you if you would like to take part in this study. 
We hope that you will consider taking part in this study. If you have any 
questions about it you may contact: 
Don Fraser 
The Cataract Outcomes Project Worker 
Eye Department 
Edgware General Hospital 
Burnt Oak Broadway 
Middlesex HA8 OAD 
Tel : 081 - 200 - 1555 extension 3592 or 3419. 
Appendix B2 
Clinical data collection booklet 
274, 
Patient ID 
Fs---TTZ T31E? 
THE CATARACT OUTCOME STUDY 
k 
THE WELLHOUSE TRUST 
CLINICAL DATA FORMS 
Patient Name: 
Hospital Number: 
Consultant: 
College of Ophthalmologists 
Patient ID 
15 1A1 
-3 
1&I 
Cataract Outcome Study 
BASELINE 
CLINICAL DATA FORM 
Patient Name: 
Patient Hospital No: 
Consultant: 
Hospital: 
This form is to be used to provide preoperative clinical data about the patient named above who is 
scheduled for cataract surgery. It should be completed during the admission episode. 
Please answer all questions on the form. If you do not know the answer to a particular question 
please write in "W" 
When the form is completed; please return to Ms P. Courtney 
College of Ophthalmologists 
17 Cornwall Terrace 
Regents Park 
London NWI 4QW 
College of Ophthalmologists 
Patient ID 
15 1 ;,. ), 13.1 
Cataract Outcome Study 
Baseline Clinical Data Form - Page I of 4 
PERSONAL DATA 
Sex: m EJ F El Date of Birth: 
Ethnic Group: (Please circle) 
/19 
I Caucasian 
2 Asian 
3 Afro-Caribbean 
4 Oriental 
5 Other 
6 Not recorded 
PRE-OPERATIVE (Please circle) Day Month Year 
Referral source: I= GP Date of referral letter: /19 
2= OMP/Optician directly Date first OPD appt: /19 
3= OMP/Optician via GP Date listed for surgery: /19 
4= Other Date admission for surgery: /19 
5= Not known 
Type of admission: El In-patient El Day case Eye order: 01st [12nd 
OPHTHALMIC HISTORY 
Does the patient have any eye disease other than cataract? El YES 0 NO (GO TO Q2) 
IF YES: Does the patient have any of the following? (Please tick YES or NO for each item) 
YES NO YES NO 
11 El Amblyopia El 1: 1 Previous retinal detachment 
11 El Chronic external disease (e. g.; blepharoconjuncfivitis) 
11 El Diabetic retinopathy (any degree) 
El El Dry eye syndrome El 11 Diabetic retinopathy with past laser treatment 
[1 0 'Fuchs' Dystrophy El El Glaucoma or ocular hypertension (any degree) 
El 0 Chronic uveitis or keratilis El El Glaucoma with central field loss or previous 
laser or filtration surgery 
El 0 Visually impairing age-related macular El El Other optic nerve disease 
degeneration (Age Related Maculopathy) 11 11 History of prior intraocular surgery 
2. MEDICAL HISTORY AT BASELINE 
Does the patient have any known medical conditions? 11 YES [I NO (GO TO Q3) 
IF YES: Does the patient have any of the following? (Please tick YES or NO for each item) 
YES NO YES NO 
El El Typed diabetes Ouvenile or ketoacidosis prone) 11 Cl Chronic renal disease 
F-1 0 Type-11 diabetes (adult; not ketoaciclosis prone) El 11 Neoplasm 
El C3 Hypertension El El Chronic steroid therapy 
11 El Angina El C3 Inflammatory bowel disease 
El El Past myocardial infarction 11 El Rheumatoid or collagen vascular disease 
0 11 Past stroke 11 Deafness 
0 El Asthma; COPD; or bronchitis Altered mental status 
3. BEST CORRECTED VISUAL ACUITY 
(Choices: 6/6,6/9,6112,6/18,6124,6/36,6/60,3/60; CF, HM; PL; NPL) 
At Ist OPD appointment: 
Date listed for surgery: 
Date of pre-op assessment / or admission: 
4. REF RACTION RIGHTEYE 
CIRCLE SPHERE CYL AXIS 
LEFT EYE +/- 
CIRCLE SPHERE CYL AXIS 
El Not Known 
College of Ophthalmologists 
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F-77 II 
Cataract outcome Study 
Baseline Clinical Data Form - Page 2 of 4 
5. KERATOMETRY IN DIOPTERS (in operated eye) 
6. AXIAL LENGTH (in operated eye) 
7. INTRAOCULAR PRESSURE (applanation) 
8. PUPILS 
RIGHT LEFT 1_1_1mm 
RIGHT LEFT 
El El Normally reactive 
11 0 Afferent defect 
El 1: 1 Cannot assess 
9. CONJUNCTIVA; CORNEA; AND SCLERA (Tick one for each eye) 
RIGHT LEFT 
11 El Normal 
11 11 Abnormal (if abnormart--ý RIGHT 
El 11 Cannot assess 
El 
11 
10. ANTERIOR CHAMBER FINDINGS (Tick one for each eye) 
LEFT (Tick all that apply) 
El Prior filtering surgery 
El Gulatta (exceeding expected for age) 
13 Oedema 
El Corneal scar reducing vision 
Graft 
Other corneal pathology_ 
RIGHT LEFT 
El D Normal 
El Cl Abnormal (if abnorniarý-ýý RIGHT LEFT (Tick all that apply) 
0 El Cannot assess El El Active uveitis or iridocyclitis 
D El Posterior synechiae 
D D Vitreous in AC 
D El Other AC findings 
]I. LENS (Tick one for each eye) 
RIGHT LEFT 
[1 0 Normal 
D El Nuclear cataract 
11 El Cortical cataract 
11 13 Posterior subcapsular cataract 
11 C1 Mixed Cataract 
11 D Other abnormality (indicate) RIGHT LEFT (Tick all that apply) 
Cannot assess EJ El Hypermature cataract 
El El Congenital cataract 
El El Secondary cataract 
Lens dislocation or subluxation 
12. OPTIC NERVE (Tick one for each eye) 
RIGHT LEFT 
11 El Normal 
Abnormal (if abnorma4 ------- RIGHT LEFT (Tick all that apply) 
Cannot assess El 11 Glaucomatous atrophy (cupping) 
11 El Non-glaucomatous atrophy 
El El Other optic nerve findings 
College of Ophthalmologists 
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Baseline Clinical Data Form - Page 3 of 4 
13. MACULA (Tick one for each eye) 
RIGHT LEFT 
D Normal 
El Abnormal (if abnormalý----) RIGHT LEFT (Tick all that apply) 
El Cannot assess El El Scattered drusen 
El 1: 1 Confluent drusen 
11 El Nongeographic (mottled) 
1: 1 El Geographic atrophy 
11 11 Neovascular change or membrane 
1: 1 El Disciform scar or hemorrhage 
11 El Macular oedema 
F-1 11 Macular hole/cyst 
EJ 11 Other macular or RPE pathology 
14 RETINA (Tick one for each eye) 
RIGHT LEFT 
El El Normal 
[I [I Abnormal (if abnorma4-ýý RIGHT LEFT (Tick all that apply) 
El El Cannot assess El El Retinal detachment 
11 11 Background diabetic retinopathy 
El El Pre-proliferative retinopathy 
El El Proliferative diabetic retinopathy 
El El Panretinal photocoagulation (previous) 
El 11 Vitreous haemorrhage 
El El Branch retinal artery occlusion 
11 1: 1 Central retinal artery occlusion 
11 El Branch retinal vein occlusion 
El 1: 1 Central retinal vein occlusion 
El El Retinal degen. (myopic; lattice; etc. ) 
El El Other retinal pathology 
15. EYE SCHEDULED FOR CATARACT SURGERY FIRST (Tick one) 11 RIGHT EJ LEFT 
16. TYPE OF SURGERY PLANNED (Tick one) 
0 Extracapsular (manual expression of nucleus) El Extracapsular (phacoemulsification) 
0 Intracapsular El Other 
17. IOL PLANNED (Tick one) 
[I Posterior chamber standard El Other 
El Posterior chamber foldable 13 None 
El Anterior chamber 
18. RISK ASSE SSMENT 
Is there increased risk in this patient of: (Please tick YES or NO for each condition) 
YES NO YES NO 
Ej El Chronic inflammation El Cystoid macular oedema 
1: 1 0 Haemorrhage or hyphaema 11 Transient IOP increase 
El El Zonular or capsular rupture El Transient hypotony 
D El Vitreous loss or vitrectomy El EJ Sustained glaucoma 
El 11 Retinal break/retinal detachment El EJ Sustained hypotony 
El 0 Corneal oedema 11 11 Other 
IF YES TO ANY OF THE ABOVE; EXPLAIN BELOW: 
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Patient ID 
1-7-T I 
Cataract Outcome Study 
Baseline Clinical Data form - Page 4 of 4 
19. EXPECTED POSTOPERATIVE ACUITY IN OPERATED EYE (Tick oiie) 
El 6/6 - 6/12 
El 6/18 - 6/24 
El 6/36 - 6/60 
El 3/60 or worse 
IF 6/12 OR WORSE; EXPLAIN BELOW: 
20. GRADE OF SURGEON MAKING PRE-OP ASSESSMENT: 
(Consultant, SR, Reg, SHO, Other) 
21. DATE OF PRE-OPERATIVE ASSESSMENT / l') 
DAY MONTH YlAR 
22. DATE LAST SEEN IN OPD CLINIC / 19 
DAY MONTH YEAR 
THANK YOU FOR COMPLETING THIS FORM 
College of Ophthalmologists 
Patient ID 
51e; k_ III 
Thank you for completing this form 
Cataract Outcome Study 
PERIOPERATIVE 
CLINICAL DATA FORM 
Patient Name: 
Patient Hospital No: 
Consultant: 
Hospital: 
This form should be completed during the patients' admission episode, meferably within 48 hours 
following surgery. 
Please answer all questions on the form. If you do not know the answer to a particular 
question please write in "DK" 
When completed; please return to: Ms P. Courtney 
College of Ophthalmologists 
17 Cornwall Terrace 
Regents Park 
London NWI 4QW 
College of Ophthalmologists 
Patient ID 
Cataract Outcome Study 
Perioperative Clinical Data Form - Page I of 2 
SURGICAL APPROACH 
OPERATED EYE (DATE OF SURGERY: El RIGHT El LEFT 
DAY MONTH YEAR 
2. TYPE OF CATARACT EXTRACTION (Tick one) 
Extracapsular (manual expression of nucleus) Extracapsular (phacoemulsification) 
Converted (Phacoemulsification converted to Intracapsular 
standard extracapsular technique) 
3. TYPE OF ANAESTHESIA (Tick one) 
1: 1 General 
El Retrobulbar block 
D Peribulbar block 
If retrobulbar or peribulbar: (Tick one in each box) 
(Tick one) 
11 Patient monitored by anaesthetist 
El Patient monitored by someone else (Specify) 
(Tick one) 
11 Block administered by surgeon 
EJ Block administered by anaesthetist 
1: 1 Block administered by someone else (Specify) 
4. GRADE OF SURGEON PERFORMING SURGERY: 
(Consultant, SR, Reg, SHO, Other) 
5. INCISION LENGTH El Small Standard Long 
6. TYPE OF CAPSULOTOMY (Tick one) 
Can opener with cystotome/needle 
Scissors capsulotomy 
D Continuous tear capsulotomy 
7. INTRAOCULAR LENS (Tick one) 
Standard posterior chamber in bag 
Standard posterior chamber in sulcus 
Foldable posterior chamber 
Anterior chamber 
Planned suturing of posterior chamber lens 
El Unplanned suturing of posterior chamber lens 
JOL planned but not implanted 
No IOL planned 
El Multifocal 
8. TYPE OF IRIDECTOMY (Tick one) 
El Peripheral iriclotomy Sector 
0 Peripheral iridectomy None 
9. INTRAOPERATIVE POSTERIOR CAPSULOTOMY? (Tick one) 
11 Yes 11 No 
5a. INCISION SITE 
El Corneal 
0 Scleral 
El Limbal 
College of Ophthalmolo ists 
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Perioperative Clinical Data Form - Page 2 of 2 
INTRACIPERATIVE AND POSTOPERATIVE COURSE 
10. INTRAOPERATIVE EVENTS 
Did the patient have any of the following? (Please tick YES or NO for each item) 
YES NO YES NO 
11 11 Globe perforation during anaesthesia El El Posterior capsular or zonular rupture 
El El Retrobulbar haemorrhage 11 El Vitreous loss/anterior vilrectomy or aspiration 
D 11 Other anaesthesia related complication El 0 Loss of nuclear fragment into vitreous 
El El Anterior chamber hemorrhage 11 El Loss of IOL into vitreous 
El El Iricloclialysis; cycloclialysis or iris trauma El 11 Choroidal haemorrhage 
El 11 Persistent iris prolapse 11 El Asymetric lens placement 
11 11 Incomplete cortical clean up El El Abnormality in wound closure 
El 11 Residual posterior capsule opacity 
11. POSTOPERATIVE EVENTS (Within 48 hours following surgery) 
Does the patient have any of the following? (Please Tick YFS or NO for each item) 
YES NO YES NO 
Endophthalmilis Ej D Cystoid macular oedema 
Wound Leak or rupture D 0 Retinal detachment 
El 0 Hyphaema El 0 Retinal tear or break (no detachment) 
11 El Posterior capsule opacification Inlraocular pressure greater than 30 mm Hg; 
11 El IOL dislocation pupillary block 
Retained lens material 11 D Intraocular pressure greater than 30 mm Hg; 
Inflammation greater than expected non pupilary block 
Iris abnormalities (atrophy; etc. ) El 0 Optic neuropathy 
Corneal oedema El 0 Other complication (Specify) 
12. IS SURGERY PLANNED FOR SECOND EYE? 
0 No El Yes. DATE if known --/--/19- 
El Yes. date unknown 
13. DATE OF SURGERY /19 
DAY MONTH YEAR 
IMPORTANT: IF CATARACT SURGERY IS SCHEDULED FOR 
THE SECOND EYE WITHIN 4 MONTHS OF THE FIRST 
SURGERY, PLEASE NOTIFY THE INTERVIEWER ASSIGNED TO 
YOUR HOSPITAL. 
Thank you for completing this form 
College of Ophthalmologists 
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Cataract Outcome Study 
4-MONTH FOLLOW UP 
CLINICAL DATA FORM 
Patient Name: 
Patient Hospital No: 
Consultant: 
Hospital: 
This form should be completed not later than 3 to 4 months after surgery. 
Please answer all questions on the form. If you do not know the answer to a particular question 
please write in 'DK. " 
When the form is completed; please return to Ms P. Courtney 
College of Ophthalmologists 
17 Cornwall Terrace 
Regents Park 
London NWI 4QW 
College of Ophthalmologists 
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4 Months Follow Up Clinical Data Form - Page 1 
;f2 
OUTCOME OF CATARACT SURGERY 
Day 0- Day 120 (First 4 Months) 
I. POSTOPERATIVE EVENTS (Tick YES or NO) 
IF YES: Give date 
YES NO DAY MONTH YEAR YES NO DAY MONTH YEAR 
El El Endophthalmilis El 0 Cystoid macular oedema 
El El Wound Leak or rupture El D Posterior vitreous detachment 
El El Hyphaema 11 El Posterior capsule opacification 
El El Retinal detachment El El Retinal scar or break 
El 0 IOL dislocation (no detachment) 
El El IOL removed or exchange El 11 Intraocular pressure 
0 El Retained lens material greater than 30 mmHg 
El El Inflammation greater El El Optic neuropathy 
than expected El El Other complication (Specify) 
El El Iris abnormalities 
(synechiae; etc) 
El El Corneal oedema greater 
than expected peripherally 
D El Corneal oedema greater 
than expected centrally 
2. SUTURES CUT? 
El Yes Number of visits at which suture(s) were cut: 
EJ No 
POSTERIOR CAPSULOTOMY PERFORMED? 
Yes (DATE: If yes: (Tick one) 
DAY MONTH YEAR Nd: YAG 
No Needle/knife 
4. CATARACT SURGERY PLANNED IN SECOND EYE? 
El No 
El Yes; planned for (DATE: Yes; planned for date unknown 
EJ Already performed (DATE: 
5. BEST CORRECTED DISTANCE ACUITY (SNELLEN) RIGHT6/1-1_1 LEFr6/1-1-1 
(Choices: 6/6,6/9,6112,6118,6124,6/36,6/60,3/60; CF; HM; PL; NPL) 
6. REFRACTION (in operated eye) +/- 
CIRCLE SPHERE CYL AXIS 
0 Not Known 
7. INTRAOCULAR PRESSURE (applanation) RIGHT 1_1_lmm LEFr 1_1_lrnm 
8. KERATOMETRY IN DIOPTERS (in operated eye)1-1-1.1-ID 
0 Not Known 
9. CORNEAL EXAMINATION (in operated eye) (Tick all that app/y) 
El Normal with secure wound and sutures 
El Wound gape / leak 
El Corneal oedema peripherally 
El Corneal oedema centrally 
D Broken sutures or protruding ends 
F-I Descemet's folds 
El Descemet's tear or detachment 
0 Other anormality: 
College of Ophthalmolo ists 
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4 Months Follow Up Clinical Data Form - Page 2 
7f 2 
10 IRIS AND PUPIL (In operated eye) (Tick all that apply) 
Normal with no iriclectomy 
Normal with surgical iridectomy 
Non reactive pupil 
Ectatic or peaked pupil 
EJ Iris atrophy (including phaco induced) 
II 
11 Posterior synechia to capsule or IOL 
El Anterior synechia 
1: 1 Afferent pupillary defect 
D Other abnormality: 
ANTERIOR CHAMBER FINDINGS (in operated eye) (Tick all that apply) 
Normal 
Inflammation (cell and flare) 
Hypopyon 
12 LENS (In operated eye) (Tick all that apply) 
0 Normally centered intraocular lens 
Edge of optic or dialling hole visible in undilated state 
Pupillary capture of IOL 
Posterior displacement of PC IOL optic or haptir 
13 OPTIC NERVE (in operated eye) (Tick all that apply) 
11 Normal 
0 Optic atrophy 
El Optic nerve haemorrhage 
14. MACULA (In operated eye) (Tick all that appty) 
Normal 
Angiographic cystoid oedema 
El Clinically significant cystoid oedema 
15. 
16. 
RETINA (Tick all that apply) 
El Normal 
El Retinal Detachment 
El Retinal tear (non-detached) 
VISUAL ACUITY in eye that had surgery 
Is vision worse than 6/12 ? 
IF YES: What is the MAIN cause?: 
El Residual lens cortex 
E3 Hyphaema 
El Other abnormality 
Posterior displacement of anterior chamber IOL 
or haplic 
Residual lens cortex 
E3 Other abnormality 
0 Glaucomalous atrophy 
El Other abnormality- 
El Age Related Maculopathy 
C1 Mdcular cyst or hole 
El Other abnormality 
El Retinal vascular occlusion 
11 Other abnormality 
OYES ONO (GOTOQ. 17) 
El Age Related Maculopathy 0 Lens clecentration or dislocation 
F-I Cystoid macular oedema 0 Astigmatism 
Posterior capsule opacification El Other (Describe) 
Corneal oedema 
17 
18 
19 
CHANGES IN FUNCTIONAL STATUS (Tick one) 
Improved functional status YES NO (Tick YES or NO for each) 
No change in functional status 11 El Improved activities of daily living 
Worsened functional status (Describe) F-1 Ll Improved reading ability 
E3 Improved driving ability 
C Improved mobility 
0 E3 Other improvements (Describe) 
FINAL REFRACrION PERFORMED El YES C NO 
13 At Hospital El By Local Optometrist 
GLASSES DISPENSED EJ YES (3 NO 
El At Hospital 0 By Local Optometrist 
20. DATE EXAMINED /19 
DAY MONTH YEAR 
Thank you for completing this form 
College of Ophthalmologists 
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Cataract Outcome Study 
12-MONTH FOLLOW UP 
CLINICAL DATA FORM 
Patient Name: 
Patient Hospital No: 
Consultant: 
Hospital: 
This form should be completed approximately 12 months after surgery. 
Please answer all questions on the form. If you do not know the answer to a particular question 
please write in "DK. " 
College of Ophthalmologists 
When the form is completed; please return to Ms P. Courtney 
College of Ophthalmologists 
17 Cornwall Terrace 
Regents Park 
London NWI 4QW 
Patient ID 
Fs-77 3 17 
Cataract Outcome Study 
12-Month Follow Up Clinical Data Form - Page 1 of 2 
OUTCOME OF CATARACT SURGERY 
Day 120 - Day 360 (4 Months to 12 Months) 
I. POSTOPERATIVE EVENTS (Tick YES or NO) 
IF YES: Give date 
YES NO DAY MONTH YEAR YES NO DAY MONTH YEAR 
El El Enclophthalmitis El El Cystoid macular oedema 
11 El Wound Leak or rupture El El Posterior vitreous detachment 
El El Hyphaema 1-1-1 EJ 1: 1 Posterior capsule opacification 
0 El Retinal detachment El El Retinal scar or break 
El El IOL dislocation (no detachment) 
D El IOL removed or exchange El El Intraocular pressure 
El El Retained lens material greater than 30 mmHg 
1: 1 El Inflammation greater El El Optic neuropathy 
than expected El El Other complication (Specify) 
El El iris abnormalities 
(synechiae; etc) 
El El Corneal oedema greater 
than expected peripherally 
El 0 Corneal oedema greater 
than expected centrally 
2. SUTU RES CUT SINCE COMPLETIO N OF 4-MONTH FOLLOW UP FORM? 
El Yes Number of visits at which suture(s) were cut: 
[I No 
3. POSTERIOR CAPSULOTOMY PERFORMED? 
0 Yes (DATE: If yes: (Tick one) 
DAY MONTH YEAR [I Nd: YAG 
No El Needle/knife 
4. CATARACT SURGERY PLANNED IN SECOND EYE? 
0 No 
El Yes; planned for (DATE: Yes; planned for date unknown El 
El Already performed (DATE: 
5. BEST CORRECTED DISTANCE ACUITY (SNELLEN) RIGHT6/1_1_1 LEFr 6/1-1-1 
(Choices: 6/6,6/9,6112,6/18,6124,6/36,6/60,3/60; CF; HM, PL; NPL) 
6. REFRACTION (in operated eye) +/- 
CIRCLE SPHERE CYL AXIS 
El Not Known 
7. INTRAOCULAR PRESSURE (applanation) RIGHT 1_1_lmm LEFr 1_1_lmm 
8. KERATOMETRY IN DIOPTERS (in operated eye) Da 
0 NotKnown 
9. CORNEAL EXAMINATION (in operated eye) (Tick all that apply) 
0 Normal with secure wound and sutures 
El Wound gape / leak 
0 Corneal oedema peripherally 
El Corneal oedema centrally 
El Broken sutures or protruding ends 
0 Descemet's folds 
El Descemet's tear or detachment 
El Other anormality: 
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10. IRIS AND PUPIL (In operated eye) (Tick all that apply) 
El Normal with no iridectomy D Posterior synechia to capsule or IOL 
Normal with surgical iridectomy 0 Anterior synechia 
Non reactive pupil 0 Afferent pupillary defect 
Ectatic or peaked pupil 0 Other abnormality: 
El Iris atrophy (including phaco induced) 
11. ANTERIOR CHAMBER FINDINGS (In operated eye) (Tick all that apply) 
Normal 11 Residual lens cortex 
inflammation (cell and flare) El Hyphaema 
El Hypopyon 0 Other abnormalit 
12. LENS (In operated eye) (Tick all that apply) 
Normally centered intraocular lens Posterior displacement of anterior chamber IOL 
or haptic 
0 Edge of optic or dialling hole visible in undilated sta te Residual lens cortex 
0 Pupillary capture of IOL Other abnormality 
El Posterior displacement of PC IOL optic or haptic 
13. OPTIC NERVE (in operated eye) (Tick all that apply) 
Ej Normal El Glaucomatous atrophy 
El Optic atrophy El Other abnormality 
El Optic nerve haemorrhage 
14. MACULA (In operated eye) (Tick all that apply) 
El Normal Age Related Maculopathy 
El Angiographic cystoid oedema El Macular cyst or hole 
0 Clinically significant cystoid oedema El Other abnormality 
15. RETINA (Tick all that apply) 
El Normal El Retinal vascular occlusion 
El Retinal Detachment El Other abnormality 
El Retinal tear (non-detached) 
16. VISUAL ACUITY in eye that had surgery 
Is vision worse than 6/12 ? DY ES El NO (GO TO Q. 17) 
IF YES: What is the MAIN cause?: 
1: 1 Age Related Maculopathy 0 Lens clecentration or dislocation 
0 Cystoid macular oedema 0 Astigmatism 
El Posterior capsule opacification 0 Other (Describe) 
El Corneal oedema 
17. CHANGES IN FUNCTIONAL STATUS (Tick one) 
EJ Improved functional status YES NO (Tick YES or NO for each) 
El No change in functional status El 0 Improved activities of daily living 
Worsened functional status (Describe) 0 1: 1 Improved reading ability 
El El Improved driving ability 
El El Improved mobility 
11 0 Other improvements (Describe) 
18. FINAL REFRACTION PERFORMED F-1 YES ONO 
El At Hospital 0 By Local Optometrist 
19. GLASSES DISPENSED El YES El NO 
0 At Hospital El By Local Optometrist 
20. DATE EXAMINED /19 
DAY MONTH YEAR 
College of Ophthalmologists 
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THE CATARACT OUTCOME STUDY 
THE WELLHOUSE TRUST 
BASELINE PATIENT INTERVIEW 
To be completed before the patient has had surgery. 
Patient Name: 
Hospital Number 
Consultant: 
Date of Interview: 
Interviewer: 
Patient ID 
THE CATARACT OUTCOME STUDY 
BASELINE PATIENT INTERVIEW 
Introduction to Patient 
Hello, my name is .I am one of the Cataract Outcome Study 
team members from the College of Ophthalmologists. You may or may not have received 
some information about this study. 
The study is being conducted at this hospital with the College of Ophthalmologists and has 
the support-of the Department of Health and your eye consultant. -it is trying to reach a better understanding of the problems people with cataracts experience in carrying out their 
daily activities and how the operation changes this. We'already have a lot of information 
on how surgery effects the eye, but there is a great need to advance our knowledge of the 
patient's experience-of the process. 
Participation.. is voluntary. Each person who agrees to take -part 
in the study will be 
interviewed three times. First before the operation, and then again around 4 and 12 
months after the operation. 
In the first interview we would ask you questions about your vision, general health, 
everyday activities and how these are affected by your cataract. You may leave an answer 
to any of the questions or even leave the study itself at any time. 
The interview will take about 45-60 minutes and will be strictly confidential. Your answers 
will not be seen by your doctor or others who are involved in your medical care. The 
information provided will go to-the College of Ophthalmologists, where only the- study 
investigators will have access to it. 
We would also like to interview after the operation around 4 and 12 months after surgery, 
to find out what difference the * 
surgery has made in your ability to see and do your 
everyday activities, as well as how satisfied you are with the results of the operation. 
Would you like to be interviewed ? (For those who have not already indicated they want to 
take part) 
Yes 1 
No 2 Reason if any 
Before you start would please complete this consent form? Please feel free to ask any 
questions about the study before you sign it. 
[Ensure the patient is given an explanatory letter about the study]. 
THE COLLEGE OF OPHTHALMOLOGISTS 
THE CATARACT OUTCOME STUDY. 
CONSENT FORM FOR PATIENTS 
1, of 
give my consent to take part in the Cataract Outcome Study. I" 
The nature of my participation and the purpose of the study have been explained to me by: 
I have also received a letter with information about the study. 4 
Signed 
Witness 
Date 
Date 
2 
COGNITIVE SCALE 
IF PATIENT SEEMS TO BE CONFUSED, SEEMS UNABLEJO UNDERSTAND WHAT YOU HAVE 
SAID TO THEM IN THE INTRODUCTION, OR SEEMS MENTALLY UNABLE TO TAKE PART IN 
THE INTERVIEW, PLEASE ASK THE FOLLOWING QUESTIONS: 
First, I have a few general questions. 
CORRECT WRONG 
1. What is your full name? 2 
2. How old are you? 2 
3. When were you born? 2 
4. Where were you born? 2 
5. What is your mother's first name? 2 
6. What is your father's first name? 2 
7. Who is the Prime Minister? 2 
8. Who was the Prime Minister before this one? 2 
9. What year is this? 2 
10. What month is this? 1 2 
11. What day oi the month is this? (What is the date? ) 1 2 
12. What is the name of the city or town you are in? 1 2 
13. What day of the week is it? 1 2 
14. What time is it now? 1 2 
BOX 1 
IF PATIENT ANSWERS 4 OR MORE QUESTIONS INCORRECTLY, 
TERMINATE INTERVIEW: 
Thank you very much for your help. That is all the information we need. I hope your 
surgery goes well. 
OTHERWISE CONTINUE. 
3 
SECTION A: GENERAL QUESTIONS ABOUT VISION 
Al. I'd like to start again by asking you some questions about your vision How much trouble do 
you now have with your vision? Is it none, a little, a moderate amount, or a great deal? 
NONE I 
LITTLE 2 
MODERATE 3 
GREAT DEAL 4 
A2. How satisfied are you now with your vision? Are you: 
Very satisfied 1 
Satisfied 2 
Dissatisfied or 3 
Very dissatisfied? 4 
A3. Have you been told you have a cataract in your right eye, left eye or both eyes? 
RIGHT 1 
LEFT 2 
BOTH 3 
A4. Have you ever had surgery for a cataract? 
YES 1 (A4a) 
NO 2 (A5 
BOX2 
A4a. Which eye? 
RIGHT 1 
LEFT 2 
A4b. When? 
DATE /19 
TERMINATE INTERVIEW SINCE PATIENT HAS HAD CATARACT SURGERY. 
A5 For which eye is cataract surgery scheduled (first)? 
RIGHT 1 
LEFT 2 
A5a. On what date is your cataract surgery scheduled? 
DATE /19 
OR 
DONTKNOW 8 
4 
BOX 3 
CHECK. A3. IF CATARACT IN ONE EYE, SKIP TO A5f. OTHERWISE, 
CONTINUE. 
A5b IF CATARACr IN BOTH EYES: Do you think you will have the other cataract removed? 
YES 1 
NO 2 (ASe) 
DONT KNOW 3 (A5e) 
A5c. Do you know when you will have it removed? 
YES 1 
NO 2 (A5e) 
A5d. On what date is that surgery planned? 
DATE /19 
OR 
DONT KNOW 8 
A5e. Who first told you that you had a cataract in the eye you are having the operation on? 
Your G. P. I 
An eye doctor 2 
Optometrist 3 
Other 4 
Do not know 8 
A5f. How long ago was that? 
YEARS 
MONTHS 
BOX 4 
IF LESS THAN 6 MONTHS AGO, SKIP TO A7. 
IF 6 MONTHS OR MORE, CONTINUE. 
A6. Why did you wait to have the surgery? 
5 
A6a. What made you decide to have the surgery now? 
AT Sometimes people tell us that they are having their cataract surgery now'because 
they think something might happen if they waited any longer. Some people think that 
(READ CHOICES). Do you think that? (CIRCLE "YES" OR 'NO" BELOW) 
DONT 
YES NO KNOW 
a. Do you think the risks of surgery would be greater if you wait? 128 
b. Do you think the improvement in your vision due to surgery will be 
greater now than it would be if you delayed the surgery? 128 
C. You might become permanently blind if you delayed the surgery 128 
d. You thought you had to wait until your cataract was "ripe" 128 
e. The risks of surgery would be lower the longer you wait 128 
A8. Do you think anything else other than what we have mentioned would happen? 
YES 1 
NO 2 (A9) 
DONTKNOW 8 (A9) 
A8a. What do you think would happen? 
A9. Have you been on any other waiting list for your cataract operation? 
YES 1ý Where? 
NO 2 How long? 
A9a. How long have you waited for surgery at this hospital? 
A9b. How concerned were you about having to wait that time? 
not at all 1 
a little 2 
a moderate amount 3 
a great deal 4 
A9c. Can you tell me if there is anything in particular that worries you / bothers you about waiting? 
Al 0. Do you currently wear glasses or contact lenses? 
YES 1 (A l Oa) 
NO 2 (Al 1) 
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A10a. Do you wear them- for reading, to see things that are faraway, or both? (IF PATIENT SAYS 
"BIFOCAL", CIRCLE BOTH) 
READING 1 
FAR AWAY 2 
BOTH 3 
Al 1. During the past month have you been bothered by any of the following symptoms in your eye 
that is scheduled for cataract surgery? (CIRCLE BELOW) 
IF YES: ASK: 
A. Are you being treated for this problem? (CIRCLE BELOW) 
B. Do you think theit is more than a 50-50 chance that this will improve after your - 
cataract surgery? (CIRCLE BELOW) 
IF YES 
C. How much improvement do you expect after your cataract surgery? Do you expect 
a little, a moderate amount or a great deal of improvement? (CIRCLE BELOW) 
(A) (8) (C) 
EXPECT TO IF YES: 
BOTHERED TREATMENT IMPROVE IMPROVEMENT EXPECTED 
YES NO YES NO YES NO DK A LITTLE MODERATE GREAT DK 
AMOUNT DEAL 
Al 2. 
AM 
A14. 
A15. 
Red painful or 
tender eye 
Feeling as if 
something were 
in your eye 
Watery 
burning or 
itching eye 
Double vision or 
distorted vision 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
8 
8 
8 
8 
1 
1 
1 
1 
2 
2 
2 
2 
3 
3 
3 
3 
8 
8 
8 
a 
All 6. A drooping eyelid 1 2 1 2 1 2 8 -2 3 8 
All 7. Spots floating 1 2 1 2 1 2. 8 2 3 8 
before your eye 
Al 8. Glare halo or 1 2 1 2 1 2 a 2 3 8 
seeing rings 
around light 
A19. Blurry vision with 1 2 1 2 1 2 8 2 3 8 
your most recent 
glasses 
A20. Things seeming 1 2 1 2 1 2 8 2 3 8 
brighter than they 
used to in a way 
that is disturbing 
A2 1. Colours looking 1 2 1 2 1 2 8 1 2 3 8 
different than they 
used to in a way 
that is disturbing 
A22. A worsening of 1 2 1 2 1 2 8 1 2 3 8 
your vision in the 
past month in 
the eye having 
surgery 
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A23. Do you have any other eye problems, conditions, or symptoms? 
YES 1 
NO 2 (A24) 
A23a. What are these? (RECORD UP TO 3) 
2. 
3. 
A24. Do you currently drive a car? 
YES I (A28) 
NO 2 
A25. Have you ever driven a car? 
YES I 
NO 2 (A34) 
A26. When did you stop driving? 
LESS THAN 6 MONTHS AGO 1 
6-12 MONTHS AGO 2 
MORE THAN 12 MONTHS AGO 3 
A27. Why did you stop driving? 
VISION 1 (A30) 
OTHER ILLNESS 2 (A30) 
OTHER REASON 3 (A30) 
A28. How much difficulty do you have driving during the day because of your vision? Do you have: 
No difficulty, I 
A little difficulty, 2 
A moderate amount of difficulty, or 3 
A great deal of difficulty? 4 
A29. How much difficulty do you have driving at night because of your vision? - Do you have: 
No difficulty, I 
" little difficulty, 2 
" moderate amount of difficulty, or 3 
" great deal of difficultyi 4 
DO NOT DRIVE AT NIGHT 5 
8 
A30. During the past year have you been involved in any road traffic accidents while -Y u- were 
driving? 
YES 1 (A31) 
NO 2 (A34) 
DID NOT DRIVE DURING PAST YEAR 3(A34) 
MFIRST I (B) SECOND', 
A31. What kind of accident? I 
A32. Do you think this was 
because of your vision? 
YES 1 (A3 4) 
NO 22 (A34) 
A33. Were there any others? 
YES 1 (A31 B) 
NO 2 (A34) 
A34. Now I'd like to ask you about injuries or accidents that people sometimes have. During the 
past year did you have any injuries or accidents, such as cuts, bruises, or falls? 
YES 
NO 
. 
2(A35) 
. 
(A)FIRST (B) SECOND 
A34a. What kind of accident? 
Probe for following: 
1. Type of injury eg. burn II 
2. Site of injury eg. arm / leg 2 2_ 
3. How injury occured eg. iron 33 
A34b. Do you think this was 
because of your vision? 
YES 
NO 22 
A34c. Were there any other 
accidents injuries this year ? 
YES (A34aB)- 
NO 2 
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A35. Poor eyesight may prevent you from doing some activities. I would like you to think of any 
activities that you are limited in doing because of your eyesight - this could include household 
activities, work, hobbies, social, or outdoor activities. Of the activities you may be limited in 
doing because of your vision which are the three that are most important to you? 
If response s "dont know" prompt with the above again 
Let's start with the'most important. (RECORD BELOW) 
B. How about the second most important? (RECORD BELOW) 
C. How about the third most important? (RECORD BELOW) 
AFTER RECORDING ACTIVITIES, ASK A36-A38 (AS APPROPRIATE) FOR EACH 
(A) 
NONE 0 
MOST IMPORTANT 
(B) 
ONLY ONE 0 
SECOND 
MOST IMPORTANT 
(C) 
ONLY TWO 0 
THIRD - 
MOST IMPORTANT 
A36. Thinking about (ACTIVITY), how 
much difficulty do you presently have 
with that? Do you have: 
A little 1 1 1 
A moderate amount 2 2 2 
A great deal, or 3 3 3 
Are you unable to do it? 4 4 4 
A37. Do you expect to be able to do 
(ACTIVITY) or do it with less difficulty 
after your cataract surgery? (EYE TO BE 
OPERATED ON) 
YES 1 1 1 
NO 2 (A36 FOR B) 2 (A36 FOR Q 2 (A39) 
A38. How much improvement in 
(ACTIVITY) do you expect after your 
cataract surgery? 
Do you expect: 
" little, I I I (A3 9) 
" moderate amount, or 2 2 2 (A39) 
" great deal? 3 3 3 (A39) 
DONTKNOW 8 8 8 (A39) 
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A39. Do you have any difficulty even with glasses in doing any of the following activities? 
(CIRCLE BELOW. IF PATIENT STATES S/HE DOES NOT DO THAT ACTIVITY, CIRCLE N/A 
FOR NOT APPLICABLE) 
IF YES: ASK: 
A. How much difficulty do you currently have: A little, a moderate amount, a great 
deal or are you unable to do (INSERT ACTIV")? (CIRCLE BELOW) 
B. Do you think there is more than a 50-50 chance that this will improve after your surgery? 
(CIRCLE BELOW) 
IF YES 
C. How much imp'rovement do you expect after your cataract surgery? Do you expect a 
little, a moderate amount or a great deal of improvement? (CIRCLE BELOW) 
(A) (B) (C) 
DIFFICULTY IF YES: EXPECT TO IF YES: 
HOW MUCH IMPROVE IMPROVEMENT EXPECTED 
Yes No N/A A MODERATE GREAT UNABLE Yes No DK A MODERATE GREAT 
trniF AMOUNT DEAL TO DO LITTLE AMOUNT DEAL DK 
A40 Reading small print such as 
labels on medicine bottles, a 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
telephone book, food labels 
A41 Reading a newspaper or a 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
book 
42 Reading a large print book '11 '2 ' '3' 1 2 3 4 1 '2 8 1 2 3 8 
print or large print newspaper 
or numbers on a telephone 
43 Recognizing people when 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
they are close to you 
. 44 Seeing steps, stairs or kerbs 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
45 Reading traffic signs, street 1 2 3 1 2 3 4 1 2, 8 1 2 3 8 
signs, shop signs 
Doing fine handwork like 
_2 
3 
'2. 
3, 4., 1 2 8 1 2 3 8 
sewing, knitting, crocheting, ' 
carpentry 
47 Writing letters, cheques, or 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
filling out forms 
Playing games such as bingo, 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
dominos, card games 
49 Taking part in sports like 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
bowling, handball, tennis, golf 
Cooking 1 2- 3 1 2 3 4 1 2 8 1 2 3 8 
Watching television 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
AS2 Getting about indoors 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
Getting about outdoors 1 2 3 1 2 3 4 1 2 8 1 2 3 8 
SECTION B: SATISFACTION WITH CARE 
Thinking about the medical care you are receiving for your cataracts from all of the doctors caring 
for your eyes, would you rate the following as excellent, very good, good, fair, or poor? 
(CIRCLE ANSWER) 
DOES 
VERY NOT DON'T 
EXCELLENT GOOD GOOD FAIR POOR ,I APPLY KNOW 
Bl. Attention your eye doctor(s) gave to what 
you had to say 12 
B2. Amount of time you had with your eye 
doctor(s) during a visit 2 
B3. Amount of time you had with your eye 
doctor(s)'staff during a visit 2 
B4. Friendliness and courtesy shown to you by 
your eye doctor(s) 12 
B5. Friendliness and courtesy shown to you by 
your eye doctor(s)'staff 2 
B6. Your eye doctor(s)' personal interest in 
you and your medical problems 12 
87. Reassurance and support offered to you 
by your eye doctor(s)' staff 12 
B8. Consideration of your personal needs and 
wants in deciding whether to perform 
cataract surgery 12 
3 4 
3 
3 
3 
3 
3 
3 
3 .4578 
89. The amount of time you were given to 
think about whethe you wanted to 
undergo cataract surgery 1234578 
B10. The opportunity you had to ask all the 
questions you wanted to about your 
cataracts and cataract surgery 1234578 
BII The answers your doctor(s) gave to all the 
questions you asked about your cataract 
and cataract surgery 123457 
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BI 2. Some'doctors explain more things to patients than other doctors. We would like you to tell us 
whether your eye doctor(s) or anyone in their hospital explained the following things to you. 
Did you receive: (CONTINUE WITH 1313) 
A. FOR EACH ITEM ANSWERED YES, ASK: 
Was the explanation excellent, very good, good, fair, or poor? 
IF YES: RATING OF EXPLANATION 
VERY DONT 
YES NO EXCELLENT GOOD GOOD FAIR POOR KNOW 
813. Explanations of procedures and 
tests performed before your 
cataract surgery 1212348 
814. An explanation of the likely 
benefits of cataract surgery 12123458 
B15. An explanation of possible harm ,"_, I the' cataract surgery might do 1212358 
816. An explanation about what might 
happen if you did not have the 
cataract surgery when it was 
recommended 12123458 
816a An explanation about the waiting 
time that you will have before 
surgery 121.2 3458 
817. An explanation about which 
activities you probably would be 
able to do after you had your 
cataract surgery 12123458 
818. An explanation about which 
activities you probably would 
still have trouble doing after 
your cataract surgery 12121458 
B19. An explanation of how you would 
probably feel during the first night 
and day after you had your 
cataract surgery 2123458 
B20. An explanation of howmuch help 
you would need during the 
first few days after your cataract 
surgery 1 -2 2348 
821. An explanation about how long it 
would take to recover completely 
from your cataract surgery 12123458 
822. An explanation about when your 
eye doctor(s) wanted you to come 
back for a check-up after 
your surgery 12123458 
823. An explanation about what 
problemsyour eye doctor(s) would 
like you to call him or her about 12123458 
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Thinking about the medical care you are receiving for your cataracts from all of the doctors caring 
for your eyes, would you rate the following excellent, very good, good, fair, or poor? (CIRCLE ANSWER). 
DOES 
VERY NOT DONT 
EXCELLENT GOOD GOOD FAIR POOR 
I 
APPLY KNOW 
B24 Once you and your doctor(s) decided you 
should have cataract surgery, the amount of 
time you had to wait before surgery could 
be done 1 2 3 4 5 7 8 
B25 Convenience of the hospital location 1 2 3 4 5 7 8 
B26 Hours when hospital visits can be scheduled 1 2 3 4 5 7 8 
B27 How easy it was to get back and forth from 
your cataract surgery 1 2 3 4 5 7 8 
B28 Arrangements for making appointments by 
phone 1 2 3 4 5 7 8 
B29 Length of time you wait for your first 
visit to Out patient Eye Dept. 1 2 3 4 5 7 8 
B30 Length of time spent waiting at the hospital 
to see your eye doctor(s) at that visit 1 2 3 4 5 7 8 
B31 Availability of information or advice by 
phone 1 2 3 4 5 7 8 
B32 How easy it is for you to reach your eye 
doctor(s) or their nurse if you need to 
talk to them 1 2 3 4 5 7 8 
B33 The thoroughness of the eye examination(s) 
when you were told you needed a cataract 
operation 
1 2 3 4 5 7 8 
B34 Thoroughness of the examination of your 
overall health 1 2 3 4 5 7 8 
B35 Completeness and quality of your eye 
doctor(s) department and facilities 1 2 3 4 5 7 8 
836 All things considered, the care I have 
received for my cataract(s) has been 1 2 3 4 5 7 8 
B37 Now, thinking about all the medical care 
that you receive, would you rate that as 1 2 3 4 5 7 8 
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SECTION C: GENERAL HEALTH STATUS 
C1. In general, would you say your health is excellent, very good, good, fair, or poor? 
EXCELLENT 1 (0) 
VERY GOOD 2 (0) 
GOOD 3 (0) 
FAIR 4 (Cl a) 
POOR 5 (Cla) 
C1 a. D6 you rate your health as (fair/poor) because of your vision? 
YES 
NO 2 (0) 
C1 b. Do you think there is more than a 50-50 chance that this will improve after your cataract 
surgery? 
YES 1 
NO 2ý (C2) 
C1 C. How much improvement in your health do you expect after your cataract surgery? 
Do you expect: 
" little, I 
" moderate amount, or 2 
" great deal? 3 
DONTKNOW 8 
C2. Comoared to other neople your own'age how would you rate your health? Would you say it 
is: 
Much better, 1 (0) 
Somewhat better, 2 (0) 
About the same, 3 (C3) 
Somewhat worse, or 4 (C2a) 
Much worse? 5 (C2a) 
C2a. Do you think your health is (somewhat/much) worse than others your own age because of 
your vision? 
YES 1 
NO 2 (C3) 
C2b. Do you think there is more than a 50-50 chance that this will improve after your cataract 
surgery? 
YES 
NO 2 (0) 
C2c. How much improvement do you expect after your cataract surgery? 
A little, 1 
A moderate amount or 2 
A great deal? 3 
DONTKNOW 8 
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C3. At the moment do you have any other health problems that you may need to see'a'doctor 
about regularly? 
[Allow the patient to respond freely first, ticking off any conditions mentioried on the list 
below]. Then ask: 
At the moment do you have any of the following conditions or symptoms? 
IF YES: (A) IF YES: 
A. How much does it interfere with your activities: How much does it 
Not at all, a little (some), or a great deal? 
interfere? 
C4. Stomach, bowel or intestinal trouble 
C5. Trouble with bladder, urine, kidneys 
C6. FOR WOMEN: Diseases of the ovaries or uterus 
C7. FOR MEN: Prostate trouble 
C8. Serious trouble with one or both ears or trouble 
with hearing 
C9. Frequent trouble with gums or mouth 
CIO. Frequent foot trouble (for example, bunions, in 
growing toenails) 
CIL Frequent skin trouble (for example, eczema) 
C1 2. Anaemia (low red blood cell count) 
C13. Phlebitis or thrombophlebitis or blood clot in 
veins or arteries 
C14. High blood pressure or hypertension 
CIS. Any heart trouble, hardening of arteries 
(arteriosclerosis) or effects of heart attack, angina 
C16. Effects of a stroke or cerebrovascular disease 
C1 7. Diabetes 
C18. Cancer or malignant tumour or growth 
C19. Recurring gall bladder or liver trouble 
C20 Haemorrhoids or piles 
C2 I. Repeated attacks of sinus trouble 
C22. Hay fever or other allergy 
C23. Thyroid trouble or goitre 
NO 
NOT A 
AT A GREAT 
ALL LITTLE DEAL 
2 23 
2 2 -3 
2 23 
2 23 
2 23 
2 23 
2 23 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
2 1 2 3 
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C24. Emotional, nervous or mental problem 1 2 
C25. Arthritis, rheumatism, bursitis 1 2 
C26. Paralysis 1 2 
C27. Repeated trouble with back or spine 1 2 
C28. Trouble with circulation in arms or legs 2 
C29. Oedema or water retention 2 
C30. Effects of fractured or broken bones 2 
C3 1. Asthma 2 
C32. Chronic bronchitis or emphysema 2 
C33. Tuberculosis 2 
C34. Some other major problem (SPECIFY) 1 2 
(A) 
IF YES: How much does it 
I interfere? 
NOT 
AT 
ALL 
A 
LITTLE 
A 
GREAT 
DEAL 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
1 2 3 
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SECTION D: MEDICAL CARE 
D1. Now I would like to ask you about the medical care you have received during the past six 
months - that is from (DATE 6 MONTHS AGO) until now. In the past 6 months, have you been admitted to a hospital as an invatient - either for an overnight stay or for a *same dar 
procedure? 
YES 1 
NO 2 (D2) 
Dla. On how many different occasions have you been admitted to the hospital as an inpatient in 
the past 6 months? 
NUMBER OF OCCASIONS: 
D1b. Including all these occasions, how many nights have you spent in a hospital in the past 6 
months? 
NUMBER OF NIGHTS: 
D2. Have you been a patient in a hospital casualty department during the past 6 months? (Do' 
not count the instances in which you have been hospitalized) 
YES 1 
NO 2 (M) 
D2a. How many times have you been a patient in a hospital casualty department in the past 6- 
months? 
NUMBER OF TIMES: 
D3. In the past 6 months, have you been an outpatient in a hospital or visited a hospital 
clinic? (Do not count casualty department visits or visits to eye doctor or eye clinics) 
YES 1 
NO 2 (D4) 
133a. How many times have you been an outpatient or visited a hospital clinic in the past 6 
months? (Do not count casualty department visits or visits to eye doctors or eye clinics) 
NUMBER OF TIMES: 
D4. Now I would like to know how many times you have seen your G. P. in the past 6 
months? 
NUMBER OF TIMES: 
D5. Over the past 6 months, how many times have you seen each of the following? 
a. Your eye consultant?: 
b. An optometrist?: 
c. Any other eye doctor?: 
Is 
NOW I WOULD LIKE TO ASK YOU ABOUT THE SERVICES THAT YOU HAVE RECEIVED IN 
YOUR HOME. 
D6. Over the past 6 months, have you received any of these ("SERVICE") in your home? 
(CIRCLE BELOW) 
For each answered YES ask how many times did you use this service in the past 2 weeks? 
(A) RECEIVED 
(6 Months) 
(B) 
IF YES, HOW MANY 
TIMES? 
(Past 2 Weeks) 
SERVICES YES NO DK DK 
D7 District Nurse 128 8 
D8 Homecare services - home help 128 8 
to do cleaning / laundry 
D9 Assistance from relatives or 128 8 
friends? (Shopping, cleaning, 
driving) 
D10 Assistance with meal 128 8 
preparation or delivery of meals 
(meals on wheels) 
D11 Other 128 8 
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SECTION E: WAITING TIME , 2, 
Now I'd like to ask some general questions about the time that people must wait before surgery. We 
are interested in how patients generally feel about the topic of waiting times, and particularly for 
cataract surgery. 
El. Presently there are waiting times for patients who are going to have many types of surgery: 
MORE 
THAN 
No 1-3 4-6 7-12 1-2 2 
wait MOS MOS MOS YEARS YEARS DK 
Ela In general what do you think is the 1 2 3 4 5 6 8 
maximum time that is reasonable for 
people to have to wait before 
having an operation that is not an 
emergency? 
Elb What is the maximum time that you 1 2 3 4 5 6 8 
think people should have to wait for 
heart surgery that is not an 
emergency? 
Elc What is the maximum time you 1 2 3 4 5 6 8 
think people should have to wait for 
hip surgery? 
Eld What is the maximum time that you 1 2 3 4 5 6 8 
think people should have to wait for 
cataract surgery? 
E2. What do you believe is the main reason for waiting times for cataract surgery? 
(CIRCLE ONE RESPONSE) 
SHORTAGE OF BEDS 1 
SHORTAGE OF OPERATING SPACEjflME 2 
SHORTAGE OF DOCTORS OR SPECIALISTS 3 
HIGH DEMAND FOR OPERATIONS/HIGH NUMBER OF PATIENTS 4 
OVERUSE/ABUSE OF HEALTH SYSTEM 5 
SHORTAGE OF FUNDS/GOVERNMENT CUTS 6 
OTHER (specify) 
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SECTION F: BACKGROUND SECTION 
F1. I'd like to ask you some general background questions. Are you currently: 
Married, 1 
Widowed, 2 
Divorced 3 
Separated, or 4 
Have you never been married? 5 
F2. Are you living alone, with friends or family, or somewhere else? 
ALONE 1 
FRIENDS OR FAMILY 2 
SOMEWHERE ELSE (SPECIFY) 3 
F3. How old are you? 
AGE: 
F4. What kind of housing do you live in? 
own home / flat 1 
Rented house flat 2 
Council house flat 3 
Nursing home 4 
Sheltered accomodation 5 
F5. What (is/was) your occupation for most of your life? 
OCCUPATION: 
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SECTION G: Time Trade Off Scenario. 
How long do you usually spend sleeping (both day and night)? 
Hours 
Minutes 
If you have difficulty sleeping, how much sleep do you think you need in total, (both day 
and night)? 
Hours 
Minutes 
I am going to read you a description of someone who takes an IMAGINARY cure before you 
answer the remaining questions. 
Think of someone who has difficulty in seeing, their vision is blurred so that they cannot read bus 
numbers. They also have difficulty making out faces on television. Imagine that this person is given 
a cure that will completely restore their eyesight. The cure has just one snag, the person must spend 
extra time sleeping to rest their eyes. The cure has no other side effects, it is not painful or 
unpleasant in any way, it just requires the person to give up some time to improve their eyesighL 
Of course this means that they will have less time each day to do the things they enjoy, but when 
they are awake, they will have perfect eyesight to do whatever they wish. 
Now please forget the person in the story. We are interested in finding out about YOU and YOUR 
eyesight. 
Please spend a little time thinking about the benefits that improved vision would bring to you. 
3. What things would you be able to do if your eyesight is improviýd? 
4. Would you be prepared to give up some time to improve your eyesight? 
Yes / No 
If 'NO' skip next question 
5. How much EXTRA time would you be prepared to spend sleeping (either during the day or 
at night) to have perfect eyesight? (Please be as precise as possible) 
Hours 
Minutes 
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SECTION H: GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS 
Before beginning the next part of this interview, I am going to read you some instructions. 
You have certain activities that you do in carrying on your life. Sometimes you do all of these 
activities. Other times, because of your state of health, you don't do these activities in the usual 
way: you may cut some out, you may do some for shorter lengths of time, you may do some in 
different ways. These changes in your activities might be recent or long standing. We are interested 
in learning about any changes that describe you today and are related to your state of health. 
I will be reading statements that people have told us describe them when they are not completely 
well. Whether or not you consider yourself sick, there may be some statements that will stand 
about because they describe you today and are related to your state of health. As I read the 
questions, think of yourself today. I will pause briefly after each statement. When you hear one that 
does describe you and is related to health please tell me and I will check it. 
Let me give you an example. I might read the statement "I am not driving my car". If this statement 
is related to your health and describes you today, you should tell me. Also, if you have not been 
driving for some time because of your health, and are still not driving today, you should answer 
wyes" to this statement. 
On the other hand, if you never drive or are not driving today because your car is being repaired, 
the statement, "I am not driving my car' is not related to your health and you should not respond to 
it. If you simply are driving less, or are driving shorter distances, and feel that the statement only 
partially describes you, please do not respond to that statement as well. 
Please tell me if you want me to slow down, repeat a statement, or stop so that you can think 
about one. Also let me know any time you would like to review the instructions. Remember we 
are interested in the recent or long standing changes in your activities that are related to your 
health. 
This section is' based, on --a copyrighted measure, 'the - Sickness - Impact Profile. It may - norbe 
reproduced or used without permission. 
Permission may be granted by: 
Dr. Marilyn Bergner 
Johns Hopkins School o Hygiene and Public Health 
624 N. Broadway 
Baltimore, MD 21205. 
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SECTION H-i GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS 
H1. Please answer "yes" to those statements that you are sure describe you today and are related 
to your state of health. (CONTINUE WITH 1-12) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount, or a great deal? 
(A) (13) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESCRIBE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
r- --- r- --- r -4 ____+ A MODERATE GREAT- 
ý 
DONT 
YES NO YES NO YES NO LITTLE T KN 
H2. I spend much of the day 1 2 12 
- 12 1 2 3 8 
lying down in order to 
rest 
H3. I sit during much of the 1 2 12 12 1 2 3 8 
day 
H4. I am sleeping or dozing 1 2 12 12 1 2 3 8 
most of the time day and 
night 
H5. I lie down more often 1 2 12 12 1 2 3 8 
during the day in order to 
rest 
H6. I sit around half-asleep 1 2 12 12 1 2 3 8 
H7. I sleep less at night, for 1 2 12 12 1 2 3 8 
example, wake up too 
early, don't fall asleep for 
a long time, awaken 
frequently 
H8. I sleep or nap more 1 2 12 12 1 2 3 8 
during the day 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H9. Please answer "yes" to those statements that you are sure describe you today and are related 
to your state of health. (CONTINUE WITH H 10) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will 
improve after your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: 
A little, a moderate amount, or a great deal? 
(A) (13) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESCRI BE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
F-+ -. 0 rp --I. F-4 - --- # ýA MODERA GREAT DONT 
YES 140 YES NO YES NO LME AMOUNT DEAL KNOW 
H10. I say how bad or useless 1 2 12 1 2 1 2 3 8 
I am, for example, that I 
am a burden on others 
H11. I laugh or cry suddenly 1 2 12 1 2 1 2 3 8 
H12. I often moan and groan 1 2 12 1 2 1 2 3 8 
in pain or discomfort 
H13. I have attempted suicide 1 2 12 1 2 1 2 3 8 
H14. I act nervous or restless 1 2 2 3 8 
H15. I keep rubbing or holding 1 2 12 1 2 1 2 3 8 
areas of my body that 
hurt or are 
uncomfortable 
H16. I act irritable and 1 2 12 1 2 1 2 3 8 
impatient with myself, for 
example, talk badly 
about myself, swear at 
myself, blame myself for 
things that happen 
H17. I talk about the future in 1 2 12 1 2 1 2 3 8 
a hopeless way 
H18. I get sudden fright 1 2 12 1 2 1 2 3 8] 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly ,, - 
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H19. Please remember to answer "yes' to those statements that you are sure describe you today 
and are related to your state of health. (CONTINUE WITH H20) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
IF YES: How much improvement do 
a moderate amount or a great deal? 
(A) 
IF YES: 
BECAUSE 
DESCRIBE 
I 
OF YOUR 
you expect after your cataract surgery. A little, 
(C) 
IF YES: 
EXPECT IF YES: 
TO IMPROVEMENT EXPECTED 
YOU VISION I IMPROVE-1 
r- --- r- 
I 
r-- --- A MODERATE 
I 
GREAT DON 
We Nn 
i 
VFq Nn vFq t4o 
I 
LITTLE AMOUNT DEAL 
[ 
KNO)WT 
H20 
H21 
H22 
H23 
I make difficult moves with 
help, for example, getting 
into or out of cars, 
bathtubs 
I do not move into or out 
of bed or chair by myself 
but am moved by a person 
or mechanical aid 
I stand only for short 
periods of time 
I do not maintain balance 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
3 
3 
3 
3 
8 
8 
8 
8 
H24 I move my hands or fingers 1 2 1 2 1 2 1 2 3 8 
with some limitation or 
difficulty 
H25 I stand up only with 1 2 1 2 1 2 1 2, 3 8 
someone's help 
H26 I kneel, stop, or bend 1 2 1 2 1 2 1 2 3 8 
down only by holding on 
to something 
H27 I am in a restricted position 1 2 1 2 1 2 1 2 3 a 
all the time 
H28 I am very dumsy in body 1 2 1 2 1 2 1 2 3 
movements 
H29 I get in and out of bed or 1 2 1 2 1 2 1 2 3 
chairs by grasping 
something for support or 
using a stick or zimmer 
walking frame 
H30 I stay lying down most of 1 2 1 2 1 2 1 2, 3 
the time 
H31 I change position 1 2 1 2 1 2 1 2 3 
frequently 
I I 
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(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESCRI BE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
r-+ ---+ r -- r--- ý 1 A MODERATE GREAT DONT 
YES NO YES NO YES NO LnTLE AMOUN KNOW 
H32 I hold onto something to 1 2 1 2 1 2 1 2 3 8 
move myself around in bed 
H33 I do not bathe myself 1 2 1 2 1 2 1 2 3 8 
completely, for example, 
require assistance with 
bathing 
H34 I do not bathe myself at all, 1 2 1 2 1 2 1 2 3 8 
but am bathed by 
someone else 
H35 I use bedpan with 1 2 1 2 1 2 1 3' 8 
assistance 
H36 I have trouble getting 1 2 1 2 1 2 1 2 3 8 
shoes, socks, or stockings 
on 
H37 I do not have control of my 1 2 1 2 1 2 1 2 3 8 
bladder 
H38 I do not fasten my clothing, 1 2 1 2 1 2 1 2 3 8 
for example, require 
assistance with buttons, 
zippers, shoelaces 
H39 I spendmost"dthe tin e 
-1 2' 1 2 1- - 2" 1-, 2 3 8 
partly undressed or in 
pyjamas 
H40 I do not have control o(my 1 2 1 2 1 2 1 2 3 8 
bowels 
H41 I dress myself, but do so 1 2 1 2 1 2 1 2 3 8 
very slowly 
H42 I get dressed only with I 1 2 1 2 1 2 1 2 3 8 
someone's help 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: , 
Am I reading clearly enough and slowly 
enough? 
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H43. Please answer "yes' to those statements that you are sure describe you today and are related 
to your state of health. (CONTINUE WITH H44) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES:, Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount or a great deal? 
(A) (B) (C) 
IF YES: IF YE S: 
BECAUSE EXPECT IF YES : 
DESCRI BE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
r- i ro r- A MODERATE GREAT DONT 
YES 140 YES NO YES NO LnTLE AMOUNT DEAL KNOýVj 
H44 I do work around the house 1 2 12 1 2 1 2 3 8 
only for short periods of 
time or rest often 
H45 I am doing less of the regular 1 2 12 1 2 1 2 3 8 
daily work around the house 
than I would usually do 
H46 I am not doing any of the 1 2 12 1 2 1 2 3 8 
regular daily work around 
the house that I would 
usually do 
H47 I am not doing any of the 1 2 12 1 2 1 2 3 8 
maintenance or repair work 
that I would usually do in my 
home or vard 
H48 I am not doing any of the 1 2 12 1 2 1 2 3 
shopping that I would 
usually do 
H49 I am not doing any of the 1 2 12 1 2 1 2 3 8 
house cleaning that I would 
usually do 
H50 I have difficulty doing 1 2 12 1 2 1 2 3 8 
handwork, for example, 
turning taps, using kitchen 
gadgets, sewing, carpentry 
H51 I am not doing any of the 1 2 12 1 2 1 2 3 8 
clothes washing that I would 
usuall do 
H52 I am not doing heavy work 1 2 12 1 2 1 2 3 8 
around the house 
H53 I have given up taking care 1 2 12 1 2 1 2 3 8 
of personal or household 
business affairs, for example, 
payin bills, banking, 
working on budget 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H54. Please answer wyes" to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H55) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount, or a great deal? 
(A) (B) (C) 
IF YES: IF YES: 
BECAUSE 
I 
EXPECT IF YES: 
DESCRIBE 
I 
OF YOUR TO IMPROVEMENT EXPECTED 
--- 1--, 1-4 AM DERATE GREAT DONT 
mr-J, 
I 
vrr mrli 
I 
vl: c pini 
I 
LrrrLE 
I 
AOMOUNT 
I 
DEAL 
I 
KNOW 
H55 
H56 
H57 
H58 
I am getting around only 
within one building 
I stay within one room 
I am staying in bed more 
I am staying in bed most of 
the time I 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2, 
2 
2 
3 
3 
3 
3 
8 
8 
8 
8 
rH59 
not now using public I am 1 2 1 2 1 2 1 2 3 8 
transportation 
H60 I stay home most of the 1 2 1 2 1 2 2 3 8 
time 
H61 I am only going to places 1 2 1 2 1 2 2 3 8 
with toilets nearby . -- I . 1. -, -. -, - I- 
H62 I am not going into town 1 2 1 2 1 2 1 2 3 8 
H63 I stay away from home 1 2 1 2 1 2 1 2 3 8 
only for brief periods of 
time 
H64 I do not get around in the 1 2 1 2 1 2 1 2 3 8 
dark or in unlit places 
without someone's help I I I 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H65. Please answer "yes" to those statements that you are -sure 
describe you today and are related 
to your state of health. (CONTINUE WITH H66) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount or a great deal? 
(Aý (B) (C) 
IF YES: IF YES: 
BECAUSE 
I 
EXPECT IF YES: 
DESCRIBE 
I 
OFYOUR TO IMPROVEMENT EXPECTED 
r- r- -I r-- --- IAI MODERATE GREAT I DONT 
vrc Wn 
I 
VFC wn vFq mn FTME AMOUNT 
I 
DEAL KNOW 
H66 I am going out less to visit 1 2 1 2 1 2 1 2 3 8 
people 
H67 I am not going out to visit 1 2 1 2 1 2 1 2 ý. 3 8 
people at all 
H68 I show less interest in other 1 2 1 2 1 2 1 2 3 8 
people's problems, for 
example, don't listen when 
they tell me about their 
problems, don't offer to 
help 
H69 I often act irritable toward 1 2 1 2 1 2 1 .2 3 
those around me, for 
example, snap at people, 
give sharp answers, 
criticise easily 
H70 I show less affection 1 2 1 2 1 2 1 2 3 8 
H71 I am doing fewer social 1 2 1 2 1 2 1 2 3 8 
activities with groups of 
people 
H72 I am cutting down the 1 2 1 2 1 2 1 2 3 8 
length of visits with friends 
H73 I am avoiding social visits 1 2 1 2 1 2 1 2 3 a 
from others 
H74 My sexual activity is 1 2 1 2 1 2 1 2 3 8 
decreased 
H75 I often express concern 1 2 1 2 1 2 1 2 3 8 
over what might be 
happening to my health 
H76 I talk less with those 1 2 1 2 1 2 1 2 3 8 
around me 
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(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESCRI BE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
r- --- r- -- F-* ---+ A MODERATE GREAT NT 
5=ý 
YES NO YES NO 
I 
YES NO LITTLE AMOUNT DEAL W 
H77 I make many demands, for. 1 2 12 1 2 1 2 3 8 
example, insist that people 
do things for me, tell them 
how to do things 
H78 I stay alone much of the 1 2 12 1 2 1 2 3 8 
time 
H79 I act disagreeable to family 1 2 12 1 2 1 2 3 8 
members, for example, I act 
spiteful, I am stubborn 
H80 I have frequent outbursts of 1 2 12 1 -2 1 2 3. '8 
anger at family members, 
for example, strike at them, 
scream, throw things at 
them 
H81 I isolate myself as much as 1 1 2 12 1 2 1 2 3 8 
can from the rest of the 
family 
H82 I am paying less attention to 1 2 12 1 2 1 2, 3 8 
the children 
H83 I refuse contact with family 1 2 12 1 2 1, 2 3 8 
members, for example, turn 
away from them 
H84 I am not doing the things 1 1 2 12 1 2 1 2 3 8 
usually do to take care of 
my children or family 
H85 I am not joking with family 1 2 12 1 2 1 2 3 8 
members as I usually do 
IF R DOES NOT RESPONDTO ANY ITEM, ASK:. Am_l reading clearly enough and slowly 
enough? 
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H86. Please answer "yes' to those statements that you are sure describe you today and are related 
to your state of bealth. (CONTINUE WITH H87) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES; Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate am ount, or a great deal? 
(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES: 
DESCRI BE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
- 
F- r- P 
I 
r- -- A MODERATE GREAT 
I 
DC)NT 
YES NO YES NO YES NO LITTLE AMOUNT DEAL OW KN 
H87 I walk shorter distances or 1 2 12 1 2 1 2 3 8 
stop to rest often 
H88 I do not walk up or down 1 2 12 1 2 1 2 3 8 
hills 
H89 I use stairs only with 1 2 12 1 2 1 2 3 8 
mechanical support, for 
example, handrail, walking 
stick, crutches 
H90 I walk up or down stairs 1 2 12 1 2 1 2 3 8 
only with assistance from 
someone else 
H91 I get around in a 1 2 12 1 2 1 2 3 8 
wheelchair 
H92 I do not walk at all 1 2 12 1 2 1 "2 3 8 
H93 I walk by myself but with 1 2 12 1 2 1 2 3 
some difficulty, for 
example, limp, wobble, 
stumble, have stiff leg 
H94 I walk only with help from 1 2 12 1 2 1_ 3 8 , someone 
H95 I go up and down stairs 1 2 12 1 2 1 2 3 
more slowly, for example, 
stop often, one step at a 
time 
H96 I do not use stairs at all 1 2 12 1 2 1 2 3 
H97 I get around only by using 1 2 12 1 2 1 2 3 
a zimmer frame, crutches, 
cane, walls, or furniture 
H98 I walk more slowly 1 2 12 1 2 1 2 3 8 
IF R DOES NOT RESPOND TO ANY ITEM, ASK:, Am I reading clearly enough and slowly 
enough? 
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H99. Please answer "yesw to those statements that you are sure describe you today and are related 
to your state of health. (CONTINUE WITH H 100) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount, or a great deal? 
(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESCRIBE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
r -. 0 r-+ ---. 0 r--#, A MODERATE GREAT DONT 
YES NO YES NO YES NO LITTLE AMOUNT DEAL KNOW 
H100 I am confused and start 1 2 12 12 1 2 3 8 
several actions at a time 
H101 I have more minor 1 2 12 12 1 2 3 8 
accidents, for example, 
drop things, trip and fall, 
bump into things 
H102 I react slowly to things 1 2 12 12 1 2 3 8 
that are said or done 
H103 I do not finish things 1 1 2 12 12 1 2 3 8 
start 
H 104 1 have difficulty reasoning 1 2 12 12 1 2 3 8 
and solving problems, for 
example, making plans, 
making decisions, 
learning new things 
H 105 1 sometimes behave as if 1 1 2 12 12 1 2 3 8 
were confused or 
disoriented in place or 
time, for example, where I 
am, who is around, 
directions, what day it is 
H106 I forget a lot for example, 1 2 12 12 1 2 3 8 
things that happened 
recently, where I put 
things, appointments 
H107 I do not keep my 1 2 12 12 1 2 3 8 
attention on any activity 
for long 
H 108 1 make more mistakes 1 2 12 12 1 2 3 8 
than usual 
H109 I have difficulty doing 1 2 12 12 1 2 3 8 
activities involving ý 
concentration and 
thinking 
IF R DOES NOT RESPOND TO ANY Ij EM, ASK: AM I reading clearly enough and slowly 
enough? 
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H1 10. Please answer "yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H 111) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount, or a great deal? 
(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESC RIBE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
A MODERATE GREAT 
L 
DONT 
5 
YES NO YES NO YES NO UTTLE AMOUNT AL DE KN OW 
H111 I am having trouble 1 2 12 12 1 2 3 8 
writing or typing 
H112 I communicate mostly by 1 2 12 12 1 2 3' 8 
gestures, for example, 
moving head, pointing, 
sign language 
H113 My speech is understood 1 2 12 12 1 2 3 8 
only by a few people who 
know me well 
H114 I often lose control of my 1 2 12 12 1 2 3 
voice when I talk, for 
example, my voice gets 
louder or softer, trembles, 
changes unexpectedly 
H115 I don't write except to 1 2 12 12 1 2 3 
sign my name 
H116 I carry on conversation 1 2 12 12 1 2 3 
only when very dose to 
the other person or 
looking at him 
H117 I have difficulty speaking, 1 2 12 12 1 2 3 8 
for example, get stuck, 
stutter, stammer, slur my 
words 
H118 I am understood with 1 2 12 12 1 2 3 
difficul 
H119 I do not speak clearly 1 2 12 12 1 2 3 
when I am under stress 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H 120. The next group of statements has to do with any work you usually do other than managing 
your home. By this we mean anything that you regard as work that you do on a regular 
basis. Do you usually do work other than managing your home? 
YES 1 (H 124) 
NO 2 
12 1. Are you retired? 
YES 1 
NO 2 (H 134) 
H 122. - Is your retirement related to your health? 
YES I 
NO 2 (H 134) 
H123. Is your retirement related to your vision? 
YES 1 (H 134) 
NO 2 (H 134) 
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A39. Do you have any difficulty even with glasses in doing any of the following activities? 
(CIRCLE BELOW. IF PATIENT STATES S/HE DOES NOT DO THAT ACTIVITY, CIRCLE 
N/A FOR NOT APPLICABLE) 
IF YES: ASK: 
A. How much difficulty do you currently have: A little, a moderate amount, a great 
deal or are you unable to do (INSERT ACTIVITY)? (CIRCLE BELOW) 
B. Has this improved since your cataract operation? (CIRCLE BELOW) 
IF YES 
C. Did this improve as much as you expected it would after your cataract operation? 
(CIRCLE BELOW) 
(A) (B) (C) 
IF YES: 
IF YES: EXPECTED 
DIFFICULTY HOW M UCH IM PROVED IMPROVEMENT 
ACHIEVED 
Yes No N/A A MODERATE GREAT UNA13LE Yes No DK Yes No- ME AMOONT DFAL TO DO 
A40 Reading small print such as 
labels on medicine bottlesa 1 2 3 1 2 3 4 1 2 8 1 2 
telephone book, food labels 
A41 Reading a newspaper or a 1 2 3 1 2 3 4 1 2 8 1 2 
book 
A42 Reading a large print book 1 2 3 1 2 3 4 1 2 8 1 2 
print or large print newspaper 
or numbers on a telephone 
A43 Recognizing people when 1 2 3 1 2 3 4 1 2 8 1 2 
they are close to you 
A44 Seeing steps, stairs or kerbs 1 2 3 1 2 3 4 1 2 8 1 2 
A45 Reading traffic signs, street 1 2 3 1 2 3 4 1 2 8 1 2 
signs, shop signs 
A46 Doing fine handwork like 1 2 3 1 2 3 4 1 2 8 1 2 
sewing, knitting, aocheting, 
carpentry 
A47 Writing letters, cheques, or 1 2 3 1 2 3 4 1 2 8 1 2 
filling out forms 
A48 Playing games such as bingo, 1 2 3 1 2 3 4 1 2 8 1 2 
dominos, card games 
A49 Taking part in sports like 1 2 3 1 2 3 4 1 2 8 1 2 
bowling, handball, tennis, golf 
A50 Cooking 1 2 3 1 2 3 4 1 2 8 1 2 
A51 Watching television 1 2 3 1 2 3 4 1 2 8 1 2 
A52 Getting about indoors 1 2 3 1 2 3 4 1 2 8 1 2 
A53 Getting about outdoors 1 2 3 1 2 3 4 1 2 8 1 2 
--a 
10 
H134. Thisgroupofsta 
, 
tements has to do with activities you usaally do in your free time. 
These activities are things that you might do for relaxation, to pass the time, or for 
entertainment. Please answer "yes' to those statements that you are sure describe you 
today and are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this,, will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount or a great deal? 
(A) (13) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES: 
DESCRI BE OFYOUR TO IMPROVEMENT EX PECTED 
YOU 
-VISION IMPROVE 
r- -- r- -- r- --- A MODERATE GREAT DONT 
YES NO YES NO YES NO LrrTLE T DEAL 
H135 I do my hobbies and 1 2 12 1 2 1 2 3 8 
recreation for shorter 
periods of time 
H136 I am going out for 1 2 12 1 2 1 2 3 8 
entertainment less often 
H137 I am cutting down on 1 2 12 1 2 1 2 3 8 
some of my usual inactive 
recreation and pastimes, 
for example, watching TV, 
playing cards, reading 
H138 I am not doing any of my 1 '2 2 "1 - 2 '2 3 
usual inactive recreation 
and pastimes for example, 
watching TV, playing 
cards, reading 
H139 I am doing more inactive 1 2 12 1 2 2 ., 
3 8 
pastimes in place of my 
other usual activities 
H 140 1 am doing fewer 1 2 12 1 2 1 2 3 8 
community activities 
H 141 1 am cutting down on 1 2 12 1 2 1 3 8 
some of my usual physical 
recreation or activities 
H142 I am not doing any of MY _'1 2- 1 -2 1 2 1 -2 -3 -- 8 
usual physical recreation 
or activities I __ 
I 
a ing clearly enough and slowly IF R DOES NOT RESPOND NY ITEM, ASK: Am Ire d 
enough? 
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H143. Please remember to answer "yes" to those statements that you are sure describe you today 
are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Do you think there is more than a 50-50 chance that this will improve after 
your cataract surgery? 
C. IF YES: How much improvement do you expect after your cataract surgery: A little, 
a moderate amount, or a great deal? 
(A) (B) (C) 
IF YES: IF YES: 
BECAUSE EXPECT IF YES : 
DESC RIBE OFYOUR TO IMPROVEMENT EXPECTED 
YOU VISION IMPROVE 
ro r-4 A MODERATE GREAT " DONT 
YES NO YES NO YES NO LnTLE MOUNT A AL DE W 
H144 I am eating much less 1 2 12 12 1 2 3 8 
than usual 
H145 I feed myself but only by 1 2 12 12 1 2 3 8 
using specially prepared 
food or utensils 
H146 I am eating special or 1 2 12 12 1 2 3 8 
different food, for 
example, soft food, bland 
diet, low-salt, low-fat, low- 
sugar 
H147 I eat no food at all but am 1 2 12 12 1 2 3 8 
taking fluids 
H148 I just pick or nibble at my 1 2 12 12 1 2 3 8 
food 
H149 I am drinking less fluids 1 2 12 1 2. 1 -2 3 8 
H150 I feed myself with help 1 2 12 12 1 2 3 8 
from someone else 
H151 I do not feed myself at all, 1 2 12 12 1 2 3 8 
but must be fed 
H152 I am eating no food at all, 1 2 12 12 1 2 3 
nutrition is taken through 
tubes or intravenous fluids 
This is the end of this section 
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CLOSING 
This is the end of the interview. Thank you very much for taking the time to answer these 
questions. 
I will see you again four months after your operation to see how you are doing and 
to find out how much your vision has changed following the removal of your cataract. 
I hope everything goes well with your surgery. 
TIME TAKEN FOR INTERVIEW: 
TO BE COMPLETED BY INTERVIEWER AT THE END OF THE INTERVIEW. 
(Please Tick as appropriate) 
PWI a. - 
Patients first language is English. 
PW1 b. 
_ 
Patients first language, other 
PW2. Interview conducted at pre-op assessment clinic, in hospital 
PW3. Interview conducted on admission to hospital 
PW4. Interview conducted in hospital at some other time 
PW5. Interview conducted at patienfs home 
PW6. Interview completed in a single session 
PW7. Interview completed in two half sessions 
PW8. Interview started, but terminated 
PW9. Interview not completed 
PWIO. 
- 
Interview started, but failed cognitive scale 
Use this space for details about cases with responses PW4, or PW7 - PWJ 0 
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THE CATARACT OUTCOME STUDY 
IN 
THE WELLHOUSE TRUST 
4 MONTH FOLLOW-UP INTERVIEW 
Patient Name: 
Hospital Number: 
Consultant: 
Date of Interview: 
Interviewer: 
Patient ID 
II1 
-1 
1 
THE CATARACT OUTCOME STUDY 
4 MONTH FOLLOW-UP INTERVIEW 
INTERVIEWER: To conduct this interview you will need to know: 
1. First eye operated on (Right or Left) 
2. Date of 1 st cataract operation 
3. Date of first interview 
4. Status of 2nd eye 
5. Activity limitations reported at Baseline 
Introduction to Patient. 
Hello, my name is - You may remember that I am one of 
the Cataract Outcome Study team members from the College of Ophthalmologists 
and that your eye consultant is taking part in this study. It is now time for our four 
Month follow-up interview. 
In this second interview we will again ask you questions about your vision, general 
health, everyday activities now that you have had your first cataract operation. 
Again, you may refuse to answer any questions at any time during the interview. 
The interview will take about 45 minutes. 
Shall we begin? 
Yes 
No 2 Reason if any 
COGNITIVE SCALE 
IF PATIENT SEEMS TO BE CONFUSED, SEEMS UNABLE TO UNDERSTAND WHAT YOU 
HAVE SAID TO THEM IN THE INTRODUCTION, OR SEEMS MENTALLY UNABLE TO 
TAKE PART IN THE INTERVIEW, PLEASE ASK THE FOLLOWING QUESTIONS: 
FirsL I have a few general questions. 
CORRECT WRONG 
1. What is your full name? 1 2 
2. How old are you? 1 2 
3. When were you born? 1 2 
4. Where were you born? 1 2- 
5. What is your mother's first name? 1 2 
6. What is your father's first name? 1 2 
7. Who is the Prime Minister? 1 2 
8. Who was the Prime Minister before this one? 2 
9. What year is this? 1 2 
10. What month is this? 1 2 
11. What day of the month is this? (What is the date? ) 1 2 
12. What is the name of the city or town you are in? .2 
13. What day of the week is it? 2 
14. What time is it now? 2 
BOX I 
IF PATIENT ANSWERS 4 OR MORE 
, 
QUESTIONS INCORRECTLY, 
TER ATE INTERVIEW: 
Thank you very much for your help. That is all the information we need. 
OTHERWISE CONTINUE. 
2 
SECTION A: GENERAL QUESTIONS ABOUT VISION 
AX-1. My records show that you were scheduled to have your first cataract removed from 
your (1 st EYE) on (DATE OF 1 ST SURGERY). Was it removed then? 
YES 1 (AX-6) 
NO 2 
AX-2 Did you have cataract surgery on your (1 st EYE) since we last spoke? 
YES 1 
NO 2 (AX-5) 
AX-3 On what date did you have the operation? 
DATE /19 
AX-4 Why was the date changed? 
BOM 
IF SURGERY WAS POSTPONED AND PERFORMED 
LESS THAN 3 MONTHS AGO, RESCHEDULE 
INTERVIEW FOR FOUR MONTHS FROM FIRST 
SURGERY. 
IF SUGERY OCCURRED 3 MONTHS AGO OR 
LONGER, GO TO A)ý6 
AX-5 Why have you not had the operaflon yet? 
BOX la 
IF SURGERY WAS NOT PERFORMED TERMINATE 
THE INTERVIEW 
AX-6 CHECK LABEL: DOES PATIENT HAVE CATARACT IN BOTH EYES? 
YES 1 (AX-8) 
NO 2 
AX-7 Have you been told you have a cataract in your other eye since the last interview? 
YES 1,, 
NO 2 (Al) 
AX-8 Have you had cataraict surgery in your (OTHER EYE) since the last interview? 
YES 1 
NO 2 (AX-1 0) 
3 
AX-9 When was the cataract in that eye removed? 
DATE /19 
GO TO Al 
AX-1 0 Do you think you will have the other cataract removed? 
YES 1 
NO 2 (Al) 
DONTKNOW 8 (Al) 
AX-1 I Do you know when you will have it removed? 
YES 1 
NO 2 (Al) 
AX-1 2 On what date is that operation planned? 
DATE /19 
OR 
DON'T KNOW 9-8 
Al. How much trouble do you now have with your vision? Is it none, a little, a moderate 
amo^ or a great deal? 
NONE 1 
LITTLE 2 
MODERATE 3 
GREAT DEAL 4 
A2. How satisfied are you now with your vision? Are you: 
Very satisfied 1 
Satisfied 2 
Dissatisfied or 3 
Very dissatisfied? 4 
AX-1 3 Is your vision better, worse, or about the same now as it was before you had cataract 
surgery? 
BETTER 1 
WORSE 2 (A10) 
THESAME 3 (A10) 
AX-1 4 How soon after surgery did you notice an improvement? 
DAYS (PROBE FOR ANSWER IN "DAYS") 
AX-1 5 How soon after surgery did you return to your usual activities? 
DAYS (PROBE FOR ANSWER IN "DAYSm) 
4 
All 0. Do you currently wear glasses or contact lenses? 
YES 1 (All Oa) 
NO 2 (All 1) 
A10a. Do you wear them for reading, to see things that are far away, or both? (IF PATIENT 
SAYS "BIFOCAU, CIRCLE BOTH) 
READING 1 
FAR AWAY 2 
BOTH 3 
All 1. During the past month have you been bothered by any of the following symptoms in 
. 
the eye that has had the cataract operation? (CIRCLE BELOW) 
IF YES: ASK: 
A. Are you being treated for this problem? (CIRCLE BELOW) 
B. Has this improved since your cataract operation? (CIRCLE BELOW) 
IF YES 
C. Did this improve as much as you had expected it would after, your cataract 
operation? (CIRCLE BELOM 
(A) (C) 
IF YES: 
EXPECTED 
BOTHERED ' TREAT- IMPROVED IMPROVEMENT 
MENT ACHIEVED 
vFq No We wn vrc mr1k riv %fcc 
A12. 
A13. 
A14. 
All 5. 
Red painful or 
tender eye 
Feeling as if 
something were 
in your eye 
Watery 
burning or 
itching eye 
Double vision or 
distorted vision 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
2 
2 
2 
2 
8 
8 
8 
8 
1 
1 
1 
1 
2 
2 
2 
2 
Al 6. A drooping eyelid 1 2 1 2 1 2 8 1 2 
Al 7. Spots floating 1 2 1 2 1 2 8 1 2 
before your eye 
All 8. Glare halo or 1 2 1 2 1 2 8 1 2 
seeing rings 
around light 
A19. Blurry vision with 1 2 1 2 1 2 8 1 2 
your most recent 
glasses 
A20. Things seeming 1 2 1 2 1 2 8 1 2 
brighter than they 
used to in a way 
that is disturbing 
A2 1. Colours looking 1 2 1 2 1 2 8 1 2 
different than they 
used to in a way 
that is disturbing 
A22. A worsening of 1 2 1 2 1 2 8 1 2 
your vision in the 
eye that was 
operated on. 
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A23. Do you have any other eye problems, conditions, or symptoms? 
YES 1 
NO 2 (A24) 
A23a. What are these? (RECORD UP TO 3) 
1. 
2. 
3. 
A24. Do you now drive a car? 
YES I (A28) 
NO 2 (A26) 
A25. NOT IN THIS VERSION 
A26. Did you stop driving after you had your first cataract removed? 
YES, AFTER 1 ST OPERATION 1 
NO, STOPPED BEFORE THAT 2 (A34) 
NEVER DROVE 3 (A34) 
A27. Why did you stop driving? 
VISION 1 (A34). 
OTHER ILLNESS 2 (A34) 
OTHER REASON 3 (A34) 
A28. How much difficulty do you have driving during the day because of your vision? Do 
you have: 
No difficulty, 1 
A little difficulty, 2 
A moderate amount of difficulty, or 3 
A great deal of difficulty? 4 
A29. How much difficulty do you have driving at night because of your vision? Do you 
have: 
No difficulty, 1 
A little difficulty, 2 
A moderate amount of difficulty, or 3 
A great deal of difficulty? 4 
DO NOT DRIVE AT NIGHT 5 
6 
A30. Between (DATE OF IIST OPERATION) and now have you been involved in any road 
traffic accidents while you were driving? 
A3 1. What kind of accident? 
YES 
NO 
1 (A31) 
2 (A34) 
k)FIRST (B) SECOND 
A32. Do you think this was 
because of your vision? 
YES 
NO 2 
A33. Were there any others? 
YES I (A31 B) 
NO 
12 
(A34) 
RST 
A34. Now I'd like to ask you about injuries or accidents you may have had since your 
cataract operation. Between (DATE OF I ST OPERAIION) and now, have you had any injuries 
or accidents, such as cuts, bruises, sprains or fractures? 
YES 1 
NO 2(A35) 
A34a. What kind of accident? 
Probe for following: 
1. Type of injury eg. burn 
2. Site of injury eg. arm / leg 
3. How injury occured eg. iron 
A34b. Do you think this was 
because of your vision? 
YES 
NO 
A34c. Were there any other 
accidents / injuries? 
YES 
NO 
1 
2 
I (A34) 
2 (A34) 
B) SECOND 
1 
2 
3 
1 
2 
I (A34aB) 
2 
1 
2 
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BOX 2 
RECORD"LIMITED ACTIVITIES"FROM BASELINE INTERVIEW, BELOW: 
MOST IMPORTANT: 
2ND MOST IMPORTANT: 
3 RD MOST IMPORTANT: 
IF NO LIMITED ACTIVITIES REPORTED, SKIP TO A39 
A35. Before your first cataract operation, you said that you were limited in doing (an 
activity/certain activities) because of your eyesight. Starting with the activity that you 
said was most important, (MOST IMPORTANT ACTIVITY), what effect has your cataract 
operation had on your ability to do this? 
Has it had no effect 1 (BOX3) 
Has it improved your ability to do (ACTIVITY), or 2 (A35a) 
Has your ability to do (ACTIVITY) become worse? 3 (A35c) 
A35a. Has your ability to do this improved as much as expected? 
YES 1 
NO 2 
A35b. How soon after the operation did you notice an improvement? 
DAYS (PROBE FOR ANSWER IN DAYS) 
A35c. Are you now able to do (ACTIVITY) with: 
No difficulty 1 
A little difficulty, 2 
A moderate amount of difficulty, 3 
A great deal of difficulty? 4 
BOX3 
IF ONLY ONE LIMITED ACTIVITY 
REPORTED, SKIP TO A39; 
OTHERWISE CONTINUE. 
A36 You said that (2ND ACTIVITY) was the second most important activity that you were 
limited in doing. What effect has your cataract operation had on your ability to do this? 
Has it had no effect 1 (BOX 4) 
Has it improved your ability to do (ACTIVITY), or 2 (A36a) 
Has your ability to do (ACTIVITY) become worse? 3 (A36c) 
A36a Has your ability to do this improved as much as you expected? 
YES 1 
NO 2 
A36b, How soon after the operation did you notice an improvement? 
DAYS (PROBE FOR ANSWER IN DAYS) 
A36c Are you now able to do (ACrIVITY) with: 
No difficulty 1 
A little difficulty, 2 
A moderate amount of difficulty, 3 
A great deal of difficulty? 4 
BOX4 
IF ONLY TWO LIMITED ACTIVITIES 
REPORTED, SKIP AS TO A39: 
OTHERWISE, CONTINUE 
A37. You Said that (3RD ACTIVITY) was the third most important activity that you were 
limited in doing. What effect has your cataract operation had on your ability to do this? 
Has it had no effect 1 (A3 9) 
Has it improved your ability to do (ACTIVITY), or 2 (A3 7a) 
Has your ability to do (ACTIVITY) become worse? 3 (A37c) 
A37a Has your ability to do this improved as much as you expected? 
YES 
NO 2 
A37b How soon after the operation did you notice an improvement? 
DAYS (PROBE FOR ANSWER IN 'DAYS") 
A37c. Are you now able to do (ACTIVITY) with: 
No difficulty 1 
A little difficulty, 2 
A moderate amount of difficulty; 3-, -- 
A great deal of difficulty? 4 
A38 NOT IN THIS VERSION 
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A39. Do you have any difficulty even with glasses in doing any of the following activities? 
(CIRCLE BELOW. IF PATIENT STATES S/HE DOES NOT DO THAT ACTIVITY, CIRCLE 
N/A FOR NOT APPLICABLE) 
IFYIES: ASK: 
A. How much difficulty do you currently have: A little, a moderate amount, a great 
deal or are you unable to do (INSERT ACTIVITY)? (CIRCLE BELOW) 
B. Has this improved since your cataract operation? (CIRCLE BELOW) 
IF YES 
C. Did this improve as much as you expected it would after your cataract operation? 
(CIRCLE BELOM 
(A) (B) (C) 
IF YES: 
IF YES: EXPECTED 
DIFFICULTY HOW M UCH IMPROVED IMPROVEMENT 
ACHIEVED 
Yes No N/A A M(X)ERATE CREAT UNABLE Yes No DK Yes No LrM F AMOUNT DFAL TO DO 
A40 Reading small print such as 
labels on medicine bottlesa 1 2 3 1 2 3 4 1 2 8 1 2 
telephone book, food labels 
A41 Reading a newspaper or a 1 2 3 1 2 3 4 1 2 8 1 2 
book 
A42 Reading a large print book 1 2 3 1 2 3 4 1 2 8 1 2 
print or large print newspaper 
or numbers on a telephone 
A43 Recognizing people when 1 2 3 1 2 3 4 1 2 8 1 2 
they are close to you 
A44 Seeing steps, stairs or kerbs. 1 2 3 1 2 3 4 1 2 8 1 2 
A45 Reading traffic signs, street 1 2 3 1 2 3 4 1 2 8 1 2 
signs, shop signs 
A46 Doing fine handwork like 1 2 3 1 2 3 4 1 2 8 1 2 
sewing, knitting, crocheting, 
carpentry 
A47 Writing letters, cheques, or 1 2 3 1 2 3 4 1 2 8 1 2 
filling out forms 
A48 Playing games such as bingo, 1 2 3 1 2 3 4 1 2 8 1 2 
dominos, card games 
A49 Taking part in sports like 1 2 3 1 2 3 4 1 2 8 1 2 
bowling, handball, tennis, golf 
ASO Cooking 1 2 3 1 2 3 4 1 2 8 1 2 
A51 Watching television 1 2 3 1 2 3 4 1 2 8 1 2 
A52 Getting about indoors 1 2 3 1 2 3 4 1 2 8 1 2 
A53 Getting about outdoors 1 2 3 1 2 3 4 1 2 8 1 2 
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SECTION B: SATISFACTION WITH CARE 
Thinking about the medical care you received for your cataracts between our first interview 
and now from all of the doctors caring for your eyes, would you rate the following as excellentý 
very good, good, fair, or poor? 
(CIRCLE ANSWER) 
DOES 
VERY NOT DONT 
EXCELLENT GOOD GOOD FAiR POOR 
I 
APPLY KNOW 
B1. Attention your eye doctor(s) gave to what 
you had to say 1 2 3 4 5 7 8 
B2. Amount of time you had with your eye 
doctor(s) during a visit 1 2 3 4 5 7 8 
B3. Amount of time you had with your eye 
doctor(s)'staff during a visit 1 2 3 4 5 7 -8 
B4. Friendliness and courtesy shown to you by 
your eye doctor(s) 1 2 3 4 5 7 8 
B5. Friendliness and courtesy shown to you by 
your eye doctor(s)' staff 1 2 3 4 5 7 8 
B6. Your eye doctor(s)' personal interest in 
you and your medical problems 1 2 3 4 5 7 8 
B7. Reassurance and support offered to you 
by your eye doctoqs)' staff 1 2 3 4 5 7 8 
B8. Consideration of your personal needs and 
wants in deciding whether to perform 
cataract surgery in your other eye 1 2 3 4 5""' 7 `8 
B9. NOT IN THIS VERSION 
1310. The opportunity you had to ask all the 
questions you wanted to about your 
cataracts and cataract surgery 1 2 3 4 5 7 8 
1311 The answers your doctor(s) gave to all the 
questions you asked about your cataract 
and cataract surgery 1 2 3 4 5 7 8 
it 
1312. Some doctors explain more things to patients than other doctors. We would like you to 
tell us whether your eye doctor(s) or anyone in their hospital explained the following 
things to you. 
Did you receive: (CONTINUE WITH B13) 
A. FOR EACH ITEM ANSWERED YES, ASK: Was the explanation excellent, very good, 
good, fair, or poor? 
IF YES: RATING OF EXPLANATION 
YES NO 
EXCELL- VERY 
ENT GOOD GOOD FAIR POOR 
605 -N7 
KNOW 
B13. Explanations of procedures and 
tests performed after your first 
cataract operation 12 12345 8 
814- NOT IN THIS VERSION 
B23 
Thinking about the medical care you received for your cataracts between our first interview and now, 
including your surgery and from all of the doctors caring for your eyes, would you rate the following 
excellent, very good, good, fair, or pood (CIRCLE ANSWER). 
DOES 
EXCELLENT VERY NOT DONT 
GOOD GOOD FAIR POOR APPLY KNOW 
B24 NOT IN THIS VERSION - 
B25 Convenience of the hospital location 1 2 3 4 5 7 -8 
B26 Hours when hospital visits can be scheduled 1 2 3 4 5 7 8 
827 How easy it was to get back and forth from 
your cataract surgery 1 2 3 4 5 7 8 
828 Arrangements for making appointments by 
phone 1 2 3 4 5 ý7 8 
B29 Length of time you wait between making an 
outpatient appointment and the day of your 1 2 3 4 5 7 8 
visit. 
B30 Length of time spent waffing at the outpatient 
clinic to see your eye doctor(s) 1 2 3 4 5 7 8 
B31 Availability of information or advice by phone 
1 2 3 4 5 7 8 
B32 How easy it is for you to reach your eye 
doctoqs) or their nurse if you need to 
talk to them 1 2 3 4 5 7 8 
B33 The thoroughness of the eye examination(s) 
since your cataract operation 1 2 3 4 5 7 
B34 NOT IN THIS VERSION 
B35 Completeness and quality of your eye 
doctoqs) department and facilities 1 2 3 4 5 7 
B36 All things considered, the care I have 
received for my cataract(s) has been 1 2 3 4 5 7 
hinking about all the medical care 
U receive, would you rate that as 1 2 3 4 5 7 
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SECTION C: GENERAL HEALTH STATUS 
C1. In general, would you say your health is excellený very good, good, fair, or poor? 
EXCELLENT I (Clb) 
VERY GOOD 2 (Cl b) 
GOOD 3 (Cl b) 
FAIR 4 (Cl a) 
POOR 5 (Cl a) 
C1 a. Do you rate your health as (fair/poor) because Of your vision? 
YES 1 
NO 2 (0) 
C1 b. Has your general health improved since your cataract operation? 
YES 1 
NO .2 (C2) 
C1 C. Did your general health improve as much as you expected after your cataract 
operation? 
YES 1 
NO 2 
C2. Coml2ared to other people your own age how wo uld you rate your health? Would you 
say it is: 
Much better, 1 (DX1) 
Somewhat better, 2 (DX1) 
About the same, 3 (DX1) 
Somewhat worse, or 4 (C2a) 
Much worse? 5 (C2a) 
C2a. Do you think your health is (somewhat/much) worse than others your own age 
because of your vision? 
'YES 
NO 2 
C2b. - C34 NOT IN THIS VERSION 
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SECTION DX: REFERRAL AND FOLLOW-UP 
DX-11 How long have you been a patient of your eye consultant? 
YEARS 
MONTHS 
DX-2 Who referred you to (him/her)? (CIRCLE ONE) 
ANOTHER OPHTHALMOLOGIST 01 
OPTOMETRIST 02 
OPTICIAN 03 
OTHER MEDICAL DOCTOR 04 
(E. G., G. P. CARDIOLOGIST) 
FAMILY MEMBER OF FRIEND 05 
SOMEONE ELSE (SPECIFY) 06 
DONT KNOW 98 
DU Who is taking care of your eyes now? 
YES NO 
a. Is your Eye Consultant taking care of your eyes? 1 2 
b. Another ophthalmologist? (eye doctor)? 2 
c. An optometrist/optician? 2 
d. Your G. P.? 1 2 
e No-one 1 2 
DX4 IF R ANSWERS'NO' TO ALL ABOVE, VERIFY'NO ONE' IS CARING FOR EYES NOW. 
D VERIFIED: NO ONE CARING FOR EYES NOW. 
DX-5 Are you still under Follow-up at the Hospital? 
1 YES 
2 NO 
9-8 DONT KNOW 
DX-6 Have you been discharged from the clinic? 
I YES 
2 NO 
9-8 DONT KNOW 
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SECTION D: MEDICAL CARE 
D1. Now I would like to ask you about the medical care you have received since the time of 
your first cataract operation until now. During this time, have you been admitted to a 
hospital as an invatient - either for an overnight stay or for a "same day" procedure? 
YES 
NO 2 (D2) 
Dla. On how many different occasions have you been admitted to the hospital as an 
inpatient between (DATE OF 1 ST OPERATION) and now? 
NUMBER OF OCCASIONS: 
D1b. Including all these occasions, how many nights have you spent in a hospital between 
(DATE OF 1 ST OPERATION) and now? 
NUMBER OF NIGHTS: 
D2. Have you been a patient in a hospital casualty department between (DATE OF 1ST 
OPERATION) and now? (Do not count the instances in which you have been 
hospitalized) 
YES 1 
NO 2 (D3) 
D2a. How many times have you been a patient in a hospital casualty department between 
(DATE OF 1 ST OPERA110N) and now? 
NUMBER OF TIMES: 
D3. Between (DATE OF 1ST OPERATION) and now have you been an outpatient in a 
hospital or visited a hospital dinic? (Do not count casualty department visits or visits to 
eye doctor or eye clinics) 
YES 1 
NO 2 (D4) 
D3a. How many times have you been an outpatient or visited a hospital clinic between 
(DATE OF 1ST OPERATION) and now? (Do not count casualty department visits or 
visits to eye doctors or eye clinics) 
NUMBER OF TIMES: 
D4. Now I would like to know how many times you have seen your G. P. between (DATE 
OF 1 ST OPERATION) and now? 
NUMBER OF 
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D5. Between (DATE OF 1ST OPERATION) and now, how many times have you seen each 
of the following? 
a. Your eye consultant?: 
b. An optometrist?: 
C. Any other eye doctor?: 
d. The doctor who did your cataract operation? 
NOW I WOULD LIKE TO ASK YOU ABOUT THE SERVICES THAT YOU HAVE RECEIVED IN 
YOUR HOME. 
D6. Since your cataract operation, have you received any of these ("SERVICES") in your 
home? (CIRCLE BELOM 
For each answered YES ask how many times did you use this service in the past 2 
weeks? 
(A) RECEIVED 
(SINCE 1ST 
OPERATION) 
(B) 
IFYES, HOW MANY 
TIMES? 
(Past 2 Weeks) 
, 
SERVICES YES NO DK DK 
D7 District Nurse 128 
D8 Homecare services - home help 128 
to do cleaning / laundry 
D9 Assistance from relatives or 1.2 8 
friends? (Shopping, cleaning, 
driving) 
D10 Assistance with meal 128 8 
preparation or delivery of meals 
(meals on wheels) 
D11 Other 128 8 
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SECTION H: GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS 
As in the first interview, I am going to ask you a series of questions about the every day 
activities you do to see if there has been a change. I will start with the instructions. 
You have certain activities that you do in carrying on your life. Sometimes you do all of these 
activities. Other times, because of your state of health, you don't do these activities in the usual 
way: you may cut some ouý you may do some for shorter lengths of time, you may do some in 
different ways. These changes in your activities might be recent or long standing. We are 
interested in learning about any changes that describe you today and are related to your state 
of health. 
I will be reading statements that people have told us describe them when they are not 
completely well. Whether or not you consider yourself sick, there may be some statements 
that will stand about because they describe You today and are related to your state of health. 
As I read the questions, think of yourself today. I will pause briefly after each statement. When 
you hear one that does describe you and is related to health please tell me and I will check it. 
Let me give you an example. I might read the statement "I am not driving my car". If this 
statement is related to your health and describes you today, you should tell me. Also, if you 
have not been driving for some time because of your health, and are still not driving today, you 
should answer "yeso to this statement 
On the other hand, if you never drive or are not driving today because your car is being 
repaired, the statement 'I am not driving my car" is not related to your health and you should 
not respond to it. If you simply are driving less, or are driving shorter distances, and feel that 
the statement only partially describes you, please do not respond to that statement as well. 
Please tell me if you want me to slow down, repeat a statemený or stop so that you can think 
about one. Also let me know any time you would like to review the instructions. Remember 
we are interested in the recent or long standing changes in your activities that are related to 
your health. 
This section is based on a copyrighted measure, the Sickness impact Profile. It may not be 
reproduced or used without permission. 
Permission may be granted by: 
Dr. Marilyn Bergner 
Johns Hopkins School o Hygiene and Public Health 
624 N. Broadway 
Baltimore, MD 21205. 
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I SECTION H: GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS 
Please answer "yes" to those statements that you are sure describe you Loday and are 
related to your state of health. (CONTINUE WITH 1-12) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r, i r, r-+ DONT 
YES NO 
-YES 
NO YES NO YES NO KNOW 
H2. I spend much of the day 1 2 12 1 2 1 2 8 
lying down in order to 
rest 
H3. I sit during much of the 1 2 12 1 2 1 2 8 
day 
H4. I am sleeping or dozing 1 2 12 1 2 1 2 8 
most of the time day and 
night 
H5. I lie down more often 1 2 12 1 2 1 2 8 
during the day in order to 
rest 
H6. I sit around half-asleep 1 2 12 1 2 1 2, 8, 
H7. I sleep less at night, for 1 2 12 1 2 1 2 8 
example, wake up too 
early, don't fall asleep for 
a long time, awaken 
frequently 
H8. I sleep or nap more 1 2 12 1 2 1 2 8 
during the day 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H9. Please answer myeso to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H 10) 
FOR EACH ITEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOM 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISIO N 
f-4 ---* r-4 
' 
-4 
F- 
(-0 - --ý DONT 
YES NO YES NO YFS NO YES NO KNOW 
H10. I say how bad or useless 1 2 1 2 1 2 1 2 8 
1 am, for example, that I 
am a burden on others 
HI 1. 1 laugh or cry suddenly 1 2 1 2 1 2 1 2 8 
H12. I often moan and groan 1 2 1 2 1 2 1 2 8 
in pain or discomfort 
H13. I have attempted suicide 1 2 1 2 1 2 1 2 8 
1114. 1 act nervous or restless 1 2 1 2 1 2 1 2 8 
H15. I keep rubbing or holding 1 2 1 2 1 2 1 2 8 
areas of my body that 
hurt or are 
uncomfortable 
H16. I act irritable and 1 2 1 2 1 2 1 2 8 
impatient with myself, for 
example, talk badly 
about myself, swear at 
myself, blame myself for 
things that happen 
H17. I talk about the future in 1 2 1 2 1 2 1 2 8 
a hopeless way 
H18. I get sudden fright 1 2 1 2 1 2 1 2 8 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H19. Please remember to answer "yes' to those statements that you are sure describe you 
Loday and are related to your state of health. (CONTINUE WITH H20) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. - IF YES: Has this improved since your cataract operation? (CIRCLE BELOW)- 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation.? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
f-4 0 r-+ ---+ r-+ 0 DONT 
YES NO YES NO YES NO YES NO KNOW 
H20 I make difficult moves with 1 2 1 2 1 2 1 2 8 
help, for example, getting 
into or out of cars, 
bathtubs 
H21 I do not move into or out 1 2 1 2 1 2 1 2 8 
of bed or chair by myself 
but am moved by a person 
or mechanical aid 
H22 I stand only for short 1 2 1 2 1 2 1 2. 8 
periods of time 
H23 I do not maintain balance 1 2 1 2 1 2 1 2 8 
H24 I move my hands or fingers' 1 '2 1 ý2 1 2 1"" 2 8- 
with some limitation or - 
difficulty 
H25 I stand up only with 1 2 1 2 1 2 1 2 8 
someone's help 
H26 I kneel, stop, or bend 1 2 1 2 1 2 1 2 8 
down only by holding on 
to something 
H27 I am in a restricted position 1 2 1 2 1 2 1 2 8 
all the time 
H28 I am very clumsy in body 1 2 1- 2 1 2 1 2 -8 
movements 
H29 I get in and out of bed or 1 2 1 2 1 2 1 2 8 
chairs by grasping 
something for support or 
using a stick or Ammer 
walking frame 
H30 I stay lying down most of 1 2 1 2 1 2 1 2 8 
the time 
H31 I change position 1 2 1 2 1 2 1 2 8 
frequently 
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(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OF YOUR IMPROVED ACHIEVED 
YOU VISION 
17-0 ----+ 17-4 ---# ----o DONT r] 1 
YES NO YES NO YES NO YES NO KNO W 
H32 I hold onto something to 1 2 1 2 1 2 1 2 8 
move myself around in bed 
H33 I do not bathe myself 1 2 1 2 1 2 1 2 8 
completely, for example, 
require assistance with 
bathing 
H34 I do not bathe myself at all, 1 2 1 2 1 2 1 2 8 
but am bathed by 
someone else 
H35 I use bedpan With 1 2 1 2 1 2 1 2 8 
assistance 
H36 I have trouble getting 1 2 1 2 1 2 1 2 8 
shoes, socks, or stockings 
on 
H37 I do not have control of my 1 2 1 2 1 2 1 2 8 
bladder 
H38 I do not fasten my dothing, 1 2 1 2 1 2 1 2 8 
for example, require 
assistance with buttons, 
zippers, shoelaces - 
H39 I spend most of the tim e 1 2 1 2 1 2 1 2 8 
partly undressed or in 
pyjamas 
H40 I do not have control of my 1 2 1 2 1 2 1 2 8 
bowels 
H41 I dress myself, but do so 1 2 1 2 1 2 1 2 8 
very slowly 
H42 I get dressed only with 1 2 1 2 1 2 1 2 8 
someone's help 
.I 
1 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H43. Please answer "yes" to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH 1-14ý) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operati, on? (CIRCLE BELOW) 
C. IF YES; Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) 
, 
(C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVE ACHIEVED 
ý YOU VISION D 
r-11 0 F-4 i r-, 0 DONT 
YES NO YES NO YES NO YES NO KNOW 
H44 I do work around the house 1 2 12 1 2 2 8 
only for short periods of 
time or rest often 
H45 I am doing less of the regular 1 2 12 1 2 2 8 
daily work around the house 
than I would usually do 
H46 I am not doing any of the 1 2 12 1 2 2 8 
regular daily work around 
the house that I would 
usually do 
H47 I am not doing any of the 1 2 12 1 2 1 2 8 
maintenance or repair work 
that I would usually do in my 
home or yard 
H48 I am not doing any of the 1 2 12 1 2 1 2 8 
shopping that I would 
usually do 
H49 I am not doing a ny of the' 1 2 12 1 2 1"- -2 81 
house cleaning that I would 
usually do 
H50 I have difficulty doing 1 2 12 1 2 1 2 8 
handwork, for example, 
turning taps, using kitchen 
gadgets, sewing, carpentry 
H51 I am not doing any of the 1 2 12 1 2 1 8 
clothes washing that I would 
usually do 
H52 I am not doing heavy work 1 2 12 1 2 1 2 8 
around the house 
H53 I have given up taking care 1 2 12 1 2 1 2 8 
of personal or household 
business affairs, for example, 
paying bills, banking, L 
working on budget 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H54. Please answer "yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H55) 
FOR EACH ITEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (8) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
17-ý r- DONT 
YES NO YES NO YES NO YES NO KNOW 
H55 I am getting around only 1 2 12 1 2 1 2 8 
within one building 
H56 I stay within one room 1 2 12 1 2 1 2 8 
H57 I am staying in bed more 1 2 12 1 2 1 2 8 
H58 I am staying in bed most of 1 2 12 1 2 1 2 8 
the time 
H59 I am not now using public 1 2 12 1 2 1 2 8 
transportation 
H60 I stay home most of the 1 2 12 1 2 1 2 8 
time 
H61 I am only going to places 1 2 12 1 2 1 2 8 
With toilets nearby 
H62 I am not going into town 1 2 12 1 2 1 2 8 
H63 I stay away from home 1 2 12 1 2 1 2 8 
only for brief periods of 
time 
H64 I do not get around In the 1 2 12 1 2 1 2 8 
dark or in unlit places 
ithout someone's heir) I 
IF R DOES NOT RESPOND TO ANY ITEM ASK: 
enough? Am I reading clearly enough and slowly 
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H65. Please answer "yes' to those statements that you are -sure 
describe you Loday and are 
related to your state of health. (CONTINUE WITH H66) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) "- 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOM 
(A) (B) (C) 
IF YES: IF YES: IF YES: - BECAUSE EXPECTED IMPROVEM ENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
F-+ ý 
I 
r-+ 1 r-, --+ I 
[- 
DONT 
YES NO YES NO YES NO YES NO KNOW 
H66 I am going out less to visit 1 2 12 1 2 1 2 8 
people 
H67 I am not going out to visit 1 2 12 1 2 1 2 8 
people at all 
H68 I show less interest in other 1 2 12 1 2 1 2 8 
people's problems, for 
example, don't listen whe'n 
they tell me about their 
problems, don't offer to 
help 
H69 I often act irritable toward 1 2 12 1 2 2 8 
those around me, for 
example, snap at people, 
give sharp answers, 
criticise easily 
H70 I show less affection 1 2 12 1 2 1 2 8 
H71 I am doing fewer social 1 2 12 1 2 1 2 8 
activities-with groups of 
people 
H72 I am cutting down the 1 2 12 1 2 2 8 
length of visits with friends 
H73 I am avoiding social visits 1 2 12 1 2 2 8 
from others 
H74 My sexual activity is 1 2 12 1 2 2 8 
decreased 
H75 I often express concern 1 2 12 1 2 1 2 8 
over what might be 
happening to my health 
H76 I talk less with those 1 2 12 1 2 -1 2 8 
around me 
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(A) (13) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYO UR IMPROVED ACHIEVED 
YOU VISIO N 
- . ................ 
F-+ 
7 
DONT 
YES NO YES NO YES NO YES NO KNOW 
H77 I make many demands, for 1 2 1 2 1 2 1 2 8 
example, insist that people 
do things for me, tell them 
how to do things 
H78 I -stay alone much of the 1 2 1 2 1 2 1 2 8 
time 
H79 I act disagreeable to family 1 2 1 2 1 2 1 2 8 
members, for example, I act 
spiteful, I am stubborn 
H80 I have frequent outbursts of 1 2 1 2 1 2 1 2 8 
anger at family members, 
for example, strike at them, 
scream, throw things at 
them 
H81 I isolate myself as much as 1 1 2 1 2 1 2 1 2 8 
can from the rest of the 
family 
H82 I am paying less attention to 1 2 1 2 1 2 1 2 8 
the children 
H83 I refuse contact with family 1 2 1 2 1 2 1 2 8 
members, for example,. tum 
away from them 
H84 I am not doing the things 1 1 2 1 2 1 2 1 2 8 
usually do to take care of 
my children or family 
H85 I am not joking with family 1 2 1 2 1 2 1 2 8 
members as I usually do 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H86. ý Please answer "yeso to those statements that you are sure describe you joday and are 
related to your state of health. (CONTINUE WITH H87) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? '(CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESC RIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r i r-* 0 DONT 
YES NO YES NO YES NO 'YES NO KNOW 
H87 I walk shorter distances or 1 2 12 1 2 1 2 8 
stop to rest often 
H88 I do not walk up or down 1 2 12 1 2 1 2 8 
hills 
H89 I use stairs only with 1 2 12 1 2 1 2 8 
mechanical support, for 
example, handrail, walking 
stick, crutches 
H90 I walk up or down stairs 1 2 12 1 2 1 2 8 
only with assistance from 
someone else 
H91 I get around in a 1 2 12 1 2 1 2 8 
wheelchair 
H92 I do not walk at all 1 2 12 1 2 1 2 8 
H93 I walk by myself but with 1 2 12 1 2 1 2 8 
some difficulty, for 
example, limp, wobble, 
stumble, have stiff leg 
H94 I walk only with help from 1 2 12 1 2 1 2 8 
someone 
H95 I go up and down stairs 1 2 12 1 2 1 2 8 
more slowly, for example, 
stop often, one step at a 
time 
H96 I do not use stairs at all 1 2 12 1 2 1 2 8 
H97 I get around only by using -11 2 1 1 2, ý-2 8, 
a Ammer frame, crutches, 
cane, walls, or furniture 
H98 I walk more slowly 1 2 12 1 2 2 8 
IF R DOLS NO I Ktbrum) iu ftN ir iI rm, t%Nr..: AM I reacling clearly enough and slowly 
enough? 
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SECTION G: Time Trade Off Scenario. 
1. How long do you usually spend sleeping (both day and night)? 
Hours 
Minutes 
2. If you have difficulty sleeping, how much sleep do you think you need in total, (both day 
and night)? 
Hours 
Minutes 
I am going to read you a description of someone who takes an IMAGINARY cure'. before you 
answer the remaining questions. - 
Think of someone who has difficulty in seeing, their vision is blurred so that they cannot read 
bus numbers. They also have difficulty making out faces on television. Imagine that this person 
is given a cure that will completely restore their eyesight. The cure has just one snag, the 
person must spend extra time sleeping to rest their eyes. The cure has no other side effects, it is, 
not painful or unpleasant in any way, it just requires the person to give up some time to 
improve their eyesight. of course this means that they will have less time each day to do the 
things they enjoy, but when they are awake, they will have perfect eyesight to do whatever 
they wish. 
Now please forget the person in the story. We are interested in finding out about YOU and 
YOUR eyesight. 
Please spend a little time thinking about the benefits that improved vision would bring to you. 
3. What things would you be able to do if your eyesight is improved? 
Would you be prepared to give up some time to improve your eyesight? 
Yes / No 
If "NO" skip next question 
5. How much EXTRA time would you be prepared to spend sleeping (either during the day 
or at night) to have perfect eyesight? (Please be as precise as possible) 
Hours 
Minutes 
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H 110. Please answer "yeso to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H 111) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES:, Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
I cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: S* 
BECAUSE EXPECTED IMPROVEMENT 6 
DESCRI BE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
NT NT 
YES NO YES NO YES NO YES 0 NO 
=w 
I am having trouble 11 2 12 1 2 1 2 8 
writing or typing 
H1 12 1 communicate mostly by 1 2 12 1 2 1 2 8 
gestures, for example, 
moving head, pointing, 
signlanguage 
H113 My speech is understood 1 2 12 1 2 1 2 8 
only by a few people who 
know me well 
H114 I often lose control of my 1 2 12 1 2 1 2 8 
voice when I talk, for 
example, my voice gets 
louder or softer, trembles, 
changes unexpectedly 
H115 I don't write except to 1 2 12 1 2 1 2 8 
sign my name 
H116 I carry on conversation 1 2 12 1 2 1 2 8 
only when very dose to _ 
the other person or 
looking at him 
H117 I have difficulty speaking, 1 2 12 1 2 1 2 8 
for example, get stuck, 
stutter, stammer, slur my 
words 
H118 I am understood with 1 2 12 1 2 1 2 8 
difficulty I I I I I 
H119 I do not speak dearly 
I 
1 2 
I 
2 1 
- 
2 
T1 
2 8 
when I am under stress 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H120. The next group of statements has to do with any work you usually do other than 
managing your home. By this we mean anything that you regard as work that you do on 
a regular basis. Do you usually do work other than managing your home? 
YES 1 (H 124) 
NO 2 
H 12 1. Are you retired? 
YES 
NO 
H 122. Is your retirement related to your health? 
YES 
NO 
H123. Is your retirement related to your vision? 
1 
2 (H134) 
1 
2 (H 134) 
YES 
NO 
1 (H134) 
2 (H 134) 
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4. Now consider the work you do and answer "yes" to those statements that you are sure 
describe you today and are related to your state of health. (if today is a Saturday or 
Sunday or some other day that you would usually have off, please respond as if today 
were a working day). 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES; Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES:, Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: If YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r --I ----I rl ----4 F-4 DONT 
YES NO YES NO I YES NO YES NO KNOW 
H125 I am not working at all 12 12 12 128 
1 ', -'-*ýVFýYOUiCIRCLED. YE5,, xTO1, T 
AIS, Sf-ATEME NTý Co W, '-RO', A. 
,, a 
-IQ 
- k 111114, 
H126 I am doing part of my job 12 12 12 128 
at home 
H127 I am not accomplishing as 12 12 12 128 
much as usual at work 
H128 I often act irritable 12 12 12 128 
toward my work 
associates, for example, 
snap at them, give sharp 
answers, criticise easily 
H129 I am working shorter 12 12 12 128 
hours 
H130 I am doing only light 12 12 12 128 
work 
H131 I work only for short 12 12 12 128 
periods of time or take 
frequent rests 
H132 I am working at my usual 12 12 12 128 
job but with some 
changes, for example, 
using different tools or 
special aids, trading some 
tasks with other workers 
H133 I do not do my job as 12 12 12 128 
carefully and accurately 
as usual 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H 134. This group of statements has to do with activities you usually do in your free time. 
These activities are things that you might do for relaxation, to pass the time, or for 
entertainment. Please answer "yes' to those statements that you are sure describe you 
today and are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r-4 P r+ --+ r-+ -4 DONT 
YES NO YES NO YES NO YES NO KNOW 
H135 I do my hobbies and 1 2 1 2 1 2 1 2 8 
recreation for shorter 
periods of time 
H136 I am going out for 1 2 1 2 1 2 1 2 8 
entertainment less often 
H137 I am cutting down on 1 2 1 2 1 2 1 2 8 
some of my usual inactive 
recreation and pastimes, 
for example, watching TV, 
playing cards, reading 
H138 I am not doing any of my 1 2 1 2 1 2 1 2 8 
usual inactive recreation 
and pastimes for example, 
watching TV, playing 
cards, reading 
H139 I am doing more inactive 1 2 A 2 1 2 1 2 8 
pastimes in place of my 
other usual activities 
H140 I am doing fewer 1 2 1 2 1 2 1 2 8 
community activities 
H141 I am cutting down on 1 2 1 2 1 2 1 2 8 
some of my usual physical 
recreation or activities 
H142 I am not doing any of my 1 2 1 2 1 2 1 2 8 
usual physical recreation 
or activities 
IF R DOES NOT RESPOND TO-ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H143. Please remember to answer "yes' to those statements that you are sure describe you 
todav are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract operation? (CIRCLE BELOW) 
C. IFYES: Did this improve as much as you had expected it would after your 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
- 
r- ---- r-- r- 
ý ý 
YES NO YES NO YES NO YES NO 
H144 I am eating much less 1 2 12 1 2 1 2 8 
than usual 
H145 I feed myself but only by 1 2 12 1 2 1 2 8 
using specially prepared 
food or utensils 
H146 I am eating special or 1 2 12 1 2 1 2 --8 
different food, for 
example, 
'soft food, bland 
diet, low-salL low-fat low- 
sugar 
H147 I eat no food at all but am 1 2 1,2 1 2 1, 2, 8- 
taking fluids 
H148 I just pick or nibble at my 1 2 1 ý2 1 2 1 2 81 
food 
H149 I am drinking less fluids 1 2 12 1 2 1 2 8 
H150 I feed myself with help 1 2 12 1 2 1 2 8' 
from someone else 
H151 I do not feed myself at all, 1 2 12 1 2 1 2 8 
but 2! ust be fed 
H152 I am eating no food at all, 1 2 12 1 2 1 2 8 
nutrition'is taken through 
tubes or intravenous fluids 
This is the end of this section 
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CLOSING 
This is the end of the interview. Thank you very much for taking the time to answer these 
questions. The information you have given us has been very important to this study 
I will see you again in eight months time to see how you are doing. We shall 
contact you shortly before we are due to see you again. 
TIME TAKEN FOR INTERVIEW: 
TO BE COMPLETED BY INTERVIEWER AT THE END OF THE INTERVIEW. 
(Please Tick as appropriate) 
PWI a., Patients first language is English. 
PWI b. 
- 
Patients first language, other 
PW2. Interview conducted in out-patient cliniq at clinical follow-up visit 
PW3. Interview conducted elsewhere in the hospital, at clinical follow-up visit 
PW4. 
- 
Interview conducted in hospital at some other time 
PW5. 
- 
Interview conducted at patient's home 
PW6. 
_ 
Interview completed in a single session 
PW7. 
- 
Interview completed in two half sessions 
PW8. 
- 
Interview started, but terminated 
PW9. 
- 
Interview not completed 
PWI 0. 
_ 
Interview started, but failed cognitive scale 
Use this space for details about cases with responses PW3-PW4, or PW7 - PWI 0 
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THE CATARACT OUTCOME STUDY 
THE WELLHOUSE TRUST 
12 MONTH FOLLOW-UP INTERVIEW 
Patient Name: 
Hospital Number: 
Consultant: 
Date of Interview- 
Interviewer: 
Patient ID 
IIII 
THE CATARACT OUTCOME STUDY 
12 MONTH FOLLOW-UP INTERVIEW 
INTERVIEWER: To conduct this interview you will need to know: 
1. First eye operated on (Right or Left) 
2. Date of 1 st cataract operation 
3. Status of 2nd eye at 4 month interview 
. 4. 
Date of 4 month interview 
5. Date of 2nd eye surgery 
6. Driving status at 4 month interview 
7. Activity limitations reported at Baseline 
Introduction to Patient. 
Hello, my name is - You may remember that I am one of 
the Cataract Outcome Study team members from the College of Ophthalmologists 
and that your eye consultant is taking part in this study. It is now time for our twelve 
month follow-up interview. 
In this third interview we will again ask you questions about your vision, general 
health, everyday activities now that you have had your first cataract operation. 
Again, you may refuse to answer any questions at any time during the interview. 
The interview will take about 45 minutes. 
Shall we begin? f, 
Yes 1 
No 2 Reason if any 
COGNITIVE SCALE 
IF PATIENT SEEMS TO BE CONFUSED, SEEMS UNABLE TO UNDERSTAND WHAT YOU 
HAVE SAID TO THEM IN THE INTRODUCTION, OR SEEMS MENTALLY UNABLE TO 
TAKE PART IN THE INTERVIEW, PLEASE ASK THE FOLLOWING QUESTIONS: 
First, I have a few general questions. 
CORRECT WRONG 
1. What is your full name? 1 2 
2. How old are you? 1 2 
3. When were you born? 1 2 
4. Where were you born? 1 2 
5. What is your mother's first name? 1 '2 
6. What is your father's first name? 1 2 
7. Who is the Prime Minister? 1 2 
8. Who was the Prime Minister before this one? 1 2 
9. What year is this? 1 2 
10. What month is this? 1 2 
11. What day of the month is this? (What is the date? ) 1 2 
12. What is the name of the c1ty or town you are in? 1 2 
13. What day of the week is it? 1 2 
14. What time is it now? 1 2 
BOX I 
IF PATIENT ANSWERS 4 OR MORE QUESTIONS INCORRECTLYp 
TERMINATE INTERVIEW: 
Thank you very much for your help. That is all the information we need. 
OTHERWISE CONTINUE. 
2 
SECTIONA: GENERAL QUESTIONS ABOUT VISION 
AX-1- AX5 NOT IN THIS VERSION 
AX-6 CHECK LABEL: WHAT WAS STATUS OF SECOND EYE AT TIME OF 4-MONTH 
INTERVIEW? 
NO CATARACT IN SECOND EYE 1 
CATARACT, NO SURGERY SCHEDULED 2 (AX-8) 
CATARACT SCHEDULED FOR REMOVAL 3 (AX-8) 
CATARACT ALREADY REMOVED 4 (AX-9) 
AX-7 Since our last interview 8 months ago in (MONTH OF FOUR-MONTH INTERVIEW), 
have you been told you have a cataract in your other eye? 
YES 1 
NO 2 (Al) 
AX-8 Have you had cataract surgery in your other eye since the last interview? 
YES 1 (AX-9A) 
NO 2 
AX-8A Is surgery scheduled for that eye? , 
YES 1 
NO 2 (Al) 
DONTKNOW 3 (Al) 
AX-813 On what date is that operation scheduled? 
DATE /19 
OR 
DONTKNOW 9-8 
GO TO All 
AX-9 My records show that you had the cataract in your (SECOND EYE) removed on 
(DATE OF SECOND SURGERY). Is that correct? ' 
YES 1 (AX-9 B) 
NO 2, 
DONT KNOW 3 (AX-913) 
AX-9A When was the cataract in that eye removed? 
DATE /19 
AX-913 Did your vision get better, worse or stay about t he same after the second cataract 
was removed? 
BETTER 
WORSE ý2 THESAME 3 
DONT KNOW 8 
3 
AM 0- AM 2 NOT IN THIS VERSION 
Al. How much trouble do you now have with your vision? Is it none, a little, a moderate 
amount, or a great deal? 
NONE 1 
LITTLE 2 
MODERATE 3 
GREAT DEAL 4 
AX-13 Overall, is your vision better, worse, or about the same now as it was at our last 
interview 8 months ago (MONTH OF 4 MONTH INTERVIEW), that is 4 months after 
your first cataract operation? 
BETTER 1 
WORSE 2 
THESAME 3 
DONT KNOW 8 
AX-1 3A Overall, how satisfied are you now with your vision? Are you: 
Very satisfied 1 
Satisfied 2 
Dissatisfied or 3 
Very dissatisfied? 4 
AX-14 Now thinking specifically about the (first) eye that was operated on, is your vision in 
that eye better, worse, or about the same now as it was at our last interview 8 months 
ago? 
BETrER 1 (AX-1 4C) 
WORSE 2 
THESAME 3 (AX14C) 
DONT KNOW 8 (AX14C) 
AM 4A Could you describe how your vision is worse? 
AX-1 4B When did you notice a change? 
AX-14C How satisfied are you now with your vision in your (FIRST EYE OPERATED ON)? Are 
you: 
Very satisfied 1 
Satisfied 2 
Dissatisfied or 3 
Very dissatisfied? 4 
AX-15, A2-A9 NOT IN THIS VERSION 
Al 0. Do you currently wear glasses or contact lenses? 
YES 1 (Al Oa) 
NO 2 (Al 1) 
4 
Al Oa. Do you wear them for reading, to see things that are far away, or both? (IF PATIENT 
SAYS"BIFOCAU, CIRCLE BOTH) 
READING 1 
FAR AWAY 2 
BOTH 3 
Al 1. 'During the past month have you been bothered by any of the following- symptoms in 
- -the 
(first) eye that was operated on to have your cataract removed? (CIRCLE BELOV4 
IF YES: ASK: 
How bothersome is it: Very, somewhatý not at all? (CIRCLE BELOW) 
B. 
. 
Are you being treated for this problem? (CIRCLE BELOW) 
(A) (13) 
IF YES TREAT- 
BOTHERED HOW BOTHERSOME? MENT 
SOME A NOT 
YES NO VERY WHAT UME AT ALL YES NO 
A12. Red painful or 1 2 1 23 4 1 2 
tender eye 
A13. Feeling as if 1 2 1 23 4 1 2 
something were 
in your eye 
A14. Watery 1 2 1 23 4 1 2 
burning or 
itching eye 
A15. Double vision or 1 2 1 23 4 1 2 
distorted vision 
A16. A drooping eyelid 1 2 1 23 4 1 2 
Al 7. Spots floating 1 2 1 23 4 1 2 
before ycxjr eye 
A18. Clare halo or 1 2 1 23 4 1 2 
seeing rings 
around light 
A19. Blurry vision with 1 2 1 23 4 1 2 
your most recent 
glasses 
A20. Things seeming 1 2 1 23 4 1 2 
brighter than they 
used to in a way 
that is disturbing 
A2 1. Colours looking 1 2 1 23 4 1 2 
different than they 
used to in a way 
that is disturbing 
A22. A worsening of 1 2 1 23 4 1 2 
your vision in the 
past month In 
the eye having 
surgery 
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A23. Do you currently have any other eye problems, conditions, or symptoms? 
YES 1 
NO 2 (A24) 
A23a. What are these? (RECORD UP TO 3) 
1 
2. 
3. 
A24. CHECK INFORMATION SHEET: WHAT WAS R'S DRIVING STATUS AT TIME OF LAST 
INTERVIEW? 
NEVER DROVE 1 
WAS NOT DRIVING THEN 2 (A2413) 
WAS DRIVING THEN 3 (A24D) 
A24A At the time of the last interview 8 months ago, you said you had never driven a car. 
Have you started driving since then? 
YES 1 (A28) 
NO 2 (A34) 
A24B At the time of the last interview 8 months ago, you said you were not driving. Are you 
driving a car now? 
YES 1 (A28) 
NO 2 
A24C Why are you not driving now? (CIRCLE ONE) 
VISION 1 (A34) 
OTHER ILLNESS 2 (A34) 
OTHER REASON 3 (A34) 
A24D. At the time of the last interview 8 months ago, you said you were driving a car, Are you 
still driving a car? 
YES 1 (A28) 
NO 2 (A25X) 
A25. NOT IN THIS VERSION 
A25X CHECK INFORMATION SHEET AND QUESTION AX-8: HAS R HAD SURGERY ON 
SECOND EYE? 
YES 1 
NO 2 (A2 7) 
6 
A26. When did you stop driving? Was it 
After your first cataract surgery but 1 
before your second surgery, or 
After your second cataract surgery? 2 
A27. Why did you stop driving? 
VISION 1 
OTHER ILLNESS 2 
OTHER REASON 3 
GO TO A30 
A28. How much difficulty do you have driving during the day because of your vision? Do 
you have: 
No difficulty, 1 
A little difficulty, 2 
A moderate amount of difficulty, or 3 
A great deal of difficulty? 4 
A28a. Has your ( firjst cataract operation made it easier for you to drive during the day? 
YES 1 
NO 2 
A29. How much difficulty do you have driving at night because of your vision? Do you 
have: 
No difficulty, --1 
A little difficulty, 2 
A moderate amount of difficulty, or 3 
A great deal of difficulty? 4 
DO NOT DRIVE AT NIGHT 5 (A30) 
A29a Has your (first) cataract operation made it easier for you to drive at night? 
YES 1 
NO 2 
7 
A30. Since the last interview 8 months ago, have you been involved in any road traffic 
accidents while ygu were driving? 
A3 1. What kind of accident? 
A32. Do you think this was 
because of your vision? 
YES 1 (A31) 
NO 2 (A34) 
DID NOT DRIVE DURING PAST YEAR 3 (A34) 
FIRST SECOND 
YES 1 
NO 2 
A33. Were there any others? 
YES 1 (A31 B) 
NO 
12 
(AW 
1 (A34) 
2 (A34) 
A34. Now I'd like to ask you about injuries or accidents you may have had, since the last 
interview 8 months ago (MONTH OF 4-MONTH INTERVIEW), and now have you had any 
injuries or accidents, such as cuts, bruises, burns, sprains, fractures or falls? 
YES 1 
NO 2 (A35) 
A34a. What kind of accident? 
Probe for following: 
1. Type of injury eg. burn 
2. Site of injury eg. arm / leg 
3. How injury occured eg. iron 
A34b. Do you think this was 
because of your vision? 
YES 
NO 
A34c. Were there any other 
accidents / injuries this year ? 
YES 
NO 
SECOND 
1 1 
2 - 2 
1 
2 
1 (A34aB) 
2 (BOX 1) 
1 (BOX 1) 
2 (BOX 1) 
S 
BOXII 
RECORD"LIMITED ACTIVITIES' FROM BASELINE INTERVIEW, BELOW: 
MOST IMPORTANT: 
2ND MOST IMPORTANT: 
3RD MOST IMPORTANT- 
IF NO LIMITED ACTIVITIES REPORTED, SKIP TO A39 
A35. Before your first cataract operation, you said that you were limited in doing (FIRST 
ACTIVITY) because of your eyesight. Compared to your ability (ACTIVITY) before your 
first cataract operation, would you say your ability to do this(ACTIVITY) now is better, 
worse, or about the same? 
BETTER I 
WORSE 2 (A35b) 
ABOUT THE SAME 3 (A35b) 
CAN'T DO FOR OTHER REASONS 6 (BOX 2) 
HASN'T TRIED IT YET 7 (BOX 2) 
A35a. Has your ability to do this improved as much as you expected it would as a result of the 
(first) cataract operation? 
YES 
NO 2 
A35b. Compared to your ability to (ACTIVITY) at the time of the last interview 8 months ago, 
would you say your ability to (ACTIVITY) now is better, worse, or about the same? 
BUTER 1 
WORSE 2 
ABOUTTHESAME 3 (BOX2) 
A35c. Are you now able to do (ACTIVITY) with: 
No difficulty 1 
A little difficulty, 2 
A moderate amount of difficulty, 3 
A great deal of difficulty, or 4 
Are you unable to do it? 5 
BOX 2 
IF ONLY ONE LIMITED ACTIVITY 
REPORTED, SKIP TO A39; 
OTHERWISE CONTINUE. 
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A36 Before your first cataract operation, you said that you were limited in (SECOND 
ACTIVITY) because of your eyesight. Compared to your ability to (ACTIVITY) before 
your first cataract operation, would you say your ability to (ACTIVITY) now is better, 
worse, or about the same? 
BETTER 1 
WORSE 2 (A36b) 
ABOUT THE SAME 3 (A36b) 
CANT DO FOR OTHER REASONS 6 (BOX 3) 
HASN'T TRIED IT YET 7 (BOX 3) 
A36a Has your ability to do this improved as much as you expected it would as a result of the 
Lfirst ) cataract operation? 
YES 1 
NO 2 
A36b Compared to your ability to (ACTIVITY) at the time of the last interview 8 months ago, 
would you say your ability to (ACTIVITY) now is better, worse, or about the same? 
BETTER 1 
WORSE 2 
ABOUT THE SAME 3 (BOX 3) 
A36c Are you now able to do (ACTIVITY) with: 
No difficulty 1 
A little difficulty, 2 
A moderate amount of difficulty, 3 
A great deal of difficulty? 4 
Are you unable to do it? 5 
BOX 3 
IF ONLY TWO LIMITED ACTIVITIES 
REPORTED, SKIP AS TO A39: 
OTHERWISE CONTINUE 
A37. Before your first cataract operation, you said that you were limited in (THIRD ACTIVITY) 
because of your eyesight. Compared to your ability to (ACTIVITY) before your first 
cataract operation, would you say your ability to (ACTIYITY) now is better, worse, or 
about the same? 
BETTER I 
WORSE 2 (A37b) 
ABOUT THE SAME 3 (A37b) 
CANT DO FOR OTHER REASONS 6 (A39) 
HASN'T TRIED IT YET 7 (A39) 
10 
A3 7a ' Has your ability to do this improved as much as you expected it would as a result of the 
first cataract operation? 
YES 1 
NO 2 
A37b Compared to your ability to (ACTIVITY) at the time of the last interview 8 months ago, 
would you say your ability to (ACTIVITY) now is better, worse, or about the same? 
BETTER 
WORSE 2 
ABOUTTHE, SAME 3(A39) 
A37c. Are you now able to do (ACTIVITY) with: 
No difficulty 1 
A little difficulty, 2, 
A moderate amount of difficulty, 3 
A great deal of difficulty? 4, 
Are you unable to do it? 5 
A38 NOT IN THIS VERSION 
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A39. Do you have any difficulty even with glasses in doing any of the following activities? 
(CIRCLE BELOW. IF PATIENT STATES S/HE DOES NOT DO THAT ACTIVITY, CIRCLE 
N/A FOR NOT APPLICABLE) 
IF YES: ASK: 
A. How much difficulty do you currently have: A little, a moderate amount, a great 
deal or are you unable to do (INSERT ACTIVITY)? (CIRCLE BELOW) 
(A) 
DIF FICULTY IF YES: 
HOW MUCH 
Yes No N/A A MODERATE CREAT UNAKE 
trmf AMOUNT DEAL TO DO 
A40 Reading small print such as 
labels on medicine botdesa 1 2 3 1 2 3 4 
telephone book, food labels 
A41 Reading a newspaper or a 1 2 3 1 2 3 4 
book 
A42 Reading a large print book 1 2 3 1 2 3 4 
print or large print newspaper 
or numbers on a telephone 
A43 Recognizing people when 1 2 3 1 2 3 4 
they are close to you 
A44 Seeing steps, stairs or kerbs 1 2 3 1 2 3 4 
A45 Reading traffic signs, street 1 2 3 1 2 3 4 
signs, shop signs 
A46 Doing fine handwork like 1 2 3 1 2 3 4 
sewing, knitting, crochefin& 
carpentry 
A47 Wrifing letters, cheques, or 1 2 3 1 2 3 4 
filling out forms 
A48 Playing games such as bingo, 1 2 3 1 2 3 4 
dominos, card games 
A49 Taking part in sports like 1 2 3 1 2 3 4 
bowling, handball, tennis, golf 
ASO Cooking 1 2 3 1 2 3 4 
A51 Watching television 1 2 3 1 2 3 4 
A52 Getting about indoors 1 2 3 1 2 3 4 
A53 Getting about outdoors 1 2 3 1 2 3 4 
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SECTION BX: PHYSICIAN FOLLOWUP 
BX-1 Now I'd like you to think about all the eye care you have received in the 8 months since 
the last interview (MONTH OF FOUR-MONTH INTERVIEW). Are you still being 
followed up in your Eye ConsultanVs Clinic for the eye that had the first operation? 
YES I (Bx-5) 
NO 2 
BX-2. When did you last see (him/her)? 
DATE /19 
PROBE: IF R DOESN'T KNOW MONTH, ASK HOW LONG AFTER SURGERY S/HE 
LAST SAW DOCTOR. 
BX-3. At that time, did the eye doctor who saw you tell you that s/he no longer needed to 
see you? 
YES I (Box 4) 
NO 2 
BX-4. Why did you stop seeing your Eye Consultant? 
L GO TO BOX 4 
BX-5. When did you last see (him/her)? 
DATE /19 
PROBE: IF R DOESN'T KNOW MONTH, ASK HOW LONG AFTER SURGERY S/HE 
LAST SAW DOCTOR. 
BOX 4 
CHECK BX-2 OR BX-5 
R LAST SAW DOCTOR BEFORE 4-MONTH INTERVIEW 1 (BX-6) 
R LAST SAW DOCTOR AFTER 4-MONTH INTERVIEW 2(BX-7) 
R DOESN'T KNOW 3(BX-6) 
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BX-6. Have you seen anyone else for eye care since the last interview 8 months ago? Have 
you seen: 
YES NO 
a. Another ophthalmologist? 12 
b. An optometrist/ optician? 12 
C. Your GP? 12 
GO TO BX-8 
BX-7. Have you seen anyone else for eye care since your last visit to your Eye Consultant/Eye 
doctor in (DATE FROM BX-2 OR BX-5)? Have you seen: 
YES NO 
a. Another ophthalmologist? 12 
b. An optometrist/ optician? 12 
C. Your GP? 12 
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SECTION B: SATISFACTION WITH CARE 
Thinking about the medical care you are receiving for yourcataracts from all of the doctors 
caring for your eyes since the time you decided to have your cataract removed, would you' rate 
the following as excellent, very good, good, fair, or poor? 
(CIRCLE ANSWER) 
I, I DOES 
VERY I NOT DONT 
FXrFl I FNT r. r)r)n nrinn rAII2 Dn^D A nni W 
B1. Attention your eye doctor(s) gave to what 
you had to say 1 2 3 4 5 7 8 
B2. Amount of time you had with your eye 
doctor(s) during a visit 1 2 3 4 5 7 8 
B3. Amount of time you had with your eye 
doctor(s)'staff during a visit 1 2 3 4 5 7 8 
B4. Friendliness and courtesy shown to you by 
your eye doctor(s) 1 2 3 4 5 7 8 
B5. Friendliness and courtesy shown to you by 
your eye doctor(s)'staff 1 2 3 4 5 7 8 
B6. Your eye doctor(s)' personal interest in 
you and your medical problems 1 2 3 4 5 7 8 
B7. Reassurance and support offered to you 
by your eye doctor(s)'staff 1 2 3 4 5 7 8 
B8. Consideration of your personal needs and 
wants in deciding whethe to perform 
cataract surgery in your other eye 1 2 3 4 5 7 8 
B9. NOT IN THIS VERSION 
B10. The opportunity you had to ask all the 
questions you wanted to about your 
cataracts and cataract surgery 1 2 4 5 7 8 
B11 The answers your doctor(s) gave to all the 
questions you asked about your cataract 
and cataract surgery 1 2 3 5 7 8 
I '. -- 
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1312. Some doctors explain more things to patients than other doctors. We would like you to 
tell us whether your eye doctor(s) or anyone in their hospital explained the following 
things to you. Did you receive: (CONTINUE WITH B 13) 
A. FOR EACH ITEM ANSWERED YES, ASK: Was the explanation excellent, very good, good, 
fair, or poor? 
IF YES: RATING OF EXPLANATION 
VERY DON'T 
YES NO 
I 
EXCELLENT GOOD GOOD FAIR POOR KN40W 
813. Explanations of procedures and 
tests performed after your first 
cataract operation 12 12345 
B13X Explanations of any problems that 
may have developed since your 
first cataract operation 12 12345 
B14B NOT IN THIS VERSION [23 
Thinking about the medical care you received for your cataracts during the last 8 months from all of 
the doctors caring for your eyes, would you rate the following excellený very good, good, fair, or 
poor? (CIRCLE ANSWER). 
DOES 
VERY NOT I)ON'T 
EXCELLENT GOOD GOOD FAIR POOR APPLY KNOW 
B24 NOT IN THIS VERSION 
B25 Convenience of the hospital location 1 2 3 4 5 7 8 
B26 Hours when hospital visits can be scheduled 1 2 3 4 5 7 8 
B27 How easy it was to get back and forth from 
your cataract surgery 1 2 3 4 5 7 8 
B28 Arrangements for making appointments by 
phone 1 2 3 4 5 7 8 
629 Length of time you wait between making an 
outpatient appointment and the day of your 1 2 3 4 5 7 8 
visit. 
B30 Length of time spent waiting at the outpatient 
clinic to see your eye doctor(s) 1 2 3 4 5 7 8 
B31 Availability of information or advice by phone 
1 2 3 4 5 7 8 
B32 How easy it is for you to reach your eye 
doctoqs) or their nurse if you need to 
talk to them 1 2 3 4 5 7 8 
B33 The thoroughness of the eye examination(s) 
ww--Mwý 
since your cataract operation 1 2 3 4 5 7 8 
B34 NOT IN THIS VERSION 
B35 Completeness and quality of your eye 
doctor(s) department and facilities 1 2 3 4 5 7 8 
B36 All things considered, the care I have 
received for my cataract(s) has been 1 2 3 4 5 7 8 
1337 Now, thinking about all the medical care -- 
that you receive, would you rate that as 1 2 3 4 5 7- 
'871 
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SECTION C: GENERAL HEALTH STATUS 
C1. In general, would you say your health is excellent very good, good, fair, or poor? 
EXCELLENT 1 (C2) 
VERY GOOD 2 (C2) 
GOOD 3 (C2) 
FAIR 4 (Cl a) 
POOR 5' (Cl a) 
Cla. ýDo you rate your health as (fair/poor) because of your vision? 
YES 1 
NO 2 (C2) 
C1 b, C1 c NOT IN THIS VERSION 
C2. Compa ed to other people your own age how would you rate your health? Would you 
say it is: 
Much better, 1 (Q) 
Somewhat better, 2 (Q) 
About the same, 3 (C3)' 
Somewhat worse, or 4 (C2a) 
Much worse? 5 '(C2a) 
C2a. Do you think your health is (somewhat/much) %ýorse than othe'rs yo ,U, r own age 
because of your vision? 
YES 
NO 2 
C2b. - C2c NOT IN THIS VERSION 
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C3. At the present time do you have any other health problems that you may need to see a 
doctor about regularly? 
[Allow the patient to respond freely first ticking off any conditions mentioned on the list 
below]. Then ask: 
At the moment do you have any of the following conditions or symptoms? 
IF YES: (A) IF YES: 
A. How much does it interfere with your activities: How much 
does it 
Not at all, a little (some), or a great deal? 
interfere? 
YES NO 
NOT 
AT 
ALL 
A 
LITTLE 
A 
GREAT 
DEAL 
C4. Stomach, bowel or intestinal trouble 1 2 1 2 3 
C5. Trouble with bladder, urine, kidneys 1 2 1 2 3 
C6. FOR WOMEN: Diseases of the ovaries or uterus 1 2 1 2 3 
C7. FOR MEN: Prostate trouble 1 2 1 2 3 
C8. Serious trouble with one or both ears or trouble 1 2 1 2 3 
with hearing 
C9. Frequent trouble with gums or mouth 1 2 1 2 3 
C10. Frequent foot trouble (for example, bunions, in 1 2 1 2 3 
growing toenails) 
CI 1. Frequent skin trouble (for example, eczema) 1 2 1 2 3 
C12. Anaernia (low red blood cell count) 1 2 1 2 3 
C13. Phlebitis or thrombophlebitis or blood clot in 1 2 1 2 3 
veins or arteries 
C14. High blood pressure or hypertension 1 2 1 2 3 
CIS. Any heart trouble, hardening of arteries 1 2 1 2 3 
(arteriosclerosis) or effects of heart attack, angina 
C1 6. Effects of a stroke or cerebrovascular disease 1 2 1 2 3 
CI 7. Diabetes 1 2 1 2 3 
C18. Cancer or malignant tumour or growth 1 2 1 2 3 
C1 9. Recurring gall bladder or liver trouble 1 2 1 2 3 
C20 Haemon-hoids or piles 1 2 1 2 3 
C2 1. Repeated attacks of sinus trouble 1 2 1 2 3 
C22. Hay fever or other allergy 1 2 1 2 3 
C23. Thyroid trouble or goitre 1 2 1 2 3 
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IF YES: How much does it 
interfere? 
NOT A 
AT A GREAT, 
YES NO ALL L117LE DEAL 
C24. Emotional, nervous or mental problem 1 27 -1 2 3 
C25. Arthritis, rheumatism, bursitis 1 2 1 2 3 
C26. Paralysis 1 2 1 2 3 
C27. Repeated trouble with back or spine 1 2 1 2 3 
C18. Trouble with circulation in arms or legs 2 1 2 3, 
C29. Oedema or water retention 2 1 2 3 
C30. Effects of fractured or broken bones 2 1 2 3 
C3 1. Asthma 1 2 1 2 3 
C32. Chronic bronchitis or emphysema 1 2 1 2 3 
C33. Tuberculosis 1 2 1 2 3 
C34. Some other major problem (SPECIFY) 2 2 3 
SECTION DX NOT IN THIS VERSION 
V, 
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SECTION D: MEDICAL CARE 
D1. Now I would like to ask you about the medical care you have received since the last 
interview in (MONTH OF FOUR-MONTH INTERVIEW). During this time, have you 
been admitted* to a hospital as an innatient - either for an overnight stay or, for a "same 
day' procedure? 
YES 1 
NO 2 (D2) 
Dla. On how many different occasions have you been admitted to the hospital as an 
inpatient between (MONTH OF FOUR-MONTH INTERVIEW) and now? 
NUMBER OF OCCASIONS: 
Di b. Including all these occasions, how many nights have you spent in a hospital between 
(MONTH OF FOUR-MONTH INTERVIEW) and now? 
NUMBER OF NIGHTS: 
D2. Have you been a patient in a hospital casualty department between (MONTH OF 
FOUR-MONTH INTERVIBM and now? (Do not count the instances in which you have 
been hospitalized) 
YES 1 
NO 2 (D3) 
132a. How many times have you been a patient in a hospital casualty department between 
(MONTH OF FOUR-MONTH INTERVIEW) and now? 
NUMBER OF TIMES: 
D3. Have you been an outpatient in a hospital or visited a hospital clinic between (MONTH 
OF FOUR-MONTH INTERVIEV4 and now? (Do not count casualty department visits or 
visits to eye doctor or eye clinics) 
YES 1 
NO 2 (D4) 
D3a. How many times have you been an outpatient or visited a hospital clinic between 
(MONTH OF FOUR-MONTH INTERVIEM and now? (Do not -count casualty 
department visits or visits to eye doctors or eye clinics) 
NUMBER OF TIMES: 
D4. Now I would like to know how many times you havc seen your G. P. between (MONTH 
OF FOUR-MONTH INTERVIEW) and now? 
NUMBER OF TIMES: 
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D5. Between (MONTH OF FOUR-MONTH INTERVIEW) and now, how many times have 
you seen each of the following? 
a. Your eye consultant?: 
b. An optometrist?: 
c. Any other eye doctor?: 
d. The doctor who did your cataract operation? 
NOW I WOULD LIKE TO ASK YOU ABOUTTHE SERVICES THAT YOU HAVE RECEIVED IN 
YOUR HOME. 
D6. Since our last interview 8 months ago, have you received any of these ("SERVICES") in 
your home? (CIRCLE BELOW) 
For each answered YES ask how many times did you use this service in the past 2 
weeks? 
(A) RECEIVED 
(in last 8 
months) 
(B) 
IF YES, HOW MANY 
TIMES? 
(Past 2 Weeks) 
SERVICES YES NO ' DK DK 
D7 District Nurse 1 2 8 8 
D8 Homecare services - home help 1 2 8 8 
to do cleaning / laundry 
D9 Assistance from' relatives or 1 2 8 8 
friends? (Shopping, cleaning, 
driving) 
D10 Assistance with meal 1 2 8 8 
preparation or delivery of meals 
(meals on wheels) 
D11 Other 
I 
1 2 8 8 
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SECTION G: Time Trade Off Scenario. 
1. How long do you usually spend sleeping (both day and night)? 
Hours 
Minutes 
2. If you have difficulty sleepin& how much sleep do you think you need in total, (both day 
and night)l 
Hours ' 
Minutes 
I am going to read you a description of someone who takes an IMAGINARY cure before you 
answer the remaining questions. 
Think of someone who has difficulty in seeing, their vision is blurred so that they cannot read 
bus numbers. They also have difficulty making out faces on television. Imagine that this person 
is given a cure that will completely restore their eyesight. The cure has just one snag, the 
person must spend extra time sleeping to rest their eyes. The cure has no other side effects, it is 
not painful or unpleasant in any way, it just requires the person to give up some time to 
improve their eyesight. Of course this means that they will have less time each day to do the 
things they enjoy, bu4 when they are awake, they will have perfect eyesight to do whatever 
they wish. 
Now please forget the person in the story. We are interested in finding out about YOU and 
YOUR eyesight. 
Please spend a little time thinking about the benefits that improved vision would bring to you. 
3. What things would you be able to do if your eyesight is improved? 
4. Would you be prepared to give up some time to improve your eyesight? 
Yes / No 
If *NO* skip next question 
5. How much EXrRA time would you be prepared to spend sleeping (either during the day 
or at night) to have perfect eyesight? (Please be as precise as possible) 
Hours 
Minutes 
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SECTION H: GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS 
As in the last interview, I am going to ask you a series of questions about the every day 
activities you do to see if there has been a change. I will start with the instructions. 
You have certain activities that you do in carrying on your life. Sometimes you do all of these 
activities. ' Other times, because of your state of health, you don't do these activities in the usual 
way: you may cut some out, you may do some for shorter lengths of time, you may do some in 
different ways. These changes in your activities might be recent or long standing. We are 
interested in learning about AU changes that describe you today and are related to your state 
of health. 
I will be reading statements that people have told us describe them when they are not 
completely well. Whether or not you consider yourself sick, there may be some statements 
that will stand about because they describe ygu today and. are related to your state of health. 
As I read the questions, think of yourself today. I will pause briefly after each statement. When 
you hear one that does describe you and is related to health please tell me and I will check it. 
Let me give you an example. I might read the statement "I am not driving my car". If this 
statement is related to your health and describes you today, you should tell me. Also,. if you 
have not been driving for some time because of your health, and are still not driving today, you 
should answer "yes' to this statement 
On the other hand, if you never drive or are not driving today because your car is being 
repaired, the statement; "I am not driving my car" is not related to your health and you should 
not respond to it. if you simply are driving less, or are driving shorter distances, and feel that 
the statement only partially describes you, please do not respond to that statement as well. 
Please tell me if you want me to slow down, repeat a statement; or stop so that you can think 
about one. Also let me know any time you would like to review the instructions. Remember 
we are interested in the recent or long standing changes in your- activities that are related to 
your health. 
This section is based on a copyrighted measure, the Sickness Impact Profile. It may not be 
reproduced or used without permission. 
Permission may be granted by: 
Dr. Marilyn Bergner 
Johns Hopkins School o Hygiene and Public Health 
624 N. Broadway 
Baltimore, MD 21205. 
23 
SECTION H: GENERAL HEALTH STATUS AND VISUAL HEALTH STATUS -1- ý 
H1. Please answer 'yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H2) 
FOR EACH [TEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since Lirg your cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your first 
cataract operation? (CIRCLE BELOW) 
(A) (8) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r-4 r-4 --4 r-O --# DONT .- 
YES NO VIES NO vrS NO YES NO KNOW 
H2. I spend much of the day 1 2 12 1 2 1 2 8 
lying down in order to 1, 
rest 
H3. I sit during much of the 1 2 12 1 2 1 2 8 
day 
H4. I am sleeping or dozing 1 2 12 1 2 1 2 8 
most of the time day and 
night 
HS. I lie down more often 1 2 12 1 2 1 2 8 
during the day in order to 
rest 
H6. I sit around half-asleep 1 2 12 1 2 1 2 8 
H7. I sleep less at nighL for 1 2 12 1 2 1 2 8 
example, wake up too 
early, don't fall asleep for 
a long time, awaken 
frequently 
H8. I sleep or nap more 1 2 12 1 2 1 2 8 
during the day 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H9. Please answer "yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H10) 
FOR EACH ITEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? 
(CIRCLE BELOM 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYO UR IMPROVED ACHIEVED 
YOU VISION 
r i r-+ ---4 
1 
DONT' 
YES NO YES NO YES NO YES NO KNOW 
1-110. 1 say how bad or useless 1 2 1 2 1 2 1 2 8 
1 am, for example, that I 
am a burden on others 
HII. - I laugh or cry suddenly 1 2 1 2 1 2 1 2 8 
1112. 1 often moan and groan 1 2 1 2 1 2 1 2 8 
in pain or discomfort 
H13. I have attempted suicide 1 2 1 2 1 2 1 2 8 
H14. I act nervous or restless 1 2 1 2 1 2 1 2 8 
1-115. 1 keep rubbing or holding 1 2 1 2 1 2 1 2 8 
areas of my body that 
hurt or are 
uncomfortable 
H16. I act irritable and 1 2 1 2 1 2 1 2 8 
impatient with myself, for 
example, talk badly 
about myself, swear at 
myself, blame myself for - things that happen 
H17. I talk about the future in 1 2 1 2 1 2 1 2 8' 
a hopeless way . 
H 18. 1 get sudden frights 1 2 1 2 1 2- 1 2 8 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H19. Please remember to answer *yes* to those statements that you are sure describe you 
today and are related to your state of health. (CONTINUE WITH H20) 
FOR EACH iTEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF VES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your (first) 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OF YOUR IMP ROVED ACHIEVED 
Yok) VISION 
r# 
__ 
--- #I 
- 
r-4 --- # DONT 
yrs NO YFS NO VF% NO YES NO KNOW 
H20 I make difficult moves with 1 2 1 2 1 2 1 2 8 
help, for example, getting 
into or out of cars, 
bathtubs 
H21 I do not move into or out 1 2 1 2 1 2 1 2 8 
of bed or chair by myself 
but am moved by a person 
or Mechanical aid 
H22 I stand only for short 1 2 1 2 1 2 1 2 8 
periods of time 
H23 I do not maintain balance 1 2 1 2 1 2 1 2 8 
H24 I move my hands or ringers 1 2 1 2 1 2 1 2 8 
with some limitation or 
difficulty 
H25 I stand up only with 1 2 1 2 1 2 1 2 8 
someone's help 
H26 I kneel, stop, or bend 1 2 1 2 1 2 1 2 8 
down only by holding on 
to something 
H27 I am in a restricted position 1 2 1 2 1 2 1 2 8 
all the time 
H28 I am very clumsy in body 1 2 1 2 1 2 1 2 8 
movements 
H29 I get In and out of bed or 1 2 1 2 1 2 1 2 8 
chairs by grasping 
something for support or 
using a stick or zimmer 
walking frame 
H30 I stay lying down most of 1 2 1 2 1 2 1 2 8 
the time 
H31 I change position 1 2 1 2 1 2 1 2 8 
frequendy 
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(A) (8) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVE MENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r-4 r- r) DONT 
YES NO YES NO YES NO YES NO KNOW 
H32 I hold onto something to 1 2 12 1 2 1 2 8 
move myself around in bed 
H33 I do not bathe myself 1 2 12 1 2 1 2 8 
completely, for example, 
require assistance with 
bathing 
H34 I do not bathe myself at all, 1 2 12 1 2 1 2 8 
but am bathed by 
someone else 
H35 I use bedpan with 1 2 12 1 2 1 2 8 
assistance 
H36 I have trouble getting 1 2 12 1 2 1 2 8 
shoes, socks, or stockings 
on 
H37 I do not have control of my 1 2 12 1 2 1 2 8 
bladder 
H38 I do not fasten my clothing, 1 2 12 1 2 1 2 8 
for example, require 
assistance with buttons, 
zippers, shoelaces 
H39 I spend most of the time 1 2 12 1 2 1 2 8 
pardy undressed or in 
pyjamas 
H40 I do not have control of my 1 2 12 1 2 1 2 8 
bowels 
H41 I dress myself, but do so 1 2 12 1 2 1 2 8 
very slowly 
H42 I get dressed only with 1 2 12 1 2 1 2 8 
someone's help I 
IF R DOES NOT RESPOND TO ANY ITEM, ASK; Am I reading clearly enough and slowly 
enough? 
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H43. Please answer *yesn to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H44) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your (first) 
cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES; 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYO UR IMPROVE ACHIEVED 
YOU VISION D 
r- --+ r-- -- r- -4 DONT 
I YFS W) YFS NO Yrs NO YES NO KNOW 
H44 I do work around the house 1 2 1 2 1 2 1 2 8 
only for short periods of 
time or rest often 
"45 1 am doing IC11 of the regular 1 2 1 2 1 2 1 2 8 
daily work around the house 
than I would usually do 
H46 I am not doing My of the 1 2 1 2 1 2 1 2 8 
regular daily work around 
the house that I would 
usually do 
H47 I am not doing j= of the 1 2 1 2 1 2 1 2 8 
maintenance or repair work 
that I would usually do in my 
home or yard 
H48 I am not doing My of the 1 2 1 2 1 2 1 2 8 
shopping that I would 
usually do 
H49 I am not doing any of the 1 2 1 2 1 2 1 2 a 
house cleaning that I would 
usually do 
HSO I have difficulty doing 1 2 1 2 1 2 1 2 8 
handwork, for example, 
turning taps, using kitchen 
gadgets, sewing, carpentry 
HSI I am not doing My of the 1 2 1 2 1 2 1 2 8 
clothes washing that I would 
usually do 
H52 I am not doing heavy work 1 2 1 2 1 2 1 2 8 
around the house 
H53 I have given up taking care 1 2 1 2 1 2 1 2 8 
of personal or household 
business affairs, for example, 
paying bills, banking, 
working on budget 
IF R DOES NOT RESPOND TO ANY MEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
28 
H54. Please answer "yes" to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H55) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: 
l 
Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: 
1 
Did this improve as much as you had expected it would after your (first) 
cataract operation? (CIRCLE BELOM 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRI BE OFYOUR IMP ROVED ACHIEVED 
YOU VISION 
r-11 i r-O 0 r-+ . ---+ 
I - 
DONT E E 
F 
YES NO YES NO YES NO YES NO KNOW 
H55 I am getting around only 1 2 12 2_ 1 2 81, 
within one building 
H56 I stay within one room 1 2 12 1 2 1 2 8 
H57 I am staying in bed more 1 2 12 1 2 1 2 8 
H58 I am staying in bed most of 1 2 12 1 2, 1 2 8 
the time 
H59 I am not now using public 1 2 12 1 2 1 2 8 
transportation 
H60 I stay home most of the 1 2 1 2' 1 2 1 2 8 
time 
H61 I am only going to places 1 2 12 1 2 1 2 8 
with toilets nearby 
H62 I am not going into town 1 2 12 1 2 1 2 8 
H63 I stay away from home 1 2 12 1 2 1 2 8 
only for brief periods of 
time 
H64 I do not get around in the 1 2 12 1 2 1 2 8 
dark or in unlit places 
without someone's help I II 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H65. Please answer 'yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H66) 
FOR EACH ITEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES. IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEM ENT 
DESCRI BE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r-4 --# r-0 --+ r ---# DONT 
yrs NO YFS NO yrs NO YES NO KNOW 
H66 I am going out less to visit 1 2 1 2 1 2 1 2 8 
people 
H67 I am not going out to visit 1 2 1 2 1 2 1 2 8 
people at all 
H68 I show less interest in other 1 2 1 2 1 2 1 2 8, 
people's problems, for 
example, don't listen when 
they tell me about their 
problems, don't offer to 
help 
H69 I often act irritable toward 1 2 1 2 1 2 1 2 8 
those around me, for 
example, snap at peopk, 
give sharp answers, 
criticise easily 
H70 I show less affection 1 2 1 2 1 2 1 2 8 
H71 I am doing fewer social 1 2 1 2 1 2 1 2 8 
activities with groups of 
people 
H72 I am cutting down the 1 2 1 2 1 2 1 2 8 
length of visits with friends 
H73 I am avoiding social visits 1 2 1 2 1 2 1 2 8 
from others 
H74 My sexual activity is 1 2 1 2 1 2 1 2 8 
decreased 
H75 I often express concern 1 2 1 2 1 2 1 2 8 
over what might be 
happening to my health 
H76 I talk less with those 1 2 1 2 1 2 1 2 8 
around me 
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(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
F-* 1 ý F-+ i r-4 ---4 DONT 
YES NO YES NO YES NO YE NO KNOW 
H77 I make many demands, for-- 1 2 12 1 2 1 2 8 
example, insist that people 
do things for me, tell them 
how to do things 
H78 I stay alone much of the 1 2 12 1 2 1 2 8 
time 
H79 I act disagreeable to family 1, 2 12 1 2 1 2 a 
members, for example, I act 
spiteful, I am stubborn 
H80 I have frequent outbursts of 1 2 12 1 2 1 2 8 
anger at family members, 
for exampleo strike at them, 
scream, throw things at 
them 
H81 I isolate myself as much as 1 1 2 12 1 2 1 2 8 
can from the rest of the 
family 
H82 I am paying less attention to 1 2 12 1 2 1 2 8 
the children 
H83 I refuse contact with family 1 2 1 2.. 1 2 1 2 8 
members, for example, turn 
away from them 
H84 I am not doing the things 1 1 2 12 1 2 1 2 8 
usually do to take care of 
my children or family 
H85 I am not joking with family 1 2 12 1 2 1 2 8 
members as I usually do 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H86. Please answer "yes* to those statements that you are ULe, describe you today and are 
related to your state of health. (CONTINUE WITH H87) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (8) (C) 
IF YES: IF YES: IF YES: 
BECAUSE ExPE&ED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
r-9 --f r-4 --4 ro ---# DONT 
VFS NO VFS NO VFS NO YES NO 
KNOW 
H87 I walk shorter distances or 1 2 1 2 1 2 1 2 8 
stop to rest often 
H88 I do not walk up or down 1 2 1 2 1 2 1 2 8 
hills 
H89 I use stairs only with 1 2 1 2 1 2 1 2 8 
mechanical support, for 
example, handrail, walking 
stick, crutches 
H90 I walk up or down stairs 1 2 1 2 1 2 1 2 El 
only with assistance from 
someone else 
H91 I get around in a 1 2 1 2 1 2 1 2 8 
wheelchair 
H92 I do not walk at all 1 2 1 2 1 2 1 2 
8 
H93 I walk by myself but with 1 2 1 2 1 2 1 
2 8 
some difficulty, for 
example, limp, wobble, 
stumble, have stiff leg 
H94 I walk only with help from 1 2 1 2 1 2 1 
2 8 
someone 
H95 I go up and down stairs 1 2 1 2 1 2 1 2 8 
more slowly, for example, 
stop often, one step at a 
time 
H96 I do not use stairs at all 1 2 1 2 1 2 1 2 8 
H97 I get around only by using 1 2 1 2 1 2 1 2 8 
a zimmer frame, crutches, 
cane, walls, or furniture 
H98 I walk more slowly 1 2 1 2 1 2 1 2 8 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H99. Please answer "yes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H 100) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
DONT 
YES NO YES NO YES NO YES NO KNOW 
1-1100 1 am confused and start 12 12 12 128 
several actions at a time 
H101 I have more minor 12 12 12 128 
accidents, for example, 
drop things, trip and fall, 
bump into things 
H102 I react slowly to things 12 12 12 128 
that are said or done 
H103 I do not finish things 1 12 12 12 128 
start 
H104 I have difficulty reasoning 12 12 12 128 
and solving problems,. for 
example, making plans, 
- making decisions, 
learning 
new things 
H105 I sometimes behave as if 1 12 12 12 128 
were confused or 
disoriented in place or 
time, for example, where I 
am, who is around, 
directions, what day it is 
H106 I forget a lot for example, 12 12 12 128 
things that happened 
recently, where I put 
things, appointments 
H107 I do not keep my 12 12 12 128 
attention on any activity 
for long 
H 108 1 make more mistakes 1 2, 12 12 12 
than usual 
H109 I have difficulty doing 12 11 12 128 
activities involving 
concentration and 
thinking 
IF R DOES NOT RESPOND TO ANY ITEM, ASK*, Am I reading clearly enough and slowly 
enough? 
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HI 10. Please answer ayes' to those statements that you are sure describe you today and are 
related to your state of health. (CONTINUE WITH H 111) 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your cataract (first) operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYO UR IMPROVED ACHIEVED 
YOU VISION 
r-4 --+ r-+ ---4 r- --- 
I I 
DONT 
yrs NO yrs No Vrs NO YES N KNOW 
H111 I am having trouble 1 2 1 2 1 2 1 2 8 
writing or typing 
11112 1 communicate mostly by 1 2 1 2 1 2 1 2 8 
gestures, for example, 
moving head, pointing, 
sign language 
H113 My speech is understood 1 2 1 2 1 2 1 2 8 
only by a few people who 
know me well 
H114 I often lose control of my 1 2 1 2 1 2 11' -2 8" 
voice when I talk, for 
example, my voice gets 
louder or softer, trembles, 
changes unexpectedly 
H115 I don't write except to 1 2 1 2 1 2 1 2 8 
sign my name 
H116 I carry on conversation 1 2 1 2 1 2 1 2 8 
only when very dose to 
the other person or 
looking at him 
H117 I have difficulty speaking, 1 2 1 2 1 2 1 2 8 
for example, get stuck 
stutter, stammer, slur my 
words 
H118 I am understood with 1 2 1 2 1 2 1 2 8 
difficulty I I I I 
H119 
- 
I do not speak dearly 
I 
I- 2 1 
-., 
I 
2. 1 2 1 
I __2 
I 
when I am under stress 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: 
enough? 
Am I reading clearly enough and slowly 
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H120. The next group of statements has to do With any work you usually do other than 
managing your home. By this we mean anything that you regard as work that you do on 
a regular basis. Do you usually do work other than managing your home? 
YES 1 (H 124) 
NO 2 
H 12 1. Are you retired? 
YES 
NO 2 (H134) 
H122. Is your retirement related to your health? 
YES 1 
NO 2 (H134) 
H 123. Is your retirement related to your vision? 
YES 1 
NO 2 (H134) 
35 
H 124. Now consider the work you do and answer 'yes" to those statements that you are sure 
describe you today and are related to your state of health. (If today is a Saturday or 
Sunday or some other day that you would usually have off, please respond as if today 
were a working day). 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
I- 
r-+ r DONT 
YES NO I YES NO YES NO YES NO KNOW 
H125 I am not working at all 121212128 
-1TW! - anw, . THEN'SKIPT0141U. M -1 ts V; ý -ý 
CIRC-W 
PC 
MMIN 
H126 I am doing part of my job 121212128 
at home 
H127 I am not accomplishing as 121212128 
much as usual at work 
H128 I often act irritable 121212128 
toward my work 
associates, for example, 
snap at them, give sharp 
answers, criticise easily 
H129 I am working shorter 121212128 
H 130 1 am doing only light 12 12 12 128 
work 
H131 I work onty for short 12 12 12 128 
periods of time or take 
frequent rests 
H132 I am working at my usual 12 12 12 128 
job but with some 
changes, for example, 
using different tools or 
special aids, trading some 
tasks with other workers 
H133 I do not do my job as 12 12 12 128 
carefully and accurately 
as usual 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H134. This group of statements has to do with activities you usually do in your free time. 
These activities are things that you might do for relaxation, to pass the time, or for 
entertainment. Please answer 'yes"to those statements that you are sure describe you 
today and are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
A. Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: 
1 
Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOW) 
(A) (B) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
:: 1 
YES NO YES NO YES NO YES No 0 
H135 I do my hobbies and 1 2 12 1 2 1 2 81 
recreation for shorter 
periods of time 
H136 I am going out for 1 2 12 1 2 1 2 8 
entertainment less often 
H137 I am cutting down on 1 2 12 1 2 1 2 8 
some of my usual inactive 
recreation and pastimes, 
for example, watching TV, 
playing cards, reading 
H138 I am not doing anv"O(my 1 2 'j' 2 1 2 '1 2' -8 
usual inactive recreation 
and pastimes for example, 
watching TV, playing 
cards, reading 
H139 I am doing more inactive 1 2 12 1 2 1 2 8 
pastimes in place of my 
other usual activities 
H140 I am doing fewer 1 2 12 1 2 1 2 6 
community activities 
H141 I am cutting down on 1 2 12 1 2 1 2 8 
some of my usual physical 
recreation or activities 
H142 I am not doing any of my 1 2 12 1 2 1 2 8 
usual physical recreation 
or activities 
IF R DOES NOT RESPOND TO ANY ITEM, ASK: Am I reading clearly enough and slowly 
enough? 
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H143. Please remember to answer "yes" to those statements that you are sure describe you 
today and are related to your state of health. 
FOR EACH ITEM ANSWERED YES, ASK: 
Do you think this is because of your vision? 
B. IF YES: Has this improved since your (first) cataract operation? (CIRCLE BELOW) 
C. IF YES: Did this improve as much as you had expected it would after your 
(first) cataract operation? (CIRCLE BELOM 
(A) (13) (C) 
IF YES: IF YES: IF YES: 
BECAUSE EXPECTED IMPROVEMENT 
DESCRIBE OFYOUR IMPROVED ACHIEVED 
YOU VISION 
DONT 
VFS 
_ 
NO yrs NO Yrs NO YES NO KNOW 
H144 I am eating much less 1 2 12 1 2 1 2 8 
than usual 
H145 I feed myself but only by 1 2 12 1 2 1 2 8 
using specially prepared 
food or utensils 
H146 I am eating special or 1 2 12 1 2 1 2 8 
different food, for 
example, soft food, bland 
diet, low-salt, low-fat, low- 
sugar 
H147 I eat no food at all but am 1 2 1 2. 1 2 1 2 8 
taking fluids 
H148 I just pick or nibble at my 1 2 12 1 2 1 2 8 
food 
H149 I am drinking less fluids 1 2 12 1 2 1 2 8 
H150 I feed myself with help 1 2 12 1 2 1 2 8 
from someone else 
H151 I do not feed myself at all, 1 2 12 1 2 1 2 8 
but must be fed 
H152 I am eating no food at all, 1 2 12 1 2 1 2 8 
nutrition Is taken through 
tubes or Intravenous fluids 
HIS3 This is the end of this section 
38 
CLOSING 
This is the end of the interview. 
taking the time to answer these 
important to this study 
Thank you very much for taking part in the study and for 
questions. The information you have given us has been very 
TIME TAKEN FOR INTERVIEW: 
TO BE COMPLETED BY INTERVIEWER AT THE END OF THE INTERVIEW. 
(Please Tick as appropriate) 
PW1 a. - 
Patients first language is English. 
PW1 b. 
- 
Patients first language, other 
PW2. Interview conducted in out-patient clinic, in hospital 
PW3. Interview conducted elsewhere 
PW4. Interview conducted in hospital at some other time 
PW5. Interview conducted at patient's home 
PW6. Interview completed in a single session 
PW7. Interview completed in two half sessions 
PW8. Interview started, but terminated 
PW9. Interview not completed 
PWI 0. 
_ 
Interview started, but failed cognitive scale 
Use this space for details about cases with responses PW3-PW4, or PW7 - PW1 0 
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APPENDIX C 
THE CATARACT OUTCOME STUDY : RESULTS 
Appendix Cl Distribution of Cataract Symptom Score 
Distribution of Comorbidity. "Bother" Score 
Appendix C2 Multiple Regression Models: 
Detem-dnants of Pre-operative Visual Function (VF-14) 
Appendix C3 Multiple Regression Models : 
Determinants of Pre-operative Quality of Life (SIP) 
Appendix C4 Multiple Regression Models: 
Determinants of Pre-operative Vision-Related 
Quality of Life (VR-SIP) 
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Appendix Cl 
Distribution of Cataract Symptom Score 
Distribution of Comorbidity "Bothee, Score 
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SYMPCAT 
valid Cum 
Value Label Value Frequency Percent Percent Percent 
. 0000 24 7.1 7.1 7.1 
20.0000 71 21.1 21.1 28.2 
40.0000 97 28.8 28.8 57.0 
60.0000 91 27.0 27.0 84.0 
80.0000 43 12.8 12.8 96.7 
100.0000 11 3.3 3.3 100.0 
------- ------- ------- 
Total 337 100.0 100.0 
Hi-Res Chart # 4: Histogram of sympcat 
Mean 45.401 Std err 1.335 Median 40.000 
Std dev 24.505 Minimum . 000 Maximum 100.000 
Valid cases 337 Missing cases 0 
COMORBS 
Value Label 
Valid Cum 
Value Frequency Percent Percent Percent 
. 0000 27 8.0 9.0 
1.1494 26 7.7 8.7 
2.2989 34 10.1 11.3 
3.4483 28 8.3 9.3 
4.5977 22 6.5 7.3 
5.7471 12 3.6 4.0 
6.8966 18 5.3 6.0 
8.0460 19 5.6 6.3 
9.1954 16 4.7 5.3 
10.3448 19 5.6 6.3 
11.4943 12 3.6 4.0 
12.6437 is 4.5 5.0 
13.7931 8 2.4 2.7 
14.9425 7 2.1 2.3 
16.0920 7 2.1 2.3 
17.2414 7 2.1 2.3 
18.3908 3 .9 1.0 
19. S402 2 .6 .7 
20.6897 1 .3 .3 
21.8391 1 .3 .3 
22.9885 5 1.5 1.7 
24.1379 4 1.2 1.3 
25.2874 1 .3 .3 26.4368 1 .3 .3 
27.5862 1 .3 .3 
29.8851 1 .3 .3 
31.0345 1 .3 .3 
33.3333 1 .3 .3 
39.0805 1 .3 .3 37 
- 
11.0 Missing 
Total 
- ----- 
337 
------- 
100.0 
------- 
100.0 
9.0 
17.7 
29.0 
38.3 
45.7 
49.7 
55.7 
62.0 
67.3 
73.7 
77.7 
82.7 
8S. 3 
87.7 
90.0 
92.3 
93.3 
94.0 
94.3 
94.7 
96.3 
97.7 
98.0 
98.3 
98.7 
99.0 
99.3 
99.7 
100.0 
Hi-Res Chart # 3: Histogram of comorbs 
Mean 7.774 Std err . 395 Median 
Std dev 6.834 minimum . 000 Maximum 
6.897 
39.081 
Valid cases 300 missing cases 37 
Appendix C2 
Multiple Regression Models: 
Determinants of Pre-operative Visual Function (VF-14) 
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File - vfa3. lst **** MULTIPLE REGRESS10N 
Equation Number 1 Dependent Variable.. VFSD 
Block Number 1. Method: Enter 
OH COMORBS SEX SYMPCAT AGE6S74 AGE75PLU BEVG3 BEVG4 
Variable (s) Entered on Step Number 
I.. BEVG4 
2.. AGE6S74 
3.. SYMPCAT 
4.. OH 
S.. SEX 
6.. COMORBS 
7.. AGE7SPLU 
B.. BEVG3 
Multiple R . 61452 
R Square . 37764 
Adjusted R Square . 36053 
Standard Error 17.98649 
Analysis of Variance 
DF Sum of Squares Mean Square 
Regression a 57123.43837 7140.42980 
Residual 291 94142.48481 323. S1369 
P 22.07149 Signif F- . 0000 
MULTIPLEREGRESS10W 
Equation Number 1 Dependent Variable.. VFSD 
---------------------- Variables in the Equation ----------------------- 
Variable B SE B 9S% Confdnce Intrvl B Beta 
OH -1.056937 2.266471 -5.517691 3.403816 -. 021957 
COMORBS -. 531262 . 156605 -. 839484 -. 223040 -. 161406 
SEX -2.336677 2.204701 -6.67S858 2.002SO3 -. 050423 
SYMPCAT -. 2497S5 . 043714 -. 335791 -. 163720 -. 272820 
AGE6S74 4.162401 3.681SO3 -3.083347 11.408149 . 086706 
AGE75PLTJ 7.699974 3. S68918 . 67S809 14.724139 . 169924 
BEVG3 22.133809 3.974267 14.31ISS7 29.955761 . 4S4SI7 
BEVG4 34.5SS5S9 3.82S171 27.027051 42.084067 . 7S2834 
(Constant) 54.78973S 6.620608 41.7S9389 67.820081 
----------- in ------------ 
Variable T Sig T 
OH -. 466 . 6413 
COMORBS -3.392 . 0008 
SEX -1.060 . 2901 
SYMPCAT -5.713 . 0000 
AGE6574 1.131 . 2591 
AGE7SPLU 2.158 . 0318 
BEVG3 S. 569 . 0000 
BEVG4 9.034 . 0000 
(Constant) 8.276 . 0000 
Residuals Statistics: 
Min Max Mean Std Dev N 
*PRED 22.7SOS 92.3719 68.6014 13.8220 300 
*RESID -56.8512 42. S739 . 0000 17.7442 300 
*ZPRED -3.3172 1.7198 . 0000 1.0000 300 
*ZRESID -3.1608 2.3670 . 0000 . 9865 300 
Total Cases - 337 
Durbin-Watson Test - 1.93337 
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vfa3. sav 
SEARCH FOR INTERACTIONS - VFSD AND OT14ER PRE-OPERATIVE VARIABLES 
******Ana1ysisofVariance 
General Factorial Model 
304 cases accepted. 
0 cases rejected because of out-of-range factor values. 
33 cases rejected because of missing data. 
12 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of variance Tests 
Variable .. VFSD 
Cochrans C(24,12) = 
Bartlett-Box F(11,11011ý 
. 16046, P- . 030 (approx. ) 
. 71059, P= . 730 
******Ana1ysisof Variance -- design 1****** 
Tests of Significance for VFSD using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 101748.31 
REGRESSION 45091.26 
AGEG3 2246.47 
SEX 976.04 
OH 89.70 
AGEG3 BY SEX 1602.04 
AGEG3 BY OH 827.40 
SEX BY OH . 37 
AGEG3 BY SEX BY OH 19.30 
(Model) 52364.06 
(Total) 1S4112.36 
291 349.65 
1 45091.26 128.96 . 000 
2 1123.24 3.21 . 042 
1 976.04 2.79 . 096 
1 89.70 . 26 . 613 
2 801.02 2.29 . 103 
2 413.70 1.18 . 308 
1 . 37 . 00 . 974 
2 9.65 . 03 . 973 
12 4363.67 12.48 . 000 
303 508.62 
R-Squared = . 340 
Adjusted R-Squared = . 313 
------------------------ 
Estimates for VFSD adjusted for 1 covariate 
---- ----- ---- 
--- individual univariate . 9500 confidence inte rvals 
AGEG3 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
2 -5.1982935 2.64179 -1.96771 . 05005 -10.39774 . 00115 
3 . 700027688 1.99425 . 35102 . 72583 -3.22496 4.62502 
SEX 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
4 2.57294954 1.53998 1.67077 . 09584 -. 45796 5.60386 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
5 -. 78098963 1.54193 -. 50650 . 61289 -3.81573 2.25375 
AGEG3 BY SEX 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
6 5.56760459 2.63017 2.11683 . 03512 . 39105 10.74416 
7 -3.5402935 1.99370 -1.77574 . 07682 -7.46420 . 38361 
AGEG3 BY OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
8 -2.0740689 2.62939 -. 78880 . 43087 -7.24910 3.10096 
9 -. 61812128 1.99479 -. 30987 . 75688 -4.54417 3.30793 
SEX BY OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
10 . 049617475 1.53281 . 03237 . 97420 -2.96719 3.06643 
AGEG3 BY SEX BY OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
11 . 047041162 
2.64247 . 01780 . 98581 -5.15373 5.24781 
12 -. 34203575 1.99475 -. 17147 . 86397 -4.26800 3.58393 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
BEV 7.85280 . 56712 . 692 11 . 356 . 000 
COVARIATE Lower -95t CL- Upper 
BEV 6.492 9.214 
Dependent variable: VFSD 
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Observed Value 
Detrencled Normal Q-Q Plot of Residuals of VFSD 
****MULTIPLEREGRESS10N**** 
Equation Number 1 Dependent Variable.. AGE 
Block Number 1. Method: Enter 
OH COMORBS SEX symPCAT BEVG3 BEVG4 VFSD 
Variable(s) Entered on Step Number 
l.. VFSD 
2.. OH 
3.. SEX 
4.. BEVG3 
S.. COMORBS 
6.. SYMPCAT 
7.. BEVG4 
multiple R . 40615 
R Square . 16496 
Adjusted R Square . 14494 
Standard Error 7.63983 
Analysis of Variance 
DF Sum of Squares Mean Square 
Regression 7 3366.72689 480.96098 
Residual 292 17043. lS311 58.36696 
F-8.24029 Signif F- . 0000 
30 NOV 95 SPSS for MS WINDOWS Release 6.1 
**** MULTIPLE REGRESSION 
Equation Number 1 Dependent Variable.. AGE 
Variables in the Equation 
Page 49 
Variable B SE B 95% Confdnce Intrvl B Beta 
OH 1.808500 . 959016 -. 078961 3.695961 . 102279 
COMORBS . 144306 . 067153 . 012140 . 276472 . 119356 
SEX * 2.405556 . 930483 S742S3 4.236859 . 141317 
SYMPCAT -. OS22S4 . 019402 -. 090438 -. 014069 -. 155392 
BEVG3 -3.547219 1.764772 -7.020505 -. 073933 -. 198305 
BEVG4 -7.602648 1.807584 -11.160193 -4.045102 -. 4509i7 
VFSD . 055461 . 024665 . 006917 . 104005 . 150987 
(Constant) 73.602847 2.872181 67.950046 79.25S648 
----------- in ------------ 
Variable T Sig T 
OH 1.886 . 0603 
COMORBS 2.149 . 0325 
SEX 2.585 . 0102 
SYMPCAT -2.693 . 007S 
BEVG3 -2.010 . 0453 
BEVG4 -4.206 . 0000 
VFSD 2.249 . 02S3 
(Constant) 25.626 . 0000 
Equation Number 1 Dependent variable.. AGE 
Residuals Statistics: 
Min Max Mean Std Dev N 
*PRED 67.9722 83.7346 74.9800 3.3556 300 
*RESID -24.3823 16.4338 . 0000 7. S499 300 
*ZPRED -2.0884 2.6090 . 0000 1.0000 300 
*ZRESID -3.1915 2.1511 . 0000 . 9882 300 
Total Cases - 337 
Durbin-Watson Test - 1.97947 
Appendix C3 
Multiple Regression Models: 
Determinants of Pre-operative Quality of Life (SIP) 
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vffu-Sa. sav Determinants of Pre-operative SIP score 
* *** MULTI PLEREG RESS10N 
Listwise Deletion of Missing Da ta 
N of Cases - 249 
Correlation, 1-tailed Sig: 
TOTAL AGE COMORBS VFSD 
TOTAL 1.000 . 282 . 604 -. 394 
. 000 . 000 . 000 
AGE . 282 1.000 . 152 . 018 
. 000 . 008 . 389 
COMORBS . 604 . 152 1.000 -. 216 
. 000 . 008 . 000 
VFSD -. 394 . 018 -. 216 1.000 
. 000 . 389 . 000 
Equation Number 1 Dependent Variable.. TOTAL 
Block Number 1. Method: Enter AGE COMORBS VFSD 
Variable(s) Entered on Step Number 
1.. VFSD 
2.. AGE 
3.. COMORBS 
Multiple R . 69281 
R Square . 47999 
Adjusted R Square . 47362 
Standard Error 6.79405 
Analysis of Variance 
DF Sum of Squares Mean Square 
Regression 3 10438.49754 3479.49918 
Residual 245 11308.99395 46.15916 
F= 75.38047 signif F= . 0000 
Variables in the Equation 
**** 
Variable B SE B 95t Confdnce Intrvl B Beta 
AGE . 239700 . 
053423 . 134473 . 344927 . 209435 
COMORBS . 692612 . 064965 . 564650 . 820574 . 509605 
VFSD -. 119995 . 019709 -. 158815 -. 081175 -. 287687 
(Constant) -3.371818 4.162896 -11.571449 4.827812 
----------- in ------------ 
Variable T Sig T 
AGE 4.487 . 0000 
COMORBS 10.661 . 0000 
VFSD -6.088 . 0000 
(Constant) -. 810 . 4187 
End Block Number 1 All requested variables entered. 
Residuals Statistics: 
Min Max Mean Std Dev N 
*PRED -2.5681 32.8825 11.5544 6.4877 249 
*RESID -18.9678 24.0025 . 0000 6.7528 249 
*ZPRED -2.1768 3.2875 . 0000 1.0000 249 
*ZRESID -2.7918 3.5329 . 0000 . 9939 249 
Total Cases 337 
Hi-Res Chart # 27: Histogram of *zresid 
Hi-Res Chart # 28: Normal p-p plot of *zresid 
Histogram 
Dependent Variable: TOTAL 
40- 
30-, 
20- 
C: 10- 
I ý' ýýý,,. I ''. 
I, I Std. Dev = . 99 cr Mean = 0.00 
LL 0N 249.00 
Regression Standardized Residual 
Normal P-P Plot of Regression Standardized Residual 
1.00 
. 75 
0 I- . 50 0- 
E 
-0 . 25 la) 
CL 
x 
w 0.00 
0 
Dependent Variable: TOTAL 
Observed Cum Prob 
)O 
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Multiple Regression Models: 
Deternýnants of Pre-operative Vision-Related Quality of Life (VR-SIP) 
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vffu-5a. sav Determinants of Pre-operative VR-SIP score 
****MULTIPLEREGRESS10N 
Listwise Deletion of Missing Data 
N of Cases = 250 
Correlation, I-tailed Sig: 
VTOTAL AGE VFSD BVHI 
VTOTAL 1.000 -. 085 -. 636 -. 380 
. 091 . 000 . 000 
AGE -. 085 1.0Q0 . 010 -. 277 
. 091 . 436 . 000 
VFSD -. 636 . 010 1.000 . 558 
. 000 . 436 . 000 
BV'HI -. 380 -. 277 . 55B 1.000 
. 000 . 000 . 000 
Block Number 1. Method: Enter AGE VFSD BVHI 
Variable (s) Entered on Step Numb er 
I. - BVHI 
2.. AGE 
3.. VFSD 
Multiple R . 64318 
R Square . 41368 
Adjusted R Square . 40653 
Standard Error 2.63773 
Analysis of Variance 
DF Sum of Squares Mean Square 
Regression 3 1207.61366 402.53789 
Residual 246 1711.57103 6.95761 
F= 57.85581 Signif F = . 0000 
Variables in the Equation 
Variable B SE B 95% Confdnce Intrvl B Beta 
AGE -. 041765 . 021728 -. 084562 . 001032 -. 099807 
VFSD -. 089748 . 009128 -. 107727 -. 071770 -. 591434 
BV14I -. 158742 . 128658 -. 412154 . 094670 -. 077227 
(Constant) 12.790975 2.157722 8.541009 17.040941 
----------- in ------------ 
Variable T Sig 
AGE -1.922 . 0557 
VFSD -9.832 . 0000 
BVHI -1.234 . 2184 
(Constant) 5.928 . 0000 
End Block Number I All requested variables entered. 
Residuals Statistics: 
Min Max Mean Std Dev N 
*PRED -1.4967 8.7144 1.9172 2.2022 250 
*RESID -5.9214 14.8193 . 0000 2.6218 250 
*ZPRED -1.5502 3.0865 . 0000 1.0000 250 
*ZRESID -2.2449 5.6182 . 0000 . 9940 250 
Total Cases 337 
Hi-Res Chart # 29: Histogram of *zres id 
Hi-Res Chart # 30: Normal p-p plot of *zresid 
Histogram 
Dependent Variable: VTOTAL 
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APPENDIX D 
THE CATARACT OUTCOME STUDY: 
RELATIONSHIPS AFTER SURGERY 
Appendix D1 Analysis of Covariance Models: 
Detertninants of Change in Visual Function at 
4 Months 
Appendix D2 Analysis of Covariance Models: 
Determinants of Change in Visual Function at 
12 Months 
Appendix D3 Analysis of Covariance Models: 
Determinants of Change in Visual Function at 4 Months 
Adjusting for pre-operative factors (capacity for change) 
- model I 
- model 2 
Appendix D4 Analysis of Covariance Models: 
Determinants of Change in Visual Function at 
12 Months Adjusting for pre-operative factors 
(capacity for change) 
- model I 
- model 2 
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Appendix DI 
Analysis of Covariance Models: 
Determinants of Change in Visual Function at 4 Months 
282 
VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL X 
CHANGE IN VF-14 SCORE AND PRE-OP BETTER EYE VISUAL ACUITY /+ MONT" 
******na1ysisofVariance****** 
272 cases accepted. 
0 cases rejected because of out-of-range factor values. 
18 cases rejected because of missing data. 
2 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH4M 
Cochrans C(135,2) . 51300, P= . 763 (approx. ) 
Bartlett-Box F(1,146464) . 07847, P= . 779 
------------------------------------- 
Combined observed Means for OH 
Variable .. VFCH4M 
OH 
0 WGT. 19.53753 
UNWGT. 19.53753 
1 WGT. 20.51897 
UNWGT. 20.51897 
Variable BVHI 
OH 
0 WGT. 9.87701 
UNWGT. 9.87701 
1 WGT. 9.17647 
UNWGT. 9.17647 
Variable AGE 
OH 
0 WGT. 73.75401 
UNWGT. 73.75401 
1 WGT. 76.69412 
UNWGT. 76.69412 
Tests of Significance for VFCH4M using UNIQUE sums of squares 
Source of Variation SS DF ms F Sig of F 
WITHIN+RESIDUAL 108671.35 268 405.49 
REGRESSION 12363.95 2 6181.97 15.25 . 000 OH 28.12 1 28.12 . 07 . 793 
(Model) 12420.23 3 4140.08 10.21 . 000 (Total) 121091.58 271 446.83 
R-Squared . 103 
Adjusted R-Squared = . 093 
------------------------------------- 
Correlations between Covariates and Predicted Dependent Variable 
COVARIATE 
VARIABLE BVHI AGE 
VFCH4M -. 858 -. 224 
------------------------------------- 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
BVHI . 736 
AGE . 050 
---------- 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 102 
OH . 000 
------------------------------------- 
Estimates for VFCH4M adjusted for 2 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
2 . 356076723 1.35226 . 26332 . 79251 -2.30633 3.01849 
***** Ana1ysi sof Vari ance -- design 1 
Regression analysis for WITHIN+RESIDUAL er ror term 
--- Individual Univariat e . 9500 confidence intervals 
Dependent variable .. VF CH4M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
BVHI -4.24801 -. 33010 . 792 -5.363 . 000 
AGE -. 43614 -. 17018 . 157 -2.781 . 006 
COVARIATE Lower -95% CL- Upper ETA Sq. 
BV14I -5.808 -2.688 . 097 
AGE -. 745 -. 127 . 028 
Adjusted and Estimated Means 
Variable .. VFCH4M 
CELL obs. Mean Adj. mean Est. Mean Raw Resid. Std. Resid. 
1 19.538 20.384 19.538 . 000 . 000 
2 20.519 19.672 20.519 . 000 . 000 
------------------------------------ 
Hi-Res Chart # 41: 0bserved, predicted, residuals for vfch4m 
Hi-Res Chart # 42: Case number vs. std. resid. for vfch4m 
Hi-Res Chart # 43: Normal q-q plot of residuals of vfch4m 
Hi-Res Chart # 44: Detrended normal q-q plot of residuals of vfch4m 
Combined Adjusted Means for OH 
Variable .. VFCH4M 
OH 
0 UNWGT. 20.38433 
1 UNWGT. 19.67217 
Dependent variable: VFCH4M 
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Detrencled Normal Q-Q Plot of Residuals of VFCH4M 
VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL gr. 
CHANGE IN VF-14 SCORE AND CHANGE IN BETTER EYE VISUAL ACUITY 14 mogm 
******na1ysisofVariance****** 
241 cases accepted. 
0 cases rejected because of out-of-range factor values. 
49 cases rejected because of missing data. 
2 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH4M 
Cochrans C(120,2) . 51594, P= . 727 (approx. ) 
Bartlett-Box F(1,105222) . 10103, P= . 751 
*****Ana1ysisof Variance -- design 
Combined Observed Means for OH 
Variable .. VFCH4M 
OH 
0 WGT. 19.77907 
UNWGT. 19-77907 
1 WGT. 20-96078 
UNWGT. 20.96078 
Variable AGE 
OH 
0 WGT. 73.86471 
UNWGT. 73.86471 
1 WGT. 77.12676 
UNWGT. 77.12676 
Variable BVCH4M 
OH 
0 WGT. 1.17647 
UNWGT. 1.17647 
1 WGT. 1.22535 
UNWGT. 1.22535 
******Ana1ysisof Vari ance --design I****** 
Tests of Significance for VFCH4M using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 93904.30 237 396.22 
REGRESSION 14989.79 2 7494.89 18.92 . 000 OH 241.42 1 241.42 
. 61 . 436 
(Model) 15059.72 3 5019.91 12.67 . 000 (Total) 108964.03 240 4S4.02 
R-Squared . 138 
Adjusted R-Squared = . 127 
------------------------------------- 
Correlations between Covariates and Predicted Dependent Variable 
COVARIATE- 
VARIABLE AGE BVCH4M 
VFCH4M -. 269 . 915 
------------------------------------- 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
AGE . 073 
BVCH4M . 837 
---------- 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 138 
OH . 003 
------------------------------------- 
Estimates for VFCH4M adjusted for 2 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
2 -1.1168132 1.43075 -. 78058 . 43583 -3.93543 1.70180 
*****Ana1ysis0f Vari ance -- design 
Regression analysis for WITHIN+RESIDUAL error term 
--- individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH4M 
COVARIATE B Beta Std. Err. t-Value 
AGE -. 40001 -. 15224 . 162 -2.464 
BVCH4M 5.17459 . 35789 . 878 5.891 
COVARIATE Lower -95t CL- Upper ETA Sq. 
AGE -. 720 -. 080 . 025 
BVCH4M 3.444 6.905 . 128 
1****** 
Sig. of t 
. 014 
. 000 
Adjusted and Estimated Means 
Variable .. VFCH4M 
CELL obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 19.779 19.253 19.779 . 000 . 000 
2 20.961 21.487 20.961 . 000 . 000 
------------------------------------- 
Hi-Res Chart # 45: Observed, predicted, residuals for vfch4m 
Hi-Res Chart # 46: Case number vs. std. resid. for vfch4m 
Hi-Res Chart # 47: Normal q-q plot of residuals of vfch4m 
Hi-Res Chart # 48: Detrended normal q-q plot of residuals of vfch4m 
Combined Adjusted Means for OH 
Variable .. VFCH4M 
OH 
0 UNWGT. 19.25312 
1 UNWGT. 21.48674 
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VFFU-3R. SAV ANALySIS OF COVARIANCE MODEL A 
CHANGE IN VF-14 SCORE AT 12 MONTHS AND PRE-OP BETTER EYE VISUAL ACUITY 
******na1ysis0fVariance****** 
261 cases accepted. 
0 cases rejected because of out-of-range factor values. 
17 cases rejected because of missing data. 
4 non-empty cells. 
I design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH12M 
Cochrans C(64,4) = 
Bartlett-Box F(3,40807) 
* 30660, P= . 296 (approx. ) 
1.67464, P- . 170 
Combined Observed Means for OH 
Variable .. VFCH12M 
OH 
0 WGT. 24.17131 
UNWGT. 26.08296 
1 WGT. 20.07914 
UNWGT. 
-- 
23.07568 
----- ---- 
Variable 
----- 
.. BVHI 
--- ------------------ 
OH 
0 WGT. 9.90556 
UNWGT. 9.86465 
1 WGT. 9.29630 
UNWGT. 
---- 
9.14430 
----- ---- 
Variable 
----- 
.. AGE 
- ------------------ 
OH 
0 WGT. 74.07222 
UNWGT. 74.21043 
1 WGT. 77.07407 
UNWGT. 76.93888 
---- 
Combined 
----- 
observed 
----- 
Means for 
----------------------- 
E212M 
Variable .. VFCH12M 
E212M 
0 WGT. 19.36727 
UNWGT. 19.03084 
1 WGT. 31.19276 
UNWGT. 
-- - 
30.12780 
----- ---- 
Variable 
----- 
.. BVHI 
- - ------------------ 
E212M 
0 WGT. 9.78689 
UNWGT. 9.69892 
1 WGT. 9.55128 
UNWGT. 
--- 
9.31003 
---- ---- 
Variable 
----- 
.. AGE 
- - - ------------------ 
E212M 
0 WGT. 74.96721 
UNWGT. 75.47669 
1 WGT. 75.08974 
UNWGT. 75.67261 
******na1ysisof Var i ance --design 1****** 
Tests of Significance for VFCH12M using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 92049.55 255 360.98 
REGRESSION 14564.17 2 7282.08 20.17 . 000 
OH 942.92 1 942.92 2.61 . 107 
E212M 3530.84 1 3530.84 9.78 . 002 
OH BY E212M 120.11 1 120.11 . 33 . 565 
(Model) 22610.22 5 4522.04 12.53 . 000 
(Total) 114659.77 260 441.00 
R-Squared . 197 
Adjusted R-Squared = . 181 
----------- 
Correlations between 
------- 
Covariates and 
-------------- 
Predicted Dependent Variable 
----- 
COVARIATE 
VARIABLE BVHI AGE 
VFCH12M -. 683 -. 265 
------------------------------------- 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
BVHI . 466 
AGE . 070 
---------- 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 137 
OH . 010 
E212M . 037 
OH BY E212M . 001 
------------------------------------- 
Estimates for VFCH12M adjusted for 2 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
2 2.46774859 1.52687 1.61621 . 10729 -. 53914 5.47464 
E212M 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
3 -4.7020384 1.50345 -3.12750 . 00197 -7.66279 -1.74128 
OH BY E212M 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
4 -. 86437205 1.49851 -. 57682 . 56457 -3.81540 2.08665 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH12M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
BVHI -4.61024 -. 35530 . 764 -6.033 . 000 
AGE -. 51046 -. 19620 . 153 -3.345 . 001 
COVARIATE Lower -95t CL- Upper ETA Sq. 
BVHI -6.115 -3.105 . 125 
AGE -. 811 -. 210 . 042 
Adjusted and Estimated Means 
Variable .. VFCH12M 
CELL obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 20.150 21.481 20.150 . 000 . 000 
2 32.016 32.613 32.016 . 000 . 000 
3 17.911 18.274 17.911 . 000 . 000 
4 28.240 25.949 28.240 . 000 . 000 
Hi-Res Chart # 69: 0bserved, predicted, residuals for vfchl2m 
Hi-Res Chart # 70: Case number vs. std. resid. for vfchl2m 
Hi-Res Chart # 71: Normal q-q plot of residuals of vfchl2m 
Hi-Res Chart # 72: Detrended normal q-q plot of residuals of vfch12m 
Combined Adjusted Means for OH 
Variable .. VFCH12M 
OH 
0 UNWGT. 27.04707 
1 UNWGT. 22.11157 
Combined Adjusted Means for E212M 
Variable .. VFCH12M 
E212M 
0 UNWGT. 19.87728 
1 UNWGT. 29.2813G 
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VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL S. 
CHANGE IN VF-14 SCORE AT 12 MONTHS AND CHANGE IN BETTER EYE VISUAL ACUITY AT 12 MONTHS 
******na1ysis0fVariance****** 
210 cases accepted. 
0 cases rejected because of out-of-range factor values. 
68 cases rejected because of missing data. 
4 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH12M 
Cochrans C(52,4) - 
Bartlett-Box F(3,26456) 
* 31780, P= . 242 (approx. ) 
2.24987, P= . 081 
Combined Observed Means for OH 
Variable .. VFCH12M 
OH 
0 WGT. 24.52758 
UNWGT. 26.36946 
1 WGT. 18.56333 
UNWGT. 21.37541 
-------------- 
Variable .. BVCH12M 
----------------------- 
OH 
0 WGT. 1.26027 
UNWGT. 1.34736 
1 WGT. 1.20313 
UNWGT. 
-- - 
1.33571 
--------- 
Variable .. AGE 
- - ----------------------- 
OH 
0 WGT. 74.01370 
UNWGT. 74.26783 
1 WGT. 76.73438 
UNWGT. 77.08714 
--------- 
Combined observed 
----- 
Means for 
----------------------- 
E212M 
Variable .. VFCH12M 
E212M 
0 WGT. 19.27357 
UNWGT. 18.57162 
1 WGT. 30.72802 
-- 
UNWGT. 
----- 
29.17326 
---- ------- 
Variable .. BVCH12M 
------------------- 
E212M 
0 WGT. 1.08844 
UNWGT. 1.09124 
1 WGT. 1.60317 
--- 
UNWGT. 
----- 
1.59184 
- ------ 
Variable .. AGE 
---------------------- 
E212M 
0 WGT. 74-SO340 
UNWGT. 74-97742 
1 WGT. 75.63492 
UNWGT. 76.37755 
******Ana1ysisof Variance -- design 1****** 
Tests of Significance for VFCH12M using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 66448.20 204 325.73 
REGRESSION 22774.84 2 11387.42 34.96 . 000 OH 440.61 1 440.61 1.35 . 246 E212M 1943.82 1 1943.82 5.97 . 015 OH BY E212M 7.13 1 7.13 . 02 . 882 
(Model) 29538.21 5 5907.64 18.14 . 000 (Total) 95986.41 209 459.27 
R-Squared . 308 
Adjusted R-Squared - . 291 
------------------------------------- 
Correlations between Covariates and Predicted Dependent Variable 
COVARIATE 
VARIABLE BVCH12M AGE 
VFCH12M . 889 -. 242 
------------------------------------- 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
BVCH12M . 791 
AGE . 058 
------------------------------------- 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 255 
OH . 007 
E212M . 028 
OH BY E212M . 000 
------------------------------------- 
Estimates for VFCH12M adjusted for 2 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
2 1.85205413 1.59240 1.16306 
. 24617 -1.28763 4.99174 
E212M 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
3 -3.8944594 1.59421 -2.44287 . 01542 -7.03770 -. 75121 
OH BY E212M 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95t CL- Upper 
4 -. 23339845 1.57699 -. 14800 . 88249 -3.34269 2.87590 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 conf idence intervals 
Dependent variable .. VFCH12M 
COVARIATE B Beta Std. Err. t -Value Sig. of t 
BVCH12M 6.81961 . 47446 . 849 8.031 . 000 
AGE -. 42937 -. 16206 . 157 -2.735 . 007 
COVARIATE Lower -95W CL- Upper ETA Sq. 
BVCH12M 5.145 8.494 . 240 
AGE -. 739 -. 120 
- 
. 035 
-------------- --- 
Adjusted and Estimated Means 
-------- ---- ------- 
Variable .. VFCH12M 
CELL Obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 20.767 21.597 20.767 . 000 . 000 
2 31.972 29.852 31.972 . 000 . 000 
3 16.376 18.359 16.376 . 000 . 000 
4 26.375 25.681 26.375 . 000 . 000 
Hi-Res Chart # 73: Observed, predicted, residuals for vfchl2m 
Hi-Res Chart # 74: Case number vs. std. resid. for vfchl2m 
Hi-Res Chart # 75: Normal q-q plot of residuals of vfchl2m 
14i-Res Chart # 76: Detrended normal q-q plot of residuals of vfch12m 
Combined Adjusted Means for OH 
Variable .. VFCH12M 
OH 
0 UNWGT. 25.72449 
1 UNWGT. 22.02038 
------------------------------------- 
Combined Adjusted Means for E212M 
Variable .. VFCH12M 
E212M 
0 UNWGT. 19.97798 
1 UNWGT. 27.76690 
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VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL 1A. 
CHANGE IN VF-14 SCORE AT 4 MONTHS AND PRE-OP BETTER EYE VISUAL ACUITY, 
ADJUSTING FOR PRE-OP VF-14 SCORE. 
******na1ysisofVariance****** 
272 cases accepted. 
0 cases rejected because of out-of-range factor values. 
18 cases rejected because of missing data. 
2 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH4M 
Cochrans C(135,2) . 51300, P= . 763 (approx. ) 
Bartlett-Box F(1,146464) . 07847, P= . 779 
Combined Observed Means for OH 
Variable .. VFCH4M 
OH 
0 WGT. 19.53753 
UNWGT. 19.53753 
1 WGT. 20.51897 
UNWGT. 20.51897 
Variable AGE 
OH 
0 WGT. 73.75401 
UNWGT. 73.75401 
WGT. 76.69412 
UNWGT. 76.69412 
Variable BVHI 
OH 
0 WGT. 9.87701 
UNWGT. 9.87701 
WGT. 9.17647 
UNWGT. 9.17647 
Variable VFSD 
OH 
0 WGT. 70.67745 
UNWGT. 70.67745 
WGT. 65.52645 
UNWGT. 65.52645 
*****Ana1y sisof Variance -- design 1 
Tests of Significance for VFCH4M using UNIQUE sums of squares 
Source of variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 55800.84 267 208.99 
REGRESSION 65234.45 3 21744.82 104.05 . 000 
OH 81.61 1 81.61 . 39 . 533 
(Model) 65290.74 4 16322.68 78.10 . 000 
(Total) 121091.58 271 446.83 
R-Squared . 539 
Adjusted R-Squared = . 532 
----------- 
Correlations between 
----- 
Covariates 
----------------- 
and Predicted Dependent Variable 
---- 
COVARIATE 
VARIABLE AGE BVHI VFSD 
VFCH4M -. 097 -. 374 -. 978 
------------------------------------ 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
AGE . 010 
BVHI . 140 
VFSD . 956 
---------- 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 539 
OH . 001 
------------------------------------- 
Estimates for VFCH4M adjusted for 3 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
2 . 606740626 . 
97094 . 62490 . 53257 -1.30493 2.51841 
******AnaIysisof Var i ance --design 1****** 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH4M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
AGE -. 08873 -. 03462 . 115 -. 774 . 440 
BVHI 2.02446 . 15731 . 692 2.925 . 004 
VFSD -. 75209 -. 80859 . 047 -15.905 . 000 
COVARIATE Lower -95t CL- Upper ETA Sq. 
AGE -. 314 . 137 . 002 
BVHI . 662 3.387 . 031 
VFSD -. 845 -. 659 . 487 
Adjusted and Estimated Means 
Variable .. VFCH4M 
CELL Obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 19.538 20.635 19.538 . 000 . 000 
2 20.519 19.422 20. S19 . 000 . 000 
------------------------------------- 
Hi-Res Chart # 49: Observed, predicted, residuals for vfch4m 
Hi-Res Chart # 50: Case number vs. std. resid. for vfch4m 
Hi-Res Chart # 51: Normal q-q plot of residuals of vfch4m 
Hi-Res Chart # 52: Detrended normal q-q plot of residuals of vfch4m 
Combined Adjusted Means for OH 
Variable .. VFCH4M 
OH 
0 UNWGT. 20.63499 
1 UNWGT. 19.42151 
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VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL 2A. 
CHANGE IN VF-14 SCORE AT 4 MONTHS AND CHANGE IN BETTER EYE VISUAL ACUITY AT 4 MONTHS 
ADJUSTING FOR PRE-OP VF-14 SCORE AND PRE-OP BETTER EYE ACUITY. 
* *Ana1ysisofVarianc e 
241 cases accepted. 
0 cases rejected because of out-of-range factor values. 
49 cases rejected because of missing data. 
2 non-empty cells. 
I design will be processed. 
----- 
Univariat 
-------------------- 
e Homogeneity of Variance Tests 
------------ 
Variable .. VFCH4M 
Coc hrans C(120,2) . 51594, P= . 727 (approx. ) 
Bar 
----- 
tlett-Box F(1,105222) 
-------------------- 
. 10103, P= . 751 
------------ 
Combined observed Means for OH 
Variable .. VFCH4M 
OH 
0 WGT. 19.77907 
UNWGT. 19.77907 
1 WGT. 20.9GO78 
UNWGT. 20.96078 
----- 
Variable 
------------------- 
.. VFSD 
------------- 
014 
0 WGT. 70.77991 
UNWGT. 70.77991 
1 WGT. 64.46078 
UNWGT. 64.46078 
----- 
Variable 
------------------- 
.. BVHI 
------------- 
OH 
0 WGT. 9.87647 
UNWGT. 9.87647 
1 WGT. 9.18310 
UNWGT. 9.18310 
----- 
Variable 
------------------- 
.. BVCH4M 
-------------- 
OH 
0 WGT. 1.17647 
UNWGT. 1.17647 
1 WGT. 1.22535 
UNWGT. 1.2253S 
----- 
Variable 
------------------- 
.. AGE 
------------- 
OH 
0 WGT. 73.86471 
UNWGT. 73.86471 
1 WGT. 77.12676 
UNWGT. 77.12676. 
******na1ysisof Vari ance --design 1****** 
Tests of Significance for VFCH4M using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 39012.99 235 166.01 
REGRESSION 69881.10 4 17470.28 105.23 . 000 
OH 30.06 1 30.06 . 18 . 671 
(Model) 69951.04 5 13990.21 84.27 . 000 
(Total) 108964.03 240 454.02 
R-Squared - . 642 
Adjusted R-Squared - . 634 
----------- 
Correlations between 
----- 
Covariates 
---------------- 
and Predicted Dependent Variable 
----- 
COVARIATE 
VARIABLE VFSD BVHI BVCH4M AGE 
VFCH4M -. 903 -. 323 . 425 -. 125 
----------- 
Squared Correlations 
--------------------- 
between Covariates and Predicted Dependent 
----- 
Variable 
VARIABLE AVER. R-SQ 
VFSD . 815 
BVHI . 105 
BVCH4M . 180 
AGE . 016 
----------- 
Effect Size Measures 
----- ---------------- ----- 
Partial 
Source of Variation ETA Sqd 
Regression . 642 
OH . 001 
----------- 
Estimates for VFCH4M 
--------------------- 
adjusted for 4 covariates 
----- 
--- Individual univariate . 9500 confidence intervals 
*****Ana1ysisof Vari ance -- design I 
Estimates for VFCH4M adjusted for 4 covariates (Cont. ) 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -95% CL- Upper 
2 -. 40543118 . 95280 -. 42551 . 67085 -2.28256 1.47169 
------------------------------------- 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH4M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
VFSD -. 81231 -. 87054 . 045 -18.147 . 000 BVHI 7.19606 . 54765 . 920 7.818 . 000 BVCH4M 6.48366 . 44842 . 855 7.581 . 000 AGE -. 02749 -. 01046 . 110 -. 249 . 803 
COVARIATE Lower -95%, CL- Upper ETA Sq. 
VFSD -. 901 -. 724 . 584 
BVHI 5.383 9.009 . 206 
BVCH4M 4.799 8.169 . 196 
AGE -. 245 . 190 . 000 
------------------------------------- 
Adjusted and Estimated Means 
Variable .. VFCH4M 
CELL Obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 19.779 19.964 19.779 
. 000 . 000 2 20.961 20.775 20.961 
. 000 . 000 
------------------------------------- 
Hi-Res Chart # 61: Observed, predicted, residuals for vfch4m 
Hi-Res Chart # 62: Case number vs. std. resid. for vfch4m 
Hi-Res Chart # 63: Normal q-q plot of residuals of vfch4m 
Hi-Res Chart # 64: Detrended normal q-q plot of residuals of vfch4m 
Combined Adjusted Means for OH 
Variable .. VFCH4M 
OH 
0 UNWGT. 19.96450 
1 UNWGT. 20.77536 
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Appendix D4 
Analysis of Covariance Models : 
Determinants of Change in Visual Function at 12 Months 
Adjusting for pre-operative factors (capacity for change) 
- model I 
- model 2 
285 
VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL 1K. 
CHANGE IN VF-14 SCORE AT 12 MONTHS AND PRE-OP BETTER EYE VISUAL ACUITY 
ADJUSTING FOR PRE-OP VF-14 SCORE. 
**Ana1ysis0fVariance 
261 cases accepted. 
0 cases rejected because of out-of-range factor values. 
17 cases rejected because of missing data. 
4 non-empty cells. 
I design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH12M 
Cochrans C(64,4) = 
Bartlett-Box F(3,40807) 
. 30660, P= . 296 (approx. ) 
1.67464, P- . 170 
--------------- 
Combined Observed Means for OH 
Variable .. VFCH12M 
OH 
0 WGT. 24.17131 
UNWGT. 26.08296 
1 WGT. 20.07914 
UNWGT. 23.07568 
--------- 
Variable .. VFSD 
----- ----------------------- 
OH 
0 WGT. 69.59420 
UNWGT- 68.19316 
1 WGT. 65.53335 
UNWGT. 62.75173 
--------- 
Variable .. BVHI 
----- ----------------------- 
OH 
0 WGT. 9.90556 
UNWGT. 9.86465 
1 WGT. 9.29630 
UNWGT. 9.14430 
Variable AGE 
OH 
0 WGT. 74.07222 
UNWGT. 74.21043 
1 WGT. 77.07407 
UNWGT. 76.93888, 
--------- 
Combined observed 
----- 
Means for 
----------------------- 
E212M 
Variable .. VFCH12M 
E212M 
0 WGT. 19.36727 
UNWGT. 19.03084 
1 WGT. 31.19276 
UNWGT. 30.12780 
--------- 
Variable .. VFSD 
----- ----------------------- 
E212M 
0 WGT. 70.79410 
UNWGT. 70.04340 
1 WGT. 62.56199 
------- 
UNWGT. 
----- 
60.90150 
--- -- 
Variable .. BVHI 
-------------------- 
E212M 
0 WGT. 9.78689 
UNWGT. 9.69892 
1 WGT. 9.55128 
UNWGT. 
- 
9.31003 
--------- 
Variable .. AGE 
-- -- ----------------------- 
E212M 
0 WGT. 74.96721 
UNWGT. 75.47669 
1 WGT. 75.08974 
UNWGT. 75.67261 
******Ana1ysisof Variance -- design I****** 
Tests of Significance for VFCH12M using UNIQUE sums of squares 
Source of Variation SS DF ms F Sig of F 
WITHIN+RESIDUAL 39401.01 254 155.12 
REGRESSION 67212.71 3 22404.24 144.43 . 000 OH 1280.19 1 1280.19 8.25 . 004 E212M 834.46 1 834.46 5.38 . 021 CH BY E212M 36.26 1 36.26 . 23 . 629 
(Model) 75258.77 6 12543.13 80.86 . 000 (Total) 114659.77 260 441.00 
R-Squared . 656 
Adjusted R-Squared - . 648 
----------- 
Correlations between 
----- 
Covariates 
---- 
and Pred 
------ 
icted Depen 
------- 
dent Variable 
---- 
COVARIATE 
VARIABLE VFSD BVHI AGE 
VFCH12M -. 959 -. 374 -. 145 
------------------------------------ 
Squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
VFSD . 920 
BVEI . 140 
AGE . 021 
---------- 
Effect Size Measures 
Partial 
Source of variation ETA Sqd 
Regression . 630 
OH . 031 
E212M . 021 
OH BY E212M . 001 
------------------------------------- 
Estimates for VFCH12M adjusted for 3 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value 
2 2.87611467 1.00117 2.87277 
E212M 
Parameter Coeff. Std. Err. t-Value 
3 -2.3056840 . 99411 -2.31935 
OH BY E212M 
Parameter Coeff. Std. Err. t-Value 
4 -. 47503566 . 98255 -. 48347 
Sig. t Lower -95% CL- Upper 
. 00441 . 90447 4.84776 
Sig. t Lower -95% CL- Upper 
. 02117 -4.26343 -. 34794-- 
Sig. t Lower -95t CL- Upper 
. 62918 -2.41002 1.45995 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH12M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
VFSD -. 78576 -. 84062 . 043 -18.423 . 000 
BVHI 1.74340 . 13436 . 608 2.867 . 004 
AGE -. 10073 -. 03872 . 102 -. 983 . 327 
COVARIATE Lower -95W CL- Upper ETA Sq. 
VFSD -. 870 -. 702 . 572 
BVHI . 546 2.941 . 031 
AGE -. 303 . 101 
----- 
. 004 
- ----- 
Adjusted 
-------- 
and Estimated Means 
- ---- ------ ------- 
Variable .. VFCH12M 
CELL Obs. Mean Adj. Mean Est. Mean Raw Resid. Std. Resid. 
1 20.150 24.675 20.150 . 000 . 000 
2 32.016 30.236 32.016 . 000 . 000 
3 17.911 19.873 17.911 . 000 . 000 
4 28.240 23.534 28.240 . 000 . 000 
Hi-Res Chart # 77: 0bserved, predicted, residuals for vfchl2m 
14i-Res Chart # 78: Case number vs. std. resid. for vfchl2m 
Hi-Res Chart # 79: Normal q-q plot of residuals of vfchl2m 
Hi-Res Chart # 80: Detrended normal q-q plot of residuals of vfchl2m 
Combined Adjusted Means for OH 
Variable .. VFCH12M 
OH 
0 UNWGT. 27.45544 
1 UNWGT. 21.70321 
----------------------------------- --- 
Combined Adjusted Means for E212M 
Variable .. VFCH12M 
E212M 
0 UNWGT. 22.273G4 
1 UNWGT. 2G. 88501 
Dependent variable: VFCH 1 2M 
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VFFU-3R. SAV ANALYSIS OF COVARIANCE MODEL 2JI. 
CHANGE IN VF-14 SCORE AT 12 MONTHS AND CHANGE IN BETTER EYE VISUAL ACUITY AT 12 MONTHS 
ADJUSTING FOR PRE-OP VF-14 SCORE AND PRE-OP BETTER EYE VISUAL ACUITY. 
******na1ysis0fVariance****** 
210 cases accepted. 
0 cases rejected because of out-of-range factor values. 
68 cases rejected because of missing data. 
4 non-empty cells. 
1 design will be processed. 
------------------------------------- 
Univariate Homogeneity of Variance Tests 
Variable .. VFCH12M 
Cochrans C(52,4) = 
Bartlett-Box F(3,26456) 
. 31780, P= . 242 (approx. ) 
2.24987, P= . 081 
combined observed Means for OH 
Variable .. VFCH12M 
OH 
0 WGT. 24.52758 
UNWGT. 26.36946 
1 WGT. 18.56333 
UNWGT. 
----- 
21.37541 
--- ----- 
Variable . 
---- 
. VFSD 
-------------------- 
OH 
0 WGT. 69.33161 
UNWGT. 68.02941 
1 WGT. 68.46519 
UNWGT. 
- 
65.72503 
- ----- 
Variable 
---- 
.. BVHI 
---- --------------------- -- 
OH 
0 WGT. 9.93151 
UNWGT. 9.87776 
1 WGT. 9.43750 
UNWGT. 9.17714 
----- 
Variable .. BVCH12M 
--------- ----------------------- 
OH 
0 WGT. 1.26027 
UNWGT. 1.34736 
1 WGT. 1.20313 
- 
UNWGT. 
- --- 
1.33571 
--- ----- 
Variable 
--- 
.. AGE 
- -------------------- 
OH 
0 WGT. 74.01370 
UNWGT. 74.26783 
1 WGT. 76.73438 
UNWGT. 77.08714 
Combined observed Means for E212M 
Variable .. VFCH12M 
E212M 
0 WGT. 19.27357 
UNWGT. 18.57162 
1 WGT. 30.72602 
UNWGT. 29.17326 
Variable VFSD 
E212M 
0 WGT. 71.51616 
UNWGT. 71.29334 
1 WGT. 63.35414 
UNWGT. 62.46110 
Variable BVHI 
E212M 
0 WGT. 9.90476 
UNWGT. 9.84062 
1 WGT. 9.49206 
UNWGT. 9.21429 
---------- 
Variable .. BVCH12M 
E212M 
0 WGT. 1.08844 
UNWGT. 1.09124 
1 WGT. 1.60317 
UNWGT. 1.59184 
variable AGE 
E212M 
0 WGT. 74.50340 
UNWGT. 74.97742 
1 WGT. 75.63492 
UNWGT. 76.3775S 
******AnaIysisof Variance -- design I****** 
Tests of Significance for VFCH12M using UNIQUE sums of squares 
Source of Variation SS DF MS F Sig of F 
WITHIN+RESIDUAL 18410.48 202 91.14 
REGRESSION 70812.56 4 17703.14 194.24 . 000 OH 112.71 112.71 1.24 . 267 
E212M 465.26 1 465.26 5.10 . 025 
OH BY E212M 36.25 1 36.25 . 40 . 529 
(Model) 77575.93 7 11082.28 121.59 . 000 (Total) 95986.41 209 , 459.27 
R-Squared . 808 
Adjusted R-Squared . 802 
----------- 
Correlations between Covariates and Predicted Dependent Variable 
---------- --- ---------- ---- 
COVARIATE 
VARIABLE VFSD BVHI BVCH 12M AGE 
VFCH12M -. 892 -. 367 . 549 -. 149 
------------------------------------ 
squared Correlations between Covariates and Predicted Dependent Variable 
VARIABLE AVER. R-SQ 
VFSD . 796 
BVHI . 135 
BVCH12M . 301 
AGE . 022 
Effect Size Measures 
Partial 
Source of Variation ETA Sqd 
Regression . 794 
OH . 006 
E212M . 025 
OH BY E212M . 002 
Estimates for VFCH12M adjusted for 4 covariates 
--- Individual univariate . 9500 confidence intervals 
OH 
Parameter Coeff. Std. Err. t-Value Sig. t Lower -9SW CL- Upper 
2 . 964626701 . 86742 1.11207 . 26743 -. 74S72 2.67498 
E212M 
Parameter Coeff. Std. Err. t-Value 
3 -1.9208918 . 85019 -2.25938 
OH BY E212M 
Parameter Coeff. Std. Err. t-Value 
4 . 530854593 . 84171 . 63069 
Sig. t Lower -95%- CL- Uppef, 
-. ', '. 
. 02493 ý-3.59727 -. 24452 
Sig. t Lower -95t CL- Upper 
. S2896 -1.12881 2.19052 
Regression analysis for WITHIN+RESIDUAL error term 
--- Individual Univariate . 9500 confidence intervals 
Dependent variable .. VFCH12M 
COVARIATE B Beta Std. Err. t-Value Sig. of t 
VFSD -. 84834 -. 88131 . 037 -22.945 . 000 
BVHI 7.36801 . 53598 . 736 10.006 . 000 
BVCH12M 7.52624 . 52362 . 662 11.365 . 000 
AGE . 08162 . 03081 . 089 . 921 . 358 
COVARIATE Lower -95% CL- Upper ETA Sq. 
VFSD -* 921 -. 775 . 723 
BVHI 5.916 8.820 . 331 
BVCH12M 6.220 8.832 . 390 
AGE 
------ 
-. 093 
------- 
. 256 
------ 
. 004 
------------------ 
Adjusted and Estimated Means 
Variable .. VFCH12M 
CELL Obs. Mean Adj. Mean 
1 20.767 23.447 
2 31.972 26.227 
3 16.376 20.456 
4 26.375 25.360 
Est. Mean Raw Resid. Std. Resid. 
20.767 . 000 . 000 
31.972 . 000 . 000 
16.376 . 000 . 000 
26.375 . 000 . 000 
Hi-Res Chart # 81: 0bserved, predicted, residuals for vfchl2m 
Hi-Res Chart # 82: Case number vs. std. resid. for vfchl2m 
Hi-Res Chart # 83: Normal q-q plot of residuals of vfchl2m 
Hi-Res Chart # 84: Detrended normal q-q plot of residuals of vfchl2m 
Combined Adjusted Means for OH 
Variable .. VFCH12M 
OH 
0 UNWGT. 24.83706 
1 UNWGT. 22.90781 
------------------------------------ 
Combined Adjusted Means for E212M 
Variable .. VFCH12M 
E212M 
0 UNWGT. 21.95155 
1 UNWGT. 25.79333 
Dependent variable: VFCH 1 2M 
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Dependent variable: VFCH 1 2M 
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